concept_id	concept_synonym_name	language_concept_id
36303327	肠杆菌属 (gyrB+metB) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303329	P sup(k) Ab SerPl Donr Ql	4180186
36303329	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Donr; k; Kell Blood Group System; Ordinal; P prime; P sup(k); Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303329	P^k 抗体:存在情况或阈值:时间点:血清/血浆^供体:序数型	4182948
36303330	Albiotic; c115; Cillimicina; Cillimycin; DRUG/TOXICOLOGY; Drugs; Lincocin; Lincocine; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303330	Lincomycin Spec-mCnt	4180186
36303330	林可霉素:质量含量:时间点:XXX:定量型	4182948
36303331	Intravenous; Intravenous tube; IO; IO.TUBE; IV; IV tube; Length; NDL; Point in time; QNT; Quan; Quant; Quantitative; Random; Tub; Tube, unspecified	4180186
36303331	Needle gauge IV tube	4180186
36303331	针头口径:长度:时间点:血管内管道:定量型	4182948
36303333	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303334	T gondii DNA Ocflu Ql NAA+probe	4180186
36303334	刚地弓形虫 DNA:存在情况或阈值:时间点:眼液:序数型:探针法.基因扩增.靶向	4182948
36303334	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Occular fluid; Ocflu; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
36303335	2; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303336	Centers for Medicare and Medicaid Assessment; No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36303338	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiology; Random; Transjugular Bx; Transjugular Bx+venography	4180186
36303338	Guided Liver Transjugular Bx+venography	4180186
36303338	旨在经颈静脉活组织检查+静脉造影术的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36303342	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B holm hIS1001; B holmseii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303342	B holm hIS1001 DNA Nph Ql NAA+probe	4180186
36303342	霍氏博德特菌 hIS1001 DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36303343	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36303344	C&S; Corn/Cnjt; Corneal; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Thrush	4180186
36303344	Fungus Corn/Cnjt Cult	4180186
36303344	真菌 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:培养	4182948
36303345	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303346	BM; BON; Bone marrow; C&S; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36303346	CMV Mar Ql Cult	4180186
36303346	巨细胞病毒:存在情况或阈值:时间点:骨髓:序数型:微生物特异性培养	4182948
36303348	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303349	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303349	HCoV RNA Corn/Cnjt Ql NAA+probe	4180186
36303349	人类冠状病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303352	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
36303353	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36303353	多层:发现:时间点:胸部>胸腺:文档型:CT	4182948
36303355	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303355	HCoV RNA Lower resp Ql NAA+probe	4180186
36303355	人类冠状病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303359	Bx; Chest Pleura; Chest.pleura; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; Rad; Radiology; Random; Thorax	4180186
36303359	Guided Chest Pleura Bx	4180186
36303359	旨在经皮活组织检查的引导:发现:时间点:胸部>胸膜:文档型:{成像方式}	4182948
36303360	Breathing; Dynamic; Flow; Gases; Insp gas flow; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
36303360	Insp gas flow Airway	4180186
36303360	吸气气体流量:体积速率:时间点:呼吸系统.气道:定量型	4182948
36303361	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; UA; UCr; UR; Urn	4180186
36303361	N-nortramadol/Creat Ur Cfm	4180186
36303361	N-去甲基曲吗多/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303362	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Operative note; Point in time; Random; Surg; Visit note	4180186
36303362	Gynecology Operative note	4180186
36303362	外科手术记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303368	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36303372	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Kala azar; LAT; LCR; Leishmaniasis; Leishmaniosis; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Visceral leishmaniasis	4180186
36303372	Leishmania DNA Tiss NAA+probe	4180186
36303372	利什曼原虫属单个未知种 DNA:存在与否或特征标识:时间点:组织与涂片:名义型:探针法.基因扩增.靶向	4182948
36303373	EMS MD arrived before paramedics	4180186
36303373	Emergency Medical Service(s); EMS MD arrived before paramedics; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36303373	急救医疗服务医师交通工具在医务辅助人员之前到达:发现:时间点:^患者:序数型	4182948
36303374	Breathing; Count/time; Lung; Lungs; Non-airway press meas; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
36303374	Resp rate Non-airway press meas	4180186
36303374	呼吸:计数型速率:时间点:呼吸系统:定量型:非气道压力测定法	4182948
36303377	#/area; Cast; Kidney; Mixed Cell Casts; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36303377	Mixed Cell Casts #/area UrnS	4180186
36303377	混合细胞管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36303378	Acd; Acid fast Stn; Acids; AFB stain; BM; BON; Bone marrow; ID; Identity or presence; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; St; Stains; Stn	4180186
36303378	Acid fast Stn Mar	4180186
36303378	显微镜观察:存在与否或特征标识:时间点:骨髓:名义型:抗酸染色法	4182948
36303382	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Sx	4180186
36303383	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Occular fluid; Ocflu; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
36303383	M tb DNA Ocflu Ql NAA+probe	4180186
36303383	结核分枝杆菌 DNA:存在情况或阈值:时间点:眼液:序数型:探针法.基因扩增.靶向	4182948
36303384	Centers for Medicare and Medicaid Assessment; Disch; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36303385	3 Self-Sustaining Sequence Replication; 3SR SR; Amebic keratitis; Amebic meningoencephalitis; Amplif; Amplification; Amplified; Cont lens; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ophthalmology; Ophtho; Ophthy; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Soil amoeba; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303385	Acanthamoeba DNA Cont lens Ql NAA+probe	4180186
36303385	棘阿米巴属单个未知种 DNA:存在情况或阈值:时间点:隐形眼镜:序数型:探针法.基因扩增.靶向	4182948
36303386	Pan; PANEL.SURVEY.GNHLTH; Panl; Perf based measure pnl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303388	基孔肯亚病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36303388	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36303388	CHIKV IgG SerPl Ql IA	4180186
36303390	Emergency Medical Service(s); Nominal; Point in time; Random; Reason rescue canceled; TRAUMA; Typ	4180186
36303390	Reason rescue canceled	4180186
36303390	当时取消救援行动的原因:类型:时间点:急救医疗服务单元:名义型	4182948
36303398	COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; FR; IAA; MEIA; MNSs Blood Group System; Non-protein bound; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; PR; Prot; Prot S; Prot S Ag + Prot S Ag.free Pnl; PS; QNT; Quan; Quant; Quantitative; Random; Relative mass concentration; RLMCNC; S prime; SUDS	4180186
36303398	Prot S Ag + Prot S Ag.free Pnl PPP IA	4180186
36303398	蛋白 S 抗原与游离型蛋白 S 抗原组套:相对质量浓度:时间点:贫血小板血浆:定量型:免疫测定法	4182948
36303400	Add; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; PTA; PTA addl; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36303400	Guided Vein PTA addl	4180186
36303400	旨在额外经皮腔内血管成形术的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36303402	Arm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Hand-Bl; Hands; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; UE; UE-Bl; Up; Upper extremity; W contr IV; WC	4180186
36303402	CT Hand-Bl W contr IV	4180186
36303402	多层^采用静脉注射对比剂:发现:时间点:上肢.双侧>手:文档型:CT	4182948
36303405	光学相干断层成像检查:发现:时间点:视网膜:文档型	4182948
36303405	Document; EYE; EYE.OCT; Finding; Findings; OCT study; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
36303405	OCT study	4180186
36303408	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303408	记录:发现:时间点:{环境}:文档型:多发性创伤	4182948
36303411	Average; Avg; DIA; Diam; Diam.mean; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Vet; Veterinary	4180186
36303411	Mean diameter Feed particles	4180186
36303411	颗粒直径.平均值:长度:时间点:饲料:定量型	4182948
36303412	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P note; Hx; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303412	Gynecology Admit H&P note	4180186
36303412	入院史与体格检查记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303414	1 week; FCN; Func; Funct; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36303415	Chemistry; Cl; Cl-; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303415	Chloride Spec-mCnc	4180186
36303415	氯:质量浓度:时间点:XXX:定量型	4182948
36303419	Maraviroc SerPl-mCnc	4180186
36303419	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303419	马拉维若:质量浓度:时间点:血清/血浆:定量型	4182948
36303420	Cont flow; Dynamic; Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36303420	Cont flow Vent	4180186
36303420	持续气流:体积速率:时间点:呼吸机:定量型	4182948
36303425	Add; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Mech thromb addl; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36303425	Guided Vein Mech thromb addl	4180186
36303425	旨在额外经皮机械性血栓切除术的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36303427	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303428	Carbamate pnl; Chemistry; Misc; Miscellaneous; Other; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303428	Carbamate pnl Spec	4180186
36303428	氨基甲酸酯组套:-:时间点:XXX:-	4182948
36303431	Mi-2 beta Ab Ser Line blot-aCnc	4180186
36303431	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B; CHD2; Chromodomain-helicase-DNA-binding protein 2; Idiopathic Inflammatory Myopathies; II; Inclusion body myositis; MI2; Mi-2 beta antibody; MSAs; Myositis-specific autoantibodies; Point in time; Polymyositis; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
36303431	Mi-2 beta 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36303432	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; DNA-Topoisomerase I; ENA; ENA Scl70; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Topo I; Topoisomerase I	4180186
36303432	ENA Scl70 Ab CSF Ql Line blot	4180186
36303432	SCL-70 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303433	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303433	hMPV RNA Corn/Cnjt Ql NAA+probe	4180186
36303433	人类偏肺病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303434	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; AO; Aortic; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random; TA + AA; Thorax	4180186
36303434	Guided TA + AA PTA	4180186
36303434	旨在经皮腔内血管成形术的引导:发现:时间点:胸部>主动脉.胸腔段 & 腹部>主动脉.腹腔段:文档型:{成像方式}	4182948
36303435	Enteric coated aspirin	4180186
36303435	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36303435	阿司匹林肠溶包衣片:发现:时间点:^患者:序数型	4182948
36303437	Aerobe; Aerobe Cult; Aerobed; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Bact; C&S; Cult; Cultures; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36303437	Bacteria Amn Aerobe Cult	4180186
36303437	细菌 已鉴定的:存在与否或特征标识:时间点:羊水:名义型:需氧微生物培养	4182948
36303441	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303443	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303444	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; PUUV; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36303444	PUUV RNA Ur Ql NAA+probe	4180186
36303444	汉坦病毒 普马拉型 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36303448	100 CD3+CD8+; Blood; CD27 Cells; CD27- cells; CD27+CD62L+ cells; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; WB; Whole blood	4180186
36303448	CD27+CD62L+ cells/100 CD3+CD8+ NFr Bld	4180186
36303448	细胞.CD27+CD62L+/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型	4182948
36303451	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303454	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303455	GM3 IgG+IgM Ser Ql Line blot	4180186
36303455	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36303455	神经节苷脂 GM3 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303456	C&S; Cult; Cultures; Eye fluid; ID; Infectious Disease; InfectiousDisease; Microbiology; Occular Fluid; OcFlu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; T gondii; Toxo; Toxoplasmosis	4180186
36303456	T gondii Ocflu Ql Cult	4180186
36303456	刚地弓形虫:存在情况或阈值:时间点:眼液:序数型:微生物特异性培养	4182948
36303460	ABS; Aby; AMA-M2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Neuro; Neurology; Ordinal; Point in time; PR; Pyruvate dehydrogenase ab; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303460	Mitochondria M2 Ab CSF Ql Line blot	4180186
36303460	线粒体 M2 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303466	Dischrgd to alt caregiver susp abuse	4180186
36303466	Dischrgd to alt caregiver susp abuse; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36303466	因为怀疑虐待而在出院时交给并非住院时的照护人员的照护人员:发现:时间点:^患者:序数型	4182948
36303468	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303469	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303470	ECOG Perform Status Imp	4180186
36303470	Cancer; CLIN; ECOG; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Perform status; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36303470	日常体能状态:印象:时间点:^患者:序数型:美国东部肿瘤协作组	4182948
36303471	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lyme; Lyme disease; Microbiology; Nominal; Point in time; Random; Relapsing fever; Spec; species; spp; Tissue; Tissue, unspecified	4180186
36303471	Borrelia Tiss Cult	4180186
36303471	疏螺旋体属单个未知种 已鉴定的:存在与否或特征标识:时间点:组织与涂片:名义型:微生物特异性培养	4182948
36303475	CLIN; CLIN.RISK; Durat; Dx; Ordinal; Point in time; QL; Qual; Qualitative; Random; Risk time diag to transpl; Scale; Screen	4180186
36303475	Risk time diag to transpl	4180186
36303475	针对风险计算的诊断至移植时间长度评分:评分:时间点:^患者:序数型	4182948
36303480	Centers for Medicare and Medicaid Assessment; III; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36303481	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303481	Rhinovirus RNA Corn/Cnjt Ql NAA+probe	4180186
36303481	鼻病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303483	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36303483	Ribosomal Ab Ser Ql Line blot	4180186
36303483	核糖体 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303487	Mycobacterial Susc Pnl Islt Genotyp	4180186
36303487	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; Islt; Isol; Mycobacterial Susc Pnl; Ordinal; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Susc; Suscept; Susceptibilities; Susceptibilty	4180186
36303487	分枝杆菌药物敏感性试验组套:-:时间点:分离株:序数型:基因分型	4182948
36303488	Chemistry; Mass Content; Misc; Miscellaneous; Na; Na+; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303488	Sodium Spec-mCnt	4180186
36303488	钠:质量含量:时间点:XXX:定量型	4182948
36303492	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303494	Date retired; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303494	Date retired	4180186
36303494	退休日期:日期:时间点:^患者:定量型	4182948
36303499	Feline; Felis domesticus; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36303501	levETIRAcetam/Creat Ur Cfm	4180186
36303501	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Keppra; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36303501	左乙拉西坦/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303502	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303503	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36303503	Vent settings Doc	4180186
36303503	设置:发现:时间点:呼吸机:文档型	4182948
36303508	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
36303510	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303510	Hearing threshold 2000 Hz Ear-L	4180186
36303510	听阈^2000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36303513	DOC.ONT; Document; Emotional stability; Finding; Findings; Point in time; Random	4180186
36303513	警示:发现:时间点:{环境}:文档型:心理健康	4182948
36303517	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303518	CD25 Cells/100 CD4 cells NFr Bld	4180186
36303518	100 CD4 cells; Blood; CD25 Cells; CD4 Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Inducer T cells; L3T4; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; W3/25; WB; Whole blood	4180186
36303518	细胞.CD25/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36303519	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36303521	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36303521	Hearing threshold 4000 Hz Ear-R	4180186
36303521	听阈^4000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36303522	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303522	摘要:发现:时间点:{环境}:文档型:妇科学	4182948
36303525	BP sys--p Exc	4180186
36303525	After; Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; EXCZ; Intravenous; IV; p Exc; Point in time; Pressure; PST; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
36303525	血管内心脏收缩期^在运动之后:压力或压强:时间点:动脉系统:定量型	4182948
36303528	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med equip or prod note; notes; Point in time; Random; Visit note	4180186
36303528	Audiology Med equip or prod note	4180186
36303528	医疗设备或产品记录:发现:时间点:{环境}:文档型:听力学	4182948
36303531	Abd; Abdo; Abdomen+; Abdominal; Add; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kyphoplasty addl level; L/sp; Levels; Levl; L-spine; Lumbar; Lumbo; LV; LVL; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord	4180186
36303531	Guided L-spine Kyphoplasty addl level	4180186
36303531	旨在额外级别椎体后凸成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36303533	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303534	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; Carbapenem resistance gene; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; WB; Whole blood	4180186
36303534	blaKPC Bld Pos Ql Probe	4180186
36303534	细菌碳青霉烯类耐药 blaKPC 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303537	C&S; Corn/Cnjt; Corneal; Cult; Cultures; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Isolated; Microbiology; Nominal; Point in time; Random; Spec	4180186
36303537	FLUV Corn/Cnjt Cult	4180186
36303537	流感病毒 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36303538	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GT1b Ganlg; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Trisialoganglioside	4180186
36303538	GT1b Ganlg IgG+IgM Ser Ql Line blot	4180186
36303538	神经节苷脂 GT1b 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303540	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
36303540	Guided L-spine Myelography	4180186
36303540	旨在脊髓造影术的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36303541	ACIF; Anticomplement Immunofluorescence; Cerebral spinal fluid; Cerebrospinal Fl; Epidemic Parotitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Mumps virus antibody; Mumps virus IgG; Mumps virus IgM; MuV; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36303541	Mumps virus Ab.IgG & IgM panel CSF IF	4180186
36303541	流行性腮腺炎病毒抗体.IgG 与 IgM 组套:-:时间点:脑脊液:-:免疫荧光法	4182948
36303543	Addiction; Algaphan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Napsalgesic; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36303543	Propoxyph Sal Cfm-mCnc	4180186
36303543	丙氧氨酚:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36303544	Brain; CAT scan; Cerebral; Cerebrum; Computed tomography; Computerized tomography; Cranial; Cranium; CT scan; Document; Finding; Findings; Head; Imaging; Intracranial; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RN; RNC; Scan; Skull; W RNC IV	4180186
36303544	PET+CT Brain metabolic W RNC IV	4180186
36303544	代谢类多层^采用静脉注射放射性核素:发现:时间点:头部>脑部:文档型:PT+CT	4182948
36303545	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303545	Bacteria CSF Anaerobe Cult	4180186
36303545	细菌 已鉴定的:存在与否或特征标识:时间点:脑脊液:名义型:厌氧微生物培养	4182948
36303548	Arm; CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; Radiology; Random; UE; Up; Upper extremity joint	4180186
36303548	Guided Should Inj	4180186
36303548	旨在注射的引导:发现:时间点:上肢>肩部:文档型:{成像方式}	4182948
36303549	C14:1; C2; Chemistry; i; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Tdecenoylcarn	4180186
36303549	Tdecenoylcarn/C2 SerPl-sRto	4180186
36303549	十四烯酰肉碱 (C14:1)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
36303550	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303552	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36303554	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; WB; Whole blood	4180186
36303554	S pyogenes hsp60 Bld Pos Ql Probe	4180186
36303554	化脓性链球菌 hsp60 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303559	Cnc; Conc; Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; EXT; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303560	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E muris eauclairensis groEL; Ehrlichia muris-like groEL gene; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303560	E muris eaucl groEL Bld Ql NAA+non-prb	4180186
36303560	鼠埃立克体欧克莱尔亚种 groEL 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36303561	Dynamic; Flow; Infl trig.flow; Infl trig.flow set; Infl trigger flow; Infl trigger flow set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume rate; vRate	4180186
36303561	Infl trigger flow set Vent	4180186
36303561	充气触发流量设置:体积速率:时间点:呼吸机:定量型	4182948
36303564	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
36303564	CT Salivary gland WO contr	4180186
36303564	多层^不采用对比剂:发现:时间点:头部>唾液腺:文档型:CT	4182948
36303565	Diethyl parathion; DRUG/TOXICOLOGY; Drugs; Ethyl Parathion; Folidol; Mass content; Metafos; Misc; Miscellaneous; Other; Parathion-methyl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Thiophos; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303565	Methyl Parathion Spec-mCnt	4180186
36303565	甲基对硫磷:质量含量:时间点:XXX:定量型	4182948
36303566	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303570	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303574	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Paraneoplastic neurological syndrome; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Small Cell Lung Cancer; SR; Zic4; Zn	4180186
36303574	Zic4 Ab Ser Line blot-aCnc	4180186
36303574	小脑锌指蛋白 4 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36303575	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
36303575	SaO2 during apnea % BldA PulseOx	4180186
36303575	氧饱和度^在呼吸暂停过程中:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
36303576	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303586	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Mult; Multi; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303588	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; RSV A; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303588	RSV A RNA Lower resp Ql NAA+probe	4180186
36303588	呼吸道合胞病毒 A 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303591	Durat; Lung; Point in time; Pos; Pos press phase dur; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303591	Pos press dur on vent in pos press mode	4180186
36303591	正压阶段持续时间:时间:时间点:呼吸机:定量型	4182948
36303592	ADMIN; Nominal; Point in time; Random	4180186
36303592	电子邮件地址:电子邮件地址:时间点:^联系人:名义型	4182948
36303594	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36303596	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303600	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; Initial eval note; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36303600	OB Initial eval note	4180186
36303600	初步评价记录:发现:时间点:{环境}:文档型:产科学	4182948
36303601	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36303601	Guided Celiac plexus Nerve block	4180186
36303601	旨在神经阻滞的引导:发现:时间点:腹部>腹腔神经丛:文档型:{成像方式}	4182948
36303604	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; c162; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; VANC; Vancocin; Vancomycin resistance gene; Vancor; WB; Whole blood	4180186
36303604	vanA Bld Pos Ql Probe	4180186
36303604	细菌万古霉素耐药 vanA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303605	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36303606	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303608	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303610	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV swine; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pig; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36303610	FLUAV swine RNA Ct Spec Qn NAA+probe	4180186
36303610	流感病毒 A 型猪源性 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36303613	CARD.PROC; Cardio; Cardiology; Clock time; CPR; CPR stop time; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303613	心肺复苏停止时间:时钟时间:时间点:^患者:定量型	4182948
36303614	Asympt; Asymptomatic; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Risk assess and screen; Risk assess+scrn note; Scn; Substance abuse; Visit note	4180186
36303614	Addiction med Risk assess+scrn note	4180186
36303614	风险评估与筛查记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36303615	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303615	Gynecology Hosp Note	4180186
36303615	记录:发现:时间点:医院:文档型:妇科学	4182948
36303616	1,25(OH)2D; 1,25(OH)2D2; Chemistry; Dextro; DHVD+DHVD2+DHVD3 Pnl; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303616	DHVD+DHVD2+DHVD3 Pnl SerPl	4180186
36303616	1,25-二羟维生素 D & 1,25-二羟维生素 D2 & 1,25-二羟维生素 D3 组套:-:时间点:血清/血浆:定量型	4182948
36303618	Bayer 39007; Baygon; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303618	Propoxur Spec-mCnt	4180186
36303618	残杀威:质量含量:时间点:XXX:定量型	4182948
36303619	OB Prog note	4180186
36303619	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36303619	病程记录:发现:时间点:{环境}:文档型:产科学	4182948
36303620	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Sx	4180186
36303621	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent	4180186
36303621	C pneum DNA Nph Ql NAA+probe	4180186
36303621	肺炎嗜性衣原体 DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36303622	Ang; Angio; Angiography; Angm; Arteriogram; c; CAT scan; Chest + PA; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; for PE; Imaging; PA; PAA; PE; Point in time; Pulm; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36303622	CT Chest + CTA PA for PE W contr IV	4180186
36303622	多层^W contrast IV && Multisection for pulmonary embolus^W contrast IV:发现:时间点:胸部 && 胸部>肺动脉类:文档型:CT && CT.血管造影术	4182948
36303623	Centers for Medicare and Medicaid Assessment; Disch; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303625	AOEObservation; Finding; Findings; Nominal; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random; Spec	4180186
36303625	Preliminary testing result Spec	4180186
36303625	初步检测结果:发现:时间点:标本:名义型	4182948
36303626	Alpha amylase; Ams; Amyl; Amylase P; Amylase.pancreatic dial fld prt; Catalytic Concentration; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Diastase; k87; Kidney; Nephrology; Pancr; Pancreatc; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
36303626	Amylase P DiafP-cCnc	4180186
36303626	淀粉酶.胰:催化浓度:时间点:腹膜透析液:定量型	4182948
36303627	Date spec was sent to PH lab	4180186
36303627	Date spec was sent to PH lab; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36303627	标本发往公共卫生实验室的日期:日期:时间点:^标本:定量型	4182948
36303628	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typ	4180186
36303628	HIV 1 subtype CSF NAA+probe	4180186
36303628	HIV 1 型亚型:类型:时间点:脑脊液:名义型:探针法.基因扩增.靶向	4182948
36303630	fusion protein; high-throughput sequencing; HPIV; HPIV1; HPIV1 F gene; HTS; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; Pork; PPIV1; PPIV1 F; Random; Swine; Vet; Veterinary	4180186
36303630	PPIV1 F Islt-Seq	4180186
36303630	猪副流感病毒 1 F 基因:序列:时间点:分离株:名义型:序列测定	4182948
36303636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303636	HCoV OC43 RNA Corn/Cnjt Ql NAA+probe	4180186
36303636	人类冠状病毒 OC43 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303637	Insp pause time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303637	Insp pause time Vent	4180186
36303637	吸气停顿时间:时间:时间点:呼吸机:定量型	4182948
36303640	Treatment or behavior affect by chal	4180186
36303640	Barriers; CLIN; Finding; Findings; Nominal; Point in time; Random; Treatment or behavior affect by chal; Tx	4180186
36303640	挑战所影响的治疗或健康行为:发现:时间点:^患者:名义型	4182948
36303643	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303644	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Walking PA.leisure-time; Walking phys activity	4180186
36303645	C0; C5; Carnitine Free; Carnitine.total; Chemistry; FC; FR; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36303645	Isovaleryl+MeButyrylcarn/C0 SerPl-sRto	4180186
36303645	异戊酰肉碱+甲基丁酰肉碱 (C5)/肉碱.游离型 (C0):物质的量比率:时间点:血清/血浆:定量型	4182948
36303648	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydrocodone metabolite; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36303648	Norhydrocodone Ur Ql Scn	4180186
36303648	去甲基氢可酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36303649	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Started; Survey; Ulcer	4180186
36303651	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36303651	Nucleosome Ab Ser Ql Line blot	4180186
36303651	核小体 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303652	CPR; CPR note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303652	心肺复苏记录:发现:时间点:{环境}:文档型:{角色}	4182948
36303653	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basem; Basemt; BM; GBM; Glom; Goodpastures; Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Serology; Serum; SR	4180186
36303653	GBM Ab Ser Ql Line blot	4180186
36303653	肾小球基底膜 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303654	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303654	EV RNA Aspirate Ql NAA+probe	4180186
36303654	肠道病毒 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36303655	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid-L+Uret; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Pelvic; Point in time; Pyelogram; Pyelography; Rad; RADIOLOGY; Random; Renal; Retro; View; VWS; W contr Retro; W contr retro IU; WC	4180186
36303655	RF Kid-L+Uret Views W contr retro IU	4180186
36303655	多重视图^采用输尿管内逆行性对比剂:发现:时间点:腹部>肾脏.左侧 & 腹部+盆腔>输尿管:文档型:放射荧光透视法	4182948
36303657	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303657	MERS-CoV RNA Nph Ql NAA+probe	4180186
36303657	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36303658	Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ	4180186
36303658	Airway suction device Type	4180186
36303658	气道内吸引装置:类型:时间点:{装置}:名义型	4182948
36303659	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; Chemo; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Hep a; Hepar; Imaging; Liver; Liver artery; Point in time; Rad; Radiology; Random; Tum chemoemb; W chemo+emb ag IA; W emb ag IA	4180186
36303659	Guided HA Tum CE -w chem+emb ag IA	4180186
36303659	旨在化学栓塞术的引导^采用动脉注射化学治疗+采用动脉注射栓塞剂:发现:时间点:腹部>肝动脉:文档型:{成像方式}	4182948
36303662	Anticoagulant med used	4180186
36303662	Anticoag; Anticoagulant med used; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36303662	所采用的抗凝药物的类型:类型:时间点:^患者:名义型	4182948
36303663	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36303664	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; Eye; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ocular pathogens pnl; Ophthalmology; Ophtho; Ophthy; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303664	Ocular pathogens pnl Corn/Cnjt NAA+probe	4180186
36303664	眼科病原体类组套:-:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303668	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36303670	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303671	Kansas City Cardiomyopathy Questionnaire; Kansas City Cardiomyopathy Questionnaire - 12 item; KCCQ; Overall KCCQ; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36303672	20M p fruct PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
36303672	Breath H2 20M p fruct PO	4180186
36303672	氢/已呼出的气体^在口服剂量果糖之后20分钟:体积分数:时间点:呼出的气体:定量型	4182948
36303673	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303675	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
36303675	CT Teeth.max WO contr	4180186
36303675	多层^不采用对比剂:发现:时间点:头部>牙齿.上颔骨:文档型:CT	4182948
36303677	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303682	Arm; Cath; CorePlaybook; CVC place; CVC w port place; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; UE; Up	4180186
36303682	Guided UE CVC w port place	4180186
36303682	旨在置入带有输液港的中心静脉导管的引导:发现:时间点:上肢:文档型:{成像方式}	4182948
36303683	Acd; Acid fast Stn; Acids; AFB stain; Eye fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Occular fluid; Ocflu; Point in time; Random; St; Stains; Stn	4180186
36303683	Acid fast Stn Ocflu	4180186
36303683	显微镜观察:存在与否或特征标识:时间点:眼液:名义型:抗酸染色法	4182948
36303688	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303689	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Tylosin tartrate; Unspecified; Vet; Veterinary	4180186
36303689	Tylosin Spec-mCnt	4180186
36303689	泰乐菌素:质量含量:时间点:XXX:定量型	4182948
36303690	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303691	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Perc; Playbook; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Thorax	4180186
36303691	Guided Lung Bx	4180186
36303691	旨在经皮活组织检查的引导:发现:时间点:胸部>肺:文档型:{成像方式}	4182948
36303692	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303694	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303694	无烟烟草戒除日期:日期:时间点:^患者:定量型	4182948
36303696	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD27+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; Total memory B cells; WB; Whole blood	4180186
36303696	CD19+CD27+ cells # Bld	4180186
36303696	细胞.CD19+CD27+:计数型浓度:时间点:全血:定量型	4182948
36303697	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303700	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
36303700	CT Mediastinum W contr IV	4180186
36303700	多层^采用静脉注射对比剂:发现:时间点:胸部>纵隔:文档型:CT	4182948
36303701	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303704	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E faecium; E faecium hsp60; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36303704	E faecium hsp60 Bld Pos Ql Probe	4180186
36303704	屎肠球菌 hsp60 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303705	High press hold time; High press hold time set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303705	High press hold time set Vent	4180186
36303705	高压保持时间设置:时间:时间点:呼吸机:定量型	4182948
36303706	Polytrauma Educ note	4180186
36303706	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303706	教育记录:发现:时间点:{环境}:文档型:多发性创伤	4182948
36303707	Ident; Identifier; Nominal; Point in time; PRO measure name; Random; Survey; SURVEY.GNHLTH	4180186
36303708	Ang; Angio; Angiography; Angm; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; Thorax; Vesl; Vessels.XXX	4180186
36303708	CTA Chest ves	4180186
36303708	多层:发现:时间点:胸部>胸部血管类:文档型:CT.血管造影术	4182948
36303711	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303712	DRUG/TOXICOLOGY; Drugs; Mass content; Mexicarbate; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Zactran; Zectane; Zectran; Zextran	4180186
36303712	Mexacarbate Spec-mCnt	4180186
36303712	兹克威:质量含量:时间点:XXX:定量型	4182948
36303713	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303714	Conn tiss; Connective tiss Ab Pnl; Connective tissue Ab; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
36303714	Connective tiss Ab Pnl Ser	4180186
36303714	结缔组织自身免疫抗体组套:-:时间点:血清:-	4182948
36303715	Absc drain cath exch; Cath; Change; CorePlaybook; Document; Drain; Exudate; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid; Replace; Spec; To be specified in another part of the message; Unspecified	4180186
36303715	Guided Unsp region Absc drain cath exch	4180186
36303715	旨在更换脓肿引流管的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36303716	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Staph; WB; Whole blood	4180186
36303716	S lugdunensis sodA Bld Pos Ql Probe	4180186
36303716	路邓葡萄球菌 sodA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303717	DOCUMENT.REF; FDA insert; Narrative; REMS applic requirements; Report; SPL; Structured Product Labelling	4180186
36303717	FDA insert REMS applic requirements	4180186
36303717	REMS 申请者要求:-:-:^FDA 包装说明书:叙述型	4182948
36303718	Gie Stn; GMS; Identity or presence; Lung; Microbiology; Nominal; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn; thoracentesis fluid	4180186
36303718	Gie Stn Plr	4180186
36303718	显微镜观察:存在与否或特征标识:时间点:胸膜液:名义型:姬姆萨染色法	4182948
36303719	2nd; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Finger.2nd-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; UE; UE-L; Up; without contrast	4180186
36303719	CT Finger.2nd-L WO contr	4180186
36303719	多层^不采用对比剂:发现:时间点:上肢.左侧>手指.第二:文档型:CT	4182948
36303720	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax	4180186
36303720	Guided Chest Thoracentesis	4180186
36303720	旨在胸腔穿刺术的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303722	Certolizumab SerPl IA-mCnc	4180186
36303722	Cimzia®; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36303722	塞妥珠单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36303725	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA Jo1; Histidyl-tRNA synthease; i; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303725	ENA Jo1 Ab CSF Ql Line blot	4180186
36303725	Jo-1 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303726	CD25+CD45RO+CD127L+/100 CD4 NFr Bld	4180186
36303726	100 CD4 cells; Blood; CD25 Cells; CD25+CD45RO+CD127L+ cells; CD4 Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Inducer T cells; L3T4; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; UCHL-1; W3/25; WB; Whole blood	4180186
36303726	细胞.CD25+CD45RO+CD127Low+/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36303728	CAT scan; Clavicle-L; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; L; LT; Point in time; Rad; RADIOLOGY; Random; Thorax; Upper extremity	4180186
36303728	CT Clavicle-L	4180186
36303728	多层:发现:时间点:胸部>锁骨.左侧:文档型:CT	4182948
36303731	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S prolificans; S prolificans DNA; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303731	S prolificans DNA Tiss Ql NAA+probe	4180186
36303731	多育赛多孢 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36303734	ZIKV IgM Titr Ser IF	4180186
36303734	寨卡病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36303734	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; ZIKV	4180186
36303735	阿夫塞疏螺旋体+伯氏疏螺旋体+加里疏螺旋体抗体.IgG 与 IgM 组套:-:时间点:血清:-:线点印迹法	4182948
36303735	B afz+burg+gari; B afz+burg+gari IgG+IgM Pnl; B afzelii; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36303735	B afz+burg+gari IgG+IgM Pnl Ser Ln blot	4180186
36303738	AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303738	Aluminum Spec-mCnt	4180186
36303738	铝:质量含量:时间点:XXX:定量型	4182948
36303739	Gynecology D/C sum	4180186
36303739	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303739	出院摘要记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303740	Alfa; Alpha BHC; Alpha hexachlorocyclohexane; Alpha-HCH; Cyclohexatriene; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303740	Alpha BHC Spec-mCnt	4180186
36303740	Alpha 六氯化苯:质量含量:时间点:XXX:定量型	4182948
36303744	CLIN; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Karnofsky Index; Karnofsky Performance Scale; Ordinal; Perform status; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36303744	KPS Imp	4180186
36303744	日常体能状态:印象:时间点:^患者:序数型:卡诺夫斯基法	4182948
36303746	BM; BON; Bone marrow; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; St; Stains; Stn	4180186
36303746	Gie Stn Mar	4180186
36303746	显微镜观察:存在与否或特征标识:时间点:骨髓:名义型:姬姆萨染色法	4182948
36303747	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Breakbone fever; Dengue fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303747	DENV1+2+3+4 RNA Bld Ql NAA+probe	4180186
36303747	登革热病毒 1+2+3+4 型 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36303750	Amcil; Amicil; Amp; Ampicilloyl; c203; c5; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Omnipen; Other; Penbritin; Point in time; Polycillin; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303750	Ampicillin Spec-mCnt	4180186
36303750	氨苄青霉素:质量含量:时间点:XXX:定量型	4182948
36303751	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36303751	趋势:类型:时间点:^患者:名义型	4182948
36303752	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Mass Content; Misc; Miscellaneous; Nicoderm; Nictoine; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303752	Nicotine Spec-mCnt	4180186
36303752	烟碱:质量含量:时间点:XXX:定量型	4182948
36303755	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Med mgmt note; notes; Point in time; Random; Visit note	4180186
36303755	Hosp Med mgmt note	4180186
36303755	药物管理记录:发现:时间点:医院:文档型:{角色}	4182948
36303757	Sympathomimetics SerPlBld Ql Cfm	4180186
36303757	Amphetamine; Benzedrine; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ephedrine; GCMS; Mescaline; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36303757	拟交感神经作用药:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学确认试验	4182948
36303760	Acd; Acid fast Stn; Acids; AFB stain; Lung; Microbiology; Ordinal; Pleural; Pleural fluid; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; St; Stains; Stn; thoracentesis fluid	4180186
36303760	Acid fast Stn Plr Ql	4180186
36303760	显微镜观察:存在情况或阈值:时间点:胸膜液:序数型:抗酸染色法	4182948
36303762	Centers for Medicare and Medicaid Assessment; Disch; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303763	DRUG/TOXICOLOGY; Drugs; Estorra; Level; Lunesta; Lunivia; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Zopiclone	4180186
36303763	Eszopiclone Ur-mCnc	4180186
36303763	右佐匹克隆:质量浓度:时间点:尿液:定量型	4182948
36303766	NTDS 2018 set	4180186
36303766	NTDS 2018 set; Pan; Panel; PANEL.TRAUMA; Panl; Pnl; Point in time; Random	4180186
36303766	美国国家创伤数据标准 - 2018年版集合:-:时间点:{环境}:-	4182948
36303767	P sup(k) Ab SerPl Ql	4180186
36303767	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; k; Kell Blood Group System; Ordinal; P prime; P sup(k); Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303767	P^k 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
36303768	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Zanaflex	4180186
36303768	tiZANidine/Creat Ur Cfm	4180186
36303768	替扎尼定/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303773	Thymus IgG Titr SerPl IF	4180186
36303773	胸腺 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
36303773	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36303774	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC fedF gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303774	EC fedF gene Islt Ql NAA+probe	4180186
36303774	大肠埃希菌 fedF 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303775	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microsporidiosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303775	Microsporid DNA Tiss Ql NAA+probe	4180186
36303775	微孢子虫 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36303777	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Polytrauma nurse; Random; Visit note	4180186
36303777	记录:发现:时间点:{环境}:文档型:多发性创伤.护士	4182948
36303778	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303780	Heart rate W pain	4180186
36303780	Count/time; Heart beat; HRTRATE.PSTN.MOLEC; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303780	心率^伴疼痛:计数型速率:时间点:XXX:定量型	4182948
36303781	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303782	Centers for Medicare and Medicaid Assessment; Finding; Findings; Integument; Nominal; Point in time; Random; Survey	4180186
36303783	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LCMV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36303783	LCMV IgG Ser Ql IA	4180186
36303783	淋巴细胞性脉络丛脑膜炎病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36303785	Add; Calf; CorePlaybook; Document; EXT; Fibula; Finding; Findings; Guid; Guide; Guided; Imaging; LE; Leg; Low; Lower extremity; Playbook; Point in time; Rad; RADIOLOGY; Random; Stent place addl; Tibia; Vesl	4180186
36303785	Guided Lower leg ves Stent place addl	4180186
36303785	旨在额外置入支架的引导:发现:时间点:下肢>小腿血管:文档型:{成像方式}	4182948
36303788	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303796	Arterial Stenosis; Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36303799	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303803	Tobacco use	4180186
36303803	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303803	烟草使用持续时间:时间:时间点:^患者:定量型	4182948
36303804	IgM cells/100 CD19 cells NFr Bld	4180186
36303804	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; IgM cells; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36303804	细胞.IgM/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36303806	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303806	Narasin Spec-mCnt	4180186
36303806	甲基盐霉素:质量含量:时间点:XXX:定量型	4182948
36303807	Ab Ao; Abd; Abd Aorta; Abd+Pel + AA; Abd+Pelvis; Abdo; Abdomen; Abdominal; Ang; Angio; Angiography; Angm; AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; Radiology; Random; W contr IV; WC	4180186
36303807	CT Abd+Pel + CTA AA W contr IV	4180186
36303807	多层^采用静脉注射对比剂:发现:时间点:腹部+盆腔 && 腹部>主动脉.腹腔段:文档型:CT && CT.血管造影术	4182948
36303809	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli heat labile gene; eltA gene; eltB gene; ETEC; ETEC heat-lab tox; ETEC heat-lab tox DNA; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303809	ETEC heat-lab tox DNA Islt Ql NAA+probe	4180186
36303809	大肠埃希菌肠产毒素型不耐热性毒素 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303810	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303811	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303812	Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Lat; Left; Levo; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Recumbant; SBP; Sys BP	4180186
36303812	BP sys--lying in L-lateral position	4180186
36303812	血管内心脏收缩期^左侧卧位:压力或压强:时间点:动脉系统:定量型	4182948
36303815	2; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303819	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36303821	E+M Radiation exposure note	4180186
36303821	Assessment; DOC.ONT; Document; E+M Radiation exposure; E+M Radiation exposure note; Encounter; Eval; Evaluation and management; Evaluation and management note; Exp; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36303821	辐射暴露评价与管理记录:发现:时间点:{环境}:文档型:{角色}	4182948
36303824	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303824	MERS-CoV RNA Nph Ql NAA+non-probe	4180186
36303824	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向	4182948
36303825	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E. coli attaching-effacing gene; EC eaeA gene; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303825	EC eaeA gene Stl Ql NAA+probe	4180186
36303825	大肠埃希菌 eaeA 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36303826	Centers for Medicare and Medicaid Assessment; LTPAC; MDS; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303827	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303827	Gossypol Spec-mCnt	4180186
36303827	棉酚:质量含量:时间点:XXX:定量型	4182948
36303830	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Study report; Visit note	4180186
36303830	Gynecology Diag study note	4180186
36303830	诊断性检查记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303831	Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Nominal; Point in time; Random; Rheum; Rheumatology; SF; SNV; St; Stains; Stn; Syn; Syn fl; Synov; Synovial fluid	4180186
36303831	Gie Stn Snv	4180186
36303831	显微镜观察:存在与否或特征标识:时间点:滑液:名义型:姬姆萨染色法	4182948
36303833	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Cardio; Cardiology; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; Heart Disease; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Pcar; PCR; Pericardial fluid; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303833	FLUAV RNA Pcar Ql NAA+probe	4180186
36303833	流感病毒 A 型 RNA:存在情况或阈值:时间点:心包液:序数型:探针法.基因扩增.靶向	4182948
36303835	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B malayi; Bancroftian filariasis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Human lymphatic filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; W bancr; W bancr+B malayi; W bancrofti; Wucheria bancrofti	4180186
36303835	W bancr+B malayi IgG4 Ser Ql IA	4180186
36303835	班氏吴策线虫+马来布鲁线虫 抗体.IgG4:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36303836	Bowel movement; Chemistry; Elect; Electr; Electrolyte; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Lytes; Osmo; Osmol; osmolarity; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
36303836	Electrolytes & Osmolality panel Stl	4180186
36303836	电解质与渗透压组套:-:时间点:大便:定量型	4182948
36303838	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303843	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36303843	脑卒中之后所过去的时间:发现:时间点:^患者:序数型	4182948
36303844	Emergency Medical Service(s); EMS; NEMSIS; Nominal; Point in time; Random; TRAUMA; Typ	4180186
36303844	现场的单元:类型:时间点:急救医疗服务系统:名义型	4182948
36303845	BM; BON; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303845	Guided Bone mar Bx	4180186
36303845	旨在经皮活组织检查的引导:发现:时间点:XXX>骨髓:文档型:{成像方式}	4182948
36303846	Cert first responder on site pre EMS; Emergency Medical Service(s); Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36303846	Cert first responder on site pre EMS	4180186
36303846	急救医疗服务单元到达时已在现场的持证第一反应人员:发现:时间点:^患者:序数型	4182948
36303851	FCN; Finding; Findings; Func; Funct; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303852	Before; Blood; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; QNT; Quan; Quant; Quantitative; WB; Whole blood	4180186
36303852	Deprecated Glucose pre-meal Bld-mCnc	4180186
36303857	Perampanel SerPl-mCnc	4180186
36303857	Anticonvulsant; Antiseizure; DRUG/TOXICOLOGY; Drugs; Fycompa; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303857	吡仑帕奈:质量浓度:时间点:血清/血浆:定量型	4182948
36303859	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303861	ADCC; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303861	Comm hlth care ADCC Note	4180186
36303861	记录:发现:时间点:成人日间照护中心:文档型:社区医疗保健服务	4182948
36303866	Cekuthoate; Chimigor 40; Cygon; Cygon 400; Daphene; De-Fend; Demos NF; Devigon; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303866	Dimethoate Spec-mCnt	4180186
36303866	乐果:质量含量:时间点:XXX:定量型	4182948
36303867	Date and time; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
36303867	初次就医时间:时间戳:时间点:^患者:定量型	4182948
36303869	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303870	Art; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Tum embol; Unspecified; W emb ag IA	4180186
36303870	Guided Spinal a Tum embol--W emb ag IA	4180186
36303870	旨在栓塞术的引导^采用动脉注射栓塞剂:发现:时间点:XXX>脊髓动脉:文档型:{成像方式}	4182948
36303874	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303874	Selenium Spec-mCnt	4180186
36303874	硒:质量含量:时间点:XXX:定量型	4182948
36303875	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303877	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303877	Norquetiapine SerPl Cfm-mCnc	4180186
36303877	去甲基喹硫平:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36303879	Arterial Stenosis; Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303880	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
36303880	T cruzi IgM Ser Ql IA	4180186
36303880	克氏锥虫 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36303883	Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36303883	Amikacin Islt Genotyp	4180186
36303883	丁胺卡那霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36303884	Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV1; DENV1+2+3+4; DENV1-4 + Zika; DENV1-4 + Zika IgA+IgG+IgM Pnl; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; i; IAA; ID; II; III; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; SUDS; To be specified in another part of the message; Unspecified; ZIKV	4180186
36303884	DENV1-4 + Zika IgA+IgG+IgM Pnl Spec IA	4180186
36303884	登革热病毒 1+2+3+4 型与寨卡病毒抗体.IgA+IgG+IgM 组套:-:时间点:XXX:-:免疫测定法	4182948
36303886	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303888	Art; Cardio; Cardiology; Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; Thromb infus D1; Thrombolysis; To be specified in another part of the message; Unspecified; W thromb via cath	4180186
36303888	Guided Art Throm inf D1 W throm in cath	4180186
36303888	旨在最初输注一天溶栓剂的引导^采用经导管给予的溶栓剂:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36303889	AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36303889	CT TA WO+W contr IV	4180186
36303889	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>主动脉.胸腔段:文档型:CT	4182948
36303893	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Throat; TMA; Transcription mediated amplification; Upper respiratory	4180186
36303893	N gonorrhoea DNA Throat Ql NAA+probe	4180186
36303893	淋病奈瑟菌 DNA:存在情况或阈值:时间点:咽喉:序数型:探针法.基因扩增.靶向	4182948
36303899	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random	4180186
36303899	多层:发现:时间点:盆腔>盆骨类:文档型:CT	4182948
36303902	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
36303902	CT L-spine by reconstr	4180186
36303902	基于重建的多层:发现:时间点:腹部>脊椎.腰段:文档型:CT	4182948
36303906	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Tot; Total PA.leisure-time; Totl	4180186
36303907	AOEObservation; Ordinal; Point in time; PR; Prelim test affect further test; Public Health; Public Health Documents; PUBLICHEALTH; Ql; Qual; Qualitative; Random; Screen; Spec	4180186
36303907	Prelim test affect further test Spec	4180186
36303907	初步检测当时影响了旨在进一步检测的提交:存在情况或阈值:时间点:标本:序数型	4182948
36303910	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303914	Bronchial alveolar lavage; Bronchoalveolar lavage; C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Thrush	4180186
36303914	Fungus BAL Cult	4180186
36303914	真菌 已鉴定的:存在与否或特征标识:时间点:支气管肺泡灌洗液:名义型:培养	4182948
36303917	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC FimF41a gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303917	EC FimF41a gene Islt Ql NAA+probe	4180186
36303917	大肠埃希菌 FimF41a 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303919	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36303921	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303923	Important functional area	4180186
36303923	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
36303923	最重要的功能方面:发现:时间点:^患者:名义型	4182948
36303924	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303928	DRUG/TOXICOLOGY; Drugs; Ergomar; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303928	Ergotamine Spec-mCnt	4180186
36303928	麦角胺:质量含量:时间点:XXX:定量型	4182948
36303931	Nominal; Point in time; Random; Typ	4180186
36303931	除颤器类型:类型:时间点:{装置}:名义型	4182948
36303932	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303934	Centers for Disease Control and Prevention; Ethnic; Ethnicity; Ethnicity detal; National tabulated ethnicity; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
36303936	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303936	会诊记录:发现:时间点:{环境}:文档型:多发性创伤	4182948
36303938	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Jaw; Mand; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
36303938	CT Teeth.mand WO contr	4180186
36303938	多层^不采用对比剂:发现:时间点:头部>牙齿.下颔骨:文档型:CT	4182948
36303940	Hgb Free Fld-mCnc	4180186
36303940	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; FR; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Free; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303940	血红蛋白.游离型:质量浓度:时间点:体液:定量型	4182948
36303941	Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303948	Age range < 1Mo old	4180186
36303948	Age range &lt; 1Mo old; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Rnge	4180186
36303948	婴幼儿年龄范围小于1个月:发现:时间点:^患者:名义型	4182948
36303950	APTA; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36303950	Functional training perf	4180186
36303950	所进行的功能训练:存在与否或特征标识:时间点:^患者:名义型	4182948
36303952	Centers for Medicare and Medicaid Assessment; Correctn; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303953	Circo virus; ID; II; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; PCV; PCV2; PCV2 RFLP patt; Point in time; Pork; Random; Restriction fragment length polymorphism; Restriction fragment length polymorphysm; Swine; Typ; Vet; Veterinary	4180186
36303953	PCV2 RFLP patt Islt RFLP	4180186
36303953	猪圆环病毒 2 型 RFLP 模式:类型:时间点:分离株:名义型:限制性片段长度多态性类实验室方法	4182948
36303954	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ENA; ENA SM; ENA SM-B; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SmB; SR	4180186
36303954	ENA SM-B Ab Ser Ql Line blot	4180186
36303954	Smith 可提取性核 B 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303956	C&S; Cult; Cultures; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec	4180186
36303956	FLUV Lower resp Cult	4180186
36303956	流感病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
36303957	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tulathromycine; Vet; Veterinary	4180186
36303957	TUL Susc Islt	4180186
36303957	托拉菌素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36303959	Anaprox; c228; c283; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36303959	Naproxen/Creat Ur Cfm	4180186
36303959	甲氧萘丙酸/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303961	Eastern Cooperative Oncology Group; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303963	Ang; Angio; Angiography; Angm; Arteriogram; c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Hrt; Hrt+CA; Imaging; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36303963	CTA Hrt+CA WO+W contr IV	4180186
36303963	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>心脏+冠状动脉类:文档型:CT.血管造影术	4182948
36303964	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303965	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303967	Iron Satn goal MFr SerPl	4180186
36303967	CLIN; Fe; FE/TIBC; Iron Satn; Iron Satn goal; Iron/Iron binding capacity.total; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transferrin saturation	4180186
36303967	铁饱和度目标:质量分数:时间点:血清/血浆:定量型	4182948
36303971	After; Finding; Findings; Hospitalization hx; Ordinal; Point in time; post ADAPTABLE; PST; QL; Qual; Qualitative; Random; Screen; Study report; Survey; SURVEY.GNHLTH	4180186
36303973	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; Initial eval note; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303973	Gynecology Initial eval note	4180186
36303973	初步评价记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303974	Addiction; Adormix; Ambien; Ambien CR; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; GCMS; Hypnogen; Illicit; Ivedal; Level; Lioran; Mass concentration; Myslee; Nasen; Nytamel; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; Zoldem; Zolpihexal; Zolpimist	4180186
36303974	Zolpidem Sal Cfm-mCnc	4180186
36303974	唑吡坦:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36303980	Antigen; Antigens; BLOOD BANK; Donr; Erythrocytes; k; KEL1; Kell Blood Group System; Ordinal; P prime; P sup(k); Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36303980	P sup(k) Ag RBC Donr Ql	4180186
36303980	P^k 抗原:存在情况或阈值:时间点:红细胞^供体:序数型	4182948
36303989	Activ; Actvty; Arbitrary rate; Movements; QNT; Quan; Quant; Quantitative; Survey; Tot; Total PA.active transport; Totl	4180186
36303990	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303990	NIV Spec-mCnt	4180186
36303990	雪腐镰刀菌醇:质量含量:时间点:XXX:定量型	4182948
36303992	Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-L; Finding; Findings; Imaging; L; LE; LE ves; LE ves-L; Leg; LE-L; LLE; Low; lower extremity vessels.left; LT; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC	4180186
36303992	CTA LE ves-L W contr IV	4180186
36303992	多层^采用静脉注射对比剂:发现:时间点:下肢.左侧>下肢血管类:文档型:CT.血管造影术	4182948
36303993	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Kidney; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random	4180186
36303993	Guided Renal a PTA	4180186
36303993	旨在经皮腔内血管成形术的引导:发现:时间点:腹部>肾动脉:文档型:{成像方式}	4182948
36303994	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Playbook; Point in time; Rad; Radiology; Random; Stent place	4180186
36303994	Guided Visceral a Stent place	4180186
36303994	旨在置入支架的引导:发现:时间点:腹部>内脏动脉:文档型:{成像方式}	4182948
36303996	Arbitrary concentration; Chemistry; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Insulin intact; Lente; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serum; Sliding; SR; Ultralente	4180186
36303996	Insulin intact Ser LC/MS/MS-aCnc	4180186
36303996	胰岛素.完整型:任意型浓度:时间点:血清:定量型:LC/MS/MS	4182948
36303997	Activity; Arterial Stenosis; Count/time; Dextro; Exercise; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304002	Hunger Vital Sign; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
36304003	Finding; Findings; Nominal; Point in time; Random; TRAUMA	4180186
36304003	救援相关因素:发现:时间点:^患者:名义型	4182948
36304005	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Foot-Bl; Ft; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
36304005	CT Foot-Bl W contr IV	4180186
36304005	多层^采用静脉注射对比剂:发现:时间点:下肢.双侧>足部:文档型:CT	4182948
36304015	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
36304017	AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
36304017	CT TA WO contr	4180186
36304017	多层^不采用对比剂:发现:时间点:胸部>主动脉.胸腔段:文档型:CT	4182948
36304019	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC oppA gene; ID; Infectious Disease; InfectiousDisease; Microbiology; o002; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36304019	EC oppA gene Bld Pos Ql Probe	4180186
36304019	大肠埃希菌 oppA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304021	Aerobe; Aerobe Cult; Aerobed; Bact; Blood - (umbilical) cord; C&S; Cord (umbilical) blood; Cord bld; Cord blood; Cult; Cultures; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36304021	Bacteria BldCo Aerobe Cult	4180186
36304021	细菌 已鉴定的:存在与否或特征标识:时间点:脐带全血:名义型:需氧微生物培养	4182948
36304022	Ordinal; Perf based measure score; Point in time; QL; Qual; Qualitative; Random; Scale; Screen; Survey; SURVEY.GNHLTH	4180186
36304024	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304027	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
36304029	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Jnt; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Spinal; Spinal Cord; Spine FJ; To be specified in another part of the message; Unspecified; Zygapophysial Joint	4180186
36304029	Guided Spine FJ Inj	4180186
36304029	旨在注射的引导:发现:时间点:XXX>脊椎小面关节:文档型:{成像方式}	4182948
36304033	Centers for Medicare and Medicaid Assessment; Othr; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36304037	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Stafac; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304037	Virginiamycin Spec-mCnt	4180186
36304037	维及尼霉素:质量含量:时间点:XXX:定量型	4182948
36304038	Ang; Angio; Angiography; Angm; Arm; Arm and hand vessels; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-Bl; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; UE; UE ves; UE ves-Bl; UE-Bl; Up; Vesl; Vessels.XXX; W contr IV; WC	4180186
36304038	CTA UE ves-Bl W contr IV	4180186
36304038	多层^采用静脉注射对比剂:发现:时间点:上肢.双侧>上肢血管类:文档型:CT.血管造影术	4182948
36304039	Abd; Abdo; Abdomen+; Abdominal; Cath; CorePlaybook; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; PC drainage; PC drn+cath place; Perc; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid	4180186
36304039	Guided Abd PC drn+cath place	4180186
36304039	旨在经皮引流+引流导管置入的引导:发现:时间点:腹部:文档型:{成像方式}	4182948
36304041	Finding; Findings; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; SDOH	4180186
36304044	Isotopic TER/1.73 sq M SerBld-ArVRat	4180186
36304044	Blood; BSA; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; SerBld; Serum; Serum or whole blood; Square Meter; SR; TER; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36304044	肾小管提取率/1.73 平方米:单位面积体积速率:时间点:血清/全血:定量型:同位素法	4182948
36304045	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV1; DENV1+2+3+4; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; i; IAA; ID; II; III; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36304045	DENV1+2+3+4 IgA+IgG+IgM Spec IA-Imp	4180186
36304045	登革热病毒 1+2+3+4 型 抗体.IgA+IgG+IgM:印象:时间点:XXX:序数型:免疫测定法	4182948
36304047	3 Self-Sustaining Sequence Replication; 3SR SR; Alpha-herpesvirus; Amplif; Amplification; Amplified; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PHV1; Point in time; Polymerase chain reaction; Porcine herpes virus 1; Probe amp; Probe with ampification; Probe with target amplification; PRV; PRV DNA; Pseudorabies; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SHV-1; Spec; Strand Displacement Amplification; Suid herpesvirus-1; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304047	PRV DNA Ct Spec Qn NAA+probe	4180186
36304047	伪狂犬病病毒 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304048	Cath; Chest Pleura; Chest.pleura; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Remove; Thorax; Tunneled Pl rem	4180186
36304048	Guided Chest Pleura Tunneled Pl rem	4180186
36304048	旨在去除隧道式导管的引导:发现:时间点:胸部>胸膜:文档型:{成像方式}	4182948
36304050	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304050	M genitalium DNA Cvx Ql NAA+probe	4180186
36304050	生殖支原体 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36304051	ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; Genotype; Genotypic; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; Myambutol; Mycobutol; Olbutam; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36304051	Ethambutol Islt Genotyp	4180186
36304051	乙胺丁醇:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36304052	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Humira; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304052	Adalimumab Ab SerPl-aCnc	4180186
36304052	阿达木单抗 抗体:任意型浓度:时间点:血清/血浆:定量型	4182948
36304053	Centers for Medicare and Medicaid Assessment; Finding; Findings; Integument; Nominal; pressure injury; Pressure ulcer; Pressure Ulcers; Report period; Survey; Tx; Txs; Ulcer	4180186
36304054	Bil; Bilat; BON; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; Temporal bone-Bl; W contr IV; WC	4180186
36304054	CT Temporal bone-Bl W contr IV	4180186
36304054	多层^采用静脉注射对比剂:发现:时间点:头部>颞骨.双侧:文档型:CT	4182948
36304055	Acd; Acid fast Stn; Acids; AFB stain; Ejaculate; Genitourinary; GU; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; St; Stains; Stn; URO; Urology	4180186
36304055	Acid fast Stn Smn	4180186
36304055	显微镜观察:存在与否或特征标识:时间点:精液:名义型:抗酸染色法	4182948
36304056	GM1 Gangl IgG Ser Ql Line blot	4180186
36304056	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ganglioside monosialo; GM1 Gangl; Immune globulin G; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304056	神经节苷脂 GM1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304059	Chemistry; Fe; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304059	Iron Spec-mCnc	4180186
36304059	铁:质量浓度:时间点:XXX:定量型	4182948
36304061	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Study report; Visit note	4180186
36304061	OB Diag study note	4180186
36304061	诊断性检查记录:发现:时间点:{环境}:文档型:产科学	4182948
36304062	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; NO3; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304062	Nitrate Spec-mCnt	4180186
36304062	硝酸根:质量含量:时间点:XXX:定量型	4182948
36304063	Chlorophenothane; DDT; Dicophane; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; o,p' - DDT; Other; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304063	o,p' - DDT Spec-mCnt	4180186
36304063	o,p'- 二氯二苯三氯乙烷:质量含量:时间点:XXX:定量型	4182948
36304064	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; RVA VP7; Vet; Veterinary	4180186
36304064	RVA VP7 Islt-Seq	4180186
36304064	轮状病毒 A VP7 基因:序列:时间点:分离株:名义型:序列测定	4182948
36304065	Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304066	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36304067	Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36304068	1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Kappa LC Free; Non-protein bound; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
36304068	Kappa LC Free 24h Ur Ql IFE	4180186
36304068	免疫球蛋白轻链.Kappa 型.游离型:存在情况或阈值:24小时:尿液:序数型:免疫固定电泳分析法	4182948
36304069	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Playbook; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Thorax	4180186
36304069	Guided Lung Cryoablation	4180186
36304069	旨在冷冻消融术的引导:发现:时间点:胸部>肺:文档型:{成像方式}	4182948
36304072	EMS personnel drove to scene	4180186
36304072	Emergency Medical Service(s); EMS personnel drove to scene; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36304072	急救医疗服务人员自行驾车到达现场:发现:时间点:服务提供者:序数型	4182948
36304073	Care plan; Dialy; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note	4180186
36304073	Dialy Plan of care note	4180186
36304073	医疗服务计划记录:发现:时间点:{环境}:文档型:透析法	4182948
36304081	CD21- cells/100 CD19 cells NFr Bld	4180186
36304081	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B2; B-2; B4; B-4; Blood; C3d receptor; CD19 Cells; CD21 Cells; CD21- cells; Cell; CELL MARKERS; Cells.CD21+; Cellularity; CR2; EBV-R; Epstein Barr virus receptor; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36304081	细胞.CD21-/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36304082	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; c162; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; VANC; Vancocin; Vancomycin resistance gene; Vancor; WB; Whole blood	4180186
36304082	vanB Bld Pos Ql Probe	4180186
36304082	细菌万古霉素耐药 vanB 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304083	c; C/sp; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr IV; WC	4180186
36304083	CT C+T-spine W contr IV	4180186
36304083	多层^采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段:文档型:CT	4182948
36304086	1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
36304086	Kappa LC 24h Ur Ql IFE	4180186
36304086	免疫球蛋白轻链.Kappa 型:存在情况或阈值:24小时:尿液:序数型:免疫固定电泳分析法	4182948
36304088	Hearing; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Ordinal; Otologic; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WBC; WBCs; White blood cell; White blood cells	4180186
36304088	WBC Ear Ql Micro	4180186
36304088	白细胞:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36304090	Topiramate/Creat Ur Cfm	4180186
36304090	Atracurium besylate; C12H21NO8S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Lennox-Gastaut syndrome; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Qudexy XR; Random; Topamax; Toprimate; Tracrium; Trokendi XR; UA; UCr; UR; Urn	4180186
36304090	托吡酯/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304091	Abd; Abd+Pelvis; Abdo; Abdominal; Bil; Bilat; Both; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kdny-Bl; Kid-Bl+Uret; Kidney; Kidneys; Nephric; Nephrology; Pelvic; Point in time; Pyelogram; Pyelography; Rad; RADIOLOGY; Random; Renal; Retro; View; VWS; W contr Retro; W contr retro IU; WC	4180186
36304091	RF Kid-Bl+Uret Views W contr retro IU	4180186
36304091	多重视图^采用输尿管内逆行性对比剂:发现:时间点:腹部>肾脏.双侧 & 腹部+盆腔>输尿管:文档型:放射荧光透视法	4182948
36304093	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304094	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304095	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304097	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cysticercosis; Cysticercus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; T sol; T sol lar; T solium; Tapeworm	4180186
36304097	T sol lar IgG CSF Ql IA	4180186
36304097	猪囊尾蚴 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
36304098	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304101	CARD.PROC; Cardio; Cardiology; Circ assist devices used; Heart Disease; Identity or presence; in Surg; Intra operative; Intraop; Intraoperative; Nominal; Point in time; Random; S prime; Surg	4180186
36304101	Circ assist devices used in Surg	4180186
36304101	所采用的循环辅助设备^术中:存在与否或特征标识:时间点:^患者:名义型	4182948
36304105	检测极限:数量(计数):时间点:实验室仪器设备:定量型	4182948
36304105	Cnt; Count; Lab Device; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304105	Lab device Detection limit	4180186
36304112	Bx; CAT scan; Computed tomography; Computerized tomography; CT guided pulmonary biopsy; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Lung; Lung-L; Perc; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Thorax	4180186
36304112	CT Guided Lung-L Bx	4180186
36304112	旨在经皮活组织检查的引导:发现:时间点:胸部>肺.左侧:文档型:CT	4182948
36304116	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304117	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonata; Starnoc; UA; UCr; UR; Urn	4180186
36304117	Zaleplon/Creat Ur Cfm	4180186
36304117	扎来普隆/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304118	FDA insert Hepatic Impairment subsection	4180186
36304118	DOCUMENT.REF; FDA insert; Liver; Narrative; Report; SPL; Structured Product Labelling	4180186
36304118	肝脏损害子节:-:-:^FDA 包装说明书:叙述型	4182948
36304120	Transfusion consent	4180186
36304120	DOC.ONT; Document; Finding; Findings; Form; Point in time; Random; Tx	4180186
36304120	血液或血液制品输注同意书:发现:时间点:{环境}:文档型:患者	4182948
36304124	14 days; 2 weeks; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Patient Health Questionnaire; PHQ9; Pnl; Survey; Sx	4180186
36304125	Low press hold time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36304125	Low press hold time Vent	4180186
36304125	低压保持时间:时间:时间点:呼吸机:定量型	4182948
36304127	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Neuro; Neurology; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Ribosomal P Protein; Rib-P; RPP; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304127	Ribosomal P Ab CSF Ql Line blot	4180186
36304127	核糖体 P 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36304130	Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Lat; Left; Levo; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Recumbant	4180186
36304130	BP dias--lying in L-lateral position	4180186
36304130	血管内心脏舒张期^左侧卧位:压力或压强:时间点:动脉系统:定量型	4182948
36304131	little p phenotype RBC Ql	4180186
36304131	BLOOD BANK; Erythrocytes; Ordinal; p; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36304131	p 表型:存在情况或阈值:时间点:红细胞:序数型	4182948
36304132	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA PM/SCL; Evening; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304132	ENA PM/SCL Ab CSF Ql Line blot	4180186
36304132	PM-SCL 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36304134	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36304137	T whipplei DNA Ocflu Ql NAA+probe	4180186
36304137	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Occular fluid; Ocflu; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T whippelii; T whippelli; T whipplei; TMA; Transcription mediated amplification; Tropheryma whippelli; Whipple's disease	4180186
36304137	Tropheryma whippelii DNA:存在情况或阈值:时间点:眼液:序数型:探针法.基因扩增.靶向	4182948
36304139	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
36304139	OB Flowsheet	4180186
36304139	流程记录单:发现:时间点:{环境}:文档型:产科学	4182948
36304140	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304141	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304143	APTA; FCN; Func; Funct; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36304143	Motor function training perf	4180186
36304143	所进行的运动功能训练:存在与否或特征标识:时间点:^患者:名义型	4182948
36304144	CorePlaybook; Document; Filter place; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Playbook; Point in time; Rad; Radiology; Random; SVC; Thorax; VC	4180186
36304144	Guided SVC Filter place	4180186
36304144	旨在置入下腔静脉滤器的引导:发现:时间点:胸部>腔静脉.上:文档型:{成像方式}	4182948
36304146	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304147	Dyspnoea questionnaire; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; RDS; Rose dyspnea score; Screen; Survey; SURVEY.GNHLTH	4180186
36304148	Centers for Medicare and Medicaid Assessment; Housing; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304149	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
36304150	Abd; Abd+Pelvis; Abdo; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Perc; Playbook; Point in time; Rad; Radiology; Random	4180186
36304150	Guided Ureter Bx	4180186
36304150	旨在经皮活组织检查的引导:发现:时间点:腹部+盆腔>输尿管:文档型:{成像方式}	4182948
36304151	GT1b Ganlg IgG Ser Ql Line blot	4180186
36304151	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GT1b Ganlg; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Trisialoganglioside	4180186
36304151	神经节苷脂 GT1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304154	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD27- cells; CD3+CD8+CD27+CD62L+ cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; WB; Whole blood	4180186
36304154	CD3+CD8+CD27+CD62L+ cells # Bld	4180186
36304154	细胞.CD3+CD8+CD27+CD62L+:计数型浓度:时间点:全血:定量型	4182948
36304155	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304161	1 week; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36304165	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Mysoline; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304165	Primidone/Creat Ur Cfm	4180186
36304165	扑米酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304167	ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nasopharynx; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pulmonary; Pulmonology; Random; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory path Pnl; Respiratory virus panel; Respiratory viruses panel; RVP; Time Resolved Fluorescence; TRF	4180186
36304167	Respiratory path Pnl Nph IF	4180186
36304167	呼吸道病原体类组套:-:时间点:鼻咽:-:免疫荧光法	4182948
36304168	Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304170	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C diff; C diff BI NAP1 027; C diff BI-NAP1 027 DNA; C difficile; Clostridium difficile; Clostridium difficile BI/NAP1/027; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; North American pulsed field gel electrophoresis type 1; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304170	C diff BI NAP1 027 DNA Stl Ql NAA+probe	4180186
36304170	艰难梭菌 BI-NAP1-027 株 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36304173	Aspirate; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36304173	Gie Stn Aspirate	4180186
36304173	显微镜观察:存在与否或特征标识:时间点:吸出物:名义型:姬姆萨染色法	4182948
36304174	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Nurse; Gynecology; notes; nursing; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304174	Gyn Nurse Note	4180186
36304174	记录:发现:时间点:{环境}:文档型:妇科学.护士	4182948
36304175	Case rprt; DOC.MISC; Document; Finding; Findings; Initial case rprt processing info; MISC; Point in time; Random	4180186
36304175	Initial case rprt processing info Doc	4180186
36304175	初步案例报告处理信息:发现:时间点:报告:文档型	4182948
36304176	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304177	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36304179	2; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304181	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; G- to GJ-tube conversion; G tube; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; UGI; Up	4180186
36304181	Guided UGI G- to GJ-tube conversion	4180186
36304181	旨在将胃造瘘管转换为胃造瘘-空肠造瘘管的引导:发现:时间点:腹部>胃肠道.上段:文档型:{成像方式}	4182948
36304182	Feline; Felis domesticus; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36304183	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cen; CENP B; CENPB; CENP-B; Centromere B; Cerebral spinal fluid; Cerebrospinal Fl; CRST syndrome; Major centromere autoantigen B; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304183	Centromere B Ab CSF Ql Line blot	4180186
36304183	着丝点蛋白 B 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36304185	Flunitrazepam Sal Cfm-mCnc	4180186
36304185	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Darkene; DRUG/TOXICOLOGY; Drugs; GCMS; Hypnodorm; Hypnor; Level; Mass concentration; Narcozep; Noriel; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Rohipnol; Rohypnol; Roipnol; Sal; Valsera	4180186
36304185	氟硝安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304186	Glutarylcarn/C16 SerPl-sRto	4180186
36304186	C16; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Hexadecanoylcarnitine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36304186	戊二酰肉碱 (C5-DC)/棕榈酰肉碱 (C16):物质的量比率:时间点:血清/血浆:定量型	4182948
36304187	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Tot; Totl	4180186
36304190	Arm; Cath; Change; CorePlaybook; Document; EXT; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Peripherally Inserted Central Venous Catheter; PIC; PICC; PICC exch; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; UE; Up	4180186
36304190	Guided UE PICC exch	4180186
36304190	旨在更换外周插入式中心静脉导管的引导:发现:时间点:上肢:文档型:{成像方式}	4182948
36304193	Change; Chest tube exch; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; Thorax	4180186
36304193	Guided Chest Chest tube exch	4180186
36304193	旨在更换胸腔插管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36304194	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36304196	carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; Hodge test; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36304196	Carbapenemase Islt Ql	4180186
36304196	碳青霉烯酶:存在情况或阈值:时间点:分离株:序数型	4182948
36304198	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36304198	ADB-PINACA pentanoate Ur Ql Cfm	4180186
36304198	ADB-PINACA 戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36304200	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304200	Guided Nerve root Nerve block	4180186
36304200	旨在神经阻滞的引导:发现:时间点:XXX>神经根:文档型:{成像方式}	4182948
36304201	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36304202	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304203	EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PR; Prot; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; ZIKV; ZIKV NS1; ZIKV NS1 Ab; ZIKV NS1 IgM Pnl	4180186
36304203	ZIKV NS1 IgM Pnl SerPl IA	4180186
36304203	寨卡病毒非结构蛋白 1 抗体.IgM 组套:-:时间点:血清/血浆:-:免疫测定法	4182948
36304204	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36304205	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304206	PCA-Tr Ab Ser Line blot-aCnc	4180186
36304206	浦肯雅细胞胞浆 Tr 型 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304206	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Hodgkin's lymphoma; Limbic encephalopathy; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
36304208	Activ; Activity; Actvty; Exercise; IPAQ Tele Long Form; Movements; Pan; Panel; Panl; Patient Telephone; Pnl; Point in time; Random; Survey	4180186
36304209	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Resp status; Started; Survey	4180186
36304210	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304210	CMV IgM SerPl Donr Ql IA	4180186
36304210	巨细胞病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆^供体:序数型:免疫测定法	4182948
36304211	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Nuflor; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304211	Florfenicol Spec-mCnt	4180186
36304211	氟甲砜霉素:质量含量:时间点:XXX:定量型	4182948
36304212	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304213	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spn; Strep; Strept; WB; Whole blood	4180186
36304213	S pneumoniae gryB Bld Pos Ql Probe	4180186
36304213	肺炎链球菌 gryB 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304214	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36304214	FLUBV IgG Ser Ql IA	4180186
36304214	流感病毒 B 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36304221	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; Thromb infus D1; Thrombolysis; W thromb via chest tube	4180186
36304221	Guided Thromb inf D1 W thromb via CT	4180186
36304221	旨在最初输注一天溶栓剂的引导^采用经胸腔插管给予的溶栓剂:发现:时间点:胸部:文档型:{成像方式}	4182948
36304222	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Post-op E/M note; Post-operative; Prenatal; Random; Visit note	4180186
36304222	OB Post-op E/M note	4180186
36304222	术后评价与管理记录:发现:时间点:{环境}:文档型:产科学	4182948
36304223	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304223	操作记录:发现:时间点:{环境}:文档型:妇科学	4182948
36304224	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36304225	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD4+CD28+HLA DR+ cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; HLA-DR; Human Leukocyte Antigen; I3; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; T44; Tp44; W3/25; WB; Whole blood	4180186
36304225	CD3+CD4+CD28+HLA DR+ cells # Bld	4180186
36304225	细胞.CD3+CD4+CD28+HLA DR+:计数型浓度:时间点:全血:定量型	4182948
36304226	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; IgE RAST; Immune globulin E; Immunoglobulin E; NR1B1; Ordinal; Peanut; Peanut (rAra h) 5; Point in time; PR; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Screen; Serum; SR	4180186
36304226	落花生 重组 (rAra h) 5 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36304226	Deprecated Peanut (rAra h) 5 IgE RAST Ql	4180186
36304227	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304228	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304230	Centers for Medicare and Medicaid Assessment; Dextro; Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Started; Survey	4180186
36304231	@ birth; Axial length; bod; Bodies; Body length; CLIN; Length; New born; Newborn; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304231	Body height @ birth Measured	4180186
36304231	身高^出生时:长度:时间点:^患者:定量型:测量法	4182948
36304233	Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36304235	Identity or presence; Isolated; Microorganisms; Nominal; Org; Organism; Organisms; Point in time; Public Health; PUBLICHEALTH; Random	4180186
36304235	Microorganism index case	4180186
36304235	微生物 已鉴定的:存在与否或特征标识:时间点:指示病例^事件:名义型	4182948
36304238	Anatomy; Bdy site; bod; Bodies; H+P; H+P.PX; Nominal; P prime; Point in time; Random	4180186
36304238	受伤身体部位:解剖学:时间点:^患者:名义型	4182948
36304239	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304240	Circo virus; high-throughput sequencing; HTS; ID; II; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Next generation sequencing; NGS; Nominal; PCV; PCV2; PCV2 Cult; Point in time; Pork; Random; Swine; Typ; Vet; Veterinary	4180186
36304240	PCV2 Islt Seq	4180186
36304240	猪圆环病毒 2 型毒株 已鉴定的:类型:时间点:分离株:名义型:序列测定	4182948
36304243	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HPIV; HPIV2; Human rubulavirus 2; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PI2; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36304243	HPIV2 Ag Lower resp Ql IF	4180186
36304243	副流感病毒 2 型 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36304245	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304245	N gonorrhoea DNA Anorectl Ql NAA+probe	4180186
36304245	淋病奈瑟菌 DNA:存在情况或阈值:时间点:肛门直肠:序数型:探针法.基因扩增.靶向	4182948
36304246	Leishmania IgM Titr Ser IF	4180186
36304246	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Kala azar; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Visceral leishmaniasis	4180186
36304246	利什曼原虫属单个未知种 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36304249	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304251	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; MeVA vac str N gene; Misc; Miscellaneous; Molecular pathology; MOLPATH; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rubeola; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36304251	MeVA vac str N gene Spec Ql NAA+probe	4180186
36304251	麻疹病毒基因型 A 疫苗株 N 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304253	Acd; Acid fast Stn; Acids; AFB stain; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SF; SNV; St; Stains; Stn; Syn; Syn fl; Synov; Synovial fluid	4180186
36304253	Acid fast Stn Snv Ql	4180186
36304253	显微镜观察:存在情况或阈值:时间点:滑液:序数型:抗酸染色法	4182948
36304254	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
36304254	SaO2 during anesthesia % BldA PulseOx	4180186
36304254	氧饱和度^在麻醉过程中:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
36304255	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Work	4180186
36304258	Blood thinning med used; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36304258	Blood thinning med used	4180186
36304258	所采用的血液稀释药物的类型:类型:时间点:^患者:名义型	4182948
36304259	Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; Thumb-R; UE; UE-R; Up; without contrast	4180186
36304259	CT Thumb-R WO contr	4180186
36304259	多层^不采用对比剂:发现:时间点:上肢.右侧>拇指:文档型:CT	4182948
36304260	Antigen; Antigens; BLOOD BANK; D phenotyping; D typing; Erythrocytes; Hematology; Heme; Nominal; Point in time; Random; Red blood cells; Red blood corpusles; Rh phenotyping; Rh typing; Typ	4180186
36304260	Rh Group Ag RBC	4180186
36304260	Rh 血型 抗原:类型:时间点:红细胞:名义型	4182948
36304262	T gondii DNA Mar Ql NAA+probe	4180186
36304262	刚地弓形虫 DNA:存在情况或阈值:时间点:骨髓:序数型:探针法.基因扩增.靶向	4182948
36304262	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
36304265	1024-57-3; CHEBI:34786; Chlordane metabolite; DRUG/TOXICOLOGY; Drugs; ENT 25,584; Epoxyheptachlor; Heptachlor epoxide; Heptachlorane; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Velsicol 53-CS-17; Vet; Veterinary	4180186
36304265	Heptachlor epoxide Spec-mCnt	4180186
36304265	七氯环氧化物:质量含量:时间点:XXX:定量型	4182948
36304269	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey; Vigorous PA.work; Vigorous phys activity	4180186
36304271	Acd; Acid fast Kiny Stn; Acid fast Stn; Acids; AFB stain; ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; St; Stains; Stn	4180186
36304271	Acid fast Kiny Stn Lower resp Ql	4180186
36304271	显微镜观察:存在情况或阈值:时间点:呼吸道.下:序数型:抗酸染色法.Kinyoun	4182948
36304272	KCCQ; Overall KCCQ; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36304275	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304275	HPIV RNA Corn/Cnjt Ql NAA+probe	4180186
36304275	副流感病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304277	DRUG/TOXICOLOGY; Drugs; Ethoprophos; Mass content; Misc; Miscellaneous; Mocap; Other; Point in time; Prophos; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304277	Ethoprop Spec-mCnt	4180186
36304277	灭克磷:质量含量:时间点:XXX:定量型	4182948
36304278	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pancr; Pancreatc; Pancreatic; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304278	Guided Pancreas Bx	4180186
36304278	旨在经皮活组织检查的引导:发现:时间点:腹部>胰:文档型:{成像方式}	4182948
36304280	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304281	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304282	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Mech thromb initial; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304282	Guided Artery Mech thromb initial	4180186
36304282	旨在初次经皮机械性血栓切除术的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36304283	Amoebiasis; Amoebic; Bowel movement; Dysentery; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prep; Random; Stl; Stool = Fecal; Wet mount; Wet prep	4180186
36304283	Amoeba Stl Wet Prep	4180186
36304283	阿米巴 已鉴定的:存在与否或特征标识:时间点:大便:名义型:湿片法	4182948
36304284	KPS panel	4180186
36304284	CLIN; Karnofsky Index; Karnofsky Performance Scale; Pan; PANEL.CLINICAL; Panl; Perform status; Perform status Pnl; Pnl; Point in time; Random	4180186
36304284	日常体能状态组套:-:时间点:^患者:-:卡诺夫斯基法	4182948
36304285	Atomoxetine/Creat Ur Cfm	4180186
36304285	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Strattera; UA; UCr; UR; Urn	4180186
36304285	托莫西汀/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304286	Cath; CorePlaybook; CVC repos; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36304286	Guided Chest CVC repos	4180186
36304286	旨在中心静脉导管复位的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36304291	Art sys; Blood pressure; Blood pressure systolic; BP; BP sys; BP sys goal; BP systolic; CLIN; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
36304291	BP sys goal	4180186
36304291	血管内收缩压目标:压力或压强:时间点:动脉系统:定量型	4182948
36304292	Abilify; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304292	ARIPiprazole/Creat Ur Cfm	4180186
36304292	阿立哌唑/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304294	CD27+CD45RO+CD62L+CCR7+/100 CD3+CD8+	4180186
36304294	100 CD3+CD8+; Blood; CD27 Cells; CD27- cells; CD27+CD45RO+CD62L+CCR7+ cells; CD27-CD45RO+CD62L-CCR7- cells; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36304294	细胞.CD27+CD45RO+CD62L+CCR7+/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型	4182948
36304299	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304299	HPIV3 RNA Corn/Cnjt Ql NAA+probe	4180186
36304299	副流感病毒 3 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304300	Abd; Abdo; Abdomen+; Abdominal; Asp; CorePlaybook; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Playbook; Point in time; Rad; Radiology; Random; Renal	4180186
36304300	Guided Kidney Cyst asp	4180186
36304300	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36304302	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Survey	4180186
36304304	Prenatal Dx	4180186
36304304	Dx; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Prenatal Dx; Random	4180186
36304304	产前诊断:发现:时间点:^患者:名义型	4182948
36304310	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36304310	CT Teeth W contr IV	4180186
36304310	多层^采用静脉注射对比剂:发现:时间点:头部>牙齿:文档型:CT	4182948
36304311	# days of training & skill practice in eating or swallowing; Centers for Medicare and Medicaid Assessment; Count/time; Deglutition; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304312	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304315	Certolizumab Ab SerPl IA-aCnc	4180186
36304315	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cimzia®; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304315	塞妥珠单抗 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304316	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304320	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304321	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B malayi; Bancroftian filariasis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Human lymphatic filariasis; IAA; ID; IgG 1; IgG subgroup 1; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; W bancr; W bancr+B malayi; W bancrofti; Wucheria bancrofti	4180186
36304321	W bancr+B malayi IgG1 Ser Ql IA	4180186
36304321	班氏吴策线虫+马来布鲁线虫 抗体.IgG1:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36304323	ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CHD2; Chromodomain-helicase-DNA-binding protein 2; Dermatomyositis; Idiopathic Inflammatory Myopathies; II; Inclusion body myositis; MI2; Mi-2 alpha antibody; MSAs; Myositis-specific autoantibodies; Point in time; Polymyositis; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
36304323	Mi-2 alpha Ab Ser Line blot-aCnc	4180186
36304323	Mi-2 alpha 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304325	Nominal; Point in time; Random; TRAUMA; Typ	4180186
36304325	移交情况:类型:时间点:^患者:名义型	4182948
36304326	Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; EXCZ; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
36304326	BP dias--W exercise	4180186
36304326	血管内心脏舒张期^采用运动:压力或压强:时间点:动脉系统:定量型	4182948
36304327	Sleep medicine MD Note	4180186
36304327	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; M.D.; MD; notes; Point in time; Random; Sleep medicine MD; Visit note	4180186
36304327	记录:发现:时间点:{环境}:文档型:睡眠医学.医师	4182948
36304333	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Seneca Valley Virus; Spec; Strand Displacement Amplification; SVA; SVA RNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304333	SVA RNA Spec Ql NAA+probe	4180186
36304333	塞内卡病毒 A RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304334	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304337	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Kala azar; LAT; LCR; Leishmaniasis; Leishmaniosis; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Visceral leishmaniasis	4180186
36304337	Leishmania DNA Mar NAA+probe	4180186
36304337	利什曼原虫属单个未知种 DNA:存在与否或特征标识:时间点:骨髓:名义型:探针法.基因扩增.靶向	4182948
36304338	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304338	Guided Soft tiss Bx	4180186
36304338	旨在经皮活组织检查的引导:发现:时间点:XXX>软组织:文档型:{成像方式}	4182948
36304339	Centers for Medicare and Medicaid Assessment; Othr; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304341	C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec	4180186
36304341	HSV Lower resp Cult	4180186
36304341	单纯疱疹病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
36304343	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Stent place	4180186
36304343	Guided BDs Stent place	4180186
36304343	旨在置入支架的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36304344	Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Imaging; L; LT; LUE; Point in time; Rad; RADIOLOGY; Random; Thumb-L; UE; UE-L; Up; without contrast	4180186
36304344	CT Thumb-L WO contr	4180186
36304344	多层^不采用对比剂:发现:时间点:上肢.左侧>拇指:文档型:CT	4182948
36304346	Tdecenoylcarn/C0 DBS-sRto	4180186
36304346	Blood; C0; C14:1; Carnitine Free; Carnitine.total; Chemistry; DBS; Dried blood spot; FC; Filter paper; FP; FR; i; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tdecenoylcarn; WB; Whole blood	4180186
36304346	十四烯酰肉碱 (C14:1)/肉碱.游离型 (C0):物质的量比率:时间点:全血.斑点:定量型	4182948
36304347	Activity; Arterial Stenosis; Count/time; Dextro; Exercise; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304349	Amikacin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c288; Genotype; Genotypic; Gentamicin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Neomycin; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Streptomycin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tobramycin	4180186
36304349	Aminoglycoside Islt Genotyp	4180186
36304349	氨基糖苷类抗生素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36304350	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C auris; C auris ITS2; Cand; Candidiasis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36304350	C auris ITS2 Spec Ql NAA+probe	4180186
36304350	耳道假丝酵母菌 ITS2 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304351	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey; Vigorous PA.yard work; Vigorous phys activity	4180186
36304353	ABS; Aby; Allergen; Allergen code d202; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; D pteron recom (rDer p) 1 Ab; D pteron recom (rDer p) 1 Ab.IgE; D pteronyss; D pteronyss (rDer p) 1; D pteronyssinus; d001; d1; European house dust mite; HDM; House dust mite; i; Immune globulin E; Immunoglobulin E; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36304353	D pteronyss (rDer p) 1 IgE Qn	4180186
36304353	屋尘螨 重组 (rDer p) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36304355	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Lung; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304355	CT Lung parenchyma WO+W contr IV	4180186
36304355	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>肺实质:文档型:CT	4182948
36304356	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304357	Adeno virus; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec	4180186
36304357	HAdV Lower resp Ql Cult	4180186
36304357	腺病毒:存在情况或阈值:时间点:呼吸道.下:序数型:微生物特异性培养	4182948
36304359	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serdolect; Serlect; SerP; SerPl; SerPlas; Sertindol; Serum; Serum or plasma; SR	4180186
36304359	Sertindole SerPl-mCnc	4180186
36304359	舍吲哚:质量浓度:时间点:血清/血浆:定量型	4182948
36304361	Addiction; Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Lioran; Myslee; Nasen; Nytamel; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; Zoldem; Zolpihexal; Zolpimist	4180186
36304361	Zolpidem Sal Ql Scn	4180186
36304361	唑吡坦:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36304362	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36304362	自杀预防记录:发现:时间点:{环境}:文档型:{角色}	4182948
36304363	Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304364	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304366	Centers for Medicare and Medicaid Assessment; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36304367	Lab AOE pnl; MISC; Pan; PANEL.MISC; Panl; Pnl; Point in time; Random	4180186
36304367	Lab AOE pnl Patient	4180186
36304367	实验室医嘱录入时附带询问的问题组套:-:时间点:^患者:-	4182948
36304374	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304378	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c201; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36304378	blaCTX-M Islt/Spm Ql	4180186
36304378	细菌头孢菌素耐药 blaCTX-M 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36304379	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304380	14 days; 2 weeks; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Patient Health Questionnaire; PHQ9; Pnl; Survey; Sx	4180186
36304381	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304382	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Hep a; Hepar; Imaging; Liver; Liver artery; Point in time; Rad; RADIOLOGY; Random; Tum embol; W emb ag IA	4180186
36304382	Guided Hep a Tum embol--W emb ag IA	4180186
36304382	旨在栓塞术的引导^采用动脉注射栓塞剂:发现:时间点:腹部>肝动脉:文档型:{成像方式}	4182948
36304386	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B microti; Babesia sp 18S rRNA Pnl; Babesia species; Babesiosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; month; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Piroplasmosis; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; rDNA; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36304386	Babesia sp 18S rRNA Pnl Bld NAA+non-pr	4180186
36304386	鼠源巴贝斯虫与分歧巴贝斯虫+MO-1 株与邓肯巴贝斯虫 18S rRNA 基因组套:-:时间点:全血:-:非探针法.基因扩增.靶向	4182948
36304387	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; V; Vet; Veterinary	4180186
36304387	Vanadium Spec-mCnc	4180186
36304387	钒:质量浓度:时间点:XXX:定量型	4182948
36304388	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304389	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Ebola + Marburg RNA; Ebola + Marburg RNA Pnl; Ebola + Marburg virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MARV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36304389	Ebola + Marburg RNA Pnl Bld NAA+probe	4180186
36304389	埃博拉病毒与马尔堡病毒 RNA 组套:-:时间点:全血:-:探针法.基因扩增.靶向	4182948
36304393	B; Beta-hexosaminidase subunit alpha; B-NAH; Catalytic Content; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Hexosaminidase A & Total Pnl; Leukocytes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Sandhoff disease; Tay Sachs Disease; WBCs; White blood cells	4180186
36304393	Hexosaminidase A & Total Pnl WBC-cCnt	4180186
36304393	Beta-N-乙酰己糖胺酶.A & Beta-N-乙酰己糖胺酶组套:催化含量:时间点:白细胞:-	4182948
36304395	4-Hydroxycoumarin; Coumadin; Coumarin; Coumarins; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Panwarfin; Point in time; QNT; Quan; Quant; Quantitative; Random; Sofarin; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304395	Warfarin Spec-mCnt	4180186
36304395	丙酮苄羟香豆素:质量含量:时间点:XXX:定量型	4182948
36304397	Ident; Identifier; Nominal; Perf based measure name; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304398	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304400	Asp; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Ln; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304400	Guided LN PC fluid asp	4180186
36304400	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>淋巴结:文档型:{成像方式}	4182948
36304401	Finding; Findings; Lung; Nominal; O2; Point in time; PULMONARY; Pulmonology; Random; Respiratory; tO2; Use of suppl O2	4180186
36304401	Use of suppl O2	4180186
36304401	辅助供氧的使用:发现:时间点:^患者:名义型	4182948
36304402	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pilosicoli; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36304402	B pilosicoli DNA Islt Ql NAA+probe	4180186
36304402	毛肠短螺旋体 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304403	Addiction med Case mgr Note	4180186
36304403	Addiction med Case mgr; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36304403	记录:发现:时间点:{环境}:文档型:成瘾医学.病例管理人员	4182948
36304405	CdtB; CdtB & Vinculin; CdtB + Vinculin Ab pnl; CdtB+Vinculin; CdtB+Vinculin Ab; EIA; ELFA; ELISA; Enzyme immunoassay; Gastro; Gastroenterology; GI; IAA; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; SUDS; VCL	4180186
36304405	CdtB + Vinculin Ab pnl Ser IA	4180186
36304405	细胞致死膨胀毒素 B 与粘着斑蛋白抗体组套:-:时间点:血清:-:免疫测定法	4182948
36304406	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304407	Bact; Hearing; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Ordinal; Otologic; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36304407	Bacilliform bact Ear Ql Micro	4180186
36304407	杆状细菌:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36304409	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Non-thromb infus; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Thrombolysis; To be specified in another part of the message; Unspecified; Vesl	4180186
36304409	Guided Ves Non-thromb infus	4180186
36304409	旨在输注非溶栓剂的引导:发现:时间点:XXX>血管:文档型:{成像方式}	4182948
36304410	ADMIN; ADMIN.PATIENT; Finding; Findings; Ordinal; Permission text messages; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36304410	Permission text messages	4180186
36304410	允许接收文本消息:发现:时间点:^患者:序数型	4182948
36304411	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Evening; PM/SCL-100; PM1-alpha; Point in time; Polymyositis; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Serology; Serum; SR; Systemic Sclerosis	4180186
36304411	PM/SCL-100 Ab Ser Line blot-aCnc	4180186
36304411	PM-SCL-100 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304414	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Circo virus; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; PCV; PCV2; PCV2 DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36304414	PCV2 DNA # Spec NAA+probe	4180186
36304414	猪圆环病毒 2 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304418	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfringens; C perfringens cpe; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304418	C perfringens cpe Islt Ql NAA+probe	4180186
36304418	产气荚膜梭菌 cpe 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304419	Bact; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
36304419	Bacteria Ur Ql	4180186
36304419	细菌:存在情况或阈值:时间点:尿液:序数型	4182948
36304421	Disch; DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
36304421	OB Discharge instruct	4180186
36304421	出院指导:发现:时间点:{环境}:文档型:产科学	4182948
36304422	CARD.PROC; Cardio; Cardiology; Clock time; CPR; CPR start time; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
36304422	CPR start time Clock time	4180186
36304422	心肺复苏开始时间:时钟时间:时间点:^患者:定量型	4182948
36304424	Micro CNAMTS panel Snv	4180186
36304424	Joint aspirate; Joint fld; Joint flu; Joint fluid; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
36304424	微生物学 CNAMTS 组套:-:时间点:滑液:-	4182948
36304427	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GM2 Gangl; Immune globulin M; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304427	GM2 Gangl IgM Ser Ql Line blot	4180186
36304427	神经节苷脂 GM2 抗体.IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304431	Addiction; Cfm; Cloud 10; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Smoke; Spice; Synthetic cannabinoid; UA; UR; Urn; XLR11; XLR-11 N-(4OH-pentyl); Zombie	4180186
36304431	XLR-11 N-(4OH-pentyl) Ur Ql Cfm	4180186
36304431	XLR-11 N-(4-羧戊基):存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36304432	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; ZIKV; ZIKV NS1; ZIKV NS1 Ab	4180186
36304432	ZIKV NS1 IgM SerPl IA-aCnc	4180186
36304432	寨卡病毒非结构蛋白 1 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304433	Bil; Bilat; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Eye socket; Finding; Findings; Head+Orbit-Bl; Imaging; Intracranial; Orbital; Orbit-Bl; Orbits; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36304433	CT Head+Orbit-Bl W contr IV	4180186
36304433	多层^采用静脉注射对比剂:发现:时间点:头部 & 头部>眼眶.双侧:文档型:CT	4182948
36304437	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304438	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304442	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV NA gene; FLUV; Fowl plague; high-throughput sequencing; HTS; IAV NA gene; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Vet; Veterinary	4180186
36304442	FLUAV NA gene Islt-Seq	4180186
36304442	流感病毒 A 型神经氨酸酶基因:序列:时间点:分离株:名义型:序列测定	4182948
36304443	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; LV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304443	PeV RNA Stl Ql NAA+probe	4180186
36304443	副肠孤病毒 RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36304444	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304446	5th; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Finger.5th-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; UE; UE-L; Up; without contrast	4180186
36304446	CT Finger.5th-L WO contr	4180186
36304446	多层^不采用对比剂:发现:时间点:上肢.左侧>手指.第五:文档型:CT	4182948
36304448	Centers for Medicare and Medicaid Assessment; Disch; Inpatient admission agency discharge items - d/c from agency; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304450	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304454	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Zn	4180186
36304454	Bacitracin zinc Spec-mCnt	4180186
36304454	杆菌肽锌:质量含量:时间点:XXX:定量型	4182948
36304456	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304457	After; Point in time; post ADAPTABLE; PST; QNT; Quan; Quant; Quantitative; Random; Study report; Survey; SURVEY.GNHLTH	4180186
36304459	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304462	Chlordiazep Sal Cfm-mCnc	4180186
36304462	Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Librium; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36304462	甲氨二氮卓:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304463	100 CD3+CD8+; Blood; CD27 Cells; CD27- cells; CD27+CD45RO+CD62L+CCR7+ cells; CD27-CD45RO+CD62L-CCR7- cells; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cells.CD27+; Cellularity; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36304463	CD27-CD45RO+CD62L-CCR7-/100 CD3+CD8+	4180186
36304463	细胞.CD27-CD45RO+CD62L-CCR7-/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型	4182948
36304469	C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Thrush	4180186
36304469	Fungus Sinus Cult	4180186
36304469	真菌 已鉴定的:存在与否或特征标识:时间点:窦:名义型:培养	4182948
36304470	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304470	Hearing threshold 500 Hz Ear-L	4180186
36304470	听阈^500 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36304471	Nominal; Point in time; Random; TRAUMA; Typ	4180186
36304471	事故中的角色:类型:时间点:^患者:名义型	4182948
36304472	Carbomethoxyhydrazone; DRUG/TOXICOLOGY; Drugs; Mass content; Mecadox; Misc; Miscellaneous; Other; Point in time; QdNO; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304472	Carbadox Spec-mCnt	4180186
36304472	卡巴氧:质量含量:时间点:XXX:定量型	4182948
36304473	No; Nominal; Num; Person name; Point in time; Random; Signature requesting SSN; Social Security #; Survey; SURVEY.CDC	4180186
36304474	Ang; Angio; Angiography; Angm; Brain; Brain + Head ves; c; CAT scan; Cerebral; Cerebrum; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT Angiogram; CT angiography; CT perfusion + CTA; CT scan; CT.cine; CTA; Document; Finding; Findings; Head; Imaging; Intracranial; PF; Point in time; Rad; Radiology; Random; Skull; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304474	CT WO con+Brain perf+CTA Head ves W cont	4180186
36304474	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部>脑部 && 头部>头部 血管类:文档型:CT.灌注 && CT.血管造影术	4182948
36304477	Age at delivery; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
36304478	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
36304478	Polytrauma H&P note	4180186
36304478	病史与体格检查记录:发现:时间点:{环境}:文档型:多发性创伤	4182948
36304479	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304482	Abd; Abd + Chest+Abd+Pel; Abd and Chest+Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
36304482	CT Abd WO + CT Chest+Abd+Pel W contr IV	4180186
36304482	多层^WO contrast && Multisection^W contrast IV:发现:时间点:腹部 && 胸部+腹部+盆腔:文档型:CT	4182948
36304483	Fetal; ID; Imm; Immune globulin G; Immune globulin M; Immunodiff; Immunodiffusion; Immunoglobulin G; Immunoglobulin M; Imun; Imune; Ordinal; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Swine; Vet; Veterinary	4180186
36304483	IgG+IgM.porcine Ser Fetus Ql ID	4180186
36304483	IgG+IgM.猪:存在情况或阈值:时间点:血清^胎儿:序数型:免疫扩散法	4182948
36304485	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304486	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Gastro; Gastroenterology; GI; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remicade; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304486	inFLIXimab Ab SerPl IA-mCnc	4180186
36304486	英利昔单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304489	Assoc; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304490	Epstein Barr 病毒抗体组套:-:时间点:血清:-	4182948
36304490	EBV; EBV Ab Pnl; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36304490	EBV Ab Pnl Ser	4180186
36304491	Centers for Medicare and Medicaid Assessment; No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Started; Survey	4180186
36304492	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304496	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; Tapeworm; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36304496	Taenia DNA Spec Ql NAA+probe	4180186
36304496	带绦虫属单个未知种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304501	Ang; Angio; Angiography; Angm; Bil; Bilat; Both; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-Bl; Finding; Findings; Heart Disease; Imaging; LE; LE vv; LE vv-Bl; LE-Bl; Leg; Low; Pelvic; Pelvic vv; Pelvis vv; Pelvis vv + LE vv-Bl; Point in time; Rad; RADIOLOGY; Random	4180186
36304501	CTA Pelvis vv + LE vv-Bl	4180186
36304501	多层:发现:时间点:盆腔>盆腔静脉类 & 下肢.双侧>下肢静脉类:文档型:CT.血管造影术	4182948
36304504	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; PCV; PCV2; PCV2 DNA; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304504	PCV2 DNA Spec Ql NAA+probe	4180186
36304504	猪圆环病毒 2 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304505	C7H17O2PS3; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Rampart; Random; Spec; Thimet; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304505	Phorate Spec-mCnt	4180186
36304505	甲拌磷:质量含量:时间点:XXX:定量型	4182948
36304507	Ang; Angio; Angiography; Angm; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; Finding; Findings; Heart Disease; Imaging; Pelvic; Pelvic vv; Pelvis vv; Point in time; Rad; Radiology; Random	4180186
36304507	CTA Pelvis vv	4180186
36304507	多层:发现:时间点:盆腔>盆腔静脉类:文档型:CT.血管造影术	4182948
36304511	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304514	Activ; Actvty; Arth; Clinical Disease Activity Index; Dis; Diseases; Dz; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Levels; Levl; LV; LVL; MDAS; Movements; Multi-biomarker disease activity score; Ordinal; Point in time; QL; Qual; Qualitative; RA; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304518	Centers for Medicare and Medicaid Assessment; Finding; Findings; Indicator; Nominal; Report period; Survey	4180186
36304522	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36304522	L pneumo Ag Tiss Ql IF	4180186
36304522	嗜肺军团菌 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36304523	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304523	HIV 1 pro DNA CSF Ql NAA+probe	4180186
36304523	HIV 1 型 前病毒 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36304527	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Legion; Legionela; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Wat	4180186
36304527	Legionella Wat Cult	4180186
36304527	军团菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:水:名义型:微生物特异性培养	4182948
36304530	100 CD19 cells; ADP-ribosyl cyclase; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD38 Cells; CD38+IgM- cells; CD38+IgM+ cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; HD-37; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Leu17; Leu-17; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; WB; Whole blood	4180186
36304530	CD38+IgM- cells/100 CD19 cells NFr Bld	4180186
36304530	细胞.CD38+IgM-/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36304534	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; TA + AA; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304534	CTA TA + AA WO+W contr IV	4180186
36304534	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>主动脉.胸腔段 & 腹部>主动脉.腹腔段:文档型:CT.血管造影术	4182948
36304537	Centers for Disease Control and Prevention; Ethnic; Ethnicity; Ethnicity detal; Mat; Maternal; Matnl; National tabulated ethnicity; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
36304542	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
36304543	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304544	# days of active range of motion; AROM; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Rnge; Survey	4180186
36304545	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36304546	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36304546	VZV DNA Fld Ql NAA+probe	4180186
36304546	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:体液:序数型:探针法.基因扩增.靶向	4182948
36304550	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zuprevo	4180186
36304550	Tildipirosin Islt KB	4180186
36304550	泰地罗新:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
36304553	Finding; Findings; Heart beat; HEART RATE.ATOM; Ordinal; Point in time; Pulse; QL; Qual; Qualitative; Random; Rhyth or arrhyth heart rate; Screen	4180186
36304553	Rhyth or arrhyth heart rate	4180186
36304553	节律性或失常性心率:发现:时间点:^患者:序数型	4182948
36304554	Abd; Abd ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Chest+Abd ves; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; Thorax; Vesl; Vessels.XXX; W contr IV; WC	4180186
36304554	CTA Chest+Abd ves W contr IV	4180186
36304554	多层^采用静脉注射对比剂:发现:时间点:胸部>胸部血管类 & 腹部>腹部血管类:文档型:CT.血管造影术	4182948
36304558	CARD.PROC; Cardio; Cardiology; CVD; Dis; Diseases; Dz; Heart Disease; Objection Ax of CVD; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36304558	Objection Ax of CVD	4180186
36304558	心血管疾病客观评估:分类:时间点:^患者:序数型:NYHA	4182948
36304559	Amplification; ARF; Blood; CDK4 inhibitor; CDK4I; CDKN2; CMM2; Cyclin-dependent kinase 4 inhibitor A gene; cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase inhibitor 2A gene; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; INK4; INK4a; Melanoma; MLM; Molecular genetics; Molecular pathology; MOLPATH; MTS1; MTS-1; Multiple tumor suppressor 1; Mut; Mutations; P14; P14ARF; p16; P16INK4; P16INK4A; P16-INK4A; P19; P19ARF; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; TP16; WB; Whole blood; Whole blood or Tissue	4180186
36304559	CDKN2A Del+Dup + Full Mut Anl Bld/T	4180186
36304559	CDK2A 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304560	Micro CNAMTS panel Bld	4180186
36304560	Blood; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36304560	微生物学 CNAMTS 组套:-:时间点:全血:-	4182948
36304562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P carinii; P jiroveci; PCP; PCR; Pneumocystis carinii; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304562	P jiroveci DNA Lower resp Ql NAA+probe	4180186
36304562	耶氏肺孢子菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304564	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inspection; Playbook; Point in time; Rad; RADIOLOGY; Random; Tube check	4180186
36304564	Guided BDs Tube check	4180186
36304564	旨在检查管道的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36304565	ANTIBIOTIC SUSCEPTIBILITIES; AST; Furacilin; Furacin; Furacin.topical; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Nitrofural; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36304565	Nitrofurazone Islt MIC	4180186
36304565	呋喃西林:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36304567	Drugs; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Pregnancies; Random; Typ	4180186
36304567	Drug use preg Mother	4180186
36304567	药物使用^在妊娠过程中:类型:时间点:^母亲:名义型	4182948
36304568	Addiction; Cfm; Cloud 10; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Smoke; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36304568	AB-FUBINACA oxobutanoate Ur Ql Cfm	4180186
36304568	AB-FUBINACA 氧代丁酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36304569	Anaero; Anaerobe; Anaerobe Cult; Bact; Bronchial alveolar lavage; Bronchoalveolar lavage; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory	4180186
36304569	Bacteria BAL Anaerobe Cult	4180186
36304569	细菌 已鉴定的:存在与否或特征标识:时间点:支气管肺泡灌洗液:名义型:厌氧微生物培养	4182948
36304570	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Gie Stn; GMS; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn	4180186
36304570	Gie Stn Amn	4180186
36304570	显微镜观察:存在与否或特征标识:时间点:羊水:名义型:姬姆萨染色法	4182948
36304572	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; species; spp	4180186
36304572	Burkholderia Lower resp Cult	4180186
36304572	伯克霍尔德氏菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
36304576	ANTIBIOTIC SUSCEPTIBILITIES; AST; Extensively drug resistant tuberculosis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MDR TB; MDR Tuberculosis; Minimum inhibitory concentration; Multi drug resistant tuberculosis; Point in time; Random; Sirturo; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; XDR TB	4180186
36304576	Bedaquiline Islt MIC	4180186
36304576	贝达喹啉:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36304577	#; 2H4; ABS; absolute; absolutes; Blood; CD4 Cells; CD4+CD25+ Cells; CD4+CD25+CD45RA+CD127Low+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Inducer T cells; L3T4; Leu18; Leu-18; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; W3/25; WB; Whole blood	4180186
36304577	CD4+CD25+CD45RA+CD127Low+ cells # Bld	4180186
36304577	细胞.CD4+CD25+CD45RA+CD127Low+:计数型浓度:时间点:全血:定量型	4182948
36304578	Abd; Abdo; Abdomen+; Abdominal; Assessment; Bx; CorePlaybook; Document; Eval; Finding; Findings; Guid; Guide; Guided; H&P; Hepar; Hepatic; History and physical; Imaging; Playbook; Point in time; Rad; Radiology; Random; Transjugular Bx; Transjugular Bx+hemo eval	4180186
36304578	Guided Liver Transjugular Bx+hemo eval	4180186
36304578	旨在经颈静脉活组织检查+血液动力学评价的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36304584	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304585	Art; Cardio; Cardiology; CorePlaybook; Document; EXT; Extr-Ul; Fem a; Fem a+Pop a; Fem a+Popliteal a; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Knee Artery; LE; Leg; Low; Perc; Playbook; Point in time; PTA; Rad; Radiology; Random; Thigh	4180186
36304585	Guided Fem a+Pop a PTA	4180186
36304585	旨在经皮腔内血管成形术的引导:发现:时间点:下肢.单侧>股动脉+腘动脉:文档型:{成像方式}	4182948
36304586	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; Survey; SURVEY.MTLHLTH; Sx	4180186
36304591	Gyn NP Note	4180186
36304591	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn NP; Gyn Nurse; notes; nursing; Point in time; Random; Visit note	4180186
36304591	记录:发现:时间点:{环境}:文档型:妇科学.执业护士	4182948
36304594	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Trachoma; Transcription mediated amplification	4180186
36304594	C trach DNA Tiss Ql NAA+probe	4180186
36304594	沙眼衣原体 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36304595	Breathing; Lung; Lungs; Minimal; minimum; Point in time; Press.min; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36304595	Press.min on vent Airway	4180186
36304595	压力.最小值^采用呼吸机:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36304598	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36304599	After; Blood; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36304599	Glucose p meal Bld-mCnc	4180186
36304599	葡萄糖^在进餐之后:质量浓度:时间点:全血:定量型	4182948
36304601	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36304601	HCoV 229E RNA Upper resp Ql NAA+probe	4180186
36304601	人类冠状病毒 229E 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36304604	Addiction; Algil; Alodan; Blood; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pethidine; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36304604	Meperidine SerPlBld Ql Scn	4180186
36304604	哌替啶:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学筛查试验	4182948
36304605	Corn/Cnjt; Corneal; Eye; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; St; Stains; Stn	4180186
36304605	Gram Stn Corn/Cnjt	4180186
36304605	显微镜观察:存在与否或特征标识:时间点:角膜/结膜:名义型:革兰氏染色法	4182948
36304606	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; species; spp; Survey	4180186
36304608	Amplification; Blood; CDS1; checkpoint kinase 2; CHK2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; hCds1; Heredity; Heritable; HuCds1; Inherited; LFS2; Li-Fraumeni syndrome; Li-Fraumeni syndrome 2; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; PP1425; RAD53; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36304608	CHEK2 Del+Dup + Full Mut Anl Bld/T	4180186
36304608	CHEK2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304609	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Operative note; Point in time; Prenatal; Random; Surg; Visit note	4180186
36304609	OB Operative note	4180186
36304609	外科手术记录:发现:时间点:{环境}:文档型:产科学	4182948
36304610	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; PSV; PSV RNA; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304610	PSV RNA Ct Spec Qn NAA+probe	4180186
36304610	猪萨佩罗病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304612	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304613	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Zonegran	4180186
36304613	Zonisamide/Creat Ur Cfm	4180186
36304613	唑尼沙胺/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304614	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV 1+2+3+4; HPIV 1+2+3+4 RNA; HPIV1; HPIV1+2+3; Human respirovirus 1; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304614	HPIV 1+2+3+4 RNA Nph Ql NAA+non-probe	4180186
36304614	副流感病毒 1+2+3+4 型 RNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向	4182948
36304618	5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; C20:4w6; C20:5w3; Chemistry; Eicosapentaenoic acid; Eicosatetraenoate; EPA; Icosapentaenoate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Timnodonate; Timnodonic Acid	4180186
36304618	EPA/AA SerPl-sRto	4180186
36304618	二十碳五烯酸/花生四烯酸:物质的量比率:时间点:血清/血浆:定量型	4182948
36304619	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA RNP; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304619	ENA RNP Ab CSF Ql Line blot	4180186
36304619	核糖核酸蛋白可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36304620	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304620	HPIV RNA Lower resp Ql NAA+probe	4180186
36304620	副流感病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304621	BoNT; Bowel movement; BTX; C bot; C bot Tox; C botulinum; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; MA; MA Nt; Microbiology; Neut; Neutr; Nominal; Point in time; Random; Stl; Stool = Fecal	4180186
36304621	C bot Tox Stl MA Nt	4180186
36304621	肉毒梭菌毒素:存在与否或特征标识:时间点:大便:名义型:小鼠生物鉴定.中和作用	4182948
36304623	3rd; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Finger.3rd-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE-R; Up; without contrast	4180186
36304623	CT Finger.3rd-R WO contr	4180186
36304623	多层^不采用对比剂:发现:时间点:上肢.右侧>手指.第三:文档型:CT	4182948
36304625	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36304626	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304627	2; Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304628	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Facial bones + Maxilla; Facial bones+Maxilla; Finding; Findings; Imaging; Intracranial; Maxillofacial-R; Point in time; R; Rad; RADIOLOGY; Random; RT; Skull; W contr IV; WC	4180186
36304628	CT Maxillofacial-R W contr IV	4180186
36304628	多层^采用静脉注射对比剂:发现:时间点:头部>颌面区域.右侧:文档型:CT	4182948
36304629	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; PCNUS place; Pelvic; Perc; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad	4180186
36304629	Guided PCNUS place	4180186
36304629	旨在经皮置入肾输尿管支架的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:{成像方式}	4182948
36304630	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiology; Random; Transhepatic tube revision	4180186
36304630	Guided Liver Transhepatic tube revision	4180186
36304630	旨在经肝修正管道的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36304634	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Calc removal; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Remove	4180186
36304634	Guided BDs Calc removal	4180186
36304634	旨在去除结石的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36304638	Meth; Method of; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
36304639	Date and time; Intubation time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Time stamp; Timestamp	4180186
36304639	Intubation time	4180186
36304639	插管时间:时间戳:时间点:^患者:定量型	4182948
36304642	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circo virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; PCV; PCV2; PCV2 Ab; Point in time; Pork; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Swine; Vet; Veterinary	4180186
36304642	PCV2 Ab Ser IA	4180186
36304642	猪圆环病毒 2 型 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304644	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304646	Asp; BM; BON; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304646	Guided Bone mar PC fluid asp	4180186
36304646	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>骨髓:文档型:{成像方式}	4182948
36304647	DRUG/TOXICOLOGY; Drugs; Level; Lodopin; Losizopilon; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Setous; SR; Zoleptil; Zotepin	4180186
36304647	Zotepine SerPl-mCnc	4180186
36304647	佐替平:质量浓度:时间点:血清/血浆:定量型	4182948
36304648	Count/time; Dextro; First; Mat; Maternal; Matnl; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
36304652	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304656	# days of training & skill practice in bed mobility; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304660	Average; Avg; Centers for Medicare and Medicaid Assessment; Fld; Flow; QNT; Quan; Quant; Quantitative; Survey; Volume Rate; vRate	4180186
36304661	Finding; Findings; Living Arrangement; Living Arrangements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Residence; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
36304662	Chemistry; cTnT; HS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin	4180186
36304662	Troponin T SerPl HS-Imp	4180186
36304662	肌钙蛋白 T.心脏:印象:时间点:血清/血浆:序数型:高灵敏度方法	4182948
36304664	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Nominal; Point in time; Random; Return of circulation	4180186
36304664	Return of circulation	4180186
36304664	恢复自主循环:发现:时间点:^患者:名义型	4182948
36304665	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; DNA NUCLEIC ACID PROBE; DNA probe; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; LV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304665	PeV RNA Aspirate Ql NAA+probe	4180186
36304665	副肠孤病毒 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36304666	1st deg burn area/BSA Est	4180186
36304666	1st deg burn area; Bdy surface; bod; Bodies; BSA; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; TRAUMA	4180186
36304666	一度烧伤面积/体表面积:面积比:时间点:^患者:定量型:估计法	4182948
36304667	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304668	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S prolificans; S prolificans DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304668	S prolificans DNA Aspirate Ql NAA+probe	4180186
36304668	多育赛多孢 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36304669	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304669	Guided Uterine a Embol	4180186
36304669	旨在栓塞的引导:发现:时间点:盆腔>子宫动脉:文档型:{成像方式}	4182948
36304670	Activ; Actvty; Arbitrary rate; Cycle PA.active transport; Movements; QNT; Quan; Quant; Quantitative; Survey	4180186
36304674	Centers for Medicare and Medicaid Assessment; Disch; Hx; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Survey	4180186
36304679	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
36304680	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Playbook; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Thorax	4180186
36304680	Guided Lung Microwave abl	4180186
36304680	旨在微波消融术的引导:发现:时间点:胸部>肺:文档型:{成像方式}	4182948
36304681	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EAEC; EAEC astA gene; EAEC EAST1 gene DNA; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304681	EAEC astA gene Islt Ql NAA+probe	4180186
36304681	大肠埃希菌肠集聚型 astA 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304686	Multiple birth set ID	4180186
36304686	ADMIN; ADMIN.PATIENT; Ident; Identifier; Mult; Multi; Nominal; Point in time; Random	4180186
36304686	多胎生产集合标识符:标识符:时间点:^患者:名义型	4182948
36304687	B burg; B burgdor; B burgdorferi; B microti; Babesiosis; Bb; Burgdorf; E chaffeensis; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; HME; Human granulocytic ehrlichiosis; Human monocytic ehrlichiosis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Piroplasmosis; Pnl; Point in time; Random; Serum; SR; Tick IgG + B burgdor Ab Pnl; Tick IgG Ab Pnl	4180186
36304687	Tick IgG + B burgdor Ab Pnl Ser	4180186
36304687	伯氏疏螺旋体抗体 & 嗜吞噬球无形体 & 鼠源巴贝斯虫 & 查菲埃立克体抗体.IgG 组套:-:时间点:血清:-	4182948
36304688	Arm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; Shoulder-Bl; UE; UE-Bl; Up; Upper extremity joint; W contr IV; WC	4180186
36304688	CT Shoulder-Bl W contr IV	4180186
36304688	多层^采用静脉注射对比剂:发现:时间点:上肢.双侧>肩部:文档型:CT	4182948
36304690	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36304690	Kanamycin Islt Genotyp	4180186
36304690	卡那霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36304692	5,8,11,14 Eicosatetraenoic acid; AA; Acd; Acid; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Fatty acid; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction	4180186
36304692	AA/Fatty acids.C14-C24 SFr SerPl	4180186
36304692	花生四烯酸/脂肪酸类.C14-C24:物质的量分数:时间点:血清/血浆:定量型	4182948
36304693	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304694	Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36304694	Guided Vein Embol	4180186
36304694	旨在栓塞的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36304696	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304700	Abd; Abdo; Abdomen+; Abdominal; Cath; Cath repos; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random	4180186
36304700	Guided Peritoneum Cath repos	4180186
36304700	旨在导管复位的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36304704	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304705	DRUG/TOXICOLOGY; Drugs; Ergot Poisonings; Ergotisms; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304705	Ergocornine Spec-mCnt	4180186
36304705	麦角柯宁碱:质量含量:时间点:XXX:定量型	4182948
36304707	Activ; Activity; Actvty; Arbitrary rate; Exercise; Moderate PA.inside chores; Moderate phys activity; Movements; QNT; Quan; Quant; Quantitative; Survey	4180186
36304708	C0; C16; Carnitine Free; Carnitine.total; Chemistry; FC; FR; Hexadecanoylcarnitine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36304708	Palmitoylcarn/C0 SerPl-sRto	4180186
36304708	棕榈酰肉碱 (C16)/肉碱.游离型 (C0):物质的量比率:时间点:血清/血浆:定量型	4182948
36304709	Chemistry; Chlorinated hydrocarb pnl; Misc; Miscellaneous; Other; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304709	Chlorinated hydrocarb pnl Spec	4180186
36304709	氯化烃组套:-:时间点:XXX:-	4182948
36304712	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36304713	Centers for Medicare and Medicaid Assessment; Integument; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304714	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
36304714	Kanamycin 2.5 ug/mL Islt SlowMyco	4180186
36304714	卡那霉素 2.5 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
36304715	A pleuropn; A pleuropn 3+6+8; A pleuropn 3+6+8+15; A pleuropn 3+6+8+15 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36304715	A pleuropn 3+6+8+15 Ab/Pos cntrl Ser IA	4180186
36304715	胸膜肺炎放线杆菌血清型 3+6+8+15 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304716	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Stricture dilation	4180186
36304716	Guided BDs Stricture dilation	4180186
36304716	旨在狭窄扩张术的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36304718	Chemistry; Dialy; Kidney; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304718	Metabolic panel.dialysis patient SerPl	4180186
36304718	代谢组套.透析患者:-:时间点:血清/血浆:-	4182948
36304720	T gondii DNA BldCo Ql NAA+probe	4180186
36304720	刚地弓形虫 DNA:存在情况或阈值:时间点:脐带全血:序数型:探针法.基因扩增.靶向	4182948
36304720	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
36304723	4th; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Finger.4th-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE-R; Up; without contrast	4180186
36304723	CT Finger.4th-R WO contr	4180186
36304723	多层^不采用对比剂:发现:时间点:上肢.右侧>手指.第四:文档型:CT	4182948
36304727	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; Rad; Radiology; Random	4180186
36304727	Guided BDs Bx	4180186
36304727	旨在经皮活组织检查的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36304729	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304729	HCoV OC43 RNA Aspirate Ql NAA+probe	4180186
36304729	人类冠状病毒 OC43 型 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36304730	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36304733	Type person perform defibrillation	4180186
36304733	CARD.PROC; Cardio; Cardiology; Heart Disease; Nominal; Person perform defibrillation; Persons; Point in time; Random; Typ; World Heatlth Organization	4180186
36304733	执行除颤的人员:类型:时间点:^患者:名义型	4182948
36304734	Hgb A1c goal MFr Bld	4180186
36304734	Blood; CLIN; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; HbA1c goal; Hgb; Hgb A1c; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36304734	血红蛋白 A1c/血红蛋白.总计目标:质量分数:时间点:全血:定量型	4182948
36304736	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dependal-M; Furoxone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36304736	Furazolidone Islt MIC	4180186
36304736	呋喃唑酮:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36304737	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304738	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36304742	CLIN; Nominal; Point in time; Random; Typ	4180186
36304742	用药文档记录状态:类型:时间点:^患者:名义型	4182948
36304743	B-cell NHL; B-cell non-hodgkin lymphoma; Blood; DNA; Document; Finding; Findings; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MALT; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Mucosa-associated lymphoid tissue lymphoma; Non-Hodgkin lymphoma; PCR; Point in time; Random; RNA; T prime; t(11;18)(BIRC3,MALT1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
36304743	t(11;18)(BIRC3,MALT1) Bld/T	4180186
36304743	t(11;18)(q21;q21)(BIRC3,MALT1) 融合转录物:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304744	Chemistry; i Phos; Inorganic phosphate; Level; Mass concentration; Misc; Miscellaneous; Other; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304744	Phosphate Spec-mCnc	4180186
36304744	磷酸盐:质量浓度:时间点:XXX:定量型	4182948
36304749	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304750	III; Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36304753	Abd; Abd+Pelvis; Abdo; Abdominal; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Genital tract; Guid; Guide; Guided; Imaging; Kid+Uret+Urethra; Kidney; Nephric; Nephrology; Pelvic; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Urth	4180186
36304753	RF Guided Kid+Uret+Urethra Dilation	4180186
36304753	旨在扩张术的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>尿道:文档型:放射荧光透视法	4182948
36304757	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36304757	Legionella DNA Tiss NAA+probe	4180186
36304757	军团菌属单个未知种 DNA:存在与否或特征标识:时间点:组织与涂片:名义型:探针法.基因扩增.靶向	4182948
36304762	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304763	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
36304763	Kanamycin 3.5 ug/mL Islt SlowMyco	4180186
36304763	卡那霉素 3.5 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
36304767	GM2 Gangl IgG+IgM Ser Ql Line blot	4180186
36304767	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GM2 Gangl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304767	神经节苷脂 GM2 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304768	Don-rec gender comb score	4180186
36304768	CLIN; CLIN.RISK; Don-rec gender comb score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scale; Screen; Sex	4180186
36304768	针对风险计算的供体-受体性别组合评分:评分:时间点:^患者:序数型	4182948
36304772	Abd; Abd vv; Abd vv + Pelvis vv; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; Finding; Findings; Heart Disease; Imaging; Pelvic; Pelvic vv; Pelvis vv; Point in time; Rad; Radiology; Random; Venogram; Venography; W contr IV; WC	4180186
36304772	CTA Abd vv + Pelvis vv W contr IV	4180186
36304772	多层^采用静脉注射对比剂:发现:时间点:腹部>腹部静脉类 & 盆腔>盆腔静脉类:文档型:CT.血管造影术	4182948
36304773	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Pradofloxacine; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36304773	PRA Susc Islt	4180186
36304773	普多沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36304774	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Legion; Legionela; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; species; spp	4180186
36304774	Legionella Lower resp Cult	4180186
36304774	军团菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
36304778	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Random; Renal; Telemedicine; Visit note	4180186
36304778	会诊记录:发现:时间点:远程医疗:文档型:肾病学	4182948
36304779	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36304779	Bacteria Sinus Aerobe Cult	4180186
36304779	细菌 已鉴定的:存在与否或特征标识:时间点:窦:名义型:需氧微生物培养	4182948
36304782	Adeno virus; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
36304782	HAdV Ag CSF Ql IA	4180186
36304782	腺病毒 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
36304784	EMS assistant qual	4180186
36304784	Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ	4180186
36304784	急救医疗服务助理资格:类型:时间点:服务提供者:名义型	4182948
36304791	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304792	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304792	阿司匹林停用日期:日期:时间点:^患者:定量型	4182948
36304793	Ang; Angio; Angiography; Angm; Arm; Arm and hand vessels; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-R; Finding; Findings; Imaging; Point in time; R; Rad; Radiology; Random; RT; RUE; UE; UE ves; UE ves-R; UE-R; Up; Vesl; Vessels.XXX; W contr IV; WC	4180186
36304793	CTA UE ves-R W contr IV	4180186
36304793	多层^采用静脉注射对比剂:发现:时间点:上肢.右侧>血管类:文档型:CT.血管造影术	4182948
36304797	Abd; Abd+Pelvis; Abdo; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Pelvic artery; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random	4180186
36304797	Guided Iliac a PTA	4180186
36304797	旨在经皮腔内血管成形术的引导:发现:时间点:腹部+盆腔>髂动脉:文档型:{成像方式}	4182948
36304799	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; i; II; Imaging; Inj; Misc; Miscellaneous; Musc; Muscl; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Trigger pt inject 1-2; Unspecified	4180186
36304799	Guided Muscle Trigger pt inject 1-2	4180186
36304799	旨在1或2次触痛点注射的引导:发现:时间点:XXX>肌肉:文档型:{成像方式}	4182948
36304800	ADCC; CHC Nurse; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
36304800	CHC Nurse ADCC Note	4180186
36304800	记录:发现:时间点:成人日间照护中心:文档型:社区医疗保健服务.护士	4182948
36304801	Pt's home Discharge teach note	4180186
36304801	*^Patient; Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Home health care; notes; Point in time; Pt's home; Random; S prime; Visit note	4180186
36304801	出院宣教记录:发现:时间点:患者的家:文档型:{角色}	4182948
36304802	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304803	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; Stent place; To be specified in another part of the message; Unspecified	4180186
36304803	Guided Artery Stent place	4180186
36304803	旨在置入支架的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36304804	Brain; CAT scan; Computed tomography; Computerized tomography; Cranial; Cranium; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Intracranial; Local; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; Skull; Tum loc	4180186
36304804	PET+CT Head+Neck Guid tum loc 18F-FDG IV	4180186
36304804	旨在肿瘤定位的引导^采用静脉注射 18F-FDG:发现:时间点:头部+颈部:文档型:PT+CT	4182948
36304806	ABS; Absorbing intrinsic; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Fac; Fact; Hematology; Heme; IF; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304806	IF Ab Ser Ql Line blot	4180186
36304806	内因子 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304809	Activ; Activity; Actvty; Exercise; Movements; Pan; Panl; Physical activity Pnl; Pnl; Point in time; Random; Survey	4180186
36304810	H+P; H+P.HX; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Wnd	4180186
36304810	Exudate Wnd	4180186
36304810	渗出物:存在情况或阈值:时间点:伤口:序数型	4182948
36304811	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Ptyalography; Rad; RADIOLOGY; Random; Sialogram; Sialography; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304811	CT Salivary gland WO+W contr IV	4180186
36304811	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部>唾液腺:文档型:CT	4182948
36304812	CARD.PROC; Cardio; Cardiology; Heart Disease; Nominal; Point in time; Random; TOAST Classification	4180186
36304812	TOAST Classification	4180186
36304812	急性缺血性卒中亚型:分类:时间点:^患者:名义型:TOAST	4182948
36304813	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304815	Chemistry; Mass Content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Vit E; Vitamin E	4180186
36304815	Tocopherol+tocotrienol Spec-mCnt	4180186
36304815	生育酚+生育三烯酚:质量含量:时间点:XXX:定量型	4182948
36304819	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304819	Sulfatide IgG Ser Ql Line blot	4180186
36304819	硫酸脑苷脂 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304820	CARD.PROC; Cardio; Cardiology; Circ assist devices used; Heart Disease; Identity or presence; Nominal; Point in time; Random; S prime	4180186
36304820	Circ assist devices used Postop	4180186
36304820	所采用的循环辅助设备^术后:存在与否或特征标识:时间点:^患者:名义型	4182948
36304822	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304824	Palmitoylcarn/C2 DBS-sRto	4180186
36304824	Blood; C16; C2; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
36304824	棕榈酰肉碱 (C16)/乙酰肉碱 (C2):物质的量比率:时间点:全血.斑点:定量型	4182948
36304827	Pan; Panel; PANEL.SURVEY.PHQ; Panl; Patient Health Questionnaire; Patient Health Questionnaire - 9 Modified for Teens; PHQ; PHQ-9 Teen; Pnl; Point in time; Random; Survey; SURVEY.PHQ	4180186
36304829	Carbapenem resist gene ID; CPR; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Resist; Resistanc; Resistant; Resistent	4180186
36304829	Carbapenem resistance gene index case	4180186
36304829	碳青霉烯类耐药基因 已鉴定的:存在与否或特征标识:时间点:指示病例^事件:名义型	4182948
36304830	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304832	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD27 Cells; CD27- cells; CD27+IgD- cells; CD27+IgD+ cells; CD27+IgD+IgM+ cells; CD27+IgD-IgM- cells; CD27+IgD-IgM+ cells; CD27-IgD+ cells; Cell; CELL MARKERS; Cellularity; HD-37; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; WB; Whole blood	4180186
36304832	CD27+IgD-IgM+/100 CD19 cells NFr Bld	4180186
36304832	细胞.CD27+IgD-IgM+/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36304833	BMI; bod; Bodies; BODY WEIGHT.ATOM; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random; Ratios; Rto	4180186
36304833	BMI Est	4180186
36304833	体质指数:比率:时间点:^患者:定量型:估计法	4182948
36304835	Ang; Angio; Angiography; Angm; AO; AoV; AV; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36304835	CTA Aortic valve W contr IV	4180186
36304835	多层^采用静脉注射对比剂:发现:时间点:胸部>主动脉瓣:文档型:CT.血管造影术	4182948
36304836	Dynamic; Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36304836	Bias flow Vent	4180186
36304836	偏流:体积速率:时间点:呼吸机:定量型	4182948
36304838	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microsporidiosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ophthalmology; Ophtho; Ophthy; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304838	Microsporid DNA Corn/Cnjt Ql NAA+probe	4180186
36304838	微孢子虫 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304841	CLIN; CLIN.RISK; Pan; PANEL.CLINICAL; Panl; PERC panel; Pnl; Point in time; Pulm; Pulmonary Function Test; Random	4180186
36304841	PERC panel PERC	4180186
36304845	Durat; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304845	Fasting duration Time Patient	4180186
36304845	禁食持续时间:时间:时间点:^患者:定量型	4182948
36304846	Bx; CAT scan; Computed tomography; Computerized tomography; CT guided pulmonary biopsy; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Lung-R; Perc; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Respiratory; RT; Thorax	4180186
36304846	CT Guided Lung-R Bx	4180186
36304846	旨在经皮活组织检查的引导:发现:时间点:胸部>肺.右侧:文档型:CT	4182948
36304848	Agg; Aggr; COAGULATION; Hematology; Heme; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
36304848	PA Rist 750 ug/mL PRP	4180186
36304848	血小板聚集.瑞斯托菌素诱导型^750 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36304852	FGF-21.intact SerPl-mCnc	4180186
36304852	Chemistry; Fac; Fact; FGF21; FGF-21.intact; iFGF21; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304852	成纤维细胞生长因子 21.完整型:质量浓度:时间点:血清/血浆:定量型	4182948
36304855	Banzel; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Lennox-Gastaut syndrome; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304855	Rufinamide/Creat Ur Cfm	4180186
36304855	卢非酰胺/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304857	III; Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36304860	Breath H2 40M p fruct PO	4180186
36304860	40M p fruct PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
36304860	氢/已呼出的气体^在口服剂量果糖之后40分钟:体积分数:时间点:呼出的气体:定量型	4182948
36304861	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304862	HuD Ab SerPl IA-aCnc	4180186
36304862	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304862	HuD 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304863	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304864	Alb; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fl; Fld; FLU; Fluid; GLB; Glob; Glob%; Globul; Globulins; Hepatology; Kidney; Liver; Mass concentration ratio; Mass ratio; MCRto; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
36304864	Albumin/Glob Fld Elph	4180186
36304864	白蛋白/球蛋白:质量比率:时间点:体液:定量型:电泳	4182948
36304865	BLOOD BANK; Donr; Erythrocytes; Ordinal; p; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36304865	little p phenotype RBC Donr Ql	4180186
36304865	p 表型:存在情况或阈值:时间点:红细胞^供体:序数型	4182948
36304868	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36304868	FLUAV Ag Lower resp Ql IF	4180186
36304868	流感病毒 A 型 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36304870	#; ABS; absolute; absolutes; Blood; CD4 Cells; CD4+CD25+ Cells; CD4+CD25+CD45RO+CD127Low+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Inducer T cells; L3T4; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; UCHL-1; W3/25; WB; Whole blood	4180186
36304870	CD4+CD25+CD45RO+CD127Low+ cells # Bld	4180186
36304870	细胞.CD4+CD25+CD45RO+CD127Low+:计数型浓度:时间点:全血:定量型	4182948
36304872	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36304872	Gram Stn Sinus	4180186
36304872	显微镜观察:存在与否或特征标识:时间点:窦:名义型:革兰氏染色法	4182948
36304873	100 CD3+CD8+; Blood; CD3 Cells; CD3+CD8+ Cells; CD45RO Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Leu2; Leu-2; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36304873	CD45RO Cells/100 CD3+CD8+ NFr Bld	4180186
36304873	细胞.CD45RO/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型	4182948
36304874	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304875	Centers for Medicare and Medicaid Assessment; Finding; Findings; Integument; Nominal; Past; Survey	4180186
36304877	C0; C8; Carnitine Free; Carnitine.total; Chemistry; FC; FR; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36304877	Octanoylcarn/C0 SerPl-sRto	4180186
36304877	辛酰肉碱 (C8)/肉碱.游离型 (C0):物质的量比率:时间点:血清/血浆:定量型	4182948
36304878	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Eye fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Occular fluid; Ocflu; Point in time; Random	4180186
36304878	Bacteria Ocflu Aerobe Cult	4180186
36304878	细菌 已鉴定的:存在与否或特征标识:时间点:眼液:名义型:需氧微生物培养	4182948
36304882	Metaxalone/Creat Ur Cfm	4180186
36304882	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Skelaxin; UA; UCr; UR; Urn	4180186
36304882	美他沙酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304886	Chemistry; Level; MAG; Magnes; Mass concentration; Mg; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304886	Magnesium Spec-mCnc	4180186
36304886	镁:质量浓度:时间点:XXX:定量型	4182948
36304887	A pleuropn; A pleuropn 10+12; A pleuropn 10+12 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36304887	A pleuropn 10+12 Ab/Pos cntrl Ser IA	4180186
36304887	胸膜肺炎放线杆菌血清型 10+12 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304888	Envir Health Note	4180186
36304888	DOC.ONT; Document; Encounter; Envir Health; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36304888	记录:发现:时间点:{环境}:文档型:环境卫生学	4182948
36304895	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36304895	记录:发现:时间点:{环境}:文档型:创伤专业	4182948
36304899	Microscopic exam pnl Ear Micro	4180186
36304899	Hearing; LM; Micro; Microbiology; Micros; Microscopic; Microscopic exam pnl; Otologic; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
36304899	显微镜检查组套:-:时间点:耳:-:显微镜检查.光学	4182948
36304903	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304907	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfrin iota tox; C perfringens; C perfringens iota; C perfringens iota toxin DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304907	C perfrin iota tox DNA Islt Ql NAA+probe	4180186
36304907	产气荚膜梭菌 iota 毒素 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304912	Abd; Abdo; Abdomen+; Abdominal; bod; Bodies; CorePlaybook; Document; Extraction; FB; FB removal; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Remove	4180186
36304912	Guided Peritoneum FB removal	4180186
36304912	旨在去除异物的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36304913	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Evening; PM-SCL75; PM-SCL-75; Point in time; Polymyositis; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Serology; Serum; SR; Systemic Sclerosis	4180186
36304913	PM-SCL75 Ab Ser Line blot-aCnc	4180186
36304913	PM-SCL-75 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304915	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Adeno virus; Amplif; Amplification; Amplified; AV A+B+C+D+E+F DNA; Deoxyribonucleic acid; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; HAdV A+B+C+D+E; HAdV A+B+C+D+E+F; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304915	HAdV A+B+C+D+E+F DNA Nph Ql NAA+probe	4180186
36304915	腺病毒 A+B+C+D+E+F DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36304916	Abd; Abd+Pelvis; Abdo; Abdominal; Ang; Angio; Angiography; Angm; Art; Arteriogram; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT Angiogram; CT angiography; CT scan; CTA; Deep inf epigastric a; DIEA; DIEP; Document; Finding; Findings; Heart Disease; Imaging; Inf; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
36304916	CTA Deep inf epigastric a W contr IV	4180186
36304916	多层^采用静脉注射对比剂:发现:时间点:腹部+盆腔>腹壁下深动脉:文档型:CT.血管造影术	4182948
36304917	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey; Tot; Total PA.work; Totl	4180186
36304919	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304919	FLUBV RNA Lower resp Ql NAA+probe	4180186
36304919	流感病毒 B 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304921	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36304921	旁观者当时观察到晕倒:发现:时间点:^患者:序数型	4182948
36304922	ADMIN; ADMIN.PATIENT; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304922	Financial responsibility	4180186
36304922	财务责任金额:数量(计数):时间点:^患者:定量型	4182948
36304923	Aflatoxicosis; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304923	Aflatoxin B2 Spec-mCnt	4180186
36304923	黄曲霉毒素 B2:质量含量:时间点:XXX:定量型	4182948
36304924	c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; FCN; Finding; Findings; Func; Funct; Hrt; Imaging; L; LT; LV function; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast; WO contr + for LV function; WO contr + for LV funtion; WO contr + for LV funtion W contr	4180186
36304924	CT Hrt	4180186
36304924	(多层^不采用对比剂) + (针对左心室功能的多层^采用静脉注射对比剂):发现:时间点:胸部>心脏:文档型:CT	4182948
36304925	2,6-diaminohexanoic acid; Ala; Alpha alanine; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; L-alanine; Lys; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36304925	Alanine/Lysine DBS	4180186
36304925	丙氨酸/赖氨酸:质量比率:时间点:全血.斑点:定量型	4182948
36304928	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; The Fibro Test	4180186
36304928	Liver fibrosis interpretation Ser-Imp	4180186
36304928	肝纤维化解释:印象:时间点:血清:序数型	4182948
36304935	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304936	Dmdt; DRUG/TOXICOLOGY; Drugs; Marlate; Mass content; Methoxy-DDT; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304936	Methoxychlor Spec-mCnt	4180186
36304936	甲氧滴滴涕:质量含量:时间点:XXX:定量型	4182948
36304937	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36304939	SOX-2 Ab SerPl IA-aCnc	4180186
36304939	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SRY (sex determinig region Y)-box 2; SUDS	4180186
36304939	SOX-2 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304941	Breathing; Exp pressure; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36304941	Exp pressure Airway	4180186
36304941	呼气压:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36304942	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304947	Occup med Immunization note	4180186
36304947	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; Occup med; Occupational health; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36304947	疫苗接种记录:发现:时间点:{环境}:文档型:职业医学	4182948
36304951	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36304951	HSV1 Ag CSF Ql IF	4180186
36304951	单纯疱疹病毒 1 型 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36304953	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; TRAUMA	4180186
36304953	跌倒高度范围:发现:时间点:^患者:序数型	4182948
36304955	CorePlaybook; Document; Drain; Drain+CT place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pl space; Playbook; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Thorax	4180186
36304955	Guided Pl space Drain+CT place	4180186
36304955	旨在引流+胸管置入的引导:发现:时间点:胸部>胸膜腔:文档型:{成像方式}	4182948
36304957	CT C+T+L-spine W contr IV	4180186
36304957	多层^采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段:文档型:CT	4182948
36304957	Abd; Abdo; Abdomen+; Abdominal; c; C/sp; C+T+L-spine; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; W contr IV; WC	4180186
36304959	Emergency Medical Service(s); Lead EMS MD at scene; Nominal; Person name; Point in time; Random; TRAUMA	4180186
36304959	Lead EMS MD at scene	4180186
36304959	负责现场管理的急救医疗服务医师:人员姓名:时间点:服务提供者:名义型	4182948
36304963	Barrier; Barriers; Challenge; CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Treatment maint challenges pnl; Tx	4180186
36304963	Treatment maint challenges pnl	4180186
36304963	治疗计划坚持难题组套:-:时间点:^患者:-	4182948
36304966	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lymph ves; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Vesl	4180186
36304966	Guided Lymph ves Ligation	4180186
36304966	旨在结扎术的引导:发现:时间点:XXX>淋巴管:文档型:{成像方式}	4182948
36304968	Acute kidney injury risk NephroCheck	4180186
36304968	Acute Renal Failure; AKI risk; ARF; Calc; Calc.NephroCheck; Calculation; Chemistry; NephroCheck test system; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Ulcer	4180186
36304968	急性肾脏损伤风险:似然性:时间点:^患者:定量型:计算法.NephroCheck	4182948
36304971	DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Toxicology Pnl; Unspecified; Vet; Vet toxic pnl; Veterinary	4180186
36304971	Vet toxic pnl XXX Qn	4180186
36304971	兽医毒理学组套:-:时间点:XXX:定量型	4182948
36304972	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304974	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36304975	CD3+CD8+CD27-CD45RO+CD62L- cells # Bld	4180186
36304975	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD27- cells; CD3+CD8+CD27+CD45RO+CD62L+ cells; CD3+CD8+CD27-CD45RO+CD62L- cells; CD8 T cells; CD8+CD27+CD45RO+CD62L+; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36304975	细胞.CD3+CD8+CD27-CD45RO+CD62L-:计数型浓度:时间点:全血:定量型	4182948
36304981	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304985	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304986	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304987	ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; PDV glyco B Ab; PHV1; Point in time; Porcine herpes virus 1; PRV; PRV glycoprot B; Pseudorabies; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary	4180186
36304987	PRV glycoprot B Ab Ser IA	4180186
36304987	伪狂犬病病毒糖蛋白 B 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304990	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36304991	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA SS-A; ENA SS-A 52kD; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSA; SS-A	4180186
36304991	ENA SS-A 52kD Ab CSF Ql Line blot	4180186
36304991	Sjogrens 综合征-a 可提取性核 52kD 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36304992	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304992	Monensin Spec-mCnt	4180186
36304992	莫能菌素:质量含量:时间点:XXX:定量型	4182948
36304996	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC gene pnl; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36304996	EC gene pnl Spec NAA+probe	4180186
36304996	大肠埃希菌基因组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36304997	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; Blood; Cell; Cellularity; Helper T cells; ID; IFN; IGRA; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu2; Leu-2; Leu3; Leu-3; Lung; M tb; M TB IFN-g; M TBIFN-g CD4+ CD8+T-cells; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Suppressor T cells; T prime; T4; T-4; T8; T-8; TB; Tsuppressor; Tuberculosis; W3/25; WB; Whole blood	4180186
36304997	M TBIFN-g CD4+ CD8+T-cells Bld-aCnc	4180186
36304997	CD4+ 和 CD8+ T-细胞所释放的结核分枝杆菌刺激型 gamma 干扰素:任意型浓度:时间点:全血:定量型	4182948
36304999	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; L intracell; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary	4180186
36304999	L intracell Ab Ser Ql IA	4180186
36304999	胞内劳森菌 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305003	C9.functional SerPl-aCnc	4180186
36305003	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305003	补体 C9.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
36305004	25(OH)D3+25(OH)D2 goal mCnc SerPl	4180186
36305004	25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25(OH)D3+25(OH)D2 goal; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; CLIN; Ercalcidiol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vitamin D 25 hydroxy	4180186
36305004	钙二醇+羟基钙二醇目标:质量浓度:时间点:血清/血浆:定量型	4182948
36305005	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Throat; Upper respiratory	4180186
36305005	N men Throat Ql Cult	4180186
36305005	脑膜炎奈瑟菌:存在情况或阈值:时间点:咽喉:序数型:微生物特异性培养	4182948
36305007	Date vaccine ind effective	4180186
36305007	Date vaccine ind effective; Immunizations; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine	4180186
36305007	疫苗接种指征生效日期:日期:时间点:^患者:定量型	4182948
36305010	Addiction med Counseling note	4180186
36305010	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305010	咨询记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305011	Arbitrary concentration; Beta 1 C-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305011	C3.functional SerPl-aCnc	4180186
36305011	补体 C3.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
36305013	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305016	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey; Swallowing/nutritional status	4180186
36305017	Outpt Hosp Consult note	4180186
36305017	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; OP; Outpt Hosp; Point in time; Random; Visit note	4180186
36305017	会诊记录:发现:时间点:门诊型医院:文档型:{角色}	4182948
36305018	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305018	HCoV NL63 RNA Corn/Cnjt Ql NAA+probe	4180186
36305018	人类冠状病毒 NL63 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305021	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Gabitril; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305021	tiaGABine/Creat Ur Cfm	4180186
36305021	噻加宾/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305031	Asp; CorePlaybook; Document; EXT; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Kn; LE; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36305031	Guided Knee Arthrocentesis	4180186
36305031	旨在经皮穿刺抽吸的引导:发现:时间点:下肢>膝关节:文档型:{成像方式}	4182948
36305032	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Tobacco use pnl	4180186
36305032	Tobacco use pnl	4180186
36305032	烟草使用组套:-:时间点:^患者:-	4182948
36305033	HCO3 goal sCnc Bld	4180186
36305033	BIC; bicar; Bicarb; Blood; CLIN; HCO3; HCO3 goal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
36305033	碳酸氢盐目标:物质的量浓度:时间点:全血:定量型	4182948
36305037	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Survey	4180186
36305039	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305039	Hearing threshold 3000 Hz Ear-L	4180186
36305039	听阈^3000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36305041	Sufficiency proc perform bystander	4180186
36305041	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sufficiency proc perform bystander; TRAUMA	4180186
36305041	旁观者所进行操作项目的充分性:发现:时间点:^患者:序数型	4182948
36305042	Activities of Daily Living; ADL and IADLs - d/c; Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305044	Year aspirin regimen began	4180186
36305044	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305044	阿司匹林治疗方案开始年份:日期:时间点:^患者:定量型	4182948
36305045	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Me-phenidate; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Ritalin; Sal	4180186
36305045	Me-phenidate Sal Cfm-mCnc	4180186
36305045	哌甲酯:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36305046	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305047	1 week; FCN; Func; Funct; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36305048	bod; Bodies; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Femoral; Femur; Finding; Findings; Guid; Guide; Guided; Head; Imaging; Local; Lower extremity; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; Tum loc; Vert to thigh; W 18F-FDG+contr IV; W contr IV; WB; WC	4180186
36305048	PET+CT Vert-thgh Guid tum loc 18F-FDG IV	4180186
36305048	旨在肿瘤定位的引导^采用静脉注射 18F-FDG+采用静脉注射对比剂:发现:时间点:全身>颅顶点至大腿中部:文档型:PT+CT	4182948
36305056	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Mass Fraction; Percent; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SpO2; Tot; Totl	4180186
36305056	COHgb % BldA PulseOx	4180186
36305056	碳氧血红蛋白/血红蛋白.总计:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
36305057	Abd; Abdo; Abdomen+; Abdominal; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Point in time; PV; Rad; Radiology; Random; Ven; Venous; W emb ag IV	4180186
36305057	Guided Portal v Embol--W emb ag IV	4180186
36305057	旨在栓塞的引导^采用静脉注射栓塞剂:发现:时间点:腹部>门静脉:文档型:{成像方式}	4182948
36305059	BP sys--W exercise	4180186
36305059	Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; EXCZ; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
36305059	血管内心脏收缩期^采用运动:压力或压强:时间点:动脉系统:定量型	4182948
36305063	Lung cancer antibody SerPl IA-Imp	4180186
36305063	肺癌抗体:印象:时间点:血清/血浆:名义型:免疫测定法	4182948
36305063	Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lung cancer Ab; MEIA; Nominal; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305064	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305065	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Hematology and Oncology; Hematology+Oncology; Heme; HemOnc; notes; Oncology; Parentrl thrpy note; Point in time; Random; Visit note	4180186
36305065	HemOnc Parentrl thrpy note	4180186
36305065	肠道外治疗记录:发现:时间点:{环境}:文档型:血液学+内科肿瘤学	4182948
36305066	Ang; Angio; Angiography; Angm; Bil; Bilat; Both; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-Bl; Finding; Findings; Heart Disease; Imaging; LE; LE vv; LE vv-Bl; LE-Bl; Leg; Low; Point in time; Rad; RADIOLOGY; Random; Venogram; Venography; W contr IV; WC	4180186
36305066	CTA LE vv-Bl W contr IV	4180186
36305066	多层^采用静脉注射对比剂:发现:时间点:下肢.双侧>下肢静脉类:文档型:CT.血管造影术	4182948
36305067	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305068	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; K pneumoniae yggE; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36305068	K pneumoniae yggE Bld Pos Ql Probe	4180186
36305068	肺炎克雷伯菌 yggE 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305071	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Sulphathiazole; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305071	Sulfathiazole Spec-mCnt	4180186
36305071	磺胺噻唑:质量含量:时间点:XXX:定量型	4182948
36305072	Antigen; Antigens; Cysticercosis; Cysticercus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T sol; T sol lar; T solium; Tapeworm	4180186
36305072	T sol lar Ag Ser Ql IA	4180186
36305072	猪囊尾蚴 抗原:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305073	No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Social Security #; SSN request date; Survey; SURVEY.CDC	4180186
36305074	Acetylisovaleryltylosin; Aivlosin; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305074	Tylvalosin Spec-mCnt	4180186
36305074	泰乐菌素:质量含量:时间点:XXX:定量型	4182948
36305075	Vedolizumab SerPl IA-mCnc	4180186
36305075	DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Entyvio; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Vedol	4180186
36305075	维多珠单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305077	CT C+T+L-spine+Sacr+Coccyx WO+W contr IV	4180186
36305077	多层^不采用 & 采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段 & 盆腔>骶骨+尾骨:文档型:CT	4182948
36305077	Abd; Abdo; Abdomen+; Abdominal; c; C/sp; C+T+L+Sacrum; C+T+L-spine; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; C-spine to Coccyx; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; L-spine+Sacrum; L-spine+Sacrum+Coccyx; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305079	c; C/sp; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Intrathecal; Myelogram; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr IT; WC	4180186
36305079	CT C+T-spine W contr IT	4180186
36305079	多层^采用鞘内对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段:文档型:CT	4182948
36305080	3 Self-Sustaining Sequence Replication; 3SR SR; Amebic keratitis; Amebic meningoencephalitis; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Soil amoeba; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305080	Acanthamoeba DNA CSF Ql NAA+probe	4180186
36305080	棘阿米巴属单个未知种 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36305081	Nominal; Point in time; Random; Typ	4180186
36305081	除颤方式:类型:时间点:{装置}:名义型	4182948
36305083	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Corn/Cnjt; Corneal; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF	4180186
36305083	HSV2 Ag Corn/Cnjt Ql IF	4180186
36305083	单纯疱疹病毒 2 型 抗原:存在情况或阈值:时间点:角膜/结膜:序数型:免疫荧光法	4182948
36305084	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305085	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36305085	Brachyspira Ag Tiss Ql ImStn	4180186
36305085	短螺旋体属单个未知种 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36305087	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; species; spp; Survey	4180186
36305088	Abd; Abdo; Abdomen+; Abdominal; Cath; Cath place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Plac of cath; Playbook; Point in time; Rad; Radiology; Random	4180186
36305088	Guided Peritoneum Cath place	4180186
36305088	旨在置入导管的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36305091	Chemistry; Haemoglobin oxygenated; HbO2; Hemoglobin oxygenated; Level; Mass concentration; O2Hb; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305091	OxyHgb Plas-mCnc	4180186
36305091	氧合血红蛋白:质量浓度:时间点:血浆:定量型	4182948
36305093	DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Toxicology Pnl; Unspecified; Vet; Vet toxic pnl; Veterinary	4180186
36305093	Vet toxic pnl Spec Ql	4180186
36305093	兽医毒理学组套:存在情况或阈值:时间点:XXX:序数型	4182948
36305097	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Foot-Bl; Ft; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
36305097	CT Foot-Bl WO contr	4180186
36305097	多层^不采用对比剂:发现:时间点:下肢.双侧>足部:文档型:CT	4182948
36305099	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305099	M genitalium DNA Anorectl Ql NAA+probe	4180186
36305099	生殖支原体 DNA:存在情况或阈值:时间点:肛门直肠:序数型:探针法.基因扩增.靶向	4182948
36305103	Time rise, walk 10ft, return sit [TUG]	4180186
36305103	H+P; H+P.PX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time rise, walk 10ft, return sitting	4180186
36305103	从椅子上站起身,步行走出10英尺,然后再返回到椅中坐姿时所用的时间:时间:时间点:^患者:定量型:起立-行走计时测试法	4182948
36305109	3; 3 questions Pnl; MISC; Pan; PANEL.MISC; Panl; Pnl; Point in time; Random	4180186
36305109	3 questions Pnl Patient	4180186
36305109	三联问题组套:-:时间点:^患者:-	4182948
36305110	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; V; Vet; Veterinary	4180186
36305110	Vanadium Spec-mCnt	4180186
36305110	钒:质量含量:时间点:XXX:定量型	4182948
36305111	Bil; Bilat; Both; c; Calf; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Fibula; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; Lower leg-Bl; Point in time; Rad; RADIOLOGY; Random; Tibia; without contrast	4180186
36305111	CT Lower leg-Bl WO contr	4180186
36305111	多层^不采用对比剂:发现:时间点:下肢.双侧>小腿:文档型:CT	4182948
36305112	GALNS DBS-cCnc	4180186
36305112	Blood; Catalytic Concentration; Chemistry; Chondroitin sulfatase; Chondroitinase; DBS; Dried blood spot; Filter paper; FP; Galactose-6-sulfate sulfatase; GalN6S; GALNS; Morquio disease, type A; MPS VI A; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36305112	N-乙酰半乳糖胺-6-硫酸酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
36305114	After; Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; EXCZ; Heart Disease; Intravenous; IV; p Exc; Point in time; Pressure; PST; QNT; Quan; Quant; Quantitative; Random	4180186
36305114	BP dias--p Exc	4180186
36305114	血管内心脏舒张期^在运动之后:压力或压强:时间点:动脉系统:定量型	4182948
36305115	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; VCL	4180186
36305115	Vinculin Ab Ser IA-aCnc	4180186
36305115	粘着斑蛋白 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36305116	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36305117	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
36305118	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Proteus sp atpD; Ql; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
36305118	Proteus sp atpD Bld Pos Ql Probe	4180186
36305118	变形杆菌属 (atpD) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305119	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfringens; C perfringens cpb; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305119	C perfringens cpb Islt Ql NAA+probe	4180186
36305119	产气荚膜梭菌 cpb 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305123	Arterial Stenosis; Centers for Medicare and Medicaid Assessment; Finding; Findings; II; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
36305125	Cerebral spinal fluid; Cerebrospinal Fl; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305125	Micro CNAMTS panel CSF	4180186
36305125	微生物学 CNAMTS 组套:-:时间点:脑脊液:-	4182948
36305129	Add; Cardio; Cardiology; CorePlaybook; Document; EXT; Extr v; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Laser ablation addl; Playbook; Point in time; Rad; RADIOLOGY; Random; Ven; Venous	4180186
36305129	Guided Extr v Laser ablation addl	4180186
36305129	旨在额外激光消融术的引导:发现:时间点:肢体>肢体静脉:文档型:{成像方式}	4182948
36305130	Centers for Medicare and Medicaid Assessment; OT; QNT; Quan; Quant; Quantitative; Survey; Tx	4180186
36305131	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305132	Add; CorePlaybook; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Kyphoplasty addl level; Levels; Levl; LV; LVL; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
36305132	Guided T-spine Kyphoplasty addl level	4180186
36305132	旨在额外级别椎体后凸成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:{成像方式}	4182948
36305135	ADMIN; ADMIN.PATIENT; Nominal; Point in time; Random; Typ	4180186
36305135	健康保险范围类型:类型:时间点:^患者:名义型	4182948
36305136	Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Point in time; PRO measure score; PRO measure score interp; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305139	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B div+MO-1 18S; B div+MO-1 18S rRNA; B divergens; Babesiosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; month; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Piroplasmosis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305139	B div+MO-1 18S rRNA Bld Ql NAA+non-probe	4180186
36305139	分歧巴贝斯虫+MO-1 株 18S rRNA 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36305141	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Periph; Playbook; PN; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305141	Guided PN Nerve block	4180186
36305141	旨在神经阻滞的引导:发现:时间点:XXX>周围神经:文档型:{成像方式}	4182948
36305142	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Babesia 18S; Babesiosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Piroplasmosis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305142	Babesia 18S rRNA Bld Ql NAA+probe	4180186
36305142	巴贝斯虫属 18S rRNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36305147	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV; PCV2b; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305147	PCV2b DNA Ct Spec Qn NAA+probe	4180186
36305147	猪圆环病毒 2b 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305148	30s CST; 30-Second Chair Stand; 30sSTS; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stands; Survey	4180186
36305150	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305154	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305154	Bordetella DNA Nph NAA+probe	4180186
36305154	博德特菌属单个未知种 DNA:存在与否或特征标识:时间点:鼻咽:名义型:探针法.基因扩增.靶向	4182948
36305155	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E faecalis; E faecalis hsp60; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36305155	E faecalis hsp60 Bld Pos Ql Probe	4180186
36305155	粪肠球菌 hsp60 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305159	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Pork; PR; PTV; Ql; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305159	PTV Spec Ql Cult	4180186
36305159	猪捷申病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36305161	Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305162	Finding; Findings; Lung; Nominal; O2; Oxygen for preoxygenation; Point in time; PULMONARY; Pulmonology; Random; Respiratory; tO2	4180186
36305162	Oxygen for preoxygenation	4180186
36305162	当时将氧气用于了预吸氧:发现:时间点:^患者:名义型	4182948
36305163	Cath; CorePlaybook; CVC lumen obstr mech thromb; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305163	Guided CVC lumen obstr mech thromb	4180186
36305163	旨在中心静脉导管管腔阻塞机械性血栓切除术的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305167	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cancer-associated retinopathy; Paraneoplastic Antibody; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Small-cell lung cancer; SR	4180186
36305167	Recoverin Ab Ser Line blot-aCnc	4180186
36305167	恢复蛋白 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36305171	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305172	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Wt; Wt gain	4180186
36305178	Arterial Stenosis; Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305181	Actino; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Tissue; Tissue, unspecified	4180186
36305181	Actinomyces Tiss Cult	4180186
36305181	放线菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:组织与涂片:名义型:微生物特异性培养	4182948
36305182	Breathing; Count/time; EXCZ; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; RESP.MOLEC; Respiratory rate; RS	4180186
36305182	Resp rate W exercise	4180186
36305182	呼吸^采用运动:计数型速率:时间点:呼吸系统:定量型	4182948
36305183	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey; Walking PA.work; Walking phys activity	4180186
36305184	Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; PTA; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36305184	Guided Vein PTA	4180186
36305184	旨在经皮腔内血管成形术的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36305185	Chemo infusion stop time Clock time	4180186
36305185	Chemo; Chemo infusion stop time; Clock time; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305185	化疗灌注停止时间:时钟时间:时间点:^患者:定量型	4182948
36305188	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305188	HSV DNA Corn/Cnjt Ql NAA+probe	4180186
36305188	单纯疱疹病毒 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305189	Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; UE; Up; without contrast	4180186
36305189	CT Finger WO contr	4180186
36305189	多层^不采用对比剂:发现:时间点:上肢>手指:文档型:CT	4182948
36305191	2; BDI II; BDI II total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
36305194	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klebsiella pneumonia carbapenemase; KPC; Mero+Vab; Meronem; Merrem; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vabomere	4180186
36305194	Mero+Vab Susc Islt	4180186
36305194	美罗培南+伐波巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36305196	C&S; Cardio; Cardiology; Cult; Cultures; Entero virus; EV; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; Spec	4180186
36305196	EV Pcar Cult	4180186
36305196	肠道病毒 已鉴定的:存在与否或特征标识:时间点:心包液:名义型:微生物特异性培养	4182948
36305199	Ang; Angio; Angiography; Angm; Arteriogram; c; CA; CA+PA; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Imaging; PAA; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36305199	CTA CA+PA W contr IV	4180186
36305199	多层^采用静脉注射对比剂:发现:时间点:胸部>冠状动脉类+肺动脉类:文档型:CT.血管造影术	4182948
36305202	CKD educ topic(s) discussed	4180186
36305202	CKD educ topic(s) discussed; CLIN; Dis; Diseases; Dz; Nominal; Point in time; Random; S prime; Typ	4180186
36305202	在此次就诊期间所讨论的慢性肾脏疾病教育主题:类型:时间点:^患者:名义型	4182948
36305205	Activity; EXCZ; Exercise; Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305206	DDE; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; o,p'- DDE; Other; P prime; p,p'-DDE; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305206	o,p'- DDE Spec-mCnt	4180186
36305206	o,p'- 二氯二苯二氯乙烯:质量含量:时间点:XXX:定量型	4182948
36305209	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305210	Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Perf based measure score; Perf based measure score interp; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305212	DRUG/TOXICOLOGY; Drugs; Haldol; Halo + Halo.reduced Pnl; Haloperidol & metabolite; Haloperidol metabolite; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Reduced Haloperidol; Serenace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305212	Halo + Halo.reduced Pnl SerPl	4180186
36305212	氟哌啶醇与还原型氟哌啶醇组套:-:时间点:血清/血浆:定量型	4182948
36305213	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Temik; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305213	Aldicarb Spec-mCnt	4180186
36305213	涕灭威:质量含量:时间点:XXX:定量型	4182948
36305215	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305215	HSV2 DNA Lower resp Ql NAA+probe	4180186
36305215	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305216	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiology; Random; TIPS revision; TIPSS	4180186
36305216	Guided Liver TIPS revision	4180186
36305216	旨在经颈静脉修正经颈静脉肝内门体静脉分流的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36305217	C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; thoracentesis fluid; Thrush	4180186
36305217	Fungus Plr Cult	4180186
36305217	真菌 已鉴定的:存在与否或特征标识:时间点:胸膜液:名义型:培养	4182948
36305220	Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Stl; Stool = Fecal; Strongyloidiasis	4180186
36305220	Strongyloides Stl Cult	4180186
36305220	类圆线虫属单个未知种 已鉴定的:存在与否或特征标识:时间点:大便:名义型:微生物特异性培养	4182948
36305221	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; Pulmotil; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305221	Tilmicosin Spec-mCnt	4180186
36305221	替米考星:质量含量:时间点:XXX:定量型	4182948
36305222	Breathing; Lung; Lungs; Point in time; Press.base; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36305222	Press.base on vent Airway	4180186
36305222	压力.基线^采用呼吸机:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36305224	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305226	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305227	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305228	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA RT; HIV 1 RNA RT gene mut; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; Random; REV; Ribonucleic acid; RT; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305228	HIV 1 RNA RT Mut Det CSF Seq	4180186
36305228	HIV 1 型 RNA 逆转录酶基因 已检出的突变:存在与否或特征标识:时间点:脑脊液:名义型:序列测定	4182948
36305229	Centers for Medicare and Medicaid Assessment; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; Prev; PT; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305231	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36305231	Guided Liver Microwave abl	4180186
36305231	旨在微波消融术的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36305233	After; Finding; Findings; Ordinal; Point in time; post ADAPTABLE; PST; QL; Qual; Qualitative; Random; Screen; Study report; Survey; SURVEY.GNHLTH	4180186
36305234	T gondii DNA Placenta Ql NAA+probe	4180186
36305234	刚地弓形虫 DNA:存在情况或阈值:时间点:胎盘:序数型:探针法.基因扩增.靶向	4182948
36305234	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Placent; Placental; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
36305240	Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Thromb infus final day; Thrombolysis; To be specified in another part of the message; Unspecified; Vesl; W thromb via cath	4180186
36305240	Guided Ves Throm inf final W thr in cath	4180186
36305240	旨在最后输注一天溶栓剂的引导^采用经导管给予的溶栓剂:发现:时间点:XXX>血管:文档型:{成像方式}	4182948
36305242	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305245	Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn	4180186
36305245	Gie Stn Lower resp	4180186
36305245	显微镜观察:存在与否或特征标识:时间点:呼吸道.下:名义型:姬姆萨染色法	4182948
36305247	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36305247	Gram Stn Islt	4180186
36305247	显微镜观察:存在与否或特征标识:时间点:分离株:名义型:革兰氏染色法	4182948
36305248	Polytrauma Case Mgr Note	4180186
36305248	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Polytrauma Case Mgr; Random; Visit note	4180186
36305248	记录:发现:时间点:{环境}:文档型:多发性创伤.病例管理人员	4182948
36305249	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305250	CD45RA Cells/100 CD4 cells NFr Bld	4180186
36305250	100 CD4 cells; 2H4; Blood; CD4 Cells; CD45RA Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu18; Leu-18; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; W3/25; WB; Whole blood	4180186
36305250	细胞.CD45RA/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36305251	4 weeks; Finding; Findings; Glonoin; Glyceryl trinitrate; GTN; Last; Nitroglycerol; NTG; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH; TNG; Trinitrin; Trinitroglycerin	4180186
36305253	inFLIXimab SerPl IA-mCnc	4180186
36305253	DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remicade; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305253	英利昔单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305255	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305258	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; River blindness; Screen; Serum; species; spp; SR; SUDS	4180186
36305258	Onchocerca IgG3 Ser Ql IA	4180186
36305258	盘尾属单个未知种 抗体.IgG3:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305264	Dermafos; DRUG/TOXICOLOGY; Drugs; Fenclofos; Mass content; Misc; Miscellaneous; Other; Phenchlorfos; Point in time; QNT; Quan; Quant; Quantitative; Random; Ronnel; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305264	Fenchlorphos Spec-mCnt	4180186
36305264	皮蝇磷:质量含量:时间点:XXX:定量型	4182948
36305267	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305267	HPIV1 RNA Corn/Cnjt Ql NAA+probe	4180186
36305267	副流感病毒 1 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305269	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305270	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305271	AB-CHMINACA OH-cyclohexyl; Addiction; Cfm; Cloud 10; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Smoke; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36305271	AB-CHMINACA OH-cyclohexyl Ur Ql Cfm	4180186
36305271	AB-CHMINACA 羟基环己基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305275	ADMIN; Ext ID; Nominal; Point in time; Random	4180186
36305275	Birth attendant Ext ID Provider	4180186
36305275	接生人员:扩展型标识符:时间点:服务提供者:名义型	4182948
36305277	FDA insert Patient counseling inform	4180186
36305277	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
36305277	患者咨询信息:-:-:^FDA 包装说明书:叙述型	4182948
36305279	DRUG/TOXICOLOGY; Drugs; Famfur; Famofos; FAMOPHOS; Famphos; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Warbexol	4180186
36305279	Famphur Spec-mCnt	4180186
36305279	氨磺磷:质量含量:时间点:XXX:定量型	4182948
36305280	T gondii DNA Tiss Ql NAA+probe	4180186
36305280	刚地弓形虫 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305280	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T gondii; T gondii DNA; Tissue; Tissue, unspecified; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification	4180186
36305281	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Housing; Living Arrangement; Living Arrangements; Location; Nominal; Point in time; Random	4180186
36305281	County of residence	4180186
36305281	居住县郡:位置:时间点:^患者:名义型	4182948
36305285	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E canis; E canis+ewin groEL; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tropical canine pancytopenia; WB; Whole blood	4180186
36305285	E canis+ewin groEL Bld Ql NAA+non-probe	4180186
36305285	犬埃立克体+尤茵埃立克体 groEL 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36305286	C&S; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305286	CMV CSF Ql Cult	4180186
36305286	巨细胞病毒:存在情况或阈值:时间点:脑脊液:序数型:微生物特异性培养	4182948
36305287	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36305288	Abd; Abd ves; Abd ves+Pelvis ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Chest+Abd ves; Chest+Abd+Pelv ves; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; Radiology; Random; Thorax; Vesl; Vessels.XXX; W contr IV; WC	4180186
36305288	CTA Chest+Abd+Pelv ves W contr IV	4180186
36305288	多层^采用静脉注射对比剂:发现:时间点:胸部>胸部血管类 & 腹部>腹部血管类 & 盆腔>盆腔血管类:文档型:CT.血管造影术	4182948
36305290	C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; Thrush	4180186
36305290	Fungus Implnt dev Cult	4180186
36305290	真菌 已鉴定的:存在与否或特征标识:时间点:植入装置:名义型:培养	4182948
36305291	Ang; Angio; Angiography; Angm; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Head + Head ves+Neck ves; Head+Neck Ves; Imaging; Intracranial; Point in time; Rad; Radiology; Random; Skull; Vesl; Vessels.XXX; W contr IV; WC	4180186
36305291	CT Head + CTA Head+Neck ves W cont IV	4180186
36305291	多层^采用静脉注射对比剂:发现:时间点:头部 && 头部>头部血管类 & 颈部>颈部血管类:文档型:CT && CT.血管造影术	4182948
36305293	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC stx2e gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga Like Toxin II; Shiga-Like Toxins; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36305293	EC stx2e gene Islt Ql NAA+probe	4180186
36305293	大肠埃希菌 Stx2e 毒素 stx2e 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305294	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305298	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36305298	VZV DNA Aspirate Ql NAA+probe	4180186
36305298	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36305301	Abd; Abd+Pel+LE-Bl; Abd+Pelvis; Abdo; Abdominal; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Pelvic; Pelvis+LE; Pelvis+LE-Bl; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
36305301	CT Abd+Pel+LE-Bl W contr IV	4180186
36305301	多层^采用静脉注射对比剂:发现:时间点:腹部+盆腔+下肢.双侧:文档型:CT	4182948
36305303	Agridip; DRUG/TOXICOLOGY; Drugs; Mass content; Meldane; Misc; Miscellaneous; Organophosphate pesticide; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305303	Coumaphos Spec-mCnt	4180186
36305303	蝇毒磷:质量含量:时间点:XXX:定量型	4182948
36305305	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305308	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305311	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36305311	Acid fast Stn Sinus	4180186
36305311	显微镜观察:存在与否或特征标识:时间点:窦:名义型:抗酸染色法	4182948
36305313	DOC.ONT; Document; Finding; Findings; Pharmacy; Point in time; Random	4180186
36305313	警示:发现:时间点:{环境}:文档型:药理学	4182948
36305315	DOC.ONT; Document; Finding; Findings; nursing; Point in time; Random	4180186
36305315	警示:发现:时间点:{环境}:文档型:护士	4182948
36305318	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avelox; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; MRD; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
36305318	Moxifloxacin 0.25 ug/mL Islt SlowMyco	4180186
36305318	莫西沙星 0.25 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
36305324	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305326	Berkmycen; Clinimycin; DRUG/TOXICOLOGY; Drugs; Glomicin; Hydroxytetracycline; Imperacon; Mass content; Misc; Miscellaneous; Other; Oxymicin; Oxytetramix; Point in time; QNT; Quan; Quant; Quantitative; Random; Riomitsin; Spec; Terramicina; Terramycin; Terramycine; Terravenos; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305326	Oxytetracycline Spec-mCnt	4180186
36305326	羟四环素:质量含量:时间点:XXX:定量型	4182948
36305328	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305334	Ang; Angio; Angiography; Angm; Brain; Brain + Head ves; Brain + Head ves+Neck ves; c; CAT scan; Cerebral; Cerebrum; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT Angiogram; CT angiography; CT perfusion + CTA; CT scan; CT.cine; CTA; Document; Finding; Findings; Head; Head+Neck Ves; Imaging; Intracranial; PF; Point in time; Rad; Radiology; Random; Skull; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WO+W contr perf + W contr; WWO	4180186
36305334	CT WO+Brain perf+CTA Head+Nec ves W cont	4180186
36305334	针对血流灌注的多层^WO & W contrast IV && Multisection^W contrast IV:发现:时间点:头部>脑部 && 头部>头部血管类 & 颈部>颈部血管类:文档型:CT.灌注 && CT.血管造影术	4182948
36305346	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305347	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crimean-Congo IgM; Crimean-Congo virus; Crimean-Congo virus Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36305347	Crimean-Congo virus IgM Ser Ql IA	4180186
36305347	克里米亚-刚果出血热病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305351	Heart rate during anesthesia	4180186
36305351	Count/time; Heart beat; HEART RATE.MOLEC; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305351	心率^在麻醉过程中:计数型速率:时间点:XXX:定量型	4182948
36305354	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305355	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305360	2; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305362	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305365	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Seneca Valley Virus; SVA; SVA VP1 gene; Vet; Veterinary	4180186
36305365	SVA VP1 gene Islt-Seq	4180186
36305365	塞内卡病毒 A VP1 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305366	ANCA IgG + S cerev IgA + IgG Pnl Ser	4180186
36305366	ACNA; ACPA; ANCA; ANCA IgG + S cerev IgA + IgG Pnl; ASCA; Bakers yeast; Baker's yeast; Cytopl; Cytoplas; f045; f403; f45; Granulocyte ab; Granulocyte nucleus ab; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Neut; Neutr; Neutrophils; Pan; Panel; PANEL.SEROLOGY; Panl; PMN; Pnl; PNM; Point in time; Random; SCA; Serology; Serum; SR; Vasculitis; Yeast	4180186
36305366	嗜中性粒细胞细胞浆抗体.IgG 与 酿酒酵母抗体.IgA 与 IgG:-:时间点:血清:-	4182948
36305368	Asp; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Jnt; Major joint; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305368	Guided Major joint Arthrocentesis	4180186
36305368	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>关节.大:文档型:{成像方式}	4182948
36305371	CD25+CD45RA+CD127L+/100 CD4 NFr Bld	4180186
36305371	100 CD4 cells; 2H4; Blood; CD25 Cells; CD25+CD45RA+CD127L+ cells; CD4 Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Inducer T cells; L3T4; Leu18; Leu-18; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; W3/25; WB; Whole blood	4180186
36305371	细胞.CD25+CD45RA+CD127Low+/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36305372	Anaero; Anaerobe; Anaerobe Cult; Ascites; Ascitic fluid; Ascitis; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Peritoneal fluid; Point in time; Prt; Random	4180186
36305372	Bacteria Prt Anaerobe Cult	4180186
36305372	细菌 已鉴定的:存在与否或特征标识:时间点:腹膜液:名义型:厌氧微生物培养	4182948
36305373	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; nursing; OP; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36305373	Nurse OP Immunization note	4180186
36305373	疫苗接种记录:发现:时间点:门诊病人:文档型:护士	4182948
36305375	Nominal; Person name; Point in time; Random; TRAUMA	4180186
36305375	Provider assuming care	4180186
36305375	负责患者照护服务的医疗服务人员:人员姓名:时间点:服务提供者:名义型	4182948
36305376	10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Licarbazepine; Mass concentration ratio; Mass ratio; MCRto; Oxcarbazepine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305376	10OH-Carbazepine/Creat Ur Cfm	4180186
36305376	10-羟基卡马西平/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305377	Breathing; Lung; Lungs; Min insp press; Minimal; minimum; Point in time; Press.min; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36305377	Min insp press Airway	4180186
36305377	吸气压力.最小值:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36305379	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305379	HPIV4 RNA Corn/Cnjt Ql NAA+probe	4180186
36305379	副流感病毒 4 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305380	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; PC fluid asp; Perc; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36305380	CT Guided Chest PC fluid asp	4180186
36305380	旨在经皮穿刺抽吸的引导:发现:时间点:胸部:文档型:CT	4182948
36305381	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Geodon; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Zeldox	4180186
36305381	Ziprasidone/Creat Ur Cfm	4180186
36305381	齐拉西酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305382	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; PTV; PTV RNA; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305382	PTV RNA Ct Spec Qn NAA+probe	4180186
36305382	猪捷申病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305384	Cancer; CLIN; ECOG; Perform status; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
36305384	ECOG Perform Status score	4180186
36305384	日常体能状态:评分:时间点:^患者:定量型:美国东部肿瘤协作组	4182948
36305385	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305386	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305386	HCoV HKU1 RNA Aspirate Ql NAA+probe	4180186
36305386	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36305389	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; STELARA®; SUDS	4180186
36305389	Ustekinumab Ab SerPl IA-mCnc	4180186
36305389	优特克单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305390	Centers for Medicare and Medicaid Assessment; LTPAC; MDS; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305393	纯音阈值听力测量组套:-:时间点:耳:-	4182948
36305393	CLIN; Hearing; Otologic; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pure tone thresh Pnl; Random	4180186
36305393	Pure tone thresh Pnl	4180186
36305395	Ca; Cal; Chemistry; Mass Fraction; Misc; Miscellaneous; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305395	Calcium MFr Spec	4180186
36305395	钙:质量分数:时间点:XXX:定量型	4182948
36305397	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Random; S pneum serotype; S pneumo; S pneumoniae; Sertyp; Spn; Strep; Strept; Typ	4180186
36305397	S pneum Sertyp Islt	4180186
36305397	肺炎链球菌 血清型:类型:时间点:分离株:名义型	4182948
36305400	Arterial Stenosis; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305401	Centers for Medicare and Medicaid Assessment; LTPAC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305402	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305403	Emergency Medical Service(s); Nominal; Person name; Point in time; Random; TRAUMA	4180186
36305403	急救医疗服务助理姓名:人员姓名:时间点:服务提供者:名义型	4182948
36305405	Amebic keratitis; Amebic meningoencephalitis; C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Soil amoeba; Spec; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp	4180186
36305405	Acanthamoeba CSF Cult	4180186
36305405	棘阿米巴属单个未知种 已鉴定的:存在与否或特征标识:时间点:脑脊液:名义型:微生物特异性培养	4182948
36305409	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVB; RVB VP7; Vet; Veterinary	4180186
36305409	RVB VP7 Islt-Seq	4180186
36305409	轮状病毒 B VP7 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305411	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305412	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305415	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Othr; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305417	Alpha-herpesvirus; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; Pseudorabies; QL; Qual; Qualitative; Random; Screen; SHV-1; Spec; Suid herpesvirus-1; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305417	PRV Spec Ql Cult	4180186
36305417	伪狂犬病病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36305424	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305424	CT Neck+Chest WO+W contr IV	4180186
36305424	多层^不采用 & 采用静脉注射对比剂:发现:时间点:颈部+胸部:文档型:CT	4182948
36305425	Asp; CorePlaybook; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305425	Guided Unsp region Cyst asp	4180186
36305425	旨在经皮囊肿抽吸的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305426	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B malayi; Bancroftian filariasis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Human lymphatic filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; W bancr; W bancr+B malayi; W bancrofti; Wucheria bancrofti	4180186
36305426	W bancr+B malayi IgG2 Ser Ql IA	4180186
36305426	班氏吴策线虫+马来布鲁线虫 抗体.IgG2:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305427	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305429	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Ulcer; Visit note	4180186
36305429	记录:发现:时间点:{环境}:文档型:脑损伤	4182948
36305431	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli heat stable gene; ETEC; ETEC sta gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305431	ETEC sta gene Islt Ql NAA+probe	4180186
36305431	大肠埃希菌肠产毒素型 sta 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305432	C&S; Cardio; Cardiology; Cult; Cultures; Fung; Fungal; Fungi; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; Thrush	4180186
36305432	Fungus Pcar Cult	4180186
36305432	真菌 已鉴定的:存在与否或特征标识:时间点:心包液:名义型:培养	4182948
36305434	ANTIBIOTIC SUSCEPTIBILITIES; AST; FLQ; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305434	FLQ Islt Genotyp	4180186
36305434	氟喹诺酮:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305435	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Reportability resp rprt	4180186
36305435	Reportability resp rprt Doc Public hlth	4180186
36305435	法定上报情况答复报告:发现:时间点:{环境}:文档型:公共卫生	4182948
36305438	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36305440	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; ZIKV	4180186
36305440	ZIKV IgA+IgG+IgM Spec IA-Imp	4180186
36305440	寨卡病毒 抗体.IgA+IgG+IgM:印象:时间点:XXX:序数型:免疫测定法	4182948
36305441	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305443	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nucynta; Oral fluid; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn; Tapal	4180186
36305443	Tapentadol Sal Ql Scn	4180186
36305443	他喷他多:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36305444	Deoxyribonucleic acid; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; M genitalium; M genitalium DNA; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; OB; ObGyn; Obstetrics; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; T vaginalis; To be specified in another part of the message; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; TV + MG; TV + MG DNA; TV + MG DNA Pnl; Unspecified	4180186
36305444	TV + MG DNA Pnl Spec	4180186
36305444	阴道毛滴虫与生殖支原体 DNA 组套:-:时间点:XXX:-	4182948
36305446	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305447	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305448	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36305448	Gynecology Phone Note	4180186
36305448	记录:发现:时间点:电话就医:文档型:妇科学	4182948
36305449	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Metacillin; Methicillin resistance gene; Metin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Staficyn; Staphicillin; WB; Whole blood	4180186
36305449	mecA Bld Pos Ql Probe	4180186
36305449	细菌甲氧西林耐药 mecA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305450	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Treatment plan; Visit note	4180186
36305450	医疗服务计划记录:发现:时间点:{环境}:文档型:妇科学	4182948
36305452	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36305452	入院时存在的情况:发现:时间点:^患者:序数型	4182948
36305453	C27H43OH; Calciol; Chemistry; Colecalciferol; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Vit D3; Vitamin D3	4180186
36305453	Vitamin D3 Spec-mCnt	4180186
36305453	胆钙化醇:质量含量:时间点:XXX:定量型	4182948
36305455	Addiction med Team; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305455	Addiction med Team Note	4180186
36305455	记录:发现:时间点:{环境}:文档型:成瘾医学.团队	4182948
36305456	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36305456	B afz+burg+gari IgM Ser Ql Line blot	4180186
36305456	阿夫塞疏螺旋体+伯氏疏螺旋体+加里疏螺旋体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36305457	CPR; CPR flowsheet; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36305457	心肺复苏流程记录单:发现:时间点:{环境}:文档型:{角色}	4182948
36305459	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305459	HSV DNA Lower resp Ql NAA+probe	4180186
36305459	单纯疱疹病毒 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305460	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nasopharynx; Nominal; Point in time; Random; Spec; species; spp	4180186
36305460	Bordetella Nph Cult	4180186
36305460	博德特菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:鼻咽:名义型:微生物特异性培养	4182948
36305461	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305462	Abd; Abd+Pelvis; Abdo; Abdominal; Add; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Pelvic artery; Perc; Playbook; Point in time; PTA; PTA addl; Rad; RADIOLOGY; Random	4180186
36305462	Guided Iliac a PTA addl	4180186
36305462	旨在额外经皮腔内血管成形术的引导:发现:时间点:腹部+盆腔>髂动脉:文档型:{成像方式}	4182948
36305463	Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305464	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Eye socket; Finding; Findings; Imaging; Intracranial; Orbital; Paranasal sinuses; Point in time; Rad; RADIOLOGY; Random; Sinus; Skull; without contrast	4180186
36305464	CT Sinuses+Orbit WO contr	4180186
36305464	多层^不采用对比剂:发现:时间点:头部>附鼻窦类+眼眶:文档型:CT	4182948
36305468	Chemistry; MAG; Magnes; Mass content; Mg; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305468	Magnesium Spec-mCnt	4180186
36305468	镁:质量含量:时间点:XXX:定量型	4182948
36305471	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA SM; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SM; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305471	ENA SM Ab CSF Ql Line blot	4180186
36305471	Smith 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36305473	Dialy; Dialysis MD; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; M.D.; MD; notes; Point in time; Random; Visit note	4180186
36305473	Dialysis MD Note	4180186
36305473	记录:发现:时间点:{环境}:文档型:透析.医师	4182948
36305474	Abd; Abd+Pelvis; Abdo; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Endograft place; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Pelvic artery; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36305474	Guided Iliac a Endograft place	4180186
36305474	旨在置入内套膜支架的引导:发现:时间点:腹部+盆腔>髂动脉:文档型:{成像方式}	4182948
36305475	4 weeks; Finding; Findings; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36305476	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305477	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microsporidiosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305477	Microsporid DNA Stl Ql NAA+probe	4180186
36305477	微孢子虫 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36305478	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305481	Lean body weight Calc	4180186
36305481	Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; Calc; Calculation; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
36305481	去脂体重:质量:时间点:^患者:定量型:计算法	4182948
36305483	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV; PCV2; PCV2 DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305483	PCV2 DNA Ct Spec Qn NAA+probe	4180186
36305483	猪圆环病毒 2 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305485	Acd; Acid fast Stn; Acids; AFB stain; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Regurgitation; Screen; St; Stains; Stn; Vom; Vomitus	4180186
36305485	Acid fast Stn Vom Ql	4180186
36305485	显微镜观察:存在情况或阈值:时间点:呕吐物:序数型:抗酸染色法	4182948
36305486	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Playbook; Point in time; Prost; Prostatic; Rad; Radiology; Random	4180186
36305486	Guided Prostate Bx	4180186
36305486	旨在活组织检查的引导:发现:时间点:盆腔>前列腺:文档型:{成像方式}	4182948
36305489	Centers for Medicare and Medicaid Assessment; III; Length; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
36305490	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med equip or prod note; notes; Point in time; Random; Visit note	4180186
36305490	Med equip or prod note	4180186
36305490	医疗设备或产品记录:发现:时间点:{环境}:文档型:{角色}	4182948
36305491	Elvitegravir SerPl-mCnc	4180186
36305491	DRUG/TOXICOLOGY; Drugs; EVG; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305491	埃替格韦:质量浓度:时间点:血清/血浆:定量型	4182948
36305492	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305498	Abd; Abdo; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC	4180186
36305498	CTA Mesenteric ves W contr IV	4180186
36305498	多层^采用静脉注射对比剂:发现:时间点:腹部>肠系膜血管类:文档型:CT.血管造影术	4182948
36305499	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305500	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; Eye fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Occular fluid; Ocflu; Point in time; Random	4180186
36305500	Bacteria Ocflu Anaerobe Cult	4180186
36305500	细菌 已鉴定的:存在与否或特征标识:时间点:眼液:名义型:厌氧微生物培养	4182948
36305501	A pleuropn; A pleuropn 5; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36305501	A pleuropn 5 Ab/Pos cntrl Ser IA	4180186
36305501	胸膜肺炎放线杆菌血清型 5 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305502	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305503	Acd; Acid; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Fatty acid; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction	4180186
36305503	DHA/Fatty acids.C14-C24 SFr SerPl	4180186
36305503	二十二碳六烯酸/脂肪酸类.C14-C24:物质的量分数:时间点:血清/血浆:定量型	4182948
36305504	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305505	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; insertions; Paracent+tube insert; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36305505	Guided Peritoneum Paracent+tube insert	4180186
36305505	旨在穿刺术+插入管道的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36305506	3 days; Centers for Medicare and Medicaid Assessment; Drugs; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
36305508	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305509	Ang; Angio; Angiography; Angm; Arteriogram; Bil; Bilat; Both; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; DVT; EXT; Extr-Bl; Finding; Findings; for PE; for PE+DVT; Heart Disease; Imaging; LE; LE vv; LE vv-Bl; LE-Bl; Leg; Low; PA; PAA; PA-Bl; PA-Bl + LE vv-Bl; PE; Point in time; Pulm; Rad; Radiology; Random; Thorax; Ven; Venogram; Venography; Venous; W contr IV; WC	4180186
36305509	CTA PA-Bl + LE vv-Bl for PE+DVT W cont IV	4180186
36305509	针对肺栓塞+深静脉血栓形成的多层^采用静脉注射对比剂:发现:时间点:胸部>肺动脉类.双侧 & 下肢.双侧>下肢静脉类:文档型:CT.血管造影术	4182948
36305510	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
36305513	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; River blindness; Screen; Serum; species; spp; SR; SUDS	4180186
36305513	Onchocerca IgG2 Ser Ql IA	4180186
36305513	盘尾属单个未知种 抗体.IgG2:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305516	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305517	P sup(k) Ag RBC BPU Ql	4180186
36305517	Antigen; Antigens; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; k; KEL1; Kell Blood Group System; Ordinal; P prime; P sup(k); Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36305517	P^k 抗原:存在情况或阈值:时间点:红细胞^血液制品单位:序数型	4182948
36305519	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
36305520	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305520	Guided Unsp region Thrombect	4180186
36305520	旨在血栓切除术的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305521	Finding; Findings; MEDS; Nominal; Point in time; Random; Thrombolysis; Thrombolysis therapy timing	4180186
36305521	Thrombolysis therapy timing	4180186
36305521	溶血栓药施用相对于心脏停搏的时机:发现:时间点:^患者:名义型	4182948
36305522	H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Random; Typ	4180186
36305522	Prenatal tests Mother	4180186
36305522	产前试验项目:类型:时间点:^母亲:名义型	4182948
36305523	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305523	M genitalium DNA Corn/Cnjt Ql NAA+probe	4180186
36305523	生殖支原体 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305524	3,4,5-triMe-phenyl Me-carb; DRUG/TOXICOLOGY; Drugs; III; Landrin 3,4,5; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305524	3,4,5-triMe-phenyl Me-carb Spec-mCnt	4180186
36305524	3,4,5-三甲威:质量含量:时间点:XXX:定量型	4182948
36305525	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305530	Abd; Abd+Pelvis; Abdo; Abdominal; Ang; Angio; Angiography; Angm; Art; Arteriogram; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT Angiogram; CT angiography; CT scan; CTA; Deep inf epigastric a; DIEA; DIEP; Document; Finding; Findings; Heart Disease; Imaging; Inf; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305530	CTA Deep inf epigastric a WO+W contr IV	4180186
36305530	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部+盆腔>腹壁下深动脉:文档型:CT.血管造影术	4182948
36305531	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Emotional stability; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36305531	Mental health Post-op E/M note	4180186
36305531	术后评价与管理记录:发现:时间点:{环境}:文档型:心理健康	4182948
36305532	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Occular fluid; Ocflu; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36305532	VZV DNA Ocflu Ql NAA+probe	4180186
36305532	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:眼液:序数型:探针法.基因扩增.靶向	4182948
36305533	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
36305535	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305535	CMV DNA Mar Ql NAA+probe	4180186
36305535	巨细胞病毒 DNA:存在情况或阈值:时间点:骨髓:序数型:探针法.基因扩增.靶向	4182948
36305539	ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; PDV glyco 1 Ab; PHV1; Point in time; Porcine herpes virus 1; PRV; PRV glycoprot 1; Pseudorabies; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary	4180186
36305539	PRV glycoprot 1 Ab Ser IA	4180186
36305539	伪狂犬病病毒糖蛋白 1 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305546	ADMIN; MD specialty; Nominal; Point in time; Random; Typ	4180186
36305546	MD specialty	4180186
36305546	医师专业:类型:时间点:服务提供者:名义型	4182948
36305547	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305547	EV RNA Fld Ql NAA+probe	4180186
36305547	肠道病毒 RNA:存在情况或阈值:时间点:体液:序数型:探针法.基因扩增.靶向	4182948
36305553	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305553	C7.functional SerPl-aCnc	4180186
36305553	补体 C7.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
36305554	Chemo; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305554	化疗灌注停止日期:日期:时间点:^患者:定量型	4182948
36305556	Blood; C0; C16; Carnitine Free; Carnitine.total; Chemistry; DBS; Dried blood spot; FC; Filter paper; FP; FR; Hexadecanoylcarnitine; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
36305556	Palmitoylcarn/C0 DBS-sRto	4180186
36305556	棕榈酰肉碱 (C16)/肉碱.游离型 (C0):物质的量比率:时间点:全血.斑点:定量型	4182948
36305557	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Vet; Veterinary	4180186
36305557	Brachyspira sp nox gene Islt-Seq	4180186
36305557	短螺旋体属 nox 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305558	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305559	Aflatoxicosis; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305559	Aflatoxin B1 Spec-mCnt	4180186
36305559	黄曲霉毒素 B1:质量含量:时间点:XXX:定量型	4182948
36305561	bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Up	4180186
36305563	Acd; Acid fast Stn; Acids; AFB stain; Ascites; Ascitic fluid; Ascitis; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Peritoneal fluid; Point in time; Prt; Random; St; Stains; Stn	4180186
36305563	Acid fast Stn Prt	4180186
36305563	显微镜观察:存在与否或特征标识:时间点:腹膜液:名义型:抗酸染色法	4182948
36305564	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36305564	Gie Stn Fld	4180186
36305564	显微镜观察:存在与否或特征标识:时间点:体液:名义型:姬姆萨染色法	4182948
36305568	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305568	HCoV HKU1 RNA Corn/Cnjt Ql NAA+probe	4180186
36305568	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305570	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305575	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305576	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36305582	C&S; Corn/Cnjt; Corneal; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Spec	4180186
36305582	HSV Corn/Cnjt Cult	4180186
36305582	单纯疱疹病毒 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36305583	Chemo; Chemo infus date and time Pnl; Date+time; Pan; PANEL.IO; Panl; Pnl; Point in time; Random; Started	4180186
36305583	Chemo infus date and time Pnl	4180186
36305583	化学治疗输液开始与停止日期和时间组套:-:时间点:^患者:-	4182948
36305586	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305587	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD4+CD27+CD45RO+CD62L+ cells; CD3+CD4+CD27-CD45RO+CD62L- cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; UCHL-1; W3/25; WB; Whole blood	4180186
36305587	CD3+CD4+CD27+CD45RO+CD62L+ cells # Bld	4180186
36305587	细胞.CD3+CD4+CD27+CD45RO+CD62L+:计数型浓度:时间点:全血:定量型	4182948
36305592	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305592	HSV1 DNA Lower resp Ql NAA+probe	4180186
36305592	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305593	Acarithion; Carbofenothion; Carbofenthion; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Oleoakarithion; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Trithion; Unspecified; Vet; Veterinary	4180186
36305593	Carbophenothion Spec-mCnt	4180186
36305593	三硫磷:质量含量:时间点:XXX:定量型	4182948
36305594	GM1 Gangl IgM Ser Ql Line blot	4180186
36305594	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ganglioside monosialo; GM1 Gangl; Immune globulin M; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36305594	神经节苷脂 GM1 抗体.IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36305596	1 day; 24 hours; 24HR; Activ; Activity; Actvty; CLIN; Count/time; Exercise; Movements; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
36305596	Sedentary activity 24h nRate	4180186
36305596	久坐少动的活动:计数型速率:24小时:^患者:定量型	4182948
36305597	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Corn/Cnjt; Corneal; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; HSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF	4180186
36305597	HSV Ag Corn/Cnjt Ql IF	4180186
36305597	单纯疱疹病毒 抗原:存在情况或阈值:时间点:角膜/结膜:序数型:免疫荧光法	4182948
36305599	Hx of CABG	4180186
36305599	CABG; H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Surg	4180186
36305599	冠状动脉旁路移植术:历史记录:时间点:^患者:序数型	4182948
36305601	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baxdela; DLX; Fluoroquinolone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305601	DLX Susc Islt	4180186
36305601	德拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36305603	ADBICA N-4OH-pentyl; ADB-PICA; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36305603	ADBICA N-4OH-pentyl Ur Ql Cfm	4180186
36305603	ADBICA N-4-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305605	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Path; Pnl; Point in time; Random; Survey	4180186
36305606	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Wire place	4180186
36305606	Guided Unsp region Wire place	4180186
36305606	旨在置入导丝的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305609	Tdecenoylcarn/C0 SerPl-sRto	4180186
36305609	C0; C14:1; Carnitine Free; Carnitine.total; Chemistry; FC; FR; i; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Tdecenoylcarn	4180186
36305609	十四烯酰肉碱 (C14:1)/肉碱.游离型 (C0):物质的量比率:时间点:血清/血浆:定量型	4182948
36305610	Cath; CorePlaybook; CVC pericath obs rem; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Remove; Spec; Subs; To be specified in another part of the message; Unspecified	4180186
36305610	Guided Unsp region CVC pericath obs rem	4180186
36305610	旨在清除中心静脉导管周围阻塞物质的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305611	DIA; Diam; Length; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Trach tube; Tub; Tube, unspecified	4180186
36305611	Trach tube Diam	4180186
36305611	直径:长度:时间点:气管切开套管:定量型	4182948
36305612	Cardiac troponin I pnl SerPl HS	4180186
36305612	Cardiac troponin I pnl; Chemistry; cTnI; HS; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TnI; TrI; Trop I; Troponin	4180186
36305612	肌钙蛋白 I.心脏 组套:-:时间点:血清/血浆:-:高灵敏度方法	4182948
36305614	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn	4180186
36305614	Gram Stn Lower resp	4180186
36305614	显微镜观察:存在与否或特征标识:时间点:呼吸道.下:名义型:革兰氏染色法	4182948
36305615	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305615	HCoV NL63 RNA Aspirate Ql NAA+probe	4180186
36305615	人类冠状病毒 NL63 型 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36305616	Glutarylcarn/C2 SerPl-sRto	4180186
36305616	C2; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36305616	戊二酰肉碱 (C5-DC)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
36305619	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chagas disease; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T cruzi; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Trypanosomiasis; Trypanosomosis	4180186
36305619	T cruzi DNA Tiss Ql NAA+probe	4180186
36305619	克氏锥虫 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305621	Phenotypic resistance method Islt	4180186
36305621	Identity or presence; Islt; Isol; Meth; Method of; MISC; Nominal; Phenotypic resistance method; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Test mthd	4180186
36305621	用于确定耐药性的表现型实验室检验方法:存在与否或特征标识:时间点:分离株:名义型:*	4182948
36305623	Electrophysiology Consult note	4180186
36305623	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305623	会诊记录:发现:时间点:{环境}:文档型:临床心脏电生理学	4182948
36305626	Bil; Bilat; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Jnt; Point in time; Rad; RADIOLOGY; Random; Skull; TMJ; TMJ-Bl; TMJS; without contrast	4180186
36305626	CT TMJ-Bl WO contr	4180186
36305626	多层^不采用对比剂:发现:时间点:头部>颞颌关节.双侧:文档型:CT	4182948
36305628	Lung; Point in time; Press.base; Press.base set; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36305628	Press.base set Vent	4180186
36305628	压力.基线设置:压力或压强:时间点:呼吸机:定量型	4182948
36305639	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; P prime; p,p'-DDD; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305639	p,p'-DDD Spec-mCnt	4180186
36305639	p,p'- 二氯二苯二氯乙烷:质量含量:时间点:XXX:定量型	4182948
36305640	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305640	Fumonisin B2 Spec-mCnt	4180186
36305640	伏马菌素 B2:质量含量:时间点:XXX:定量型	4182948
36305641	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305643	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36305643	Cannabinol SerPlBld Cfm-mCnc	4180186
36305643	大麻酚:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36305644	#; ABS; absolute; absolutes; ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD38+ Cells; CD19+CD38+IgM- cells; CD19+CD38+IgM+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Cyclic ADP-ribose hydrolase; HD-37; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Leu17; Leu-17; Number concentration; Number Concentration (count/vol); Plasmablasts; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; Transitional B cells; WB; Whole blood	4180186
36305644	CD19+CD38+IgM+ cells # Bld	4180186
36305644	细胞.CD19+CD38+IgM+:计数型浓度:时间点:全血:定量型	4182948
36305645	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36305646	Cath; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Remove; Thorax; Tun CVC wo port removal; Tunneled CVC rem	4180186
36305646	Guided Chest Tun CVC wo port removal	4180186
36305646	旨在去除不带输液港的隧道式中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36305648	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36305648	OB Hosp Note	4180186
36305648	记录:发现:时间点:医院:文档型:产科学	4182948
36305650	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; hMPV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF	4180186
36305650	hMPV Ag Nph Ql IF	4180186
36305650	人类偏肺病毒 抗原:存在情况或阈值:时间点:鼻咽:序数型:免疫荧光法	4182948
36305653	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
36305653	CT Pelvis bones W contr IV	4180186
36305653	多层^采用静脉注射对比剂:发现:时间点:盆腔>盆骨类:文档型:CT	4182948
36305656	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305656	HCoV NL63 RNA Lower resp Ql NAA+probe	4180186
36305656	人类冠状病毒 NL63 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305657	5th; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Finger.5th-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE-R; Up; without contrast	4180186
36305657	CT Finger.5th-R WO contr	4180186
36305657	多层^不采用对比剂:发现:时间点:上肢.右侧>手指.第五:文档型:CT	4182948
36305658	Point in time; QNT; QoL score; Quan; Quant; Quantitative; Random; Scale; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36305660	Admit eval note; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305660	Addiction med Admit eval note	4180186
36305660	入院评价记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305661	Asp; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Jnt; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305661	Guided Joint Arthrocentesis	4180186
36305661	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>关节:文档型:{成像方式}	4182948
36305662	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305662	FLUAV RNA Lower resp Ql NAA+probe	4180186
36305662	流感病毒 A 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305663	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305663	HSV1 DNA Corn/Cnjt Ql NAA+probe	4180186
36305663	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305664	CD; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305664	Cadmium Spec-mCnt	4180186
36305664	镉:质量含量:时间点:XXX:定量型	4182948
36305666	Addiction; AKB48; APINACA; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36305666	AKB48 N-pentanoate Ur Ql Cfm	4180186
36305666	AKB48 N-戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305670	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Symptoms present 24H	4180186
36305670	Symptoms present 24H Reported	4180186
36305670	存在至少24小时的症状:发现:时间点:^患者:序数型:报告法	4182948
36305672	AE1 Anion Exchanger; Bands; bnd; Chemistry; Hematology; Heme; IFE; Ifix; III; Immunofixation electrophoresis; Kidney; Level; M Protein; M Protein 3; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn	4180186
36305672	M Protein 3 Ur IFE-mCnc	4180186
36305672	蛋白质.单克隆型 区带 3:质量浓度:时间点:尿液:定量型:免疫固定电泳分析法	4182948
36305673	#; ABS; absolute; absolutes; B220; Blood; CD3 Cells; CD3+CD45+ Cells; CD3-CD45+ cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; LCA; Leu4; Leu-4; Leukocyte common antigen; Ly5; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
36305673	CD3-CD45+ cells # Bld	4180186
36305673	细胞.CD3-CD45+:计数型浓度:时间点:全血:定量型	4182948
36305676	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36305676	HCoV HKU1 RNA Upper resp Ql NAA+probe	4180186
36305676	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36305680	H+P; H+P.HX; History; Nominal; P prime; Point in time; Random	4180186
36305680	Hx of Occupational hazard	4180186
36305680	职业危害:历史记录:时间点:^患者:名义型	4182948
36305686	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rochalimaea species; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36305686	Bartonella DNA Tiss Ql NAA+probe	4180186
36305686	巴尔通体属单个未知种 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305691	Emergency Medical Service(s); EMS; Ident; Identifier; NEMSIS; Nominal; Point in time; Random; TRAUMA	4180186
36305691	Station name EMS Sys	4180186
36305691	站所名称:标识符:时间点:急救医疗服务系统:名义型	4182948
36305693	CorePlaybook; Document; Extraction; Filter removal; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Playbook; Point in time; Rad; Radiology; Random; Remove; SVC; Thorax; VC	4180186
36305693	Guided SVC Filter removal	4180186
36305693	旨在去除静脉滤器的引导:发现:时间点:胸部>腔静脉.上:文档型:{成像方式}	4182948
36305694	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305696	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C&S; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; Gyn; Gynecology; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SVC	4180186
36305696	CMV Amn Ql Shell Vial Cult	4180186
36305696	巨细胞病毒:存在情况或阈值:时间点:羊水:序数型:细胞培养瓶培养法	4182948
36305697	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36305697	Bacteria Sinus Anaerobe Cult	4180186
36305697	细菌 已鉴定的:存在与否或特征标识:时间点:窦:名义型:厌氧微生物培养	4182948
36305699	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Stomach upset meds; Typ	4180186
36305699	Stomach upset meds	4180186
36305699	用于治疗胃部不适的药物的类型:类型:时间点:^患者:名义型	4182948
36305700	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305701	bod; Bodies; CorePlaybook; Document; FB; FB retrieval; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Vesl	4180186
36305701	Guided Ves FB retrieval	4180186
36305701	旨在取出异物的引导:发现:时间点:XXX>血管:文档型:{成像方式}	4182948
36305702	III; Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36305703	F hepatica Ab Titr Ser CF	4180186
36305703	肝片吸虫 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36305703	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); F hepatica; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
36305704	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumophilia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36305704	L pneumo DNA Tiss Ql NAA+probe	4180186
36305704	嗜肺军团菌 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305705	Blood; CLIN; Haemoglobin; Hb; Hgb; Hgb goal; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36305705	Hgb goal mCnc Bld	4180186
36305705	血红蛋白目标:质量浓度:时间点:全血:定量型	4182948
36305709	Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305711	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305712	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305713	2nd deg burn area/BSA Est	4180186
36305713	2nd; 2nd deg burn area; Bdy surface; bod; Bodies; BSA; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; TRAUMA	4180186
36305713	二度烧伤面积/体表面积:面积比:时间点:^患者:定量型:估计法	4182948
36305715	Cand; Candidiasis; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Monilia; Nominal; Point in time; Random; species; spp; Thrush	4180186
36305715	Candida Islt	4180186
36305715	假丝酵母属单个未知种 已鉴定的:存在与否或特征标识:时间点:分离株:名义型	4182948
36305716	DRUG/TOXICOLOGY; Drugs; Hexadrin; Mass content; Mendrin; Misc; Miscellaneous; Nendrin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305716	Endrin Spec-mCnt	4180186
36305716	异狄氏剂:质量含量:时间点:XXX:定量型	4182948
36305718	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; World Heatlth Organization	4180186
36305721	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Cath; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; PTBD; Rad; RADIOLOGY; Random; Remove; Transhep cath remove	4180186
36305721	Guided BDs Transhep cath remove	4180186
36305721	旨在经肝去除导管的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36305722	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36305722	疫苗接种记录:发现:时间点:{环境}:文档型:{角色}	4182948
36305723	Liver fibr score SerPl Calc.ELF	4180186
36305723	Calc; Calc.ELF; Calculation; Chemistry; Liver fibr score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305723	肝纤维化评分:评分:时间点:血清/血浆:定量型:计算法.ELF	4182948
36305724	Chemistry; k; K+; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305724	Potassium Spec-mCnc	4180186
36305724	钾:质量浓度:时间点:XXX:定量型	4182948
36305725	Bil; Bilat; BON; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; Temporal bone-Bl; without contrast	4180186
36305725	CT Temporal bone-Bl WO contr	4180186
36305725	多层^不采用对比剂:发现:时间点:头部>颞骨.双侧:文档型:CT	4182948
36305730	NK cytotox.7.5:1 E:T/Pos cntrl Bld MC	4180186
36305730	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.7.5:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36305730	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 7.5:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36305732	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Extraction; Finding; Findings; GJ-tube removal; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Remove; UGI; Up	4180186
36305732	Guided UGI GJ-tube removal	4180186
36305732	旨在去除胃造瘘-空肠造瘘管的引导:发现:时间点:腹部>胃肠道.上段:文档型:{成像方式}	4182948
36305733	LDLc goal mCnc SerPl	4180186
36305733	Chol; Choles; Cholest; Cholesterol total; Cholesterols; CLIN; LDLc; LDL-C; LDLc goal; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305733	胆固醇.LDL 之中的 目标:质量浓度:时间点:血清/血浆:定量型	4182948
36305734	Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; Thromb infus; Thrombolysis; W thromb via CVC	4180186
36305734	Guided Thromb infus W thromb via CVC	4180186
36305734	旨在输注溶栓剂的引导^采用经中心静脉导管给予的溶栓剂:发现:时间点:胸部:文档型:{成像方式}	4182948
36305740	Centers for Medicare and Medicaid Assessment; Finding; Findings; Memory/recall ability; Nominal; Past; Survey	4180186
36305742	Arterial Stenosis; Count/time; Dextro; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305743	100 CD3+CD4+; Blood; CD27 Cells; CD27- cells; CD27+CD45RO+CD62L+CCR7+ cells; CD27-CD45RO+CD62L-CCR7- cells; CD3 Cells; CD3+CD4+ cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cells.CD27+; Cellularity; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; UCHL-1; W3/25; WB; Whole blood	4180186
36305743	CD27-CD45RO+CD62L-CCR7-/100 CD3+CD4+	4180186
36305743	细胞.CD27-CD45RO+CD62L-CCR7-/100 个细胞.CD3+CD4+:计数型分数:时间点:全血:定量型	4182948
36305744	Diaf; DiafP; Dialysate; Dialysis fluid; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Kidney; Microbiology; Nephrology; Nominal; Peritoneal Dialysis fluid; Point in time; Random; Renal; St; Stains; Stn	4180186
36305744	Gram Stn DiafP	4180186
36305744	显微镜观察:存在与否或特征标识:时间点:腹膜透析液:名义型:革兰氏染色法	4182948
36305746	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305747	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Started; Survey	4180186
36305748	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305749	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
36305750	Resp rate W pain	4180186
36305750	Breathing; Count/time; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; RESP.MOLEC; Respiratory rate; RS	4180186
36305750	呼吸^伴疼痛:计数型速率:时间点:呼吸系统:定量型	4182948
36305754	Obesity med Phone Note	4180186
36305754	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305754	记录:发现:时间点:电话就医:文档型:肥胖医学	4182948
36305756	Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; PRO measure pnl; Random; Survey; SURVEY.GNHLTH	4180186
36305758	Add; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; Thromb infusion addl day; Thrombolysis; W thromb via chest tube	4180186
36305758	Guided Thromb inf add day W throm via CT	4180186
36305758	旨在额外输注一天溶栓剂的引导^采用经胸腔插管给予的溶栓剂:发现:时间点:胸部:文档型:{成像方式}	4182948
36305761	DOC.MISC; Document; Finding; Findings; Med admin.brief; MISC; Point in time; Random	4180186
36305761	Med admin.brief	4180186
36305761	药物施用.简报:发现:时间点:^患者:文档型	4182948
36305762	BDI FS; Pan; Panel; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Survey	4180186
36305766	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cardio; Cardiology; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; Heart Disease; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Pcar; PCR; Pericardial fluid; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305766	FLUBV RNA Pcar Ql NAA+probe	4180186
36305766	流感病毒 B 型 RNA:存在情况或阈值:时间点:心包液:序数型:探针法.基因扩增.靶向	4182948
36305767	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norwalk virus; Nucleic acid sequence based analysis; NV G I & II RNA pnl; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305767	NV G I & II RNA pnl Stl NAA+probe	4180186
36305767	诺如病毒基因群 I 与 II RNA 组套:-:时间点:大便:-:探针法.基因扩增.靶向	4182948
36305768	Centers for Medicare and Medicaid Assessment; PT; QNT; Quan; Quant; Quantitative; Survey; Tx	4180186
36305769	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305770	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305775	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Throat; TMA; Transcription mediated amplification; Upper respiratory	4180186
36305775	M genitalium DNA Throat Ql NAA+probe	4180186
36305775	生殖支原体 DNA:存在情况或阈值:时间点:咽喉:序数型:探针法.基因扩增.靶向	4182948
36305778	B; Beta-hexosaminidase subunit alpha; B-NAH; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Hexosaminidase A & Total Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Sandhoff disease; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tay Sachs Disease	4180186
36305778	Hexosaminidase A & Total Pnl SerPl	4180186
36305778	Beta-N-乙酰己糖胺酶.A & Beta-N-乙酰己糖胺酶组套:-:时间点:血清/血浆:-	4182948
36305780	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Low; Lower resp; Lung; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36305780	L pneumo Ag Lower resp Ql IF	4180186
36305780	嗜肺军团菌 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36305781	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36305783	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Listeria sp tuf; Listeriosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
36305783	Listeria sp tuf Bld Pos Ql Probe	4180186
36305783	李斯特菌属 (tuf) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305785	100 CD4 cells; Blood; CD25 Cells; CD25+CD127- cells; CD25-CD127+ cells; CD4 Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; IL-7R; IL-7R alpha; ILR2; Inducer T cells; L3T4; Leu3; Leu-3; Number fraction; p90 Il7 R; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; Treg Cell; W3/25; WB; Whole blood	4180186
36305785	CD25-CD127+ cells/100 CD4 cells NFr Bld	4180186
36305785	细胞.CD25-CD127+/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36305788	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305792	AQP4 H2O channel IgG Titr CSF IF	4180186
36305792	水通道蛋白 4 受体 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36305792	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Water channel aquaporin-4	4180186
36305795	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305797	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Nominal; Point in time; Random; Survey	4180186
36305798	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305799	Cont lens; Eye; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; St; Stains; Stn	4180186
36305799	Gram Stn Cont lens	4180186
36305799	显微镜观察:存在与否或特征标识:时间点:隐形眼镜:名义型:革兰氏染色法	4182948
36305805	DRUG/TOXICOLOGY; Drugs; Identity or presence; Misc; Miscellaneous; Nominal; Other; Other Chemical; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305805	Other Chemical Spec	4180186
36305805	化学物质 XXX:存在与否或特征标识:时间点:XXX:名义型	4182948
36305806	EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T gondii; T gondii IgG+IgM pnl; Toxo; Toxoplasmosis	4180186
36305806	T gondii IgG+IgM pnl SerPl IA	4180186
36305806	刚地弓形虫抗体.IgG 与 IgM 组套:-:时间点:血清/血浆:-:免疫测定法	4182948
36305807	ADMIN; Nominal; Point in time; Proc+Serv+Supp mod; Random; Typ	4180186
36305807	Proc+Serv+Supp mod	4180186
36305807	操作项目、服务项目或供应品修饰成分:类型:时间点:^患者:名义型	4182948
36305810	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD27+ cells; CD19+CD27+IgD+ Cells; CD19+CD27+IgD+IgM+ cells; CD19+CD27+IgD-IgM- cells; CD19+CD27+IgD-IgM+ cells; Cell; CELL MARKERS; Cellularity; Class-switched memory B cells; Cnt; Count; Count/volume; CT; HD-37; IgM-only memory B cells; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Marginal zone or nonswitched memory B cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; Total memory B cells; WB; Whole blood	4180186
36305810	CD19+CD27+IgD+IgM+ cells # Bld	4180186
36305810	细胞.CD19+CD27+IgD+IgM+:计数型浓度:时间点:全血:定量型	4182948
36305813	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305814	Centers for Medicare and Medicaid Assessment; Finding; Findings; II; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sequence based typing; Survey	4180186
36305817	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; LTPAC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305821	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Mixed connective tissue disorder; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Raynaud's Disease; Rh Blood Group System; Ribonuclear protein; RNP; Serology; Serum; snRNP; snRPC; SR; Systemic lupus erythematosus; U1 RNP; U1 snRNP; U1 snRNP-C; U1RNP	4180186
36305821	U1 snRNP-C Ab Ser Line blot-aCnc	4180186
36305821	U1 小细胞核核糖核蛋白 C 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36305822	Baytex; DRUG/TOXICOLOGY; Drugs; Entex; Mass content; Mercaptophos; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305822	Fenthion Spec-mCnt	4180186
36305822	倍硫磷:质量含量:时间点:XXX:定量型	4182948
36305833	DOC.ONT; Document; Finding; Findings; Operative order; Point in time; Random; Surg	4180186
36305833	Operative order	4180186
36305833	外科手术医嘱:发现:时间点:{环境}:文档型:{角色}	4182948
36305835	Ketoprofen/Creat Ur Cfm	4180186
36305835	2-(meta-benzylphenyl) propionate; C16H14O3; c388; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305835	酮洛芬/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305838	Diethyl parathion; DRUG/TOXICOLOGY; Drugs; Ethyl Parathion; Folidol; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Thiophos; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305838	Parathion Spec-mCnt	4180186
36305838	对硫磷:质量含量:时间点:XXX:定量型	4182948
36305839	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K oxytoca; K oxytoca ompA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36305839	K oxytoca ompA Bld Pos Ql Probe	4180186
36305839	产酸克雷伯菌 (ompA) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305840	Abd; Abd+Pelvis; Abdo; Abdominal; Add; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Pelvic artery; Playbook; Point in time; Rad; Radiology; Random; Stent place addl	4180186
36305840	Guided Iliac a Stent place addl	4180186
36305840	旨在额外置入支架的引导:发现:时间点:腹部+盆腔>髂动脉:文档型:{成像方式}	4182948
36305842	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Moderate PA.work; Moderate phys activity; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey	4180186
36305843	Bacillus stearothermophilus; C&S; Cult; Cultures; G stearothermophilus; ID; Infectious Disease; InfectiousDisease; Lab Device; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36305843	G stearothermophilus Lab Device Ql Cult	4180186
36305843	嗜热脂肪土芽孢杆菌:存在情况或阈值:时间点:实验室仪器设备:序数型:培养	4182948
36305845	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Pork; PR; PSV; Ql; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305845	PSV Spec Ql Cult	4180186
36305845	猪萨佩罗病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36305846	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36305847	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; DBS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Dried blood spot; Filter paper; FP; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
36305847	CMV DNA # DBS NAA+probe	4180186
36305847	巨细胞病毒 DNA:计数型浓度:时间点:全血.斑点:定量型:探针法.基因扩增.靶向	4182948
36305849	Abd; Abd+Pelvis; Abdo; Abdominal; Change; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Replace; Ureterostomy exch through ileal cond	4180186
36305849	Guided Ureterostomy exch thr ileal cond	4180186
36305849	旨在更换经回肠膀胱尿流改道的输尿管造瘘的引导:发现:时间点:腹部+盆腔>输尿管:文档型:{成像方式}	4182948
36305851	Brn; Burn; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36305851	Gram Stn Burn	4180186
36305851	显微镜观察:存在与否或特征标识:时间点:烧伤:名义型:革兰氏染色法	4182948
36305853	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305854	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305855	100 CD3+CD4+; Blood; CD28 Cells; CD28+HLA DR+ cells; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; HLA-DR; Human Leukocyte Antigen; I3; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; T44; Tp44; W3/25; WB; Whole blood	4180186
36305855	CD28+HLA DR+ cells/100 CD3+CD4+ NFr Bld	4180186
36305855	细胞.CD28+HLA DR+/100 个细胞.CD3+CD4+:计数型分数:时间点:全血:定量型	4182948
36305856	Life support discontinued	4180186
36305856	Finding; Findings; Life support discontinued; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36305856	当时终止了生命支持:发现:时间点:^患者:序数型	4182948
36305857	Breathing; Count/time; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; RESP.MOLEC; Respiratory rate; RS	4180186
36305857	Resp rate during anesthesia	4180186
36305857	呼吸^在麻醉过程中:计数型速率:时间点:呼吸系统:定量型	4182948
36305858	DOC.MISC; Document; Exam findings; Finding; Findings; MISC; Point in time; Random	4180186
36305858	Umbilical cord exam findings	4180186
36305858	检查发现:发现:时间点:脐带:文档型	4182948
36305859	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305859	Hearing threshold 1000 Hz Ear-L	4180186
36305859	听阈^1000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36305860	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Started; Survey	4180186
36305863	Abd; Abdo; Abdomen+; Abdominal; Cholangioscopy+calc removal; CorePlaybook; Document; Extraction; Finding; Findings; Gall bladder; GB; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Remove	4180186
36305863	Guided GB Cholangioscopy+calc removal	4180186
36305863	旨在胆道镜检查+去除结石的引导:发现:时间点:腹部>胆囊:文档型:{成像方式}	4182948
36305865	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305866	Ang; Angio; Angiography; Angm; Arm; Arm and hand vessels; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-L; Finding; Findings; Imaging; L; LT; LUE; Point in time; Rad; Radiology; Random; UE; UE ves; UE ves-L; UE-L; Up; Vesl; Vessels.XXX; W contr IV; WC	4180186
36305866	CTA UE ves-L W contr IV	4180186
36305866	多层^采用静脉注射对比剂:发现:时间点:上肢.左侧>血管类:文档型:CT.血管造影术	4182948
36305869	Alltox; Camphechlor; Camphochlor; Chlorinated camphene; Chlorocamphene; DRUG/TOXICOLOGY; Drugs; Geniphene; Mass content; Misc; Miscellaneous; Motox; Octachlorocamphene; Other; Penphene; Phenacide; Phenatox; Point in time; Polychlorocamphene; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Toxakil; Unspecified; Vet; Veterinary	4180186
36305869	Toxaphene Spec-mCnt	4180186
36305869	毒杀芬:质量含量:时间点:XXX:定量型	4182948
36305870	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36305870	CT Mastoid W contr IV	4180186
36305870	多层^采用静脉注射对比剂:发现:时间点:头部>乳突:文档型:CT	4182948
36305871	Aldocit; Aldrex; Aldrite; Aldrosol; Compound 118; Dimethanonaphthalene; Drinox; DRUG/TOXICOLOGY; Drugs; HHDM; HHDN; HHPN; Kortofin; Mass content; Misc; Miscellaneous; Octalene; OMS-194; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Seedrin; Spec; Tatuzinho; Tipula; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305871	Aldrin Spec-mCnt	4180186
36305871	艾氏剂:质量含量:时间点:XXX:定量型	4182948
36305872	CD19+CD27+IgD-IgM+ cells # Bld	4180186
36305872	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD27+ cells; CD19+CD27+IgD+ Cells; CD19+CD27+IgD+IgM+ cells; CD19+CD27+IgD-IgM- cells; CD19+CD27+IgD-IgM+ cells; Cell; CELL MARKERS; Cellularity; Class-switched memory B cells; Cnt; Count; Count/volume; CT; HD-37; IgM-only memory B cells; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Marginal zone or nonswitched memory B cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; Total memory B cells; WB; Whole blood	4180186
36305872	细胞.CD19+CD27+IgD-IgM+:计数型浓度:时间点:全血:定量型	4182948
36305873	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gluc; Glucouronide; III; Illicit; Naloxone-3-beta-glucuronide; Naloxone-3G; Narcan; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36305873	Naloxone-3G Ur Ql Scn	4180186
36305873	钠洛酮-3-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36305875	Ang; Angio; Angiography; Angm; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Finding; Findings; Imaging; LE; LE ves; Leg; Low; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX	4180186
36305875	CTA LE ves	4180186
36305875	多层:发现:时间点:下肢>下肢血管类:文档型:CT.血管造影术	4182948
36305876	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord	4180186
36305876	Guided L-spine Kyphoplasty	4180186
36305876	旨在椎体后凸成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36305878	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiology; Random; TIPS place; TIPSS	4180186
36305878	Guided Liver TIPS place	4180186
36305878	旨在经颈静脉置入经颈静脉肝内门体分流的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36305884	bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305886	Centers for Medicare and Medicaid Assessment; Finding; Findings; II; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sequence based typing; Survey	4180186
36305887	Cath; Change; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Replace; Thorax; Tun CVC wo port exch	4180186
36305887	Guided Chest Tun CVC wo port exch	4180186
36305887	旨在更换不带输液港的隧道式中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36305890	Infl trig press; Infl trig press set; Lung; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36305890	Infl trig press set Vent	4180186
36305890	充气触发压力设置:压力或压强:时间点:呼吸机:定量型	4182948
36305891	2,3,5-trimethacarb; DRUG/TOXICOLOGY; Drugs; II; III; Landrin 3,4,5; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305891	2,3,5-trimethacarb Spec-mCnt	4180186
36305891	2,3,5-三甲威:质量含量:时间点:XXX:定量型	4182948
36305896	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
36305897	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305899	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Parentrl thrpy note; Point in time; Random; Visit note	4180186
36305899	Nurse Parentrl thrpy note	4180186
36305899	肠道外治疗记录:发现:时间点:{环境}:文档型:护士	4182948
36305900	Arterial Stenosis; Count/time; Dextro; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305902	14 days; 2 weeks; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Patient Health Questionnaire; PHQ9; Pnl; Survey; Sx	4180186
36305908	History; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.CDC	4180186
36305910	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305911	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36305911	P2 phenotype RBC BPU Ql	4180186
36305911	P2 表型:存在情况或阈值:时间点:红细胞^血液制品单位:序数型	4182948
36305912	Cardio; Cardiology; CorePlaybook; Document; EXT; Extr v; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Ven; Venous	4180186
36305912	Guided Extr v Laser ablation	4180186
36305912	旨在激光消融术的引导:发现:时间点:肢体>肢体静脉:文档型:{成像方式}	4182948
36305914	FDA insert REMS partic requirements	4180186
36305914	DOCUMENT.REF; FDA insert; Narrative; REMS partic requirements; Report; SPL; Structured Product Labelling	4180186
36305914	REMS 参与者要求:-:-:^FDA 包装说明书:叙述型	4182948
36305918	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B malayi; Bancroftian filariasis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Human lymphatic filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; W bancr; W bancr+B malayi; W bancrofti; Wucheria bancrofti	4180186
36305918	W bancr+B malayi IgG3 Ser Ql IA	4180186
36305918	班氏吴策线虫+马来布鲁线虫 抗体.IgG3:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305919	Centers for Medicare and Medicaid Assessment; Dextro; Neuro & emot & behav status - start care; Neuro emotional behavioral status; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305921	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S anginosus grp; S anginosus gryB; S. anginosus; S. milleri group; Screen; Strep; Strep anginosus; Strept; WB; Whole blood	4180186
36305921	S anginosus gryB Bld Pos Ql Probe	4180186
36305921	咽峡炎链球菌族 gyrB 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305923	Pimozide/Creat Ur Cfm	4180186
36305923	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305923	哌迷清/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305924	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36305927	Difficult intubation reason; Finding; Findings; Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory	4180186
36305927	Difficult intubation reason	4180186
36305927	插管困难原因:发现:时间点:^患者:名义型	4182948
36305928	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; HSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36305928	HSV Ag CSF Ql IF	4180186
36305928	单纯疱疹病毒 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36305931	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; S prime; Survey	4180186
36305932	Centers for Medicare and Medicaid Assessment; Finding; Findings; Indicator; Nominal; Report period; Survey	4180186
36305937	4 weeks; Finding; Findings; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36305938	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305939	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; RVA VP4; Vet; Veterinary	4180186
36305939	RVA VP4 Islt-Seq	4180186
36305939	轮状病毒 A VP4 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305940	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36305940	Hearing threshold 8000 Hz Ear-R	4180186
36305940	听阈^8000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36305941	Abd; Abd+Pelvis; Abdo; Abdominal; Change; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Nephrour stent exch; Pelvic; Perc; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Replace; Ureter+Blad	4180186
36305941	Guided Kid+Uret+Blad Nephrour stent exch	4180186
36305941	旨在经皮更换肾输尿管支架的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:{成像方式}	4182948
36305942	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36305945	Addiction med OP Note	4180186
36305945	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Substance abuse; Visit note	4180186
36305945	记录:发现:时间点:门诊病人:文档型:成瘾医学	4182948
36305946	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd	4180186
36305946	伤口边缘组套:-:时间点:伤口:-	4182948
36305947	Ab Ao; Abd; Abd Aorta; Abd+Pel + AA; Abd+Pelvis; Abdo; Abdomen; Abdominal; Ang; Angio; Angiography; Angm; AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; Radiology; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305947	CT Abd+Pel + CTA AA WO+W contr IV	4180186
36305947	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部+盆腔 && 腹部>主动脉.腹腔段:文档型:CT && CT.血管造影术	4182948
36305951	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bact 23S rRNA azith res mut; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rDNA; Resist; Resistanc; Resistant; Resistent; ribosomal RNA; Screen; Spec; Zithromax	4180186
36305951	Bact 23S rRNA azith res mut Islt/Spm Ql	4180186
36305951	细菌 23S rRNA 基因阿奇霉素耐药性突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36305953	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305955	1 week; FCN; Func; Funct; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36305959	Activ; Activity; Actvty; Exercise; IPAQ SA Long Form; Movements; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
36305960	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36305960	FLUBV Ag Tiss Ql IF	4180186
36305960	流感病毒 B 型 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36305961	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV HA gene; FLUV; Fowl plague; high-throughput sequencing; HTS; IAV HA gene; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Vet; Veterinary	4180186
36305961	FLUAV HA gene Islt-Seq	4180186
36305961	流感病毒 A 型血凝素基因:序列:时间点:分离株:名义型:序列测定	4182948
36305962	Aminophylline; Biophyllin; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Continus; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Lasma; Mass concentration ratio; Mass ratio; MCRto; Nuelin; Phyllocontin; Point in time; Pro-vent; QNT; Quan; Quant; Quantitative; Random; Sabidal SR; Slo-Phyllin; Somophyllin; Somophylline; Theo; Theo-dur; Theolair; UA; UCr; Uniphyllin; UR; Urn	4180186
36305962	Theophylline/Creat Ur Cfm	4180186
36305962	茶碱/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305963	#/area; Cast; Gran Casts; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36305963	Gran Casts #/area UrnS	4180186
36305963	颗粒管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36305965	C&S; Circo virus; Cult; Cultures; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; PCV; PCV2; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305965	PCV2 Spec Ql Cult	4180186
36305965	猪圆环病毒 2 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36305966	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305976	1 minute; Count/time; Lung; Mult; Mult sigh breaths del; Multi; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Respiratory rate	4180186
36305976	Mult sigh breaths del 1M Vent	4180186
36305976	呼吸.所提供的多次深呼吸:计数型速率:1分钟:呼吸机:定量型	4182948
36305978	1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Lambda LC; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
36305978	Lambda LC 24h Ur Ql IFE	4180186
36305978	免疫球蛋白轻链.Lambda 型:存在情况或阈值:24小时:尿液:序数型:免疫固定电泳分析法	4182948
36305979	Safety checklist Vent Doc	4180186
36305979	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36305979	安全检查清单:发现:时间点:呼吸机:文档型	4182948
36305981	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305982	Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c213; Garamycin; Genirr; Genj; Genotype; Genotypic; Gent; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305982	Gentamicin Islt Genotyp	4180186
36305982	庆大霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305983	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305983	Ethylene Glycol Spec-mCnt	4180186
36305983	乙烯乙二醇:质量含量:时间点:XXX:定量型	4182948
36305985	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; AO; Aortic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; TA + AA; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305985	CT TA + AA WO+W contr IV	4180186
36305985	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>主动脉.胸腔段 & 腹部>主动脉.腹腔段:文档型:CT	4182948
36305986	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305988	Anticoag; Anticoagulant received in last 7D or since admission/reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305989	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305990	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305991	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV1; DENV1+2+3+4; DENV1-4 + Zika; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; i; IAA; ID; II; III; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; MEIA; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; SUDS; To be specified in another part of the message; Unspecified; ZIKV	4180186
36305991	DENV1-4 + Zika IgA+IgG+IgM Spec IA-Imp	4180186
36305991	登革热病毒 1+2+3+4 型与寨卡病毒 抗体.IgA+IgG+IgM:印象:时间点:XXX:名义型:免疫测定法	4182948
36305992	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S stercoralis; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; Strongyloidiasis; TMA; Transcription mediated amplification	4180186
36305992	S stercoralis DNA Stl Ql NAA+probe	4180186
36305992	粪类圆线虫 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36305993	B; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305993	Boron Spec-mCnt	4180186
36305993	硼:质量含量:时间点:XXX:定量型	4182948
36305998	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36306001	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306004	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Ganglioside monosialo; GM1 Gangl; Immune globulin M; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36306004	GM1 Gangl IgM CSF Ql Line blot	4180186
36306004	神经节苷脂 GM1 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36306005	NY-ESO-1 Ab SerPl IA-aCnc	4180186
36306005	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CTAG1; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; MEIA; New York esophageal squamous cell carcinoma 1; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36306005	NY-ESO-1 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36306007	Abd; Abdo; Abdomen+; Abdominal; Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Perc; Point in time; Pyelogram; R; Rad; RADIOLOGY; Random; Renal; RT	4180186
36306007	CT Guided Kidney-R Bx	4180186
36306007	旨在经皮活组织检查的引导:发现:时间点:腹部>肾脏.右侧:文档型:CT	4182948
36306008	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36306008	Guided Neck or Chest Soft tissue Bx	4180186
36306008	旨在经皮活组织检查的引导:发现:时间点:颈部+胸部>软组织:文档型:{成像方式}	4182948
36306009	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Sx	4180186
36306011	Absc drain cath check; Cath; CorePlaybook; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Inspection; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid; Spec; To be specified in another part of the message; Unspecified	4180186
36306011	Guided Unsp region Absc drain cath check	4180186
36306011	旨在检查脓肿引流管的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36306013	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36306015	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306017	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36306019	ANTIBIOTIC SUSCEPTIBILITIES; AST; AVYCAZ; Ceftaz; Epsilometer; Estrip; E-strip; Forj; Fortaz; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; Zavicefta	4180186
36306019	cefTAZidime+Avibactam Islt Grad strip	4180186
36306019	头孢他啶+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
36306020	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36306025	Ang; Angio; Angiography; Angm; Arteriogram; c; CA; CA+PV; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; Finding; Findings; Heart; Heart Disease; Imaging; Point in time; Pulm vv; Rad; RADIOLOGY; Random; Thorax; Venogram; Venography; W contr IV; WC	4180186
36306025	CTA CA+PV W contr IV	4180186
36306025	多层^采用静脉注射对比剂:发现:时间点:胸部>冠状动脉类+肺静脉类:文档型:CT.血管造影术	4182948
36306026	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S apiospermum; S apiospermum DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306026	S apiospermum DNA Aspirate Ql NAA+probe	4180186
36306026	尖端赛多孢 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36306029	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36306033	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Telemedicine; Visit note	4180186
36306033	会诊记录:发现:时间点:远程医疗:文档型:血液学	4182948
36306034	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; Nudrazod; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36306034	Isoniazid Islt Genotyp	4180186
36306034	异烟肼:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36306035	外观:外观:时间点:XXX.拭子:叙述型	4182948
36306035	Appear; Appearance; Appr; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
36306035	Description of swab	4180186
36306037	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306038	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36306038	GM3 IgG Ser Ql Line blot	4180186
36306038	神经节苷脂 GM3 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36306039	CD3+CD8+CD28+HLA DR+ cellls # Bld	4180186
36306039	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD28+HLA DR+ cellls; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HLA-DR; Human Leukocyte Antigen; I3; Leu2; Leu-2; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T44; T8; T-8; T8 suppressor cells; Tp44; Tsuppressor; WB; Whole blood	4180186
36306039	细胞.CD3+CD8+CD28+HLA DR+:计数型浓度:时间点:全血:定量型	4182948
36306041	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
36306041	HCV IgG SerPlBld Ql IA.rapid	4180186
36306041	丙型肝炎病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速	4182948
36306043	Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
36306043	BP dias--during anesthesia	4180186
36306043	血管内心脏舒张期^在麻醉过程中:压力或压强:时间点:动脉系统:定量型	4182948
36306044	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
36306044	T gondii Ab SerPl IA	4180186
36306044	刚地弓形虫 抗体/阴性对照:相对比率:时间点:血清/血浆:定量型:免疫测定法	4182948
36306045	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306045	Legionella DNA Lower resp NAA+probe	4180186
36306045	军团菌属单个未知种 DNA:存在与否或特征标识:时间点:呼吸道.下:名义型:探针法.基因扩增.靶向	4182948
36306046	Centers for Medicare and Medicaid Assessment; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36306047	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent	4180186
36306047	C pneum DNA Lower resp Ql NAA+probe	4180186
36306047	肺炎嗜性衣原体 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36306048	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV M gene; FLUV; Fowl plague; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Matrix protein; Microbiology; MP; Next generation sequencing; NGS; Nominal; Point in time; Random; Vet; Veterinary	4180186
36306048	FLUAV M gene Islt-Seq	4180186
36306048	流感病毒 A 型 M 基因:序列:时间点:分离株:名义型:序列测定	4182948
36306049	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Cath; Change; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; PTBD; Rad; RADIOLOGY; Random; Replace; Transhep cath exchange	4180186
36306049	Guided BDs Transhep cath exchange	4180186
36306049	旨在经肝更换导管的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36306050	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36306050	Hearing threshold 500 Hz Ear-R	4180186
36306050	听阈^500 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36306056	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GT1a Gangl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Trisialoganglioside	4180186
36306056	GT1a Gangl IgG+IgM Ser Ql Line blot	4180186
36306056	神经节苷脂 GT1a 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36306057	1 minute; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Respiratory rate	4180186
36306057	Breaths.sigh del 1M Vent	4180186
36306057	呼吸.所提供的深呼吸:计数型速率:1分钟:呼吸机:定量型	4182948
36306060	30s CST; 30-Second Chair Stand; 30sSTS; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stands; Survey	4180186
36306061	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfringens; C perfringens etx gene; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306061	C perfringens etx gene Islt Ql NAA+probe	4180186
36306061	产气荚膜梭菌 etx 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36306064	KIT Exon 17 Mut Anl Bld/T	4180186
36306064	Blood; CD117; c-KIT; Document; Finding; Findings; KIT Exon 17; mast/stem cell growth factor receptor; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mut Anl; Mutations; PBT; PCR; piebald trait; Point in time; Proto-oncogene tyrosine-protein kinase Kit; Random; SCFR; soluble KIT variant; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
36306064	KIT 基因外显子 17 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36306065	CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; LE; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; Radiology; Random	4180186
36306065	Guided Hip Inj	4180186
36306065	旨在注射的引导:发现:时间点:下肢>髋关节:文档型:{成像方式}	4182948
36306067	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
36306067	CT Neck+Chest W contr IV	4180186
36306067	多层^采用静脉注射对比剂:发现:时间点:颈部+胸部:文档型:CT	4182948
36306070	AggRecetin; Arbitrary concentration; Clot; Clottable; COAGULATION; Coagulation assay; Cofact; Fac; Fact; Hematology; Heme; Inhib; Inhibit; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Risto; Tilt tube; Von will; Vonwillebrand; vWf; vWF.ristocetin cofactor inhibitor; vWf:RCo	4180186
36306070	vWF.ristocetin cofactor inhibitor PPP	4180186
36306070	von Willebrand 因子.瑞斯托菌素辅助因子抑制剂:任意型浓度:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36306071	Add; Cardio; Cardiology; CorePlaybook; Document; Endovasc device place addl; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36306071	Guided Vein Endovasc device place addl	4180186
36306071	旨在额外置入血管内装置的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36306072	C&S; Cult; Cultures; Food sample; Foods; Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36306072	Fungus Food Ql Cult	4180186
36306072	真菌:存在情况或阈值:时间点:食物:序数型:培养	4182948
36306074	Brodan; Detmol UA; Dowco 179; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306074	Chlorpyrifos Spec-mCnt	4180186
36306074	毒死蜱:质量含量:时间点:XXX:定量型	4182948
36306076	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
36306076	OB Pre-op note	4180186
36306076	术前评价与管理记录:发现:时间点:{环境}:文档型:产科学	4182948
36306077	Outpt Hosp D/C sum	4180186
36306077	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; OP; Outpt Hosp; Point in time; Random; Visit note	4180186
36306077	出院摘要记录:发现:时间点:门诊型医院:文档型:{角色}	4182948
36306081	Ang; Angio; Angiography; Angm; AO; Aortic; Arteriogram; c; CA; CA+PA; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; Coronary aa+PA+TA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Imaging; PAA; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36306081	CTA Coronary aa+PA+TA W contr IV	4180186
36306081	多层^采用静脉注射对比剂:发现:时间点:胸部>冠状动脉类+肺动脉类+主动脉.胸腔段:文档型:CT.血管造影术	4182948
36306082	Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36306083	Lab Device 99% URL	4180186
36306083	99% URL; Arbitrary; Lab Device; Point in time; QNT; Quan; Quant; Quantitative; Random; Up	4180186
36306083	第99百分位数参考值上限:任意型:时间点:实验室仪器设备:定量型	4182948
36306087	Brain; Cranial; Cranium; Document; Finding; Findings; Guid; Guide; Guided; Head aa; Imaging; Intracranial; Non-thromb infus; Point in time; Rad; RADIOLOGY; Random; Skull; Thrombolysis	4180186
36306087	Guided Head Arteries Non-thromb infus	4180186
36306087	旨在输注非溶栓剂的引导:发现:时间点:头部>动脉类:文档型:{成像方式}	4182948
36306088	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E. coli 987P pilus gene; EC fasA gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306088	EC fasA gene Islt Ql NAA+probe	4180186
36306088	大肠埃希菌 fasA 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36306090	C pylori; C&S; Campylobacter pylori; Cult; Cultures; H pyl; H pylori; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified	4180186
36306090	H pylori Tiss Ql Cult	4180186
36306090	幽门螺杆菌:存在情况或阈值:时间点:组织与涂片:序数型:微生物特异性培养	4182948
36306091	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; Typ; Ulcer	4180186
36306093	CorePlaybook; Document; Fid marker place; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Mark; Playbook; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Thorax	4180186
36306093	Guided Lung Fid marker place	4180186
36306093	旨在置入基准标记的引导:发现:时间点:胸部>肺:文档型:{成像方式}	4182948
36306094	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36306095	个人健康目标:发现:时间点:^患者:名义型	4182948
36306095	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
36306096	Bact; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GP bact; GP bact identified; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Isolated; Microbiology; Nominal; Point in time; Pos; Random; WB; Whole blood	4180186
36306096	GP bact Bld Pos Probe-Imp	4180186
36306096	革兰氏阳性细菌 已鉴定的:印象:时间点:血液.生长阳性:名义型:DNA探针	4182948
36306098	HSCT risk panel EBMT	4180186
36306098	CLIN; CLIN.RISK; HSCT risk panel; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
36306098	造血干细胞移植风险组套:-:时间点:^患者:-:EBMT	4182948
36306099	Low press hold time; Low press hold time set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36306099	Low press hold time set Vent	4180186
36306099	低压保持时间设置:时间:时间点:呼吸机:定量型	4182948
36306101	Before; Dose med or substance; Point in time; pre ADAPTABLE; QNT; Quan; Quant; Quantitative; Random; Study report; Survey; SURVEY.GNHLTH	4180186
36306104	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306105	Chemistry; cTnI; HS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TnI; TrI; Trop I; Troponin	4180186
36306105	Troponin I SerPl HS-mCnc	4180186
36306105	肌钙蛋白 I.心脏:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
36306106	Finding; Findings; Ordinal; Phys abuse investigation initiated; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36306106	Phys abuse investigation initiated	4180186
36306106	当时启动了身体虐待调查:发现:时间点:^患者:序数型	4182948
36306108	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
36306108	临床病程:发现:时间点:^患者:名义型	4182948
36306109	#/area; Cast; Epi; Epith; Epith Casts; Epithelia; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36306109	Epith Casts #/area UrnS	4180186
36306109	上皮细胞管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36306112	4 weeks; Finding; Findings; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36306113	CD3-CD45+ cells NFr Bld	4180186
36306113	B220; Blood; CD3 Cells; CD3+CD45+ Cells; CD3-CD45+ cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Gated cells; LCA; Leu4; Leu-4; Leukocyte common antigen; Ly5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
36306113	细胞.CD3-CD45+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
36306115	MDA5 Ab Ser Line blot-aCnc	4180186
36306115	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-CADM-140; Anti-MDA5 autoantibodies; Arbitrary concentration; Autoantibodies; Autoantibody; Interferon-induced helicase C domain-containing protein 1; Juvenile dermatomyositis; Melanoma differentiation-associated gene 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
36306115	MDA5 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36306118	Systemic sclerosis panel Ser IA	4180186
36306118	EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR; SUDS	4180186
36306118	系统性硬化病组套:-:时间点:血清:-:免疫测定法	4182948
36306120	Lower respiratory; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spt; Sputum	4180186
36306120	Micro CNAMTS panel Spt	4180186
36306120	微生物学 CNAMTS 组套:-:时间点:痰液:-	4182948
36306121	Arrival time first responder; Clock time; Point in time; QNT; Quan; Quant; Quantitative; Random; TRAUMA	4180186
36306121	Arrival time first responder	4180186
36306121	第一反应人员到达时间:时钟时间:时间点:^患者:定量型	4182948
36306123	Antigen; Antigens; BLOOD BANK; Erythrocytes; k; KEL1; Kell Blood Group System; Ordinal; P prime; P sup(k); Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36306123	P sup(k) Ag RBC Ql	4180186
36306123	P^k 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
36306124	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Ixel; Mass concentration ratio; Mass ratio; MCRto; Mildalcipran; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; Toledomin; UA; UCr; UR; Urn	4180186
36306124	Milnacipran/Creat Ur Cfm	4180186
36306124	米那普仑/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36306127	Lifetime Risk for genetic disease	4180186
36306127	CLIN; CLIN.RISK; Dis; Diseases; Dz; Gene dis assessed; Gene disease lifetime risk; Genetics; Genomic; Ordinal; Ql; Qual; Qualitative; Risk; Screen	4180186
36306127	出现所评估遗传性疾病的终生风险:似然性:一生:^患者:序数型	4182948
36306129	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36306129	检查清单:发现:时间点:{环境}:文档型:妇科学	4182948
36306130	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
36306130	CT Sacrum+Coccyx WO contr	4180186
36306130	多层^不采用对比剂:发现:时间点:盆腔>骶骨+尾骨:文档型:CT	4182948
36306131	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36306135	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S aureus; Screen; Staph; WB; Whole blood	4180186
36306135	S aureus gyrB Bld Pos Ql Probe	4180186
36306135	金黄色葡萄球菌 gyrB 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36306138	CARD.PROC; Cardio; Cardiology; Dose med or substance; Energy; Heart Disease; Largest; Max defibrillation dose; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36306138	Max defibrillation dose	4180186
36306138	除颤剂量.最大值:能量:时间点:剂量药物或剂量物质:定量型	4182948
36306141	Abd; Abd ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Chest+Abd ves; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; Thorax; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36306141	CTA Chest+Abd ves WO+W contr IV	4180186
36306141	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>胸部血管类 & 腹部>腹部血管类:文档型:CT.血管造影术	4182948
36306142	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Typ; Vet; Veterinary	4180186
36306142	Brachyspira Islt Seq	4180186
36306142	短螺旋体属单个未知种:类型:时间点:分离株:名义型:序列测定	4182948
36306146	Before; Finding; Findings; Ordinal; Point in time; pre ADAPTABLE; Ql; Qual; Qualitative; Random; Screen; Study report; Survey; SURVEY.GNHLTH	4180186
36306147	CLIN; Finding; Findings; Nominal; Point in time; Random; SDOH; Treatment maint challenges; Tx; Txs	4180186
36306147	Treatment maint challenges	4180186
36306147	关于坚持治疗或健康行为方面的难题:发现:时间点:^患者:名义型	4182948
36306149	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36306151	BP w and post exercise pnl	4180186
36306151	After; Art sys; BP; BP w and post exercise pnl; EXCZ; Pan; PANEL.BP; Panl; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
36306151	运动时及运动后血管内血压组套:-:时间点:动脉系统:定量型	4182948
36306153	SRA 1.0 IU/mL LMW heparin Ser-aCnc	4180186
36306153	5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; Arbitrary concentration; C10H12N2O; Clexane; Enoxaparin; Enteramine; Hep; Hepar; Heparin dependent platelet antibody; Heparn; HIT/HITT; LMWH; LMWH-induced thrombocytopenia; Lovenox; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serotonin release assay; Serum; SR; SRA; SRA 1.0 IU; SRA 1.0 IU/mL heparin; SRA 1.0 IU/mL LMW heparin; Thrombocytopenia with thrombosis syndrome; Wt	4180186
36306153	5-羟色胺释放分析 1.0 IU/mL 肝素.低分子量:任意型浓度:时间点:血清:定量型	4182948
36306155	40M p Lac PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
36306155	Breath H2 40M p Lac PO	4180186
36306155	氢/已呼出的气体^在口服剂量乳糖之后40分钟:体积分数:时间点:呼出的气体:定量型	4182948
36306158	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36306158	团体咨询记录:发现:时间点:{环境}:文档型:初级保健服务	4182948
36306159	Denagard; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306159	Tiamulin Spec-mCnt	4180186
36306159	泰妙菌素:质量含量:时间点:XXX:定量型	4182948
36306160	Dis; Diseases; DOC.ONT; Document; Dz; Finding; Findings; ID; Infectious Disease; InfectiousDisease; Point in time; Random	4180186
36306160	警示:发现:时间点:{环境}:文档型:感染性疾病	4182948
36306162	CorePlaybook; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; T-spine ICN	4180186
36306162	Guided T-spine ICN Nerve block	4180186
36306162	旨在神经阻滞的引导:发现:时间点:胸部>脊椎.胸段 肋间神经:文档型:{成像方式}	4182948
36306163	Elec conductivity Wat	4180186
36306163	Elec conductivity; Fluid conductance; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Wat	4180186
36306163	电导率:液体传导性:时间点:水:定量型	4182948
36306164	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Femoral; Femur; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; Point in time; Rad; RADIOLOGY; Random; Thigh-Bl; without contrast	4180186
36306164	CT Thigh-Bl WO contr	4180186
36306164	多层^不采用对比剂:发现:时间点:下肢.双侧>大腿:文档型:CT	4182948
36306168	CKD educ panel	4180186
36306168	CKD educ panel; CLIN; Dis; Diseases; Dz; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
36306168	慢性肾脏疾病教育组套:-:时间点:^患者:-	4182948
36306169	C&S; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; Eye fluid; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Occular Fluid; OcFlu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36306169	CMV Ocflu Ql Cult	4180186
36306169	巨细胞病毒:存在情况或阈值:时间点:眼液:序数型:微生物特异性培养	4182948
36306170	Foreign material Food Ql	4180186
36306170	Food sample; Foods; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36306170	外来物质:存在情况或阈值:时间点:食物:序数型	4182948
36306171	Audiology; Hearing; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LM; Micro; Microbiology; Micros; Microscopic; Mites; Nominal; Otologic; Point in time; Random	4180186
36306171	Mite Ear Micro	4180186
36306171	螨 已鉴定的:存在与否或特征标识:时间点:耳:名义型:显微镜检查.光学	4182948
36306172	Centers for Disease Control and Prevention; Ethnicity; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
36306174	Asympt; Asymptomatic; DOC.ONT; Document; Finding; Findings; Hx; Medical Hx screening form; OP; Point in time; Random; Scn	4180186
36306174	OP Medical Hx screening form	4180186
36306174	病史筛查表单:发现:时间点:门诊病人:文档型:患者	4182948
36306176	Finding; Findings; H+P; H+P.HX; Levels; Levl; LV; LVL; Nominal; Occupation; P prime; Point in time; Random; Supervisory level; Work	4180186
36306176	Supervisory level or pay grade	4180186
36306176	岗位监督级别或工资等级:发现:时间点:^患者:名义型	4182948
36306178	Blood; BSA pred.black; Chemistry; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; Pred GFR.black; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36306178	GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat	4180186
36306178	肾小球滤过率/1.73 平方米.预测型.黑人:单位面积体积速率:时间点:血清/血浆/全血:定量型:基于肌酐的公式 (CKD-EPI)	4182948
36306185	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36306185	ADBICA N-pentanoate Ur Ql Cfm	4180186
36306185	ADBICA N-戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36306186	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Nephrouret stent removal; Pelvic; Perc; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Remove; Renal; Ureter+Blad	4180186
36306186	Guided PCNUS removal	4180186
36306186	旨在经皮去除肾输尿管支架的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:{成像方式}	4182948
36306188	C&S; Cult; Cultures; EMCV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36306188	EMCV Tiss Ql Cult	4180186
36306188	脑心肌炎病毒:存在情况或阈值:时间点:组织与涂片:序数型:微生物特异性培养	4182948
36306189	Bil; Bilat; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Eye socket; Finding; Findings; Head+Orbit-Bl; Imaging; Intracranial; Orbital; Orbit-Bl; Orbits; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
36306189	CT Head+Orbit-Bl WO contr	4180186
36306189	多层^不采用对比剂:发现:时间点:头部 & 头部>眼眶.双侧:文档型:CT	4182948
36306190	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S apiospermum; S apiospermum DNA; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36306190	S apiospermum DNA Tiss Ql NAA+probe	4180186
36306190	尖端赛多孢 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36306191	GM3 IgM Ser Ql Line blot	4180186
36306191	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin M; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36306191	神经节苷脂 GM3 抗体.IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36306195	Add; CorePlaybook; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; Vertebroplasty addl	4180186
36306195	Guided T-spine Vertebroplasty addl	4180186
36306195	旨在额外椎体成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:{成像方式}	4182948
36306196	Abcid; Agribon; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primor; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36306196	Ormetoprim+Sulfadimethoxine Islt MIC	4180186
36306196	奥美普林+磺胺二甲氧嘧啶:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36306197	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306197	Diphacinone Spec-mCnt	4180186
36306197	敌鼠钠:质量含量:时间点:XXX:定量型	4182948
36306200	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; Survey; Ulcer	4180186
36306202	Acti Test; Activ; Actvty; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Movements; Necroinflammatory activ interp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36306202	Necroinflammatory activ interp Ser-Imp	4180186
36306202	坏死性炎症活动度解释:印象:时间点:血清:序数型	4182948
36306203	B atrophaeus; Bacillus subtilis var. niger; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Lab Device; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36306203	B atrophaeus Lab Device Ql Cult	4180186
36306203	萎缩芽孢杆菌:存在情况或阈值:时间点:实验室仪器设备:序数型:培养	4182948
36306204	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K88; EC K88 DNA; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306204	E coli K88 DNA Islt Ql NAA+probe	4180186
36306204	大肠埃希菌 K88 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36306207	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36306208	BON; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36306208	Guided Bone Bx	4180186
36306208	旨在经皮活组织检查的引导:发现:时间点:XXX>骨:文档型:{成像方式}	4182948
36306209	ABS; Aby; Antby; Anti; Antibodies; Antibody; ASMA; Autoantibodies; Autoantibody; F-actin; Hepatology; Liver; Musc; Muscl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SMA; SR	4180186
36306209	SMA Ab Ser Ql Line blot	4180186
36306209	肌动蛋白.平滑肌 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36306211	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B hyody; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36306211	B hyody DNA Islt Ql NAA+probe	4180186
36306211	猪痢疾短螺旋体 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36306215	High press hold time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36306215	High press hold time Vent	4180186
36306215	高压保持时间:时间:时间点:呼吸机:定量型	4182948
36306217	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P note; Hx; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36306217	OB H&P note	4180186
36306217	病史与体格检查记录:发现:时间点:{环境}:文档型:产科学	4182948
36306222	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306223	Achromycin V; C18; c211; C75; Chemiciclina; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Panmycin; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tetrabioptal; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306223	Tetracycline Spec-mCnt	4180186
36306223	四环素:质量含量:时间点:XXX:定量型	4182948
36306224	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306229	Particle diameter.mean	4180186
36306330	Pregnancy intention in the next Y	4180186
36306332	Abdomen>Celiac plexus	4180186
36306402	Chest>Spine.thoracic intercostal nerve	4180186
36306442	Cytolethal distending toxin B & Vinculin Ab panel	4180186
36306541	Chest>Thymus gland	4180186
36306574	Cells.CD19+IgM+	4180186
36306633	Upper extremity.right>Thumb	4180186
36306699	Upper extremity.left>Finger.fifth	4180186
36306718	Head>Head arteries	4180186
36306783	Head>Maxillofacial region	4180186
36306863	Chest>Lung.right	4180186
36306877	Abdomen>Peritoneum	4180186
36306963	Upper extremity.right>Finger.fourth	4180186
36306971	E super little w	4180186
36306984	Upper extremity.left>Finger.fourth	4180186
36307065	Abdomen+Pelvis+Lower extremity	4180186
36307114	Melanoma-associated antigen A4	4180186
36307209	Chest>Lung.left	4180186
36307216	XXX>Soft tissue	4180186
36307224	Pelvis>Pelvis veins	4180186
36307290	Upper extremity.right>Finger.second	4180186
36307323	Upper extremity.right>Finger.third	4180186
36307326	KIT gene.c.2447A>T	4180186
36307389	99th percentile upper reference limit	4180186
36307404	Chemical XXX	4180186
36307515	Upper extremity.right>Finger.fifth	4180186
36659621	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659623	Finding; Findings; H+P; H+P.PX; Med admin transnasal; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36659623	Med admin transnasal	4180186
36659623	当时是否经鼻施用药物:发现:时间点:^患者:序数型	4182948
36659624	1,3-Beta-D-Glucan; B; Beta glucan; Cerebral spinal fluid; Cerebrospinal Fl; i; ID; III; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36659624	1,3 beta glucan CSF-mCnc	4180186
36659624	1,3 Beta 葡聚糖:质量浓度:时间点:脑脊液:定量型	4182948
36659625	CHEMISTRY.CHALLENGE TESTING; Dermatologic; DTH Anergy Pnl; Epidermis; Hypersens; Hypersnstvty; Integument; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Skn	4180186
36659625	DTH Anergy Pnl Skin	4180186
36659625	迟发型超敏反应无反应性组套:-:时间点:皮肤:-	4182948
36659627	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B8 CMV CD8 Cells; Human Leukocyte Antigen; IFN; IFN-g HLA-B8 CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659627	IFN-g HLA-B8 CMV CD8 Cells # Bld FC	4180186
36659627	细胞.CD8.HLA-B8 CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659629	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; hypocretin neuropeptide precursor; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; NRCLP1; OX; Point in time; PPOX; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659629	PPOX Full Mut Anl Bld/T Seq	4180186
36659629	PPOX 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659632	Centers for Medicare and Medicaid Assessment; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
36659633	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659633	HEV RNA Spec Ql NAA+probe	4180186
36659633	戊型肝炎病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36659635	100WBC; Atypical lymphocytes; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Stem prod; Variant lymphocytes; Variant Lymphs; WBC; WBCs; White blood cell; White blood cells	4180186
36659635	Variant Lymphs/leuk NFr Stem prod Manual	4180186
36659635	淋巴细胞.异型/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659636	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36659636	Fracture reduction	4180186
36659636	当时是否进行了骨折复位:发现:时间点:^患者:序数型	4182948
36659637	垂直棱镜.下射:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36659637	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-down	4180186
36659637	Corr lens V prism-down by LM	4180186
36659638	Genitourinary; GU; HGPIN; High grade PIN; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; Prost; Prostate; Prostati; QL; Qual; Qualitative; Random; Screen; Spec; URO; Urology	4180186
36659638	HGPIN Spec Ql Micro	4180186
36659638	高分级前列腺上皮内瘤:存在情况或阈值:时间点:标本:序数型:显微镜检查类实验室方法	4182948
36659642	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BDV; Beef; Bovine viral diarrhea; BVD; BVDV; BVDV subtype; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mucosal disease; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Pestivirus; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659642	BVDV subtype Spec NAA+probe	4180186
36659642	牛病毒性腹泻病毒亚型:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
36659643	Aldosterone + Na Pnl 24h Ur	4180186
36659643	1 day; 24 hours; 24HR; Aldosterone + Na Pnl; Chemistry; Na; Na+; Pan; PANEL.CHEMISTRY; Panl; Pnl; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
36659643	醛固酮与钠离子组套:-:24小时:尿液:定量型	4182948
36659649	Disch; H+P; H+P.HX; ICU discharge date; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659649	ICU discharge date	4180186
36659649	重症监护病房出院日期:日期:时间点:^患者:定量型	4182948
36659650	Blood; CD240CE; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; RH; Rh blood group gene, CcEe antigens; Rh blood group, CcEe antigens; RH30A; Rh4; RHC; RHCE allele; RHCE allele Ee; RHE; Rhesus blood group gene, CcEe antigens; RhIVb(J); RHIXB; RHPI; RhVI; RhVIII; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659650	RHCE allele Ee Geno Bld/T	4180186
36659650	RHCE 基因等位基因 Ee:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659653	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
36659653	PA Epineph 50 umol/L PRP	4180186
36659653	血小板聚集.肾上腺素诱导型^50 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36659655	Axis step; EYE; EYE.REFRACTION; KM; Nominal; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; Random; Typ	4180186
36659655	轴向测量增量:类型:时间点:角膜曲率计:名义型	4182948
36659655	Axis step KM	4180186
36659656	Acer; Chemistry; Dis; Diseases; Dz; f377; Genetics; Heredity; Heritable; Inherited; MSUD; MSUD therapy monitor Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659656	MSUD therapy monitor Pnl SerPl	4180186
36659656	枫糖浆尿症治疗监测组套:-:时间点:血清/血浆:定量型	4182948
36659662	Blood; Chromosom; Chromosomes; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659662	Chromosome rearrangement Bld/T	4180186
36659662	染色体重排:存在与否或特征标识:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
36659663	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659664	Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WNV; WNV IgG+IgM Pnl	4180186
36659664	WNV IgG+IgM Pnl CSF	4180186
36659664	西尼罗河病毒抗体.IgG 与 IgM 组套:-:时间点:脑脊液:序数型	4182948
36659665	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659666	Hgb Pnl Bld HPLC	4180186
36659666	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Pnl; High performance liquid chromatography; High pressure liquid chromatography; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36659666	血红蛋白组套:-:时间点:全血:-:高效液相色谱分析法	4182948
36659673	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659673	Glucagon p fast SerPl-mCnc	4180186
36659673	胰高血糖素^在热量型禁食之后:质量浓度:时间点:血清/血浆:定量型	4182948
36659674	Cardio; Cardiology; Chemistry; Coenzyme Q10; CoQ10; CO-Q10; Heart Disease; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Ubiquinone10; WBCs; White blood cells	4180186
36659674	Ubiquinone10 WBC-sCnt	4180186
36659674	泛醌 10:物质的量含量:时间点:白细胞:定量型	4182948
36659675	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659678	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659679	Blood; Chemistry; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; TTR; TTR width at half height; WB; Whole blood	4180186
36659679	TTR width at half height Bld Qn	4180186
36659679	甲状腺素视黄质运载蛋白半高宽:质量:时间点:全血:定量型	4182948
36659680	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659680	SBF2 gene Full Mut Anl Bld/T Seq	4180186
36659680	SBF2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659683	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36659684	M synoviae Ab Titr Ser IA	4180186
36659684	鸡滑膜支原体 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659684	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M synoviae; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36659685	5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; Blood; C20:4w6; COAGULATION; Eicosatetraenoate; Hematology; Heme; Length; MA AA; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
36659685	最大凝块强度幅度.花生四烯酸诱导型:长度:时间点:全血:定量型:血栓弹力描记术.共振	4182948
36659685	MA AA Bld Res TEG	4180186
36659686	Criteria for case classification	4180186
36659686	Criteria for case classification; Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random	4180186
36659686	用于病例分类的评判准则:发现:时间点:^患者:名义型	4182948
36659689	Arsenite Ur-mCnc	4180186
36659689	亚砷酸盐:质量浓度:时间点:尿液:定量型	4182948
36659689	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36659690	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; mutY (E. coli) homolog; mutY homolog; MYH; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659690	MUTYH gene Full Mut Anl Bld/T Seq	4180186
36659690	MUTYH 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659691	100 CD3+CD8+; Blood; CD3 Cells; CD3+CD8+ Cells; CD8 Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Dynamic; Esoteric; FC; IFN; IFN-g CD8 Cells; IGRA; Leu2; Leu-2; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
36659691	细胞.CD8.PMA+离子霉素刺激性 gamma 干扰素产生型/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36659691	IFN-g CD8 Cells/100 CD3+CD8+ NFr Bld FC	4180186
36659695	Disability	4180186
36659695	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36659695	残疾:类型:时间点:^患者:名义型	4182948
36659697	Household contacts	4180186
36659697	ADMIN; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659697	居所接触:数量(计数):时间点:^患者:定量型	4182948
36659698	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B mayonii; B mayonii oppA2; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Tick-Borne Disease; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36659698	B mayonii oppA2 Spec Ql NAA+non-probe	4180186
36659698	梅奥疏螺旋体 oppA2 基因:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36659700	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; lysozyme; LYZF1; LZM; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659700	LYZ Full Mut Anl Bld/T Seq	4180186
36659700	LYZ 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659702	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659703	Clin Path Telehealth Note	4180186
36659703	Clin Path; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; Path; Point in time; Random; Telemedicine; Visit note	4180186
36659703	记录:发现:时间点:远程医疗:文档型:临床病理学	4182948
36659704	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; DFS70; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36659704	DFS70 IgG SerPl IA-aCnc	4180186
36659704	致密细斑 70 蛋白 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36659705	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Arbitrary concentration; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36659705	EBV DNA Amn NAA+probe-aCnc	4180186
36659705	Epstein Barr 病毒 DNA:任意型浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36659706	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36659709	ADF; AGEL; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; gelsolin; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659709	GSN Full Mut Anl Bld/T Seq	4180186
36659709	GSN 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659710	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; IgA+IgG; IgA+IgG+IgM; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Lyme; Lyme disease; Lymes; Microbiology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36659710	B burgdor IgA+IgG+IgM CSF-Imp	4180186
36659710	伯氏疏螺旋体 抗体.IgA 与 IgG 与 IgM:印象:时间点:脑脊液:名义型	4182948
36659711	2; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659712	Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Point in time; Random; RNA transcriptome profiling; RNA-Seq; Tissue; Tissue, unspecified; transcriptional profiling; WB; Whole blood; Whole blood or Tissue; Whole mRNA Seq Analysis	4180186
36659712	全 mRNA 转录物组序列分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659712	Whole mRNA Seq Analysis Bld/T Seq	4180186
36659714	Chemistry; Fetal; Kidney; Level; Na; Na+; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; UA; UR; Urn	4180186
36659714	钠:物质的量浓度:时间点:尿液^胎儿:定量型	4182948
36659714	Sodium Ur Fetus-sCnc	4180186
36659715	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36659716	3h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36659716	Insulin 3h p meal SerPl-aCnc	4180186
36659716	胰岛素^在进餐之后3小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36659718	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659719	2D p tet tox ID; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn; Tetanus Rx; Tetanus Rx^2D p tet tox ID	4180186
36659719	Tetanus Rx 2D p tet tox ID Diam	4180186
36659719	破伤风反应风团^在皮内注射破伤风类毒素之后2天:直径:时间点:皮肤:定量型	4182948
36659722	Imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; SDOH; Survey	4180186
36659723	Centers for Medicare and Medicaid Assessment; Finding; Findings; O2; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; tO2	4180186
36659724	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659726	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659727	BCD541; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gemin 1; GEMIN1; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Kugelberg-Welander disease; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; SMA; SMA gene; SMA@; SMA1; SMA2; SMA3; SMA4; SMN; SMNT; SMV; spinal muscular atrophy; Survival motor neuron protein gene; survival of motor neuron 1, telomeric; T-BCD541; TDRD16A; Tissue; Tissue, unspecified; WB; Werdnig-Hoffmann disease; Whole blood; Whole blood or Tissue	4180186
36659727	SMN1 gene Full Mut Anl Bld/T Seq	4180186
36659727	SMN1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659729	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659731	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659732	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Patient Telephone; Ql; Qual; Qualitative; Screen; Survey	4180186
36659733	3h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659733	C peptide 3h p meal SerPl-mCnc	4180186
36659733	C 肽^在进餐之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
36659735	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659735	P aeruginosa DNA Lower resp Ql NAA+probe	4180186
36659735	铜绿假单胞菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659736	B avium Ab Titr Ser IA	4180186
36659736	禽博德特菌 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659736	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B avium; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36659743	Blood; Genetics; GRIK4 c.83-10039T&gt;C; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1954787; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659743	GRIK4 c.83-10039T>C Geno Bld/T	4180186
36659743	GRIK4 基因.c.83-10039T>C:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659744	17-Hydroxycorticosterone; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortis F p corticotropin stim Pnl; Cortrosyn; F; FR; hydrocortisone; Non-protein bound; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim; Tumor marker	4180186
36659744	Cortis F p corticotropin stim Pnl SerPl	4180186
36659744	促肾上腺皮质激素刺激后游离型皮质醇组套:-:时间点:血清/血浆:定量型	4182948
36659745	1 1/2 hours; 1 1/2 HR; 1.5h p meal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659745	Glucagon 1.5h p meal SerPl-mCnc	4180186
36659745	胰高血糖素^在进餐之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36659746	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Calicivirus; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; f213; Hemorrhagic septicemia; i; Infectious necrotic hepatitis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oryctalagus spp; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Rabbit hemorrhagic disease; Random; RHDV; RHDV1; RHDVa; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral hemorrhagic disease	4180186
36659746	RHDV1 RNA Ct Spec Qn NAA+probe	4180186
36659746	兔出血症病毒 1 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659749	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BCV; Beef; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659749	BCV RNA Ct Spec Qn NAA+probe	4180186
36659749	牛冠状病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659752	Axis step; EYE; EYE.REFRACTION; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; RM; Typ	4180186
36659752	Type of Axis step	4180186
36659752	轴向测量增量:类型:时间点:屈光计:名义型	4182948
36659753	横纹肌 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659753	Stria Mus Ab Titr Ser IA	4180186
36659753	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cardio; Cardiology; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heart Disease; Heredity; Heritable; IAA; Inherited; MEIA; Musc; Muscl; Neuro; Neurology; Point in time; Random; Serology; Serum; Skeletal muscle; SMA; SmQn; SR; Stria Mus; SUDS; Titer; Titered; Titre; Ttr	4180186
36659755	Assay related variables pnl; Pan; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
36659755	Assay related variables pnl PhenX	4180186
36659755	检测相关变量组套:-:时间点:^患者:-:PhenX	4182948
36659759	PCA-Tr IgG Titr Ser IF	4180186
36659759	浦肯雅细胞胞浆 Tr 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36659759	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalopathy; Neuro; Neurology; Oncology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCA-Tr Ab; PCD; PNS; Point in time; Purkinje Cells Tr Ab; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36659760	Reason spec not collected	4180186
36659760	Finding; Findings; Nominal; Point in time; Random; Reason spec not collected; Spec	4180186
36659760	关于未采集标本的原因:发现:时间点:标本:名义型	4182948
36659764	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659766	2q37.3; AGT; AGT1; AGXT1; alanine-glyoxylate aminotransferase; Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; L-alanine: glyoxylate aminotransferase 1; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; oxalosis I; PCR; PH1; Point in time; primary hyperoxaluria type 1; Random; sequencing of entire coding region; serine:pyruvate aminotransferase; SPAT; SPT; Tissue; Tissue, unspecified; TLH6; WB; Whole blood; Whole blood or Tissue	4180186
36659766	AGXT gene Del+Dup + Full Mut Anl Bld/T	4180186
36659766	AGXT 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659769	Calcaneous; Document; EXT; Films; Finding; Findings; GE 2V; Heel; II; Imaging; LE; Leg; Low; Minimum 2 views; Os calcis; Oscalcis; Plain Films; Point in time; Rad; RADIOLOGY; Random; View; VWS; Xray; X-ray	4180186
36659769	XR Heel GE 2V	4180186
36659769	多重视图 GE 双重:发现:时间点:下肢>跟骨:文档型:X射线摄影术	4182948
36659772	A,B; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA class I Ab.IgG prozone; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659772	HLA class I Ab.IgG prozone SerPl FC	4180186
36659772	HLA-A 与 B 与 C (I 类) 抗体.IgG 伴前带效应:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659773	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; GE 6V; GE 6V W R+L-bending; Imaging; L/sp; Lateral bending; Left; Left Sidebending; Levo; L-spine; L-spine+Sacrum; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Plain Films; Point in time; R prime; Rad; RADIOLOGY; Random; Right; Right Sidebending; Spinal; Spinal Cord; View; VWS; W R+L-bending; W R+L-bending); Xray; X-ray	4180186
36659773	XR L-spine+Sacrum GE 6V W R+L-bending	4180186
36659773	多重视图 GE 六重^采用右侧弯曲+采用左侧弯曲:发现:时间点:腹部>脊椎.腰段 & 盆腔>骶骨:文档型:X射线摄影术	4182948
36659774	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659774	棱镜:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36659774	L corr lens Prism by LM	4180186
36659778	Acetylglucosaminylasparagine; Asparaginylglucosamine; Aspartylglucosamine; Aspartylglucosylamine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
36659778	天冬氨酰氨基葡萄糖:物质的量浓度:时间点:脑脊液:定量型	4182948
36659778	Aspartylglycosamine CSF-sCnc	4180186
36659779	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36659781	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659782	Myelopathy Ab pnl CSF	4180186
36659782	Cerebral spinal fluid; Cerebrospinal Fl; Myelopathy Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36659782	脊髓病自身免疫抗体组套:-:时间点:脑脊液:-	4182948
36659783	3.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659783	Glucose 3.5h p meal SerPl-mCnc	4180186
36659783	葡萄糖^在进餐之后3.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36659787	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659787	Aerodigestive med Telehealth Note	4180186
36659787	记录:发现:时间点:远程医疗:文档型:呼吸消化道医学	4182948
36659788	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Liver; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659788	丙型肝炎病毒 抗体:印象:时间点:血清/血浆:名义型	4182948
36659788	HCV Ab SerPl-Imp	4180186
36659790	HLA-A + B + C (class I) IgG Pnl SerPl FC	4180186
36659790	A,B; Dynamic; FC; HLA ANTIGEN; HLA class I; HLA-A + B + C (class I) IgG Pnl; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Immune globulin G; Immunoglobulin G; Pan; PANEL.HLA; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659790	HLA-A 与 B 与 C (I 类) 抗体.IgG 组套:-:时间点:血清/血浆:-:流式细胞测量术	4182948
36659791	Cell susp Vol Spec	4180186
36659791	Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Volume	4180186
36659791	细胞悬液:体积型属性:时间点:标本:定量型	4182948
36659792	1 1/2 hours; 1 1/2 HR; 1.5h p meal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36659792	胰岛素^在进餐之后1.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36659792	Insulin 1.5h p meal SerPl-aCnc	4180186
36659796	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36659796	Needs smoke detector	4180186
36659796	需要家用烟雾探测器:发现:时间点:^照护人员:序数型	4182948
36659798	Disease, Hansen; Disease, Hansen's; H+P; H+P.HX; Hansen Disease; Hansens Disease; ID; Infectious Disease; InfectiousDisease; Nominal; P prime; Point in time; Random; Typ	4180186
36659798	麻风:类型:时间点:^患者:名义型	4182948
36659800	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36659801	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cat (rFel d) 7; Dextro; e231; Feline; Felis domesticus; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36659801	猫 重组 (rFel d) 7 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36659801	Deprecated Cat (rFel d) 7 IgE RAST Ql	4180186
36659802	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659803	3 Self-Sustaining Sequence Replication; 3SR SR; American plague; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; yellow jack; YFV	4180186
36659803	YFV RNA Spec Ql NAA+probe	4180186
36659803	黄热病病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36659805	Age init cig use adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Smoke; Smokes; Smoking; Tobacco	4180186
36659805	Age init cig use adult proto	4180186
36659805	PhenX - 初次吸烟起始年龄 - 成年人方案 030703:-:时间点:^患者:-:PhenX	4182948
36659806	100WBC; Bands; bnd; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659806	Neuts Band/leuk NFr Stem prod Manual	4180186
36659806	嗜中性粒细胞.带状核/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659807	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659808	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B miyamotoi; B miyamotoi glpQ; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TBRF; Tick Borne Diseases; tick-borne relapsing fever; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36659808	B miyamotoi glpQ Spec Ql NAA+probe	4180186
36659808	宫本疏螺旋体 glpQ 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36659814	Perip ven access avail	4180186
36659814	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Perip ven access avail; Periph; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36659814	外周静脉通路可用情况:发现:时间点:^患者:序数型	4182948
36659818	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36659819	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
36659821	BM Transplant Prog note	4180186
36659821	BM Transplant; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36659821	病程记录:发现:时间点:{环境}:文档型:骨髓移植	4182948
36659825	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36659827	17 hydroxy pregnenolone; 17-alpha-Hydroxypregnenolone; 17-OH Pregnenolone; 17OH-Preg; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Preg + 17-OH Preg pnl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659827	Preg + 17-OH Preg pnl SerPl	4180186
36659827	孕烯醇酮 & 羟基孕烯醇酮组套:-:时间点:血清/血浆:定量型	4182948
36659828	Horm; Pan; Panel; PANEL.PHENX; Panl; PhenX - Creatine GH+steroids use proto; Pnl; Point in time; Random; Ste; Steriods; Steroid	4180186
36659828	PhenX - Creatine GH+steroids use proto	4180186
36659828	PhenX - 肌酸生长激素和类固醇使用方案 230801:-:时间点:^患者:-:PhenX	4182948
36659829	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659829	HPIV3 RNA Lower resp Ql NAA+non-probe	4180186
36659829	副流感病毒 3 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36659830	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Insulin p Cfst + meal Pnl; Lente; NPH; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Stim; Ultralente	4180186
36659830	Insulin p Cfst + meal Pnl SerPl	4180186
36659830	禁食后和进餐刺激胰岛素组套:-:时间点:血清/血浆:-	4182948
36659831	Blood; BRPK; Del; Deletions; Document; Finding; Findings; FLJ27236; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; PARK6; PCR; Point in time; PTEN induced putative kinase 1; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659831	PINK1 gene Del Bld/T	4180186
36659831	PINK1 基因 缺失:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659834	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659835	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659841	HAV IgM + total Pnl SerPl	4180186
36659841	HAV; HAV IgM + total Pnl; HAV IgM+total; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
36659841	甲型肝炎病毒抗体.IgM 与总计组套:-:时间点:血清/血浆:序数型	4182948
36659843	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; M catarr DNA; M catarrhalis; Microbiology; Micrococcus catarrhalis; NAA+probe; NAAT; NASBA; Neisseria catarrhalis; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659843	M catarrhalis DNA Lower Resp Ql NAA+prb	4180186
36659843	卡他莫拉菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659845	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
36659845	GD1b Gangl IgM Ser Ql IA	4180186
36659845	神经节苷脂 GD1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36659846	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B sp panel; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Relapsing fever; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36659846	B sp panel Spec NAA+non-probe	4180186
36659846	疏螺旋体属组套:-:时间点:XXX:-:非探针法.基因扩增.靶向	4182948
36659850	Contact w/U.S. case	4180186
36659850	Contact w/U.S. case; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; S prime	4180186
36659850	是否接触的是美国或国际病例:发现:时间点:^患者:名义型	4182948
36659852	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659852	记录:发现:时间点:远程医疗:文档型:伦理学	4182948
36659854	by KM; Corneal; EYE; EYE.REFRACTION; Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Upper extremity	4180186
36659854	R cornea Curvature radius.steep by KM	4180186
36659854	曲率半径.陡峭:长度:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36659857	Cerebral spinal fluid; Cerebrospinal Fl; Dementia autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36659857	Dementia autoimmune Ab pnl CSF	4180186
36659857	痴呆自身免疫抗体组套:-:时间点:脑脊液:-	4182948
36659862	Adrenalin; Adrenaline; Adreneline; CHEMISTRY.CHALLENGE TESTING; E; Endocrine; Endocrinology; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Stand); WB; Weight bearing	4180186
36659862	Epineph stand Plas-mCnc	4180186
36659862	肾上腺素^直立位:质量浓度:时间点:血浆:定量型	4182948
36659865	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-out; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659865	L corr lens H prism-out by LM	4180186
36659865	水平棱镜.出射:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36659866	Calc; Calculation; Corr lens; EYE; EYE.LENSOMETRY; Inverse Length; L; L corr lens; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Sph equiv	4180186
36659866	L corr lens Sph equiv Calc	4180186
36659866	等效球镜值:长度倒数:时间点:矫正镜片.左侧:定量型:计算法	4182948
36659867	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; CMV; CMV DNA Pnl; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659867	CMV DNA Pnl Amn NAA+probe	4180186
36659867	巨细胞病毒 DNA 组套:-:时间点:羊水:-:探针法.基因扩增.靶向	4182948
36659868	AlphaL integrin chain; Blood; CD11a Cells; Cell; CELL MARKERS; Cellularity; LFA-1alpha; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36659868	CD11a Cells Bld Ql	4180186
36659868	细胞.CD11a:存在情况或阈值:时间点:全血:序数型	4182948
36659876	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp viral path DNA+RNA Pnl; Respiratory; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659876	Resp viral DNA+RNA Pnl Low Resp NAA+prb	4180186
36659876	呼吸道病毒性病原体 DNA 与 RNA 组套:-:时间点:呼吸道.下:-:探针法.基因扩增.靶向	4182948
36659877	Diet; Dietetics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition; Nutrition+Dietetics; Point in time; Random; Telemedicine; Visit note	4180186
36659877	Nutr+diet Telehealth Note	4180186
36659877	记录:发现:时间点:远程医疗:文档型:营养学与膳食学	4182948
36659882	Chol + Trigl Pnl Fld	4180186
36659882	胆固醇与甘油三酯组套:-:时间点:体液:定量型	4182948
36659882	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Chol; Chol + Trigl Pnl; Choles; Cholest; Cholesterol total; Cholesterols; Fl; Fld; FLU; Fluid; Lipid; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
36659883	Blood; EPHX; EPHX1 c.416A&gt;G; EPOX; Genetics; Heredity; Heritable; His139Arg; HYL1; Inherited; MEH; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs2234922; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659883	EPHX1 c.416A>G Geno Bld/T	4180186
36659883	EPHX1 基因.c.416A>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659884	MPS panel Ur	4180186
36659884	硫酸皮肤素 & 硫酸类肝素 & 软骨素-6-硫酸酯 & 硫酸角质素组套:-:时间点:尿液:定量型	4182948
36659884	C6S; Chemistry; Chondroitin B sulfate; Chondroitin sulfate B; Chondroitin sulfate C; Chondrotin; Dermatin; HS; keratosulfate; MPS panel; Mucopolysaccharides; Mucopolysaccharidosis; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; UA; UR; Urn	4180186
36659885	Blood; Chemistry; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; TTR; WB; Whole blood	4180186
36659885	TTR Bld Qn	4180186
36659885	甲状腺素视黄质运载蛋白:质量:时间点:全血:定量型	4182948
36659886	Heavy Met Pnl Nail	4180186
36659886	DRUG/TOXICOLOGY; Drugs; Heavy met; Heavy Met Pnl; Metal; Nails; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Ungal nail	4180186
36659886	重金属组套:-:时间点:甲:-	4182948
36659887	Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Catalytic Content; Cfm; Chemistry; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GAA; GCMS; Genetics; Glucoinvertase; Glucosidosucrase; Heredity; Heritable; Inherited; Leukocytes; Maltase; Maltase-glucoamylase; Point in time; Pompe disease; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
36659887	Acid A-Glucosidase WBC Cfm-cCnt	4180186
36659887	Alpha 葡糖苷酶:催化含量:时间点:白细胞:定量型:毒理学确认试验	4182948
36659889	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36659889	B19V DNA Amn NAA+probe-Log IU	4180186
36659889	细小病毒 B19 DNA:对数型任意浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36659890	ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mycobacterial ID Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36659890	Mycobacterial ID Pnl Spec	4180186
36659890	分枝杆菌鉴定组套:-:时间点:XXX:-:分子遗传学类实验室方法	4182948
36659892	Finding; Findings; Nominal; Point in time; Random; TRAUMA	4180186
36659892	卡压:发现:时间点:^患者:名义型	4182948
36659894	WOC Telehealth Note	4180186
36659894	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note; WOC	4180186
36659894	记录:发现:时间点:远程医疗:文档型:伤口、造口和大小便节制照护服务	4182948
36659897	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; LAM; LAM Ag; M tb; M tuberculosis; MEIA; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; TB; Tuberculosis; UA; UR; Urn	4180186
36659897	结核分枝杆菌脂阿拉伯甘露聚糖 抗原:存在情况或阈值:时间点:尿液:序数型:免疫测定法.快速	4182948
36659897	LAM Ag Ur Ql IA.rapid	4180186
36659898	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; Mat fetal med; notes; OB; ObGyn; Obstetrics; Point in time; Random; Telemedicine; Visit note	4180186
36659898	Mat fetal med Telehealth Note	4180186
36659898	记录:发现:时间点:远程医疗:文档型:母胎医学	4182948
36659899	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Inherited; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-P/Q Bind; Voltage-dependent calcium channels	4180186
36659899	VGCC-P/Q Bind IgG+IgM Ser IA-sCnc	4180186
36659899	PQ 型电压门控钙离子通道结合 抗体.IgG+IgM:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36659900	Adenomatosis polyposis coli; adenomatous polyposis coli; Adenomatous polyposis of the colon; Amplification; Blood; BTPS2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; DP2; DP2.5; DP3; Familial adenomatous polyposis; FAP; Finding; Findings; FPC; full gene sequencing; Full Mut Anl; Genetics; GS; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; PPP1R46; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659900	APC gene Del+Dup + Full Mut Anl Bld/T	4180186
36659900	APC 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659903	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B7 CMV CD8 Cells; Human Leukocyte Antigen; IFN; IFN-g HLA-B7 CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659903	细胞.CD8.HLA-B7 CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659903	IFN-g HLA-B7 CMV CD8 Cells # Bld FC	4180186
36659904	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification	4180186
36659904	S pneum DNA Lower resp Ql NAA+probe	4180186
36659904	肺炎链球菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659906	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B1; B-1; B4; B-4; Blood; Bp35; CD19 Cells; CD20 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Hematology; Heme; Leu12; Leu-12; Leu16; Leu-16; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36659906	CD20 Cells/100 CD19 cells NFr Bld	4180186
36659906	细胞.CD20/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36659908	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36659911	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arterivirus; DNA NUCLEIC ACID PROBE; DNA probe; EAV; Equin; Equine viral arteritis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659911	EAV RNA Ct Spec Qn NAA+probe	4180186
36659911	马动脉炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659912	Calc; Calculation; CLIN; CLIN.RISK; Endocrine; Endocrinology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
36659912	Diabetes risk Score Calc	4180186
36659912	糖尿病风险:评分:时间点:^患者:定量型:计算法	4182948
36659916	1 year; 12Mos; Pan; Panel; Panl; Pnl; S prime; SDOH	4180186
36659917	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659918	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-in; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
36659918	R corr lens H prism-in by LM	4180186
36659918	水平棱镜.入射:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36659919	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36659919	Noroxycodone Ur-mCnc	4180186
36659919	去甲基羟考酮:质量浓度:时间点:尿液:定量型	4182948
36659920	Pan; Panel; Panl; Pnl; Point in time; Random; SDOH; SEEK-R; Survey	4180186
36659922	Blood; Genetics; Heredity; Heritable; HLUG4; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1902023; T prime; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 2 family, polypeptide B15; UDPGT 2B8; UDPGT2B15; UDPGTH3; UGT2B15 c.253G&gt;T; UGT2B8; WB; Whole blood; Whole blood or Tissue	4180186
36659922	UGT2B15 c.253G>T Geno Bld/T	4180186
36659922	UGT2B15 基因.c.253G>T:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659924	LM Prism step InvLen	4180186
36659924	EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Prism step; Random	4180186
36659924	棱镜测量增量:长度倒数:时间点:透镜屈光度计:名义型	4182948
36659926	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659927	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; U diversum; Unspecified; Vet; Veterinary	4180186
36659927	U diversum DNA Ct Spec Qn NAA+probe	4180186
36659927	差异脲原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659931	Continuity assessment record and evaluation; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC	4180186
36659931	WOC D/C sum	4180186
36659931	出院摘要记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
36659932	Consult note; Dialy; Dialy+Ther Apher; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Random; Renal; Ther; Visit note	4180186
36659932	Dialy+Ther Apher Consult note	4180186
36659932	会诊记录:发现:时间点:{环境}:文档型:透析+治疗性血浆置换	4182948
36659934	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659934	HSV 1+2 DNA Pnl CSF NAA+non-probe	4180186
36659934	单纯疱疹病毒 1 与 2 型组套:-:时间点:脑脊液:-:非探针法.基因扩增.靶向	4182948
36659935	biotinase; biotinidase; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659935	BTD gene Full Mut Anl Bld/T Seq	4180186
36659935	BTD 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659937	GD1b Gangl IgM Titr Ser IA	4180186
36659937	神经节苷脂 GD1b 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659937	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Neuro; Neurology; Point in time; Random; Serology; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
36659939	adrenoceptor beta 2; Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659939	ADRB2 Mut Anl Bld/T	4180186
36659939	ADRB2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659944	IBDV Ab Titr Ser IA	4180186
36659944	传染性法氏囊病病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659944	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; Gumboro disease; IAA; IBDV; ID; Infectious bursal disease; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36659945	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; VZ; VZV; Zoster	4180186
36659945	VZV DNA Spec Ql NAA+non-probe	4180186
36659945	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36659946	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659946	记录:发现:时间点:远程医疗:文档型:胃肠病学	4182948
36659949	Chemistry; Enz; Enzyme; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Lysosomal Enzymes Scn; Narrative; Point in time; Random; Report; Scn; Scr; Scrn; UA; UR; Urn	4180186
36659949	溶酶体酶类筛查:印象:时间点:尿液:叙述型	4182948
36659949	Lysosomal Enzymes Scn Ur-Imp	4180186
36659950	10q23del; Amplification; Bannayan-Zonana syndrome; Blood; BZS; CWS1; DEC; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GLM2; Heredity; Heritable; Human mutated in multiple advanced cancers protein (MMAC1) mRNA, complete cds; Inherited; MGC11227; MHAM; MMAC1; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutated in multiple advanced cancers 1; Mutations; PCR; Phosphatase and tensin homolog; Point in time; PTEN1; Random; sequencing of entire coding region; TEP1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659950	PTEN gene Del+Dup + Full Mut Anl Bld/T	4180186
36659950	PTEN 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659953	Connective Tiss IgG Pnl SerPl	4180186
36659953	结缔组织自身免疫抗体.IgG 组套:-:时间点:血清/血浆:-	4182948
36659953	Conn tiss; Connective Tiss IgG Pnl; Connective tissue Ab; Immune globulin G; Immunoglobulin G; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659955	垂直棱镜.上射:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36659955	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up	4180186
36659955	Corr lens V prism-up by LM	4180186
36659956	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor G39/40; B burgdorferi; Bb; Blood; Blt; Burgdorf; Cnt; Count; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; RIBA; WB; WBLOT; West blot; West blt; Western blot; Whole blood	4180186
36659956	B burgdor G39/40 IgG bands Bld IB	4180186
36659956	伯氏疏螺旋体 G39_40 抗体.IgG 区带:数量(计数):时间点:全血:定量型:免疫印迹法	4182948
36659957	Axonal autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659957	Axonal autoimmune Ab pnl SerPl	4180186
36659957	轴突自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36659959	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; i; Immune globulin G; Immunoglobulin G; Neuro; Neurology; Oncology; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Yo Ab	4180186
36659959	PCA-1 IgG Ser Ql Line blot	4180186
36659959	浦肯雅细胞胞浆 1 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36659960	Centers for Medicare and Medicaid Assessment; Compx; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36659961	ICU admission date	4180186
36659961	H+P; H+P.HX; ICU admission date; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659961	重症监护病房入院日期:日期:时间点:^患者:定量型	4182948
36659962	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659962	K pneumon DNA Lower resp Ql NAA+probe	4180186
36659962	肺炎克雷伯菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659965	Genitourinary; GU; IDC-P; Intraductal CA Prostate; Micro; Micros; Microscopic; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; URO; Urology	4180186
36659965	前列腺导管内癌:存在情况或阈值:时间点:标本:序数型:显微镜检查类实验室方法	4182948
36659965	Intraductal CA Prostate Spec Ql Micro	4180186
36659966	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36659966	HLA-DQA1	4180186
36659966	HLA-DQA1:类型:时间点:全血/组织:名义型	4182948
36659968	A,B; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA class I Ab.IgG med risk; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659968	HLA class I Ab.IgG med risk SerPl FC	4180186
36659968	HLA-A 与 B 与 C (I 类) 抗体.IgG 中度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659972	O-去甲基文拉法新:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36659972	ODV SerPl Ql Scn	4180186
36659972	Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Pristiq; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Venlafaxine metabolite	4180186
36659978	activated charcoal; After; Clot; Clottable; Coag; Coagulation assay; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; Direct oral anticoagulants; DOAC Remove; DOAC-Stop; dRVV; dRVVT; Hematology; Heme; Neut; Neutr; p DOAC neut; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
36659978	dRVVT p DOAC neut PPP	4180186
36659978	稀释蝰蛇毒诱导型凝血过程^在直接口服抗凝剂中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36659979	A,B; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA class I Ab.IgG high risk; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659979	HLA class I Ab.IgG high risk SerPl FC	4180186
36659979	HLA-A 与 B 与 C (I 类) 抗体.IgG 高度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659981	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; Gumboro disease; IAA; IBDV; ID; Infectious bursal disease; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36659981	IBDV Ab/Pos cntrl Ser IA	4180186
36659981	传染性法氏囊病病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36659983	Beef; BRSV; C&S; Cult; Cultures; HRSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36659983	BRSV Spec Ql Cult	4180186
36659983	牛呼吸道合胞病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36659987	Ident; Identifier; Nominal; Pathology; Point in time; Random; Spec	4180186
36659987	Tissue block ID Spec	4180186
36659987	组织块标识符:标识符:时间点:标本:名义型	4182948
36659988	#; ABS; absolute; absolutes; Ag; Blood; CD107ab HLA-B8 CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B8 CMV CD8 Cells; Human Leukocyte Antigen; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659988	CD107ab HLA-B8 CMV CD8 Cells # Bld FC	4180186
36659988	细胞.CD8.HLA-B8 CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659989	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659989	S aureus DNA Lower resp Ql NAA+probe	4180186
36659989	金黄色葡萄球菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659991	AR.auto; Eye; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Sph equiv; Vision; Visual	4180186
36659991	L eye Sph equiv AR.auto	4180186
36659991	等效球镜值:长度倒数:时间点:眼睛.左侧:定量型:自动验光仪.自动	4182948
36659994	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A1 CMV CD8 Cells; Human Leukocyte Antigen; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659994	HLA-A1 CMV CD8 Cells # Bld FC	4180186
36659994	细胞.CD8.HLA-A1 CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659995	Cath placed dur EMS trans	4180186
36659995	Cath; Cath placed dur EMS trans; Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ	4180186
36659995	急救医疗服务运输过程中所使用的导管类型:类型:时间点:^患者:名义型	4182948
36659996	CLIN; CLIN.RISK; PAM Score; PAM Score Pnl; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
36659996	Revised PAM Score Pnl	4180186
36659998	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Rad; Radiology; Random; Telemedicine; Visit note	4180186
36659998	IR Telehealth Note	4180186
36659998	记录:发现:时间点:远程医疗:文档型:介入放射医学	4182948
36660001	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian infectious bronchitis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; IBV; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660001	IBV Ab/Pos cntrl Ser IA	4180186
36660001	传染性支气管炎病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660003	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660003	B19V DNA Amn NAA+probe-Log#	4180186
36660003	细小病毒 B19 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660004	Blood; C2orf25; cblD; CL25022; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; metabolism of cobalamin associated D; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660004	MMADHC Full Mut Anl Bld/T Seq	4180186
36660004	MMADHC 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660010	2; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660011	Australia antigen; HBs; HBsAG; HBV; HBV surface; HBV surface Ag Pnl; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
36660011	HBV surface Ag Pnl SerPl	4180186
36660011	乙型肝炎病毒表面抗原组套:-:时间点:血清/血浆:-	4182948
36660014	AEV Ab Titr Ser IA	4180186
36660014	禽脑脊髓炎病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36660014	ABS; Aby; AEV; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bird; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36660015	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; hLKB1; Inherited; LKB1; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PJS; Point in time; Random; sequencing of entire coding region; serine/threonine kinase 11; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660015	STK11 gene Del+Dup + Full Mut Anl Bld/T	4180186
36660015	STK11 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660017	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660017	贝氏柯克斯体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660017	C burnet DNA Ct Spec Qn NAA+probe	4180186
36660018	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660023	Vortioxetine SerPl Cfm-mCnc	4180186
36660023	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660023	沃替西汀:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36660025	EYE; EYE.REFRACTION; KM; Nominal; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; Random; Refract pwr; Refract pwr step; Typ	4180186
36660025	Type of Refract pwr step	4180186
36660025	屈光能力测量增量:类型:时间点:角膜曲率计:名义型	4182948
36660026	1 year; 12Mos; Finding; Findings; Last; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660027	Trauma D/C sum	4180186
36660027	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660027	出院摘要记录:发现:时间点:{环境}:文档型:创伤专业	4182948
36660028	Movement autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660028	Movement autoimmune Ab pnl SerPl	4180186
36660028	运动障碍自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36660034	Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660034	VEGFA Mut Anl Bld/T	4180186
36660034	VEGFA 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660036	1 day; 24 hours; 24HR; 3; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexa-CP; Hexa-CPr3; Hexaporphyrin; Mass rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36660036	Hexa-CPr3 24h Stl-mRate	4180186
36660036	六羧基卟啉 III:质量速率:24小时:大便:定量型	4182948
36660037	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; i; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Sphere N 1	4180186
36660037	Corr lens Sphere N 1 by LM	4180186
36660037	近视球镜度 1:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660038	1 year; 12Mos; Pan; Panel; Panl; Pnl; S prime; SDOH	4180186
36660039	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA Pnl; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660039	Resp path DNA+RNA Pnl Lower Resp NAA+prb	4180186
36660039	呼吸道病原体类 DNA 与 RNA 组套:-:时间点:呼吸道.下:-:探针法.基因扩增.靶向	4182948
36660040	ABS; Aby; Antby; Anti; Antibodies; Antibody; APMV; APMV1; APMV-1; Autoantibodies; Autoantibody; Avian paramyxovirus type 1; Avian pneumoencephalitis; Bird; EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NDV; Newcastle disease; Paramyxo virus; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660040	APMV1 Ab/Pos cntrl Ser IA	4180186
36660040	禽副粘病毒 1 型 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660041	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; L; Last; LT; month; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey	4180186
36660044	activated charcoal; After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; Direct oral anticoagulants; DOAC Remove; DOAC-Stop; dRVV; dRVVT; dRVVT confirm; EXS; Hematology; Heme; Lipid; Neut; Neutr; p DOAC neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
36660044	dRVVT confirm p DOAC neut PPP	4180186
36660044	稀释蝰蛇毒诱导型凝血过程.过量磷脂^在直接口服抗凝剂中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36660045	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
36660048	BM; BON; Bone marrow; Chr 14q32 Rearr; Chromosom; Chromosomes; Cyto loc; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; IGH gene; IGH gene rearrangements; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Multiple myeloma; Plasma cell myeloma; Point in time; Random; Rearr; Rearrangement	4180186
36660048	Chr 14q32 Rearr Mar FISH	4180186
36660048	染色体区域 14q32 重排:发现:时间点:骨髓:文档型:FISH	4182948
36660049	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660050	bisphosphoglycerate mutase; Blood; Document; DPGM; ECYT8; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660050	BPGM Full Mut Anl Bld/T Seq	4180186
36660050	BPGM 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660051	记录:发现:时间点:远程医疗:文档型:伤口护理管理	4182948
36660051	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660052	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660052	副流感病毒 2 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660052	HPIV2 RNA Lower resp Ql NAA+non-probe	4180186
36660053	270 min; 4 1/2 hours; 4.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660053	胰高血糖素^在进餐之后4.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660053	Glucagon 4.5h p meal SerPl-mCnc	4180186
36660054	瞳距.双眼近用:长度:时间点:眼镜:定量型:透镜屈光度计法	4182948
36660054	by LM; EYE; EYE.LENSOMETRY; Focimeter; Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; PD binoc; PD binoc near; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660054	Glasses PD binoc near by LM	4180186
36660055	3.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660055	Glucagon 3.5h p meal SerPl-mCnc	4180186
36660055	胰高血糖素^在进餐之后3.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660059	Coll; Collect; Collected; H+P; H+P.HX; History; Nominal; P prime; Point in time; Random; Spec; Spec collection problem	4180186
36660059	Hx of Spec collection problem	4180186
36660059	标本采集问题:历史记录:时间点:^患者:名义型	4182948
36660061	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
36660061	Hypnotics Sal Ql Cfm	4180186
36660061	安眠药:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36660064	BM; BON; Bone marrow; Chr 1q+9+11+15 aneu 13q; Chr 1q+9+11+15 aneu 13q Del; Chromosom; Chromosomes; Cyto loc; Del; Deletions; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Point in time; Random	4180186
36660064	Chr 1q+9+11+15 aneu 13q Del Mar FISH	4180186
36660064	染色体 1q 与 9 与 11 与 15 非整倍体性 与 染色体区域 13q 缺失:发现:时间点:骨髓:文档型:FISH	4182948
36660067	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; Levels; Levl; LV; LVL; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660069	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Cerebral spinal fluid; Cerebrospinal Fl; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
36660069	C immitis IgG CSF Ql ID	4180186
36660069	粗球孢子菌 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫扩散法	4182948
36660073	Corr lens; EYE; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
36660073	镜片类型:类型:时间点:矫正镜片:序数型	4182948
36660074	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; B19 virus; B19V; B19V DNA Pnl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; Parvo; Parvo virus; Parvov; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660074	B19V DNA Pnl Amn NAA+probe	4180186
36660074	细小病毒 B19 DNA 组套:-:时间点:羊水:-:探针法.基因扩增.靶向	4182948
36660076	AVREOV Ab Titr Ser IA	4180186
36660076	禽呼肠孤病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36660076	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; AVREOV; Bird; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Reo virus; REOV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36660077	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; Herpes zoster; HHV-3; HSV; HSV 1 + 2 + VZV DNA Pnl; HSV 1+2; HSV1; HSV1+2; Human herpesvirus 3; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Shingles; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; VZ; VZV; VZV DNA Pnl; Zoster	4180186
36660077	单纯疱疹病毒 1 & 2 & 水痘带状疱疹病毒 DNA 组套:-:时间点:XXX:-:非探针法.基因扩增.靶向	4182948
36660077	HSV 1 + 2 + VZV DNA Pnl Spec NAA+non-prb	4180186
36660078	100WBC; Eos; Eosin; Eosino; Eosinophil; Eosins; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660078	Eosinophil/leuk NFr Stem prod Manual	4180186
36660078	嗜酸性粒细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660079	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; VZ; VZV; Zoster	4180186
36660079	VZV DNA Amn NAA+probe-Log#	4180186
36660079	水痘带状疱疹病毒 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660080	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36660080	普拉佐米星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
36660080	Plazomicin Islt Grad strip	4180186
36660084	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660086	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; II; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Sphere N 2	4180186
36660086	Corr lens Sphere N 2 by LM	4180186
36660086	近视球镜度 2:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660090	ABS; Aby; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hu; Hu1; i; Immune globulin G; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36660090	神经元细胞核 1 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36660090	Hu1 IgG Ser Ql Line blot	4180186
36660091	24(R),25-dihydroxycholecalciferol; 24,25(OH)2 VitD; 24,25-dihydroxy cholecalciferol; 24,25-dihydroxy vitamin D; 24,25-Dihydroxyvitamin D; 24,25-Dihydroxyvitamin D2 +24,25-Dihydroxyvitamin D3; 24r-Hydroxy calcidiol; 24R-OH-Calcidiol; 25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25D3+25D2/24,25D3+24,25D2; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3/24,25 Dihydroxyvitamin D; 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3/24,25 Dihydroxyvitamin D2+24,25 Dihydroxyvitamin D3; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; Chemistry; CYP24A1 gene; Ercalcidiol; Ercalcidiol+calcidiol/24r-Hydroxycalcidiol; Esoteric; Hydroxy calcidiol; Hypercalcemia; Mass...	4180186
36660091	25(OH)D3+25(OH)D2/24,25(OH)2 VitD SerPl	4180186
36660091	钙二醇+羟基钙二醇/24r-羟基钙二醇+24r,25-羟基钙化醇:质量比率:时间点:血清/血浆:定量型	4182948
36660092	Alfa; Alpha defensin; alpha Defensins; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; HNP-1; HNP-2; HNP-3; Human neutrophil peptide; Human neutrophil peptides; i; IAA; ID; II; III; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; MEIA; neutrophil peptide; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SF; SNV; SUDS; Syn; Syn fl; Synov; Synovial fluid	4180186
36660092	Alpha 防御素 1+2+3:存在情况或阈值:时间点:滑液:序数型:免疫测定法	4182948
36660092	Alpha defensins 1+2+3 Snv Ql IA	4180186
36660094	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 组套:-:时间点:血清/血浆:-:流式细胞测量术	4182948
36660094	2; Dynamic; FC; HLA ANTIGEN; HLA class II; HLA class II Ab.IgG Pnl; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Immune globulin G; Immunoglobulin G; Pan; PANEL.HLA; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660094	HLA class II Ab.IgG Pnl SerPl FC	4180186
36660095	Blood; Document; Fib2; fibrinogen alpha chain; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660095	FGA Full Mut Anl Bld/T Seq	4180186
36660095	FGA 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660097	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microsporidia 18S rRNA Pnl; Microsporidiosis; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; rDNA; ribosomal RNA; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660097	Microsporidia 18S rRNA Pnl NAA+non-prb	4180186
36660097	微孢子虫属 18S rRNA 基因组套:-:时间点:XXX:-:非探针法.基因扩增.靶向	4182948
36660098	Neuro surgery Telehealth Note	4180186
36660098	记录:发现:时间点:远程医疗:文档型:神经外科学	4182948
36660098	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro surgery; notes; Point in time; Random; Surg; Telemedicine; Visit note	4180186
36660099	Pan; Panel; PANEL.SURVEY.PHQ; Panl; Patient Health Questionnaire; PHQ; PHQ-8; Pnl; Point in time; Random; Survey; SURVEY.PHQ	4180186
36660101	ORT Ab Titr Ser IA	4180186
36660101	鼻气管炎鸟杆菌 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36660101	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; AvORT; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; ORT; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36660102	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660104	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
36660104	PhenX - ethnicity protocol	4180186
36660104	PhenX - 族群方案 010502:-:时间点:^患者:-:PhenX	4182948
36660105	Blood; CTS; CTS1; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; HEL111; Heredity; Heritable; high-throughput sequencing; HsT2651; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PALB; Point in time; Random; sequencing of entire coding region; TBPA; Tissue; Tissue, unspecified; transthyretin; Transthyretin (prealbumin, amyloidosis type I) gene; WB; Whole blood; Whole blood or Tissue	4180186
36660105	TTR gene Full Mut Anl Bld/T Seq	4180186
36660105	TTR 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660107	3 Self-Sustaining Sequence Replication; 3SR SR; A vaginae; Amplif; Amplification; Amplified; BV bacteria; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Genital vaginal; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
36660107	BV bacteria rRNA Vag Ql NAA+probe	4180186
36660107	卷曲乳杆菌+格氏乳杆菌+詹氏乳杆菌+阴道加德纳菌+阴道阿托波氏菌 rRNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
36660109	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
36660109	PA ADP 1.2 umol/L PRP	4180186
36660109	血小板聚集.二磷酸腺苷诱导型^1.2 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36660111	AGTR1 c.1166A&gt;C; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; WB; Whole blood	4180186
36660111	AGTR1 c.1166A>C Geno Bld	4180186
36660111	AGTR1 基因.c.1166A>C:基因型:时间点:全血:名义型:分子遗传学类实验室方法	4182948
36660113	Calc; Calculation; Corr lens; EYE; EYE.LENSOMETRY; Inverse Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Sph equiv	4180186
36660113	Corr lens Sph equiv Calc	4180186
36660113	等效球镜值:长度倒数:时间点:矫正镜片:定量型:计算法	4182948
36660116	2.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660116	C peptide 2.5h p meal SerPl-mCnc	4180186
36660116	C 肽^在进餐之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660117	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
36660117	R corr lens Axis by LM	4180186
36660117	轴:角度:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660118	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660122	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660123	ADMIN; ADMIN.DEMOG; Enrolled tribe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36660123	Enrolled tribe	4180186
36660123	是否加入了某一部落:发现:时间点:^患者:序数型	4182948
36660125	Australia antigen; e; Hbe; HBs; HBsAG; HBV; HBV surf Ag + HBV e Ab + Ag Pnl; HBV surface; Hep; Hep B; Hep Be; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Rh Blood Group System; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
36660125	乙型肝炎病毒表面抗原与 e 抗体与抗原组套:-:时间点:血清/血浆:-	4182948
36660125	HBV surf Ag + HBV e Ab + Ag Pnl SerPl	4180186
36660126	Amplification; BCC7; Blood; Cellular tumor antigen p53; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; LFS1; Li-Fraumeni syndrome; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; P53; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; TRP53; Tumor protein p53; WB; Whole blood; Whole blood or Tissue	4180186
36660126	TP53 gene Del+Dup + Full Mut Anl Bld/T	4180186
36660126	TP53 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660129	7a-hydroxy-4-cholesten-3-one; 7a-OH-4-chol-3-one; 7-hydroxy-4-cholesten-3-one; Alfa; Chemistry; Genetics; Heredity; Heritable; Hydrox; III; Inherited; Level; Mass concentration; Neuro; Neurology; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660129	7a-OH-4-chol-3-one SerPl-mCnc	4180186
36660129	7-Alpha 羟基-4-胆甾烯-3-酮:质量浓度:时间点:血清/血浆:定量型	4182948
36660130	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Number fraction; Ophthalmology; Ophtho; Ophthy; Percent; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT; Ultraviolet Ray; UVT	4180186
36660130	R corr lens UVT by LM	4180186
36660130	紫外线透射率:计数型分数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660131	ABS; Aby; Ac Phos; Acd; Acid phosphatase.total; Acids; AcP; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honey bee (rApi m) 3; Honeybee; i001; i1; i215; IgE RAST; III; Immune globulin E; Immunoglobulin E; Ordinal; Phos; Phosphtase; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36660131	意大利蜜蜂酸性磷酸酶 重组 (rApi m) 3 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36660131	Deprecated Honey bee (rApi m) 3 IgE RAST Ql	4180186
36660135	30M p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660135	Glucose 30M p meal SerPl-mCnc	4180186
36660135	葡萄糖^在进餐之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36660136	Allergen; Allergens; ALLERGY TESTING; Alrgen; Multiplex allergen test; Multiplex allergy array; Multiplex Allergy Pnl; Pan; PANEL.ALLERGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660136	Multiplex Allergy Pnl SerPl	4180186
36660136	多重变应原组套:-:时间点:血清/血浆:-	4182948
36660137	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660138	A,B; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA class I Ab.IgG low risk; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660138	HLA class I Ab.IgG low risk SerPl FC	4180186
36660138	HLA-A 与 B 与 C (I 类) 抗体.IgG 低度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660140	Hu1 IgG Titr CSF IF	4180186
36660140	神经元细胞核 1 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660140	ABS; Aby; ACIF; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660141	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36660141	LGI1 IgG Ser Ql CBA IFA	4180186
36660141	富亮氨酸胶质瘤失活蛋白 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36660144	Desmoglein 3 IgG Ser IA-aCnc	4180186
36660144	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; Desmoglein 3 IgG; DSG; DSG3; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36660144	桥粒芯蛋白 3 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36660145	After; Chemistry; Genetics; Heredity; Heritable; Inherited; Leu; Level; p diet; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ther	4180186
36660145	亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
36660145	Leucine p diet SerPl-sCnc	4180186
36660148	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660149	羟考酮与代谢产物组套:-:时间点:尿液:-:毒理学确认试验	4182948
36660149	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Lortab; Metabolite; Metb; OxyCODONE+metabolites Pnl; OxyContin; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Percocet; Percodan; Pnl; Point in time; PotentialForAbuse; Random; UA; UR; Urn; Vicodin	4180186
36660149	OxyCODONE+metabolites Pnl Ur Cfm	4180186
36660151	Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Scale; SDOH	4180186
36660152	1 day; 2,3-dinor 11B-PG F2a; 2,3-dinor-11beta-Prostaglandin F2a; 2,3-dinor-11b-PGF2alpha; 23BPG; 24 hours; 24HR; 9S,11S,15S-Trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid; Alfa; B; Chemistry; CR; Crea; Creat; Esoteric; II; III; Mass concentration ratio; Mass ratio; MCRto; PG; PGF2; PGF2A; PGF2alpha; Prostaglandin F2A; QNT; Quan; Quant; Quantitative; Systemic Mastocytosis; UA; UCr; UR; Urn	4180186
36660152	2,3-dinor 11B-PG F2a/Creat 24h Ur	4180186
36660152	2,3-二去甲 11 beta-前列腺素 F2 alpha/肌酐:质量比率:24小时:尿液:定量型	4182948
36660155	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660155	E coli DNA Lower resp Ql NAA+probe	4180186
36660155	大肠埃希菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660156	ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; Dipeptidyl peptidase-like protein 6 IgG; DPPX; DPPX Ab; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660156	DPPX IgG CSF Ql CBA IFA	4180186
36660156	二肽氨基肽酶样蛋白 6 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36660157	Document; Finding; Findings; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Point in time; Random; Sarcoma gene fusion analysis; Tissue; Tissue, unspecified	4180186
36660157	Sarcoma gene fusion analysis Tiss Seq	4180186
36660157	针对肉瘤的基因融合转录本分析:发现:时间点:组织与涂片:文档型:序列测定	4182948
36660159	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660159	HSPB8 gene Full Mut Anl Bld/T Seq	4180186
36660159	HSPB8 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660161	Emergency Medical Service(s); Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36660161	急救医疗服务危机干预:发现:时间点:^见证人:序数型	4182948
36660166	Finding; Findings; No; Num; Ordinal; Phone #; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660168	Dextro; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
36660169	CV2 IgG Titr Ser IF	4180186
36660169	CV2 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660169	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; Collapsin response mediator protein 5 Ab.IgG; CRMP5; CRMP-5; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Point in time; POP66; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; ULIP	4180186
36660170	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian mycoplasmosis; Chronic respiratory disease; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M gallisep; M gallisepticum; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660170	M gallisep DNA Ct Spec Qn NAA+probe	4180186
36660170	鸡毒支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660172	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660172	Proteus sp DNA Lower resp Ql NAA+probe	4180186
36660172	变形杆菌属单个未知种 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660173	Cancer; Genitourinary; Grade grp basis; GU; International Society of Urological Pathology grade; ISUP grade group; Nominal; Oncology; PATHOLOGY; Point in time; Prost; Prostate CA grade grp; Prostatic; PrT; Random; tumors; tumour; tumours; Typ; URO; Urology	4180186
36660173	Grade grp basis PrT	4180186
36660173	前列腺癌分级分组依据:类型:时间点:前列腺肿瘤:名义型	4182948
36660175	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Fowl typhoid; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; Pullorum disease; QL; Qual; Qualitative; Random; S gallinarum; S gallinarum+pullorum; S pullorum; Sal; Salmonel; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Vet; Veterinary; WB; Whole blood	4180186
36660175	S gallinarum+pullorum Ab SerPlBld Aggl	4180186
36660175	鸡伤寒沙门菌+鸡白痢沙门菌 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:凝集试验法	4182948
36660183	15M p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660183	葡萄糖^在进餐之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36660183	Glucose 15M p meal SerPl-mCnc	4180186
36660184	2.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660184	葡萄糖^在进餐之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660184	Glucose 2.5h p meal SerPl-mCnc	4180186
36660187	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; GCMS; Gluc; Glucouronide; Mass Content; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660187	乙基葡糖苷酸:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
36660187	Ethyl glucuronide Mec Cfm-mCnt	4180186
36660188	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660191	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660193	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B8 CMV CD8 Cells; Human Leukocyte Antigen; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660193	细胞.CD8.HLA-B8 CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660193	HLA-B8 CMV CD8 Cells # Bld FC	4180186
36660194	髓系肿瘤染色体分析:发现:时间点:全血/骨髓:文档型:末端配对序列测定法	4182948
36660194	Bld/Mar; Blood; BM; BON; Bone marrow; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Hematology; Heme; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Karyotype; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MPSeq; Myelo; Myeloid neoplasm chrom analy; Next generation sequencing; NGS; Oncology; Point in time; Random; WB; Whole blood; Whole blood or Bone marrow	4180186
36660194	Myeloid neoplasm chr analy Bld/Mar MPSeq	4180186
36660195	Assessment; Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note	4180186
36660195	MAiD Eval note	4180186
36660195	评价记录:发现:时间点:{环境}:文档型:临终医疗援助	4182948
36660199	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; II; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36660199	CASPR2 IgG Ser Ql CBA IFA	4180186
36660199	接触蛋白关联蛋白 2 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36660204	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660205	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Avian infectious bronchitis; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; IBV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36660205	传染性支气管炎病毒 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660205	IBV RNA # Spec NAA+probe	4180186
36660206	Cancer; Genitourinary; GU; International Society of Urological Pathology grade; ISUP grade group; Oncology; Ordinal; Pathology; Point in time; Prost; Prostate CA grade grp; Prostatic; PrT; Ql; Qual; Qualitative; Random; Scale; Screen; tumors; tumour; tumours; URO; Urology	4180186
36660206	前列腺癌分级分组:评分:时间点:前列腺肿瘤:序数型	4182948
36660206	Prostate CA grade grp PrT Ql	4180186
36660207	Deoxyribonucleic acid; HBV; Hep; Hep B; Hepatis; Hepatit; HepB; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660207	HBV DNA SerPl-Imp	4180186
36660207	乙型肝炎病毒 DNA:印象:时间点:血清/血浆:名义型	4182948
36660210	牛呼吸道合胞病毒 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
36660210	BRSV NAb Titr Ser Nt	4180186
36660210	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beef; BRSV; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); HRSV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; RSV; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT	4180186
36660211	Endocrinology D/C sum	4180186
36660211	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Endocrine; Endocrinology; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660211	出院摘要记录:发现:时间点:{环境}:文档型:内分泌学	4182948
36660212	Chemistry; CR; Crea; Creat; Creat Pnl; Cys(SO3H); Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SSC HypoXan Xan Urate Pnl; UA; UCr; UR; Urates; Uric acid; Urn	4180186
36660212	SSC HypoXan Xan Urate Pnl Ur	4180186
36660212	磺酰半胱氨酸、次黄嘌呤、黄嘌呤、尿酸及肌酐组套:-:时间点:尿液:定量型	4182948
36660213	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660213	FLUAV H1 RNA Lower resp Ql NAA+probe	4180186
36660213	流感病毒 A 型血凝素 H1 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660214	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660214	Fam Med Telehealth Note	4180186
36660214	记录:发现:时间点:远程医疗:文档型:家庭医学	4182948
36660215	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Compx; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660216	Abortus blauw; Blue-eared pig disease; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Lelystad virus; Microbiology; Mystery swine disease; Next generation sequencing; NGS; Number fraction; Percent; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Post Acute Care; PRRS; PRRSV; PRRSV ORF5 gene; PRRSV ORF5 seq; PRRSV Prime Pac Hmlgy; QNT; Quan; Quant; Quantitative; Random; Seuchenhafter spatabort der schweine; SIRSV; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary	4180186
36660216	PRRSV Prime Pac Hmlgy Islt Seq-NFr	4180186
36660216	猪生殖与呼吸综合征病毒 ORF5 基因序列 Prime Pac 同源物:计数型分数:时间点:分离株:定量型:序列测定	4182948
36660217	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
36660217	PA Epineph 0.5 umol/L PRP	4180186
36660217	血小板聚集.肾上腺素诱导型^0.5 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36660218	Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Scale; SDOH	4180186
36660220	3 Self-Sustaining Sequence Replication; 3SR SR; A marginale; Amplif; Amplification; Amplified; Anaplasmosis; Bovine anaplasmosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660220	A marginale DNA Ct Spec Qn NAA+probe	4180186
36660220	边缘无形体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660223	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DQA1 + HLA-DQB1 typing Pnl; Human Leukocyte Antigen; Inherited; Molecular genetics; Pan; PANEL.HLA; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660223	HLA-DQA1 + HLA-DQB1 typing Pnl Bld/T	4180186
36660223	HLA-DQA1 & HLA-DQB1 分型组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
36660224	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honey bee DPP (rApi m) 5; Honeybee; i001; i1; i216; Immune globulin E; Immunoglobulin E; M5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36660224	Honey bee DPP (rApi m) 5 IgE Qn	4180186
36660224	意大利蜜蜂二肽基肽酶 重组 (rApi m) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36660225	ABS; Aby; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hu; Hu2; II; Immune globulin G; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Serum; SR	4180186
36660225	Hu2 IgG Ser Ql Line blot	4180186
36660225	神经元细胞核 2 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36660228	Chr 13+15+16+18+21+22+X+Y aneup; Chromosom; Chromosomes; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Point in time; Products of Conception; Random	4180186
36660228	Chr 13+15+16+18+21+22+X+Y aneup POC FISH	4180186
36660228	染色体 13+15+16+18+21+22+X+Y 非整倍体性:发现:时间点:怀孕产物:文档型:FISH	4182948
36660231	Paraneoplastic Ab Pnl CSF IF	4180186
36660231	ACIF; Anticomplement Immunofluorescence; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Pan; PANEL.SEROLOGY; Panl; Paraneoplastic Ab Pnl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36660231	副肿瘤抗体组套:-:时间点:脑脊液:-:免疫荧光法	4182948
36660234	IR D/C sum	4180186
36660234	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Rad; Radiology; Random; Visit note	4180186
36660234	出院摘要记录:发现:时间点:{环境}:文档型:介入放射医学	4182948
36660235	1 month; 1 month (30 days); 2; 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660238	#; ABS; absolute; absolutes; Ag; Blood; CD107ab HLA-A1 CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A1 CMV CD8 Cells; Human Leukocyte Antigen; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660238	CD107ab HLA-A1 CMV CD8 Cells # Bld FC	4180186
36660238	细胞.CD8.HLA-A1 CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660241	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Symptom res status	4180186
36660241	Symptom res status	4180186
36660241	症状缓解状态:发现:时间点:^患者:序数型	4182948
36660243	Ab Ao; Abd; Abd Aorta; Abd+Pelvis; Abdo; Abdomen; Abdominal; AO; Aortic; Document; DOP; DUPLEX; Echography; Finding; Findings; Heart; Imaging; Inf; IVC; Pelvic; Point in time; Rad; Radiology; Random; Sonogram; Sonograph; Sonography; T Ao+Abd Ao+IVC+Ves-Il; TA + AA; Thorax; ULS; Ultrasound; VC; Vesl; Vessels.XXX	4180186
36660243	DOP T Ao+Abd Ao+IVC+Ves-Il	4180186
36660243	多层:发现:时间点:胸部>主动脉.胸腔段 & 腹部>主动脉.腹腔段+腔静脉.下 & 腹部+盆腔>髂血管类:文档型:超声.多普勒	4182948
36660244	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660245	Heavy Met Pnl 24h Ur	4180186
36660245	1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Heavy met; Heavy Met Pnl; Metal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; UA; UR; Urn	4180186
36660245	重金属组套:-:24小时:尿液:-	4182948
36660246	PCA-2 IgG Titr Ser IF	4180186
36660246	浦肯雅细胞胞浆 2 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660246	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660248	AR.auto; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
36660248	Eye Corneal vertex AR.auto	4180186
36660248	角膜顶点距离:长度:时间点:眼睛:定量型:自动验光仪.自动	4182948
36660249	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Telemedicine; Visit note	4180186
36660249	记录:发现:时间点:远程医疗:文档型:外科学	4182948
36660253	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; Cand; Candida sp group; Candidiasis; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
36660253	白色假丝酵母+都柏林假丝酵母+近平滑假丝酵母+热带假丝酵母 RNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
36660253	Candida sp group RNA Vag Ql NAA+probe	4180186
36660254	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660256	Hu2 IgG Titr Ser IF	4180186
36660256	神经元细胞核 2 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660256	ABS; Aby; ACIF; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu2; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; RI; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660257	Blood; BSA.pred; Chemistry; Creat+Cyst CKD-EPI; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36660257	肾小球滤过率/1.73 平方米.预测型:单位面积体积速率:时间点:血清/血浆/全血:定量型:基于肌酐和半胱氨酸蛋白酶抑制剂 C 的公式 (CKD-EPI)	4182948
36660257	GFR/BSA.pred SerPlBld Creat+Cyst CKD-EPI	4180186
36660258	ANKK1 c.2137G&gt;A; Blood; DRD2/ANKK1 Taq1A polymorphism; Genetics; Glu713Lys; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NM_178510.2(ANKK1):c.2137G&gt;A (p.Glu713Lys); Nominal; PCR; Point in time; Random; rs1800497; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660258	ANKK1 c.2137G>A Geno Bld/T	4180186
36660258	ANKK1 基因.c.2137G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660259	Activ; Actvty; Blood; CP12; CYP1A2 gene prod met act; cytochrome P450, family 1, subfamily A, polypeptide 2; Drug metabolism; Gene prod met act imp; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P3-450; P450(PA); PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660259	CYP1A2 gene prod met act Bld/T-Imp	4180186
36660259	CYP1A2 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
36660262	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660264	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660265	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660267	Pharmacology Telehealth Med mgmt note	4180186
36660267	药物管理记录:发现:时间点:远程医疗:文档型:药理学	4182948
36660267	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med mgmt note; notes; Pharmacy; Point in time; Random; Telemedicine; Visit note	4180186
36660268	Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; MAiD Team; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note	4180186
36660268	MAiD Team Note	4180186
36660268	记录:发现:时间点:{环境}:文档型:临终医疗援助.团队	4182948
36660270	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B gar+afz oppA2; B garinii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660270	B gar+afz oppA2 Spec Ql NAA+non-probe	4180186
36660270	加里疏螺旋体抗体+阿夫塞疏螺旋体 oppA2 基因:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36660276	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660278	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Telemedicine; Visit note	4180186
36660278	Ophthalmol Telehealth Note	4180186
36660278	记录:发现:时间点:远程医疗:文档型:眼科学	4182948
36660279	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PHQ	4180186
36660280	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36660281	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Numorphan; Numorphone; Opana; Oxycodone metabolite; OxyMORphone+Noroxymorph Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; PotentialForAbuse; Random; UA; UR; Urn	4180186
36660281	OxyMORphone+Noroxymorph Pnl Ur Cfm	4180186
36660281	羟吗啡酮与去甲基羟吗啡酮组套:-:时间点:尿液:-:毒理学确认试验	4182948
36660283	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36660285	PCA-Tr IgG CSF Ql Line blot	4180186
36660285	浦肯雅细胞胞浆 Tr 型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36660285	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Hodgkin's lymphoma; Immune globulin G; Immunoglobulin G; Limbic encephalopathy; Neuro; Neurology; Oncology; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCA-Tr Ab; PCD; PNS; Point in time; PR; Purkinje Cells Tr Ab; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660286	Cleft+Craniofacial Telehealth Note	4180186
36660286	Cleft+Craniofacial; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660286	记录:发现:时间点:远程医疗:文档型:裂隙与颅面医学	4182948
36660287	Agammaglobulinaemia tyrosine kinase gene; AGMX1; AT; ATK; B cell progenitor kinase gene; Blood; BPK; Bruton agammaglobulinemia tyrosine kinase; Bruton agammaglobulinemia tyrosine kinase gene; Bruton's tyrosine kinase gene; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IMD1; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; PSCTK1; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; Tyrosine-protein kinase gene; WB; Whole blood; Whole blood or Tissue; XLA	4180186
36660287	BTK gene Full Mut Anl Bld/T Seq	4180186
36660287	BTK 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660289	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660290	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Patient Telephone; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660292	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-out; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
36660292	R corr lens H prism-out by LM	4180186
36660292	水平棱镜.出射:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660294	Rel to ind w conf/susp ill	4180186
36660294	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Rel to ind w conf/susp ill; Typ	4180186
36660294	与存在已确诊或疑似疾病个人之间的关系:类型:时间点:^患者:名义型	4182948
36660297	Acd; Acids; Blood; Branched chain aa Pnl; Chains; Chemistry; Chn; DBS; Dried blood spot; Filter paper; FP; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36660297	Branched chain aa Pnl DBS	4180186
36660297	支链氨基酸组套:-:时间点:全血.斑点:定量型	4182948
36660300	Delta hepatitis; Dextro; HDV; HDV RNA Pnl; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660300	HDV RNA Pnl SerPl	4180186
36660300	丁型肝炎病毒 RNA 组套:-:时间点:血清/血浆:-	4182948
36660303	Tetanus Rx 1D p tet tox ID Diam	4180186
36660303	破伤风反应风团^在皮内注射破伤风类毒素之后1天:直径:时间点:皮肤:定量型	4182948
36660303	1D p tet tox ID; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn; Tetanus Rx; Tetanus Rx^1D p tet tox ID	4180186
36660305	ABS; Aby; AEV; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bird; EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660305	AEV Ab/Pos cntrl Ser IA	4180186
36660305	禽脑脊髓炎病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660306	Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; rs833061; T prime; Tissue; Tissue, unspecified; Vascular endothelial growth factor; VEGF-1498; VEGFA c.-1498C&gt;G + C&gt;T; WB; Whole blood; Whole blood or Tissue	4180186
36660306	VEGFA c.-1498C>G + C>T Geno Bld/T	4180186
36660306	VEGFA 基因.c.-1498C>G & c.-1498C>T:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660307	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660307	FLUAV H3 RNA Lower resp Ql NAA+probe	4180186
36660307	流感病毒 A 型血凝素 H3 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660308	Caregiver for person at-risk	4180186
36660308	Caregiver for person at-risk; Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Persons; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36660308	年龄相关主诉、慢性病或虚弱人员的照护人员:发现:时间点:^患者:序数型	4182948
36660311	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
36660313	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660318	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660320	Centers for Medicare and Medicaid Assessment; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
36660321	Blood; Carbamazapine; carBAMazepine hypersens geno Pnl; Carbamezapine; Carbazepine; CRBM; Epitol; Genetics; Heredity; Heritable; Hypersens; Hypersnstvty; Inherited; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; Pnl; Point in time; Random; Tegretol; Teril; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660321	carBAMazepine hypersens geno Pnl Bld/T	4180186
36660321	卡马西平超敏性基因型组套:-:时间点:全血/组织:-	4182948
36660322	透镜屈光度计组套:-:时间点:矫正镜片:-:透镜屈光度计法	4182948
36660322	Lensmeter Pnl	4180186
36660322	by LM; Corr lens; EYE; Focimeter; Lensmeter pnl; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random	4180186
36660323	Workplace part of crit infrastructure	4180186
36660323	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Workplace is critical infrastructure	4180186
36660323	工作场所是关键基础设施的组成部分:发现:时间点:^患者:序数型	4182948
36660324	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660329	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660329	人类冠状病毒 NL63 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660329	HCoV NL63 RNA Low resp Ql NAA+non-probe	4180186
36660330	1 year; 12Mos; QNT; Quan; Quant; Quantitative; S prime; Scale; SDOH	4180186
36660331	1 1/2 hours; 1 1/2 HR; 1.5h p meal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660331	C peptide 1.5h p meal SerPl-mCnc	4180186
36660331	C 肽^在进餐之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660336	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; Cand; Candidiasis; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
36660336	C glabrata RNA Vag Ql NAA+probe	4180186
36660336	光滑假丝酵母 RNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
36660337	3 months; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey	4180186
36660338	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B7 CMV CD8 Cells; Human Leukocyte Antigen; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660338	HLA-B7 CMV CD8 Cells # Bld FC	4180186
36660338	细胞.CD8.HLA-B7 CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660339	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660339	记录:发现:时间点:远程医疗:文档型:牧养关怀	4182948
36660340	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660343	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660344	4h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660344	Glucose 4h p meal SerPl-mCnc	4180186
36660344	葡萄糖^在进餐之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660345	3.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660345	C peptide 3.5h p meal SerPl-mCnc	4180186
36660345	C 肽^在进餐之后3.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660346	CD11a + CD11b + CD18 Pnl Bld	4180186
36660346	AlphaL integrin chain; AlphaM integrin chain; AlphaM-beta2; Beta2; Beta-2 integrin; Beta-2 integrin chain; Blood; C3biR; CD11a + CD11b + CD18 Pnl; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; CELL MARKERS; CR3; LAD-1; Leu15; Leu-15; Leukocyte Adhesion Deficiency Syndrome; Leukocyte adhesion deficiency syndrome type 1; LFA-1alpha; Mac-1; Mo1; Ordinal; Pan; PANEL.CELLMARK; Panl; Pheno; Phenotypic; Pnl; Point in time; QL; Qual; Qualitative; R3; Random; Screen; WB; Whole blood	4180186
36660346	CD11a 与 CD11b 与 CD18 表现型分型组套:-:时间点:全血:序数型	4182948
36660347	5,8,11,14 Eicosatetraenoic acid; AA; AA % aggregation; Arachidonic acid; Arch acid; Blood; C20:4w6; Calc; Calculation; Clot strength AA induced; COAGULATION; Eicosatetraenoate; Hematology; Heme; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36660347	Clot strength AA induced LenFr Bld Calc	4180186
36660347	凝块强度.花生四烯酸诱导型:长度分数:时间点:全血:定量型:计算法	4182948
36660348	Chemistry; Fetal; k; K+; Kidney; Level; Nephrology; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; UA; UR; Urn	4180186
36660348	Potassium Ur Fetus-sCnc	4180186
36660348	钾:物质的量浓度:时间点:尿液^胎儿:定量型	4182948
36660351	30s CST; 30-Second Chair Stand; 30sSTS; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Stands; Survey	4180186
36660352	2.5h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660352	Insulin 2.5h p meal SerPl-aCnc	4180186
36660352	胰岛素^在进餐之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660353	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660354	apoAII; Apo-AII; apolipoprotein A2; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660354	APOA2 Full Mut Anl Bld/T Seq	4180186
36660354	APOA2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660355	二肽氨基肽酶样蛋白 6 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660355	DPPX IgG Titr Ser IF	4180186
36660355	ABS; Aby; ACIF; Amiopep; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; Dipeptidyl peptidase-like protein 6 IgG; DPPX; DPPX Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660356	270 min; 4 1/2 hours; 4.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660356	Glucose 4.5h p meal SerPl-mCnc	4180186
36660356	葡萄糖^在进餐之后4.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660358	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660358	肠道病毒 RNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36660358	EV RNA Amn Ql NAA+probe	4180186
36660359	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660360	Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Neck+Chest Ves; Point in time; Rad; Radiology; Random; Thorax; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36660360	多层^不采用 & 采用静脉注射对比剂:发现:时间点:颈部>颈部血管类 & 胸部>胸部血管类:文档型:CT.血管造影术	4182948
36660360	CTA Neck+Chest Ves WO+W contr IV	4180186
36660364	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660364	HCoV OC43 RNA Low resp Ql NAA+non-probe	4180186
36660364	人类冠状病毒 OC43 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660367	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B burg; B burgdor; B burgdorferi; B burgdorferi oppA2; Bb; Burgdorf; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Lymes; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660367	B burgdorferi oppA2 Spec Ql NAA+non-prb	4180186
36660367	伯氏疏螺旋体 oppA2 基因:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36660369	Exp; Exp source 30D prior onset; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Srce; Typ	4180186
36660369	Exp source 30D prior onset	4180186
36660369	疾病发作前30天内的暴露来源:类型:时间点:^患者:名义型	4182948
36660375	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; VZV DNA Pnl; Zoster	4180186
36660375	VZV DNA Pnl Amn NAA+probe	4180186
36660375	水痘带状疱疹病毒 DNA 组套:-:时间点:羊水:-:探针法.基因扩增.靶向	4182948
36660376	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
36660378	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660381	2; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA classII Ab.IgG prozone; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660381	HLA classII Ab.IgG prozone SerPl FC	4180186
36660381	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 伴前带效应:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660383	Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; rs1570360; Tissue; Tissue, unspecified; Vascular endothelial growth factor; VEGF-1154; VEGFA c.-1154A&gt;G; VEGFA transcript variant; WB; Whole blood; Whole blood or Tissue	4180186
36660383	VEGFA 基因.c.-1154A>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660383	VEGFA c.-1154A>G Geno Bld/T	4180186
36660385	Immunology D/C sum	4180186
36660385	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660385	出院摘要记录:发现:时间点:{环境}:文档型:免疫学	4182948
36660386	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; II; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660386	CASPR2 IgG CSF Ql CBA IFA	4180186
36660386	接触蛋白关联蛋白 2 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36660387	After; C peptide p Cfst + meal Pnl; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Pan; PANEL.CHALLENGE; Panl; Pept; Pl; Plasma; Plsm; Pnl; Point in time; Pro-insulin c peptide; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim	4180186
36660387	C peptide p Cfst + meal Pnl SerPl	4180186
36660387	禁食后和进餐刺激 C 肽组套:-:时间点:血清/血浆:-	4182948
36660389	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660391	Centers for Medicare and Medicaid Assessment; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
36660393	Assessment; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note; WOC	4180186
36660393	WOC Eval note	4180186
36660393	评价记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
36660395	Activated protein C cofactor; APC; Blood; Coagulation Factor V - Leiden gene; coagulation factor V (proaccelerin, labile factor); Document; Finding; Findings; full gene sequencing; Full Mut Anl; FVL; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Labile factor; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PCCF; Point in time; Proaccelerin gene; Random; RPRGL1; sequencing of entire coding region; THPH2; Thrombophilia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660395	F5 gene Full Mut Anl Bld/T Seq	4180186
36660395	F5 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660396	血液肿瘤染色体分析:发现:时间点:全血/骨髓:文档型:末端配对序列测定法	4182948
36660396	Bld/Mar; Blood; BM; BON; Bone marrow; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Hemato; Hematologic chrom analy; Hematology; Heme; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Karyotype; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; MPSeq; Next generation sequencing; NGS; Oncology; Point in time; Random; WB; Whole blood; Whole blood or Bone marrow	4180186
36660396	Hematologic chrom analy Bld/Mar MPSeq	4180186
36660398	Blood; CD240CE; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; RH; Rh blood group gene, CcEe antigens; Rh blood group, CcEe antigens; RH30A; Rh4; RHC; RHCE allele; RHCE allele Cc; RHE; Rhesus blood group gene, CcEe antigens; RhIVb(J); RHIXB; RHPI; RhVI; RhVIII; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660398	RHCE allele Cc Geno Bld/T	4180186
36660398	RHCE 基因等位基因 Cc:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660399	ABS; Aby; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Glial nuc type 1; i; Immune globulin G; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; Sox1; Sox1 nuclear antigen; SR	4180186
36660399	Deprecated Glial nuc type 1 IgG Ser Ql Line blot	4180186
36660400	4h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660400	C peptide 4h p meal SerPl-mCnc	4180186
36660400	C 肽^在进餐之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660401	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660404	Cancer; Genitourinary; Gleason Basis; GU; Nominal; Oncology; PATHOLOGY; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours; Typ; URO; Urology	4180186
36660404	Gleason Basis PrT	4180186
36660404	Gleason 评分依据:类型:时间点:前列腺肿瘤:名义型	4182948
36660405	Beta2; Beta-2 integrin; Beta-2 integrin chain; Blood; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; CD18 Cells; Cell; CELL MARKERS; Cellularity; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36660405	CD18 Cells Bld Ql	4180186
36660405	细胞.CD18:存在情况或阈值:时间点:全血:序数型	4182948
36660406	Genetics; Genomic; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; Origin germline gen var; Point in time; Random; Typ	4180186
36660406	Origin germline gen var	4180186
36660406	胚系遗传变异起源:类型:时间点:^患者:名义型	4182948
36660407	Beef; BHV1; BoHV; BoHV1; BOHV-1; Bovine herpes virus; C&S; Cult; Cultures; Herpes virus; i; IBR; ID; Infectious bovine rhinotracheitis; Infectious Disease; Infectious pustular vulvovaginitis; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36660407	BoHV1 Spec Ql Cult	4180186
36660407	牛疱疹病毒 1 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36660408	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660409	ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Low; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660410	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660410	L corr lens Axis by LM	4180186
36660410	轴:角度:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36660412	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Pancreatic secretory trypsin inhibitor precursor; PCTT; Point in time; PSTI; Random; sequencing of entire coding region; serine peptidase inhibitor, Kazal type 1; Serine protease inhibitor, Kazal type 1; Spink3; TATI; TCP; Tissue; Tissue, unspecified; Tumor-associated trypsin inhibitor; WB; Whole blood; Whole blood or Tissue	4180186
36660412	SPINK1 gene Full Mut Anl Bld/T Seq	4180186
36660412	SPINK1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660414	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Patient Telephone; Ql; Qual; Qualitative; Screen; Survey	4180186
36660415	aMPV Ab Titr Ser IA	4180186
36660415	禽肺病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36660415	ABS; Aby; aMPV; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian pneumovirus; Bird; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Swollen head syndrome; Titer; Titered; Titre; TRTV; Ttr; Turkey rhinotracheitis; Vet; Veterinary	4180186
36660420	A marginale; ABS; Aby; Anaplasmosis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bovine anaplasmosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; NEG; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660420	A marginale Ab Ser IA	4180186
36660420	边缘无形体 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660421	Biliary Neo Chrom Analysis; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Karyotype; Molecular pathology; MOLPATH; Oncology; Point in time; Random; Tissue; Tissue, unspecified	4180186
36660421	胆道肿瘤染色体分析:发现:时间点:组织与涂片:文档型	4182948
36660421	Biliary Neo Chrom Analysis Tiss	4180186
36660423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian pasterurellosis; DNA NUCLEIC ACID PROBE; DNA probe; Fowl cholera; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; P multoc; P multoc Tox; P multoc Tox toxA; P multocida; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660423	P multoc Tox toxA Spec Ql NAA+probe	4180186
36660423	多杀巴斯德氏菌毒素 toxA 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36660424	Airway suction &or cleared; Finding; Findings; H+P; H+P.PX; Lung; Ordinal; P prime; Point in time; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
36660424	Airway suction &or cleared	4180186
36660424	当时气道是否经过吸引和或清理:发现:时间点:^患者:序数型	4182948
36660426	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660430	ARPKD; Blood; Document; FCYT; Fibrocystin gene; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Polycystic Kidney and Hepatic Disease 1 (Autosomal Recessive); Random; sequencing of entire coding region; TIGM1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660430	PKHD1 gene Full Mut Anl Bld/T Seq	4180186
36660430	PKHD1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660433	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660438	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660439	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660439	FGD4 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660439	FGD4 gene Full Mut Anl Bld/T Seq	4180186
36660442	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660442	记录:发现:时间点:远程医疗:文档型:医疗保健服务导航员	4182948
36660442	Navigator Telehealth Note	4180186
36660444	Blood; Document; F8VWF; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; von Willebrand factor; von Willebrand Factor gene; VWD; WB; Whole blood; Whole blood or Tissue	4180186
36660444	VWF gene Full Mut Anl Bld/T Seq	4180186
36660444	VWF 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660445	Disease stg class method	4180186
36660445	CLIN; Dis; Disease stg; Disease stg class method; Diseases; Dz; Meth; Method of; Nominal; Point in time; Random; Typ	4180186
36660445	疾病分期分类方法:类型:时间点:^患者:名义型:*	4182948
36660448	Blood; Chemistry; II; Neuro; Neurology; Point in time; Prealbumin; QNT; Quan; Quant; Quantitative; Random; TTR; TTR 2; WB; Whole blood	4180186
36660448	甲状腺素视黄质运载蛋白峰值 2:质量:时间点:全血:定量型	4182948
36660448	TTR 2 Bld Qn	4180186
36660450	15M p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660450	Insulin 15M p meal SerPl-aCnc	4180186
36660450	胰岛素^在进餐之后15分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
36660451	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Narcotic; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
36660451	Narcotics Sal Ql Cfm	4180186
36660451	麻醉剂:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36660461	After; Chemistry; Genetics; Heredity; Heritable; Inherited; Level; p diet; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ther; Val	4180186
36660461	Valine p diet SerPl-sCnc	4180186
36660461	缬氨酸^在治疗性饮食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
36660463	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660463	GARS gene Full Mut Anl Bld/T Seq	4180186
36660463	GARS 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660468	ID & Authority panel	4180186
36660468	ADMIN; ID & Authority panel; ID assign auth; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
36660468	标识符与分配机构组套:-:时间点:^患者:-	4182948
36660469	肿瘤染色体分析:发现:时间点:组织与涂片:文档型:末端配对序列测定法	4182948
36660469	Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Karyotype; Molecular pathology; MOLPATH; MPSeq; Next generation sequencing; NGS; Oncologic chrom analy; Oncology; Point in time; Random; solid organ neoplasia; Tissue; Tissue, unspecified	4180186
36660469	Oncologic chrom analy Tiss MPSeq	4180186
36660473	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660474	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660474	HPIV4 RNA Lower resp Ql NAA+non-probe	4180186
36660474	副流感病毒 4 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660475	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36660478	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV1; EHV-1; Equid; Equid alphaherpesvirus 1; Equin; Equine abortion herpesvirus; Equine rhinopneumonitis; Herpes virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660478	EHV1 RNA Ct Spec Qn NAA+probe	4180186
36660478	马疱疹病毒 1 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660479	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660480	HCO3 p secretin stim Pnl Fld	4180186
36660480	After; B/F; BF; BIC; bicar; Bicarb; bod; Bodies; Body fluid; Body fluid, unsp; CHEMISTRY.CHALLENGE TESTING; Fl; Fld; FLU; Fluid; HCO3; HCO3 p secretin stim Pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Stim	4180186
36660480	肠促胰液素刺激后碳酸氢盐组套:-:时间点:体液:定量型	4182948
36660482	Ca; Cal; Chemistry; Fetal; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn	4180186
36660482	钙:质量浓度:时间点:尿液^胎儿:定量型	4182948
36660482	Calcium Ur Fetus-mCnc	4180186
36660485	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Persons; QL; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660487	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660488	ANTIBIOTIC SUSCEPTIBILITIES; Celbenin; Dimethoxypenicillin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Metacillin; Metin; Molecular genetics; MRSA; MRSA SCCmec+orfX; o71; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; S aureus; Screen; Spec; Staficyn; Staph; Staphicillin; Staphylococcus cassette chromosome (SCCmec)	4180186
36660488	MRSA SCCmec+orfX Islt/Spm Ql	4180186
36660488	金黄色葡萄球菌甲氧西林耐药 SCCmec+orfX 连接部位:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36660489	anti-HBc; HBc; HBV; HBV core; HBV core IgM Pnl; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660489	HBV core IgM Pnl SerPl	4180186
36660489	乙型肝炎病毒核心抗体.IgM 组套:-:时间点:血清/血浆:-	4182948
36660490	1 month; 1 month (30 days); 30 days; ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up	4180186
36660491	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660491	人类冠状病毒 229E 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660491	HCoV 229E RNA Low resp Ql NAA+non-probe	4180186
36660493	by KM; Eye; Eyeball; Keratometry pnl; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Vision; Visual	4180186
36660493	Keratometry pnl	4180186
36660493	角膜曲率检测组套:-:时间点:眼睛:-:角膜曲率测量法	4182948
36660494	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660494	NDRG1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660494	NDRG1 gene Full Mut Anl Bld/T Seq	4180186
36660496	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian pasterurellosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fowl cholera; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; P multoc; P multocida; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660496	多杀巴斯德氏菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660496	P multoc DNA Ct Spec Qn NAA+probe	4180186
36660505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M iowae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660505	M iowae DNA Ct Spec Qn NAA+probe	4180186
36660505	依阿华支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660506	Cancer; Genitourinary; Gleason 4+5; Gleason 4+5/Total; GU; Micro; Micros; Microscopic; Oncology; PATHOLOGY; Point in time; Prost; Prostatic; PrT; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; tumors; tumour; tumours; URO; Urology	4180186
36660506	Gleason 4+5/Total AreaFr PrT Micro	4180186
36660506	Gleason 模式 4+5 的前列腺肿瘤面积/肿瘤总面积:面积分数:时间点:前列腺肿瘤:定量型:显微镜检查类实验室方法	4182948
36660507	Chemistry; Cl; Cl-; Fetal; Kidney; Level; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; UA; UR; Urn	4180186
36660507	氯:物质的量浓度:时间点:尿液^胎儿:定量型	4182948
36660507	Chloride Ur Fetus-sCnc	4180186
36660510	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36660510	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Traumatic Brain Injuries; TRF	4180186
36660510	GFAP alpha IgG Ser Ql IF	4180186
36660511	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
36660511	R corr lens Prism by LM	4180186
36660511	棱镜:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660513	屈光能力.平均值:长度倒数:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36660513	Average; Avg; by KM; Corneal; EYE; EYE.REFRACTION; Inverse Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; Refract pwr; RT	4180186
36660513	R cornea Refractive power.mean by KM	4180186
36660515	Arsenic; DMA; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36660515	Dimethylarsinate Ur-mCnc	4180186
36660515	二甲基砷酸盐:质量浓度:时间点:尿液:定量型	4182948
36660517	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660519	Calcium Sweat-mCnc	4180186
36660519	Ca; Cal; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SWT	4180186
36660519	钙:质量浓度:时间点:汗液:定量型	4182948
36660520	Abd; Abd ves; Abd ves+Pelvis ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; without contrast	4180186
36660520	CTA Abd ves+Pelvis ves WO contr	4180186
36660520	多层^不采用对比剂:发现:时间点:腹部>腹部血管类 & 盆腔>盆腔血管类:文档型:CT.血管造影术	4182948
36660522	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor 49736; B burgdorferi; Bb; Blood; Blt; Burgdorf; Cnt; Count; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; RIBA; WB; WBLOT; West blot; West blt; Western blot; Whole blood	4180186
36660522	B burgdor 49736 IgG bands Bld IB	4180186
36660522	伯氏疏螺旋体 49736 抗体.IgG 区带:数量(计数):时间点:全血:定量型:免疫印迹法	4182948
36660523	Biopsy site Patient	4180186
36660523	活组织检查部位:解剖学:时间点:^患者:名义型	4182948
36660523	Anatomy; Bx; Nominal; Pathology; Point in time; Random	4180186
36660524	Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note	4180186
36660524	MAiD Phone Note	4180186
36660524	记录:发现:时间点:电话就医:文档型:临终医疗援助	4182948
36660526	4h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660526	Insulin 4h p meal SerPl-aCnc	4180186
36660526	胰岛素^在进餐之后4小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660527	DULoxetine Sal Cfm-mCnc	4180186
36660527	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Cymbalta; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Yentreve	4180186
36660527	度洛西汀:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36660528	HLA class I + II IgG Pnl SerPl FC	4180186
36660528	HLA I 与 II 类 抗体.IgG 组套:-:时间点:血清/血浆:-:流式细胞测量术	4182948
36660528	2; Dynamic; FC; HLA ANTIGEN; HLA class I + II; HLA class I + II IgG Pnl; Human Leukocyte Antigen; Immune globulin G; Immunoglobulin G; Pan; PANEL.HLA; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660530	Brucella Ab Titr CSF Capture aggl	4180186
36660530	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Capture aggl; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr	4180186
36660530	布鲁氏菌属单个未知种 抗体:滴定度:时间点:脑脊液:定量型:凝集试验法.免疫捕获	4182948
36660531	Calc; Calculation; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration	4180186
36660531	Glycerol Ser Calc-sCnc	4180186
36660531	甘油:物质的量浓度:时间点:血清:定量型:计算法	4182948
36660532	Revised PAM Total score	4180186
36660532	CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
36660533	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
36660533	照护服务管理记录:发现:时间点:{环境}:文档型:矫形外科学	4182948
36660534	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime; Wt	4180186
36660535	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Occupational Therapy; OT; Point in time; Random; Telemedicine; Visit note	4180186
36660535	OT Telehealth Note	4180186
36660535	记录:发现:时间点:远程医疗:文档型:职业疗法	4182948
36660536	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660536	HSV2 DNA Spec Ql NAA+non-probe	4180186
36660536	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36660538	100WBC; Cell; Cellularity; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660538	Other cells/leuk NFr Stem prod Manual	4180186
36660538	其他细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660539	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Persons; QL; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660540	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660541	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC	4180186
36660541	WOC Phone Note	4180186
36660541	记录:发现:时间点:电话就医:文档型:伤口、造口和大小便节制照护服务	4182948
36660545	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660548	5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660548	C peptide 5h p meal SerPl-mCnc	4180186
36660548	C 肽^在进餐之后5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660550	Antigen; Antigens; Australia antigen; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Liver; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
36660550	乙型肝炎病毒表面 抗原:印象:时间点:血清/血浆:名义型	4182948
36660550	HBV surface Ag SerPl-Imp	4180186
36660552	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Equine rhinitis B virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660552	马鼻病毒 A 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660552	Erbovirus A RNA Ct Spec Qn NAA+probe	4180186
36660556	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian mycoplasmosis; Chronic respiratory disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660556	M gallisep Ab/Pos cntrl Ser IA	4180186
36660556	鸡毒支原体 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660557	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660558	Blood; Celiac IgA + HLA + Sero; Dis; Diseases; Dz; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Immune globulin A; Immunoglobulin A; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660558	乳糜泻 IgA & HLA 分型 & 血清学组套:-:时间点:全血/组织:-	4182948
36660558	Celiac IgA + HLA + Sero Bld/T	4180186
36660559	30M p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660559	Glucagon 30M p meal SerPl-mCnc	4180186
36660559	胰高血糖素^在进餐之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36660560	5HTT; 5-HTT; 5HTTLPR; 5-HTTLPR; 5-hydroxytryptamine transporter gene; Blood; Genetics; Heredity; Heritable; hSERT; HTT; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; OCD1; PCR; Point in time; Random; Serotonin transporter gene; SERT; SERT1; SLC6A4 5-HTTLPR; solute carrier family 6 (neurotransmitter transporter), member 4; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660560	SLC6A4 5-HTTLPR Geno Bld/T	4180186
36660560	SLC6A4 基因 5-HTTLPR 变异:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660563	AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Chromogenic assay; Circulating anticoagulant; Coag; ENZY; Enzymatic assay; F8; Fac; Fact; Fact VIII; Fact VIII Inhib; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Inhib; Inhibit; Interp; Interpretation; Nominal; Plas; Platelet poor plasma; Point in time; Random; Thrombocyte cofactor A; VIII:C	4180186
36660563	凝血因子 VIII 抑制剂:印象:时间点:贫血小板血浆:名义型:凝血因子酶学测定法	4182948
36660563	Fact VIII Inhib PPP Chro-Imp	4180186
36660565	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660567	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660568	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Calicivirus; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; f213; Hemorrhagic septicemia; II; Infectious necrotic hepatitis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oryctalagus spp; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Rabbit hemorrhagic disease; Random; RHDV; RHDV2; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral hemorrhagic disease	4180186
36660568	RHDV2 RNA Ct Spec Qn NAA+probe	4180186
36660568	兔出血症病毒 2 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660571	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36660573	#; ABS; absolute; absolutes; Ag; Blood; CD107ab CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; CMV CD8 Cells; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660573	CD107ab CMV CD8 Cells # Bld FC	4180186
36660573	细胞.CD8.CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660574	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH	4180186
36660575	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660576	PCA-2 IgG Titr CSF IF	4180186
36660576	浦肯雅细胞胞浆 2 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660576	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660578	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 6; e230; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36660578	狗 重组 (rCan f) 6 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36660578	Deprecated Dog (rCan f) 6 IgE RAST Ql	4180186
36660581	ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; Dipeptidyl peptidase-like protein 6 IgG; DPPX; DPPX Ab; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36660581	DPPX IgG Ser Ql CBA IFA	4180186
36660581	二肽氨基肽酶样蛋白 6 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36660582	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-N Bind; Voltage-dependent calcium channels	4180186
36660582	VGCC-N Bind Ab Ser IA-sCnc	4180186
36660582	N 型电压门控钙离子通道结合 抗体:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660585	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; hydroxymethylbilane synthase; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PBGD; PBG-D; Point in time; PORC; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UPS; WB; Whole blood; Whole blood or Tissue	4180186
36660585	HMBS Full Mut Anl Bld/T Seq	4180186
36660585	HMBS 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660587	瞳距.双眼近用:长度:时间点:眼睛:定量型:自动验光仪.自动	4182948
36660587	Eye PD binoc near AR.auto	4180186
36660587	AR.auto; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD binoc; PD binoc near; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
36660588	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660589	anti-HBc; HBc; HBV; HBV core; HBV core Ab Pnl; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660589	HBV core Ab Pnl SerPl	4180186
36660589	乙型肝炎病毒核心抗体组套:-:时间点:血清/血浆:-	4182948
36660597	Blood; Document; Finding; Findings; formimidoyltransferase cyclodeaminase; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; LCHC1; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660597	FTCD Full Mut Anl Bld/T Seq	4180186
36660597	FTCD 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660598	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660598	Monocytes/leuk NFr Stem prod Manual	4180186
36660598	单核细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660599	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660600	EYE; EYE.REFRACTION; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; RM; Sphere increment; Typ	4180186
36660600	Sph incr RM	4180186
36660600	球镜测量增量:类型:时间点:屈光计:名义型	4182948
36660601	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Inherited; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-N Bind; Voltage-dependent calcium channels	4180186
36660601	VGCC-N Bind IgG+IgM Ser IA-sCnc	4180186
36660601	N 型电压门控钙离子通道结合 抗体.IgG+IgM:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660605	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660605	HLA-DRB1 IgG SerPl FC	4180186
36660605	HLA-DRB1 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660610	最近接触确诊病例的日期和时间:日期:时间点:^患者:定量型	4182948
36660610	D/T most recent contact w case; Date+time; H+P; H+P.PX; ID; Infectious Disease; InfectiousDisease; P prime; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random	4180186
36660610	D/T most recent contact w case	4180186
36660611	曲率半径.平均值:长度:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36660611	Average; Avg; by KM; Corneal; EYE; EYE.REFRACTION; Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Upper extremity	4180186
36660611	R cornea Curvature radius.mean by KM	4180186
36660614	Care plan; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note; WOC	4180186
36660614	WOC Plan of care note	4180186
36660614	医疗服务计划记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
36660616	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; AvORT; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; ORT; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660616	ORT Ab/Pos cntrl Ser IA	4180186
36660616	鼻气管炎鸟杆菌 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660618	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Frac; Fract; Fraction; Fractionated; Fractionation; Mass rate; mRate; Pan; PANEL.CHEMISTRY; Panl; Pnl; Porphyrin Fract Pnl; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36660618	卟啉类成分组套:质量速率:24小时:大便:定量型	4182948
36660618	Porphyrin Fract Pnl 24h Stl-mRate	4180186
36660619	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660620	Blood; chymotrypsin C; CLCR; Document; ELA4; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660620	CTRC Full Mut Anl Bld/T Seq	4180186
36660620	CTRC 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660621	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660621	Geri med Telehealth Note	4180186
36660621	记录:发现:时间点:远程医疗:文档型:老年医学	4182948
36660622	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660623	浓缩红细胞:体积型属性:时间点:标本:定量型	4182948
36660623	Packed RBC Vol Spec	4180186
36660623	Discocytes; Erthrocyte; Erythrocyte; Packed RBC; Point in time; PRBC; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spec; Volume	4180186
36660624	1 hour; 1.0Hr; 1h p meal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660624	Glucagon 1h p meal SerPl-mCnc	4180186
36660624	胰高血糖素^在进餐之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660625	Chemistry; M Protein; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Ordinal; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660625	M Protein SerPl Ql	4180186
36660625	蛋白质.单克隆型:存在情况或阈值:时间点:血清/血浆:序数型	4182948
36660631	Chemistry; CR; Crea; Creat; Fetal; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn	4180186
36660631	Creat Ur Fetus-mCnc	4180186
36660631	肌酐:质量浓度:时间点:尿液^胎儿:定量型	4182948
36660632	神经节苷脂 GD1b 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
36660632	GD1b Gangl IgG Titr Ser IA	4180186
36660632	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Neuro; Neurology; Point in time; Random; Serology; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
36660634	Blood; coproporphyrinogen oxidase; COX; CPO; CPX; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; HCP; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660634	CPOX Full Mut Anl Bld/T Seq	4180186
36660634	CPOX 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660635	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660636	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660636	RAB7A gene Full Mut Anl Bld/T Seq	4180186
36660636	RAB7A 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660637	Blood; Coagulation factor XI; Document; Finding; Findings; full gene sequencing; Full Mut Anl; FXI; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Lemierre syndrome; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Plasma thromboplastin antecedent; Point in time; PTA; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660637	F11 Full Mut Anl Bld/T Seq	4180186
36660637	F11 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660644	3 months; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660646	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660653	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660655	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Telemedicine; Visit note	4180186
36660655	Radiation Onc Telehealth Note	4180186
36660655	记录:发现:时间点:远程医疗:文档型:放射肿瘤学	4182948
36660656	CBC W Diff Pnl Stem prod	4180186
36660656	带有细胞分类的全血细胞计数组套:-:时间点:^干细胞产品:定量型	4182948
36660656	CBC W Diff Pnl; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod	4180186
36660658	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660658	记录:发现:时间点:远程医疗:文档型:快速反应团队	4182948
36660659	After; B/F; BF; BIC; bicar; Bicarb; bod; Bodies; Body fluid; Body fluid, unsp; CHEMISTRY.CHALLENGE TESTING; Fl; Fld; FLU; Fluid; Gastro; Gastroenterology; GI; HCO3; Level; p SCT; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
36660659	HCO3 p SCT Fld-sCnc	4180186
36660659	碳酸氢盐^在给予肠促胰液素之后:物质的量浓度:时间点:体液:定量型	4182948
36660660	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Telemedicine; Visit note	4180186
36660660	记录:发现:时间点:远程医疗:文档型:血管外科学	4182948
36660661	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honey bee DPP (rApi m) 5; Honeybee; i001; i1; i216; IgE RAST; Immune globulin E; Immunoglobulin E; M5; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36660661	意大利蜜蜂二肽基肽酶 重组 (rApi m) 5 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36660661	Deprecated Honey bee DPP (rApi m) 5 IgE RAST Ql	4180186
36660663	Addiction; Amrix; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Flexaril; Flexeril; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36660663	Cyclobenzaprine Sal Cfm-mCnc	4180186
36660663	环苯扎林:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36660667	Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; Erythrocytes; Frac; Fract; Fraction; Fractionated; Fractionation; Hematology; Heme; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Protoporph; Protoporphrn; Protoporphyrin fract Pnl; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
36660667	Protoporphyrin fract Pnl RBC	4180186
36660667	原卟啉成分组套:-:时间点:红细胞:定量型	4182948
36660668	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660669	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Johnes disease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M avium; M avium paraTB; Microbiology; Misc; Miscellaneous; Myco; Mycobact; Mycobacterium paratuberculosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Paratuberculosis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; ssp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified; Vet; Veterinary	4180186
36660669	M avium paraTB DNA Ct Spec Qn NAA+probe	4180186
36660669	鸟型分枝杆菌副结核亚种 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660672	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660674	屈光能力.平均值:长度倒数:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36660674	Average; Avg; by KM; Corneal; EYE; EYE.REFRACTION; Inverse Length; L; L cornea; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Refract pwr	4180186
36660674	L cornea Refractive power.mean by KM	4180186
36660678	Hu3 IgG Titr Ser IF	4180186
36660678	神经元细胞核 3 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660678	ABS; Aby; ACIF; ANA IgG; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type III; Nuc; Oncology; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660679	Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ	4180186
36660679	Bag-mask ventilation	4180186
36660679	所采用的球囊面罩通气类型:类型:时间点:^患者:名义型	4182948
36660682	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; MEIA; Microbiology; Misc; Miscellaneous; Myco; Mycobact; Mycobacterium paratuberculosis; Other; Paratuberculosis; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; ssp; SUDS; To be specified in another part of the message; Tuberculosis; Unspecified; Vet; Veterinary	4180186
36660682	M avium paraTB Ab/Pos cntrl Spec IA	4180186
36660682	鸟型分枝杆菌副结核亚种 抗体/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36660683	by KM; CYL; Eye; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ; Vision; Visual	4180186
36660683	Type of Cylinder mode by by KM	4180186
36660683	柱镜模式:类型:时间点:眼睛:序数型:角膜曲率测量法	4182948
36660684	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660684	Lymphocytes/leuk NFr Stem prod Manual	4180186
36660684	淋巴细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660687	曲率半径.平均值:长度:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36660687	Average; Avg; by KM; Corneal; EYE; EYE.REFRACTION; L; L cornea; Length; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Upper extremity	4180186
36660687	L cornea Curvature radius.mean by KM	4180186
36660689	Patient refused spec collection	4180186
36660689	Coll; Collect; Collected; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Refused spec collection; Screen; Spec	4180186
36660689	是否拒绝采集标本:发现:时间点:^患者:序数型	4182948
36660696	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660697	Dis; Diseases; Dz; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36660697	乳糜泻血清学组套:-:时间点:血清:-	4182948
36660697	Celiac disease serology panel Ser	4180186
36660702	Hu1 IgG Titr Ser IF	4180186
36660702	神经元细胞核 1 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660702	ABS; Aby; ACIF; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660708	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
36660709	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
36660709	GD1b Gangl IgG Ser Ql IA	4180186
36660709	神经节苷脂 GD1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36660711	Symptoms 24H	4180186
36660711	1 day; 24 hours; 24HR; Finding; Findings; H+P; H+P.PX; Nominal; P prime; Past; Sx; Symptoms 24H	4180186
36660711	过去24小时期间的症状:发现:24小时:^患者:名义型	4182948
36660712	DPPX IgG Titr CSF IF	4180186
36660712	二肽氨基肽酶样蛋白 6 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660712	ABS; Aby; ACIF; Amiopep; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; Dipeptidyl peptidase-like protein 6 IgG; DPPX; DPPX Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660713	Activ; Actvty; AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Chromogenic assay; Circulating anticoagulant; Coag; ENZY; Enzymatic assay; F8; Fac; Fact; Fact VIII; Fact VIII Act + Inhib Pnl; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; Inhib; Inhibit; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Random; Thrombocyte cofactor A; VIII:C	4180186
36660713	Fact VIII Act + Inhib Pnl PPP Chro	4180186
36660713	凝血因子 VIII 活性与抑制剂组套:-:时间点:贫血小板血浆:-:凝血因子酶学测定法	4182948
36660715	4h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660715	Glucagon 4h p meal SerPl-mCnc	4180186
36660715	胰高血糖素^在进餐之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660719	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
36660724	Epilepsy autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660724	Epilepsy autoimmune Ab pnl SerPl	4180186
36660724	癫痫自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36660725	Acd; Acid fast Stn; Acids; AFB stain; ID; Infectious Disease; InfectiousDisease; Lower respiratory; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; sp3; Spec; Spt; Sputum; St; Stains; Stn	4180186
36660725	Acid fast Stn sp3 Spt Ql	4180186
36660725	显微镜观察^第3个标本:存在情况或阈值:时间点:痰液:序数型:抗酸染色法	4182948
36660726	3.5h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660726	Insulin 3.5h p meal SerPl-aCnc	4180186
36660726	胰岛素^在进餐之后3.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660727	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; Epstein-Barr virus; Hetero; Heteroph; Hetr; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
36660727	Heteroph Ab SerPlBld Ql IA.rapid	4180186
36660727	异嗜性 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速	4182948
36660729	by KM; Corneal; EYE; EYE.REFRACTION; L; L cornea; Length; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Upper extremity	4180186
36660729	L cornea Curvature radius.flat by KM	4180186
36660729	曲率半径.平坦:长度:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36660730	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
36660735	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Isopenta-CP; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36660735	Isopenta-CP 24h Stl-mRate	4180186
36660735	异五羧基卟啉:质量速率:24小时:大便:定量型	4182948
36660736	After; Chemistry; Genetics; Heredity; Heritable; Ile; Inherited; Level; Maple syrup urine disease; MSUD (Maple Syrup Urine Disease); p diet; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ther	4180186
36660736	Isoleucine p diet SerPl-sCnc	4180186
36660736	异亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
36660737	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660740	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV4; Equin; Equine rhinopneumonitis; Herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660740	EHV4 RNA Ct Spec Qn NAA+probe	4180186
36660740	马疱疹病毒 4 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660741	Navigator Conf eval note	4180186
36660741	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660741	会议记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
36660743	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36660744	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660746	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660746	Promyelocytes/leuk NFr Stem prod Manual	4180186
36660746	早幼粒细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660845	Influenza virus A & Influenza virus B & SARS coronavirus 2 & SARS-related coronavirus RNA panel	4180186
36661357	PANEL.EYE	4180186
36661370	SARS-CoV-2 N gene # Resp NAA+probe	4180186
36661370	SARS 冠状病毒 2 N 基因:计数型浓度:时间点:呼吸道:定量型:探针法.基因扩增.靶向	4182948
36661370	#; 2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Breathing; Cnt; Corona virus; Count; Count/volume; COVID19; COVID-19; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; QNT; Quan; Quant; Quantitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; Viral Pneumonias; Wuhan coronavirus	4180186
36661372	SARS-CoV-2 IgA Titr SerPl IF	4180186
36661372	SARS 冠状病毒 2 抗体.IgA:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
36661372	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; PH; Pl; Plasma; Plsm; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Viral Pneumonias; Wuhan coronavirus	4180186
36661374	SARS-CoV-2 IgG Titr SerPl IF	4180186
36661374	SARS 冠状病毒 2 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
36661374	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PH; Pl; Plasma; Plsm; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Viral Pneumonias; Wuhan coronavirus	4180186
36661375	流感病毒 A & 流感病毒 B & SARS 冠状病毒 2 已鉴定的:存在与否或特征标识:时间点:呼吸道:名义型:探针法.基因扩增.靶向	4182948
36661375	FLUABV + SARS-CoV-2 Resp NAA+probe	4180186
36661375	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV + SARS-CoV-2 identified; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan...	4180186
36661376	流感病毒 A & 流感病毒 B & SARS 冠状病毒 2 RNA 组套:-:时间点:呼吸道:-:探针法.基因扩增.靶向	4182948
36661376	FLUABV + SARS-CoV-2 Pnl Resp NAA+prb	4180186
36661376	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2 RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplificat...	4180186
36661379	AOEObservation; Disease; Disorder; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Virus	4180186
36661379	针对所关注的情况的第一个检验/检查项目:发现:时间点:^患者:序数型	4182948
36661379	First test for condition of interest	4180186
36661382	Admitted to ICU for condition; AOEObservation; Disease; Disorder; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; PH; Point in time; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Screen; Transferred; Virus	4180186
36661382	因为所关注的情况而住入重症监护病房:发现:时间点:^患者:序数型	4182948
36661382	Admitted to ICU for condition	4180186
36661396	SARS coronavirus 2 N gene	4180186
36661397	COVID-19+Intubation advance directives	4180186
36661401	SARS coronavirus 2 ORF1ab region	4180186
36661410	Clot strength.platelet thromboxane A2 receptor inhibited	4180186
36661415	Corrective lens.right	4180186
36661416	In the last 12Mo, did you ever not eat for a whole day because there wasn't enough money for food	4180186
36661419	Cells.CD8.HLA-A2 CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36661421	FASI v1.0 - Motorized wheelchair &or scooter - usual performance	4180186
36661427	Sit to stand - most dependent performance during the past Mo	4180186
36661436	SARS coronavirus 2 S gene	4180186
36661438	In the last 12Mo, did any of the children ever not eat for a whole day because there wasn't enough money for food	4180186
36661439	FLCN gene deletion+duplication & full mutation analysis	4180186
36661441	Pelvis & Lower extremity.unilateral>Hip	4180186
36661443	Cells.CD8.PMA+ionomycin stimulated CD107a+b expressing	4180186
36661460	Multisection^WO & W contrast IV && Multisection^WO contrast	4180186
36661465	View && Views supine + upright + lateral-decubitus	4180186
36661473	Tyrosinemia newborn screening follow-up & therapeutic monitoring panel	4180186
36661487	Airway was suctioned &or cleared	4180186
36661488	AGTR1 gene.c.1166A>C	4180186
36661492	Lying to sitting on side of bed - most dependent performance during the past Mo	4180186
36661499	Cells.CD8.HLA-A2 CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36661503	Medical aid in dying.team	4180186
36661512	Identifier & Assigning authority panel	4180186
36661515	In the last 12Mo, did you lose weight because there wasn't enough money for food	4180186
36661537	Probe.amp.tar.CDC primer-probe set N1	4180186
36661557	SARS coronavirus 2 Ab.neut	4180186
36661562	In the last 12Mo, were you ever hungry but didn't eat because there wasn't enough money for food	4180186
36661569	SARS coronavirus 2 whole genome	4180186
36661571	NPC1 gene+NPC2 gene deletion+duplication & full mutation analysis	4180186
36661572	Cells.CD8.HLA-B7 CMV specific	4180186
36661573	Cells.CD8.CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36661581	Vertical prism.up	4180186
36661584	Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior & Abdomen+Pelvis>Iliac vessels	4180186
36661591	OxyCODONE & metabolites panel	4180186
36661595	ANKK1 gene.c.2137G>A	4180186
36661615	Maximum clot strength amplitude.arachidonate induced	4180186
36661621	Living arrangement priorities for the next 6Mo	4180186
36661635	HLA-A & B & C (class I) Ab.IgG with prozone effect	4180186
36661637	DRD2 gene.c.-585A>G	4180186
36661638	Refractive power.mean	4180186
36661642	Horizontal prism.in	4180186
36661646	SARS coronavirus 2 Ab.IgG+IgM	4180186
36661682	Symptoms in the last 24H	4180186
36661687	SARS coronavirus+SARS coronavirus 2	4180186
36661689	Cells.CD21lowCD38-	4180186
36661690	Curvature radius.mean	4180186
36661698	Go up and down 12 steps - most dependent performance during the past Mo	4180186
36661699	Cells.CD8.HLA-A2 CMV specific	4180186
36661706	Cholesterol & triglyceride panel	4180186
36661711	Shower &or bathe self - most dependent performance during the past Mo	4180186
36661720	Horizontal prism.out	4180186
36661730	Need for and availability of a reacher &or grabber	4180186
36661733	SARS coronavirus 2 Ab	4180186
36661736	Lipid & glucose panel	4180186
36661738	Heavier periodic housework - most dependent performance during the past Mo	4180186
36661745	Intensive care unit admission date	4180186
36661759	Chromosome 9 & 11 & 15 aneuploidy	4180186
36661764	SARS coronavirus 2 Ag	4180186
36661771	APC gene deletion+duplication & full mutation analysis	4180186
36661773	Apis mellifera acid phosphatase recombinant (rApi m) 3	4180186
36661774	Respiratory viral pathogens DNA & RNA panel	4180186
36661780	Connective tissue autoimmune Ab.IgG panel	4180186
36661782	HLA-DP & DQ & DR (class II) Ab.IgG high risk	4180186
36661787	Platelet & HLA glycoprotein antibody panel	4180186
36661789	Mycobacterial stain & culture panel	4180186
36661790	Four or more drinks in 1D in the past 3Mo	4180186
36661798	Staphylococcus aureus & Staphylococcus aureus.methicillin resistant	4180186
36661821	Dog recombinant (rCan f) 6 Ab.IgE	4180186
36661837	COVID-19+Evaluation note	4180186
36661841	Have you and a partner fought a lot in the past 3Mo	4180186
36661874	Walk 150 feet - most dependent performance during the past Mo	4180186
36661876	Need for and availability of a cane &or crutch	4180186
36661878	Motorized wheelchair &or scooter use	4180186
36661881	Wheels for 15M - most dependent performance during the past Mo	4180186
36661883	SARS coronavirus 2 Ab panel	4180186
36661884	In the last 12Mo, did you ever cut the size of any of the children's meals or skip meals because there wasn't enough money for food	4180186
36661886	SARS coronavirus 2 Ab.IgG	4180186
36661891	OPRM1 gene.c.118A>G	4180186
36661894	Tetanus reaction wheal^1D post tetanus toxoid ID	4180186
36661897	Makes a light cold meal - most dependent performance during the past Mo	4180186
36661904	Walk 50 feet with two turns - most dependent performance during the past Mo	4180186
36661909	COVID-19+Intubation+Conference note	4180186
36661910	Oral hygiene - most dependent performance during the past Mo	4180186
36661918	In the last 12Mo, I couldn't feed my children a balanced meal, because I couldn't afford that	4180186
36661920	Lactobacillus crispatus+gasseri+jensenii+Gardnerella vaginalis+Atopobium vaginae	4180186
36661924	Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Prime Pac	4180186
36661926	Caregiving priorities for the next 6Mo	4180186
36661931	Medication management.injectable medications - most dependent performance during the past Mo	4180186
36661933	HLA-DRB3 & HLA-DRB4 & HLA DRB5 Ab.IgG	4180186
36661940	Glycerol & glycerol-corrected triglyceride panel	4180186
36661950	Hemoglobin HPLC & electrophoresis panel	4180186
36661955	Curvature radius.steep	4180186
36661965	CDH1 gene deletion+duplication & full mutation analysis	4180186
36661970	Light shopping- most dependent performance during the past Mo	4180186
36661971	Number of human papillomavirus vaccine doses received	4180186
36661976	Need for and availability of an orthotic &or brace	4180186
36661980	COVID-19+Intubation+Evaluation note	4180186
36661985	HLA-DP & DQ & DR (class II) Ab.IgG intermediate risk	4180186
36661986	MECP2 gene deletion+duplication & full mutation analysis	4180186
36662011	Neck>Neck vessels & Chest>Chest vessels	4180186
36662014	Unpaid caregiver's ability and willingness to provide medical procedure &or treatment assistance	4180186
36662015	Level of unpaid caregiver assistance in the past Mo	4180186
36662024	Dialysis+Therapeutic apheresis	4180186
36662029	Wash upper body - most dependent performance during the past Mo	4180186
36662033	In the last 12Mo, my children were not eating enough because I just couldn't afford enough food	4180186
36662049	SARS coronavirus 2 Ab.IgA+IgM	4180186
36662058	AGXT gene deletion+duplication & full mutation analysis	4180186
36662061	Pregnenolone & 17-Hydroxypregnenolone panel	4180186
36662068	COVID-19+Intubation+Cardiopulmonary resuscitation note	4180186
36662082	Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol ratio panel	4180186
36662086	Walks across a street - most dependent performance during the past Mo	4180186
36662108	Chair &or bed-to-chair transfer - usual functional ability	4180186
36662110	Clot strength.arachidonate induced	4180186
36662136	Need for and availability of a motorized wheelchair &or scooter	4180186
36662137	Which of these statements best describes the food eaten in your household in the last 12Mo	4180186
36662139	Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol	4180186
36662140	SARS coronavirus 2	4180186
36662143	Cells.CD8.CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36662149	HLA-A & B & C (class I) Ab.IgG intermediate risk	4180186
36662156	Tetanus reaction wheal^2D post tetanus toxoid ID	4180186
36662162	Clostridioides difficile toxin & BI-NAP1-027 strain DNA panel	4180186
36662175	Corrective lens.left	4180186
36662187	Complex financial management - most dependent performance during the past Mo	4180186
36662195	Have you used an illegal drug or a prescription medication for nonmedical reasons in the past 3Mo	4180186
36662197	Putting on &or taking off footwear - usual functional ability	4180186
36662198	Chromosome 1q & 9 & 11 & 15 aneuploidy & chromosome region 13q	4180186
36662209	Sit to lying - most dependent performance during the past Mo	4180186
36662217	F2 gene.c.20210G>A & F5 gene.c.1691G>A panel	4180186
36662220	Cells.CD8.PMA+ionomycin stimulated gamma interferon producing/100 cells.CD3+CD8+	4180186
36662224	Cells.CD8.HLA-B7 CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36662233	Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE	4180186
36662235	Mobility priorities for the next 6Mo	4180186
36662240	Cells.CD8.CMV specific	4180186
36662251	Instrumental activities of daily living priorities for the next 6Mo	4180186
36662279	HLA-A & B & C (class I) Ab.IgG low risk	4180186
36662594	This parent group contains a single group of LOINC terms for the molecular detection of SARS-CoV-2.	4180186
36662595	This parent group contains a single group of LOINC terms for detection of SARS-CoV-2, including molecular, antigen, and culture codes.	4180186
36674183	Goal Attainment Scaling-Light score	4180186
36674183	Goal Attainment Scaling-Light score (observable entity)	4180186
36674186	Insertion of peripherally inserted central catheter using ultrasonographic guidance (procedure)	4180186
36674186	Insertion of peripherally inserted central catheter using ultrasonographic guidance	4180186
36674186	Ultrasound guided insertion of peripherally inserted central catheter	4180186
36674191	Intellectual disability, seizures, hypotonia, ophthalmologic, skeletal anomalies syndrome (disorder)	4180186
36674191	Congenital disorder of glycosylation due to PIGT deficiency	4180186
36674191	MCAHS (multiple congenital anomalies, hypotonia, seizures syndrome) type 3	4180186
36674191	Congenital disorder of glycosylation due to PIGT (phosphatidylinositol glycan anchor biosynthesis class T) deficiency	4180186
36674193	XPDS - X-linked parkinsonism with spasticity syndrome	4180186
36674193	X-linked parkinsonism with spasticity syndrome (disorder)	4180186
36674197	Phalangeal microgeodic syndrome (disorder)	4180186
36674197	Phalangeal osteolysis	4180186
36674200	Proliferative retinopathy of left eye with diabetes mellitus	4180186
36674200	Proliferative diabetic retinopathy of left eye	4180186
36674200	Proliferative retinopathy of left eye due to diabetes mellitus (disorder)	4180186
36674202	Blepharoconjunctivitis of left eye (disorder)	4180186
36674203	Blepharoconjunctivitis of right eye (disorder)	4180186
36674204	Borderline angle-closure glaucoma of right eye (disorder)	4180186
36674205	Borderline angle-closure glaucoma of left eye (disorder)	4180186
36674208	Harvesting of sheet of fascia from fascia lata by stripper (procedure)	4180186
36674209	Carer unable to cope	4180186
36674209	Caregiver unable to cope (finding)	4180186
36674212	Extracorporeal shockwave lithotripsy of calculus of right kidney using fluoroscopic guidance (procedure)	4180186
36674212	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of right kidney	4180186
36674212	Extracorporeal shockwave lithotripsy of calculus of right kidney using fluoroscopic guidance	4180186
36674213	Extracorporeal shockwave lithotripsy of calculus of left kidney using fluoroscopic guidance	4180186
36674213	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of left kidney	4180186
36674213	Extracorporeal shockwave lithotripsy of calculus of left kidney using fluoroscopic guidance (procedure)	4180186
36674214	Product containing anisotropine (medicinal product)	4180186
36674216	Product containing docusate and ferrous fumarate (medicinal product)	4180186
36674217	Docusate- and glycerol-containing product	4180186
36674217	Product containing docusate and glycerol (medicinal product)	4180186
36674218	Product containing aspirin and isosorbide (medicinal product)	4180186
36674221	Erythromycin- and sulfafurazole-containing product	4180186
36674221	Product containing erythromycin and sulfafurazole (medicinal product)	4180186
36674222	Product containing colfosceril (medicinal product)	4180186
36674223	Product containing estradiol and medroxyprogesterone (medicinal product)	4180186
36674224	Product containing neomycin and polymyxin B and prednisolone (medicinal product)	4180186
36674226	Allergy to coagulation factor	4180186
36674226	Allergy to coagulation protein (finding)	4180186
36674226	Allergy to clotting factor	4180186
36674227	Extracorporeal shockwave lithotripsy of calculus of bilateral kidneys using fluoroscopic guidance (procedure)	4180186
36674227	Extracorporeal shockwave lithotripsy of calculus of bilateral kidneys using fluoroscopic guidance	4180186
36674227	Extracorporeal shockwave lithotripsy of calculus of both kidneys using fluoroscopic guidance	4180186
36674227	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of both kidneys	4180186
36674227	Extracorporeal shockwave lithotripsy of calculus of left and right kidney using fluoroscopic guidance	4180186
36674228	Familial omphalocele syndrome with facial dysmorphism (disorder)	4180186
36674230	Product containing ethanolamine (medicinal product)	4180186
36674235	Product containing calcium carbonate and etidronic acid (medicinal product)	4180186
36674236	Bite of squirrel (event)	4180186
36674237	Product containing amlodipine and hydrochlorothiazide and olmesartan (medicinal product)	4180186
36674238	Human immunodeficiency virus entry inhibitor (disposition)	4180186
36674238	HIV entry inhibitor	4180186
36674238	HIV post-attachment inhibitor	4180186
36674239	Product containing hydrochlorothiazide and olmesartan (medicinal product)	4180186
36674240	Ibalizumab (substance)	4180186
36674241	Product containing chlorhexidine and industrial methylated spirit (medicinal product)	4180186
36674242	Pegvaliase (substance)	4180186
36674243	Diatrype species	4180186
36674243	Diatrype	4180186
36674243	Genus Diatrype (organism)	4180186
36674245	Injection of both facet joints of cervical spine using fluoroscopic guidance	4180186
36674245	Injection of bilateral facet joints of cervical spine using fluoroscopic guidance (procedure)	4180186
36674245	Injection of left and right facet joint of cervical spine using fluoroscopic guidance	4180186
36674245	Injection of bilateral facet joints of cervical spine using fluoroscopic guidance	4180186
36674247	Injection of right facet joint of thoracic spine using fluoroscopic guidance	4180186
36674247	Injection of right facet joint of thoracic spine using fluoroscopic guidance (procedure)	4180186
36674248	Injection of bilateral facet joints of thoracic spine using fluoroscopic guidance	4180186
36674248	Injection of left and right facet joint of thoracic spine using fluoroscopic guidance	4180186
36674248	Injection of bilateral facet joints of thoracic spine using fluoroscopic guidance (procedure)	4180186
36674248	Injection of both facet joints of thoracic spine using fluoroscopic guidance	4180186
36674249	Sodium retention (disorder)	4180186
36674250	Na overload	4180186
36674250	Hypernatremia (disorder)	4180186
36674250	Hypernatraemia	4180186
36674250	Na excess	4180186
36674250	Sodium overload	4180186
36674256	Injection of left facet joint of lumbar spine using fluoroscopic guidance	4180186
36674256	Injection of left facet joint of lumbar spine using fluoroscopic guidance (procedure)	4180186
36674257	Injection of both facet joints of lumbar spine using fluoroscopic guidance	4180186
36674257	Injection of bilateral facet joints of lumbar spine using fluoroscopic guidance	4180186
36674257	Injection of left and right facet joint of lumbar spine using fluoroscopic guidance	4180186
36674257	Injection of bilateral facet joints of lumbar spine using fluoroscopic guidance (procedure)	4180186
36674258	Injection of left facet joint using fluoroscopic guidance (procedure)	4180186
36674258	Injection of left facet joint using fluoroscopic guidance	4180186
36674260	Seghers syndrome	4180186
36674260	Imperforate oropharynx, costovertebral anomalies syndrome (disorder)	4180186
36674261	PARC syndrome	4180186
36674261	PARC (poikiloderma, alopecia, retrognathism, cleft palate) syndrome	4180186
36674261	Poikiloderma, alopecia, retrognathism, cleft palate syndrome (disorder)	4180186
36674263	Freeing of adhesions of trigeminal nerve	4180186
36674263	Division of adhesions of trigeminal nerve	4180186
36674263	Lysis of adhesions of trigeminal nerve (procedure)	4180186
36674264	Bite of insect (event)	4180186
36674265	Bite of venomous arthropod (event)	4180186
36674266	Bite of thrip (event)	4180186
36674270	Reconstruction using free flap (procedure)	4180186
36674270	Reconstruction with free flap	4180186
36674271	Deep third degree burn of abdomen (disorder)	4180186
36674272	Full thickness burn of abdomen (disorder)	4180186
36674272	Third degree burn of abdomen	4180186
36674276	Vasoproliferative tumour of retina	4180186
36674276	Vasoproliferative tumor of retina (disorder)	4180186
36674278	Visual snow syndrome (disorder)	4180186
36674279	Bite of nonvenomous insect (event)	4180186
36674286	Product containing alclometasone in cutaneous dose form (medicinal product form)	4180186
36674288	Product containing diflorasone in cutaneous dose form (medicinal product form)	4180186
36674290	Product containing piperazine (medicinal product)	4180186
36674291	Repair of supravalvar aortic stenosis (procedure)	4180186
36674292	Extension Namespace {1000220}	4180186
36674292	Extension Namespace {1000220} (namespace concept)	4180186
36674293	Substance with adrenergic receptor antagonist mechanism of action (substance)	4180186
36674295	Substance with cannabinoid receptor agonist mechanism of action (substance)	4180186
36674296	Substance with cellular transport activator mechanism of action (substance)	4180186
36674298	Substance with cytochrome P450 17A1 inhibitor mechanism of action (substance)	4180186
36674299	Substance with cytochrome P450 2D6 inhibitor mechanism of action (substance)	4180186
36674300	Substance with dehydrogenase inhibitor mechanism of action (substance)	4180186
36674301	Substance with enzyme activator mechanism of action (substance)	4180186
36674305	Fiberoptic endoscopic excision of lesion of mucous membrane of esophagus (procedure)	4180186
36674305	Fibreoptic endoscopic mucosal resection of lesion of oesophagus	4180186
36674305	Fiberoptic endoscopic mucosal resection of lesion of esophagus	4180186
36674305	Fibreoptic endoscopic excision of lesion of mucous membrane of oesophagus	4180186
36674307	Repair of recurrent epigastric hernia (procedure)	4180186
36674313	Bacteroides coprosuis (organism)	4180186
36674314	Fusarium chlamydosporum complex (organism)	4180186
36674315	Product containing coagulation factor Xa (medicinal product)	4180186
36674320	Laparoscopic repair of recurrent incisional hernia using biological mesh (procedure)	4180186
36674320	Laparoscopic hernioplasty using biological mesh for recurrent incisional hernia	4180186
36674321	Nudix hydrolase 15 normal metaboliser	4180186
36674321	Nudix hydrolase 15 normal metabolizer (finding)	4180186
36674321	Nudix hydrolase 15 normal metabolizer	4180186
36674321	NUDT15 normal metaboliser	4180186
36674323	NUDT15 poor metaboliser	4180186
36674323	Nudix hydrolase 15 poor metaboliser	4180186
36674323	Nudix hydrolase 15 poor metabolizer (finding)	4180186
36674323	Nudix hydrolase 15 poor metabolizer	4180186
36674324	Haemolytic uraemic syndrome suspected	4180186
36674324	Hemolytic uremic syndrome suspected (situation)	4180186
36674325	Tuberculosis suspected (situation)	4180186
36674326	Extension Namespace {1000221} (namespace concept)	4180186
36674326	Extension Namespace {1000221}	4180186
36674327	Extension Namespace {1000222} (namespace concept)	4180186
36674327	Extension Namespace {1000222}	4180186
36674328	Borate (substance)	4180186
36674329	Product containing only abacavir (medicinal product)	4180186
36674330	Product containing only abacavir and lamivudine (medicinal product)	4180186
36674333	Binimetinib (substance)	4180186
36674334	Product containing only abacavir and dolutegravir and lamivudine (medicinal product)	4180186
36674336	Mitogen-activated protein kinase kinase inhibitor (disposition)	4180186
36674338	Mitogen-activated protein kinase kinase 1 inhibitor (disposition)	4180186
36674340	Substance with mitogen-activated protein kinase kinase 2 inhibitor mechanism of action (substance)	4180186
36674342	Laparoscopic repair of spigelian hernia using biological mesh with fascial closure (procedure)	4180186
36674342	Laparoscopic spigelian hernioplasty using biological mesh with fascial closure	4180186
36674347	Obstruction co-occurrent and due to hernia of abdominal wall (disorder)	4180186
36674348	Prolapse of urethral mucosa (disorder)	4180186
36674349	Product containing apomorphine in oromucosal dose form (medicinal product form)	4180186
36674351	Endotracheopulmonary dose form (dose form)	4180186
36674355	Ethinylestradiol- and ferrous fumarate- and norgestrel-containing product	4180186
36674355	Product containing ethinylestradiol and ferrous fumarate and norgestrel (medicinal product)	4180186
36674359	Combined endoscopic and laparoscopic excision of polyp of colon (procedure)	4180186
36674360	Nursing care plan (record artifact)	4180186
36674361	Plain X-ray for ulnar variance view (procedure)	4180186
36674362	Surgical distraction of externally adjustable spinal deformity correction system (procedure)	4180186
36674363	Endoscopic mucosal resection of lesion of sigmoid colon using rigid sigmoidoscope (procedure)	4180186
36674365	Hypermobility of thoracic spine	4180186
36674365	Hypermobility of thoracic spine (finding)	4180186
36674366	Mechanical break-force limb muscle tester (physical object)	4180186
36674366	Mechanical back, leg and chest dynamometer	4180186
36674369	Multiple physiological parameter long-term ambulatory recorder (physical object)	4180186
36674370	Rigid video ureterorenoscope (physical object)	4180186
36674379	Ocular albinism with congenital sensorineural deafness (disorder)	4180186
36674379	Waardenburg syndrome type 2 with ocular albinism	4180186
36674384	Progeroid and marfanoid aspect, lipodystrophy syndrome (disorder)	4180186
36674386	Open avulsion fracture (morphologic abnormality)	4180186
36674390	Corticosteroid-binding globulin deficiency (disorder)	4180186
36674390	Transcortin deficiency	4180186
36674392	Autosomal recessive osteopetrosis type 7	4180186
36674392	Osteopetrosis hypogammaglobulinaemia syndrome	4180186
36674392	Autosomal recessive osteoclast-poor osteopetrosis with hypogammaglobulinaemia	4180186
36674392	Autosomal recessive osteoclast-poor osteopetrosis with hypogammaglobulinemia	4180186
36674392	Osteopetrosis hypogammaglobulinemia syndrome (disorder)	4180186
36674393	Interstitial granulomatous dermatitis with arthritis (disorder)	4180186
36674393	IGDA - interstitial granulomatous dermatitis with arthritis	4180186
36674393	Ackerman dermatitis syndrome	4180186
36674395	OXA-48 carbapenemase-producing bacteria (organism)	4180186
36674397	Nephrocystin 3-related Meckel-like syndrome (disorder)	4180186
36674397	NPHP3 (nephrocystin 3) related Meckel-like syndrome	4180186
36674397	Meckel-like syndrome type 1	4180186
36674397	Nephrocystin 3-related Meckel-like syndrome	4180186
36674397	Goldston syndrome	4180186
36674397	Renal, hepatic, pancreatic dysplasia, Dandy-Walker cysts syndrome	4180186
36674397	Meckel syndrome type 7	4180186
36674398	Chronic EBV (Epstein-Barr virus) infection syndrome	4180186
36674398	Chronic Epstein-Barr virus infection syndrome (disorder)	4180186
36674398	CAEBV (chronic active Epstein-Barr virus infection) syndrome	4180186
36674399	Product containing stiripentol in oral dose form (medicinal product form)	4180186
36674407	Traumatic event (event)	4180186
36674408	Sting by mollusc (event)	4180186
36674409	Harvester ant venom (substance)	4180186
36674410	Sting by harvester ant (event)	4180186
36674413	Aughton Hufnagle syndrome	4180186
36674413	Ankyloblepharon filiforme adnatum with imperforate anus syndrome (disorder)	4180186
36674414	Product containing chloral derivative (product)	4180186
36674416	Amputation of right forefoot (procedure)	4180186
36674419	Antiglaucoma therapeutic role (role)	4180186
36674421	Antiflatulent therapeutic role (role)	4180186
36674423	Abortifacient therapeutic role (role)	4180186
36674424	Antiacne therapeutic role (role)	4180186
36674425	Antimigraine therapeutic role (role)	4180186
36674426	Analgesic therapeutic role (role)	4180186
36674429	Ganglion cyst of right dorsal wrist (disorder)	4180186
36674430	Antiarrhythmic therapeutic role (role)	4180186
36674432	Antiasthmatic therapeutic role (role)	4180186
36674433	Anticoagulant therapeutic role (role)	4180186
36674434	Anticonvulsant therapeutic role (role)	4180186
36674436	Astringent therapeutic role (role)	4180186
36674437	Bronchodilator therapeutic role (role)	4180186
36674440	Emetic therapeutic role (role)	4180186
36674444	Gastric acidifier therapeutic role (role)	4180186
36674445	Hypnotic therapeutic role (role)	4180186
36674449	Bursitis of right hip (disorder)	4180186
36674451	Extension Namespace {1000225}	4180186
36674451	Extension Namespace {1000225} (namespace concept)	4180186
36674454	Hepatology care plan (record artifact)	4180186
36674459	Rheumatology care plan (record artifact)	4180186
36674461	Telfer Sugar Jaeger syndrome	4180186
36674461	Piebald trait with neurologic defects syndrome (disorder)	4180186
36674463	Exposure to iodine (event)	4180186
36674464	Bowel cleanser therapeutic role (role)	4180186
36674466	Imaging therapeutic role (role)	4180186
36674471	AT-hook DNA binding motif containing 1-related intellectual disability, obstructive sleep apnea, mild dysmorphism syndrome	4180186
36674471	AT-hook DNA binding motif containing 1-related intellectual disability, obstructive sleep apnoea, mild dysmorphism syndrome	4180186
36674471	Xia Gibbs syndrome	4180186
36674471	AT-hook DNA binding motif containing 1-related intellectual disability, obstructive sleep apnea, mild dysmorphism syndrome (disorder)	4180186
36674471	AHDC1-related intellectual disability, obstructive sleep apnoea, mild dysmorphism syndrome	4180186
36674473	Fibulin 1-related developmental delay, central nervous system anomaly, syndactyly syndrome (disorder)	4180186
36674473	Fibulin 1-related developmental delay, central nervous system anomaly, syndactyly syndrome	4180186
36674478	Neonatal autoimmune hemolytic anemia (disorder)	4180186
36674478	Neonatal autoimmune haemolytic anaemia	4180186
36674480	Lutetium and/or lutetium compound (substance)	4180186
36674480	Lutetium and/or lutetium compound	4180186
36674480	Lutetium and lutetium compound (substance)	4180186
36674481	ABCD2 (Age, Blood pressure, Clinical features, Duration, Diabetes) stroke risk score	4180186
36674481	ABCD2 (Age, Blood pressure, Clinical features, Duration, Diabetes) score	4180186
36674481	Age, Blood pressure, Clinical features, Duration, Diabetes 2 score (observable entity)	4180186
36674483	Assessment using American Society of Anesthesiologists Physical Status Classification System (procedure)	4180186
36674484	AUDIT-PC (Alcohol Use Disorders Identification Test for Primary Care) score	4180186
36674484	Alcohol Use Disorders Identification Test for Primary Care score (observable entity)	4180186
36674484	Alcohol Use Disorders Identification Test Piccinelli Consumption score	4180186
36674486	Assessment using ADS (Alcohol Dependence Scale)	4180186
36674486	Assessment using Alcohol Dependence Scale (procedure)	4180186
36674489	Oxygen and/or oxygen compound	4180186
36674489	Oxygen and/or oxygen compound (substance)	4180186
36674489	Oxygen and oxygen compound (substance)	4180186
36674490	Intellectual disability, obesity, prognathism, eye and skin anomalies syndrome (disorder)	4180186
36674490	MOMES syndrome	4180186
36674491	Argon and/or argon compound	4180186
36674491	Argon and/or argon compound (substance)	4180186
36674491	Argon and argon compound (substance)	4180186
36674492	Krypton and/or krypton compound (substance)	4180186
36674492	Krypton and/or krypton compound	4180186
36674492	Krypton and krypton compound (substance)	4180186
36674494	Neon and/or neon compound (substance)	4180186
36674494	Neon and/or neon compound	4180186
36674494	Neon and neon compound (substance)	4180186
36674495	Xenon and/or xenon compound (substance)	4180186
36674495	Xenon and/or xenon compound	4180186
36674495	Xenon and xenon compound (substance)	4180186
36674501	Product containing only alanylglutamine (medicinal product)	4180186
36674503	Product containing only brivaracetam (medicinal product)	4180186
36674504	Product containing only docusate (medicinal product)	4180186
36674505	Product containing only fluoride (medicinal product)	4180186
36674506	Product containing only nabilone (medicinal product)	4180186
36674507	Product containing only opium (medicinal product)	4180186
36674508	Severe intellectual disability and progressive spastic paraplegia (disorder)	4180186
36674508	AP4 deficiency syndrome	4180186
36674509	Temple syndrome (disorder)	4180186
36674512	Pressure bandage (physical object)	4180186
36674513	Microphthalmia, retinitis pigmentosa, foveoschisis, optic disc drusen syndrome (disorder)	4180186
36674513	Nanophthalmos, retinitis pigmentosa, foveoschisis, optic disc drusen syndrome	4180186
36674514	Ehlers-Danlos syndrome due to tenascin-X deficiency (disorder)	4180186
36674514	Ehlers-Danlos syndrome classic-like type	4180186
36674517	Atypical hypotonia cystinuria syndrome (disorder)	4180186
36674522	Construction of interposition anastomosis using tissue engineered blood vessel (procedure)	4180186
36674523	Construction of interposition anastomosis of femoro-popliteal artery graft using tissue engineered blood vessel (procedure)	4180186
36674525	Harvest of bone graft from tarsal bone and metatarsal bone (procedure)	4180186
36674528	Emergomyces pasteurianus (organism)	4180186
36674528	Emergomyces pasteurianus	4180186
36674528	Emmonsia pasteuriana (organism)	4180186
36674530	Hormographiella aspergillata (organism)	4180186
36674531	Cladophialophora modesta (organism)	4180186
36674533	Medical care (regime/therapy)	4180186
36674534	Xepiculopsis graminea	4180186
36674534	Myrothecium gramineum (organism)	4180186
36674535	Acia fuscoatra	4180186
36674535	Phlebia fuscoatra	4180186
36674535	Hydnum fuscoatrum	4180186
36674535	Mycoleptodon fuscoater	4180186
36674535	Steccherinum fuscoatrum	4180186
36674535	Mycoleptodon fuscoatrum	4180186
36674535	Mycoacia fuscoatra (organism)	4180186
36674535	Odontia fuscoatra	4180186
36674536	Acia	4180186
36674536	Genus Mycoacia (organism)	4180186
36674536	Mycoacia	4180186
36674537	Angiofollicular lymph node hyperplasia (morphologic abnormality)	4180186
36674539	Product containing porcine factor VIII in parenteral dose form (medicinal product form)	4180186
36674540	Product containing only porcine factor VIII in parenteral dose form (medicinal product form)	4180186
36674543	Chloral (substance)	4180186
36674545	Product containing only pegvaliase in parenteral dose form (medicinal product form)	4180186
36674546	Product containing secukinumab in parenteral dose form (medicinal product form)	4180186
36674547	Product containing only selexipag (medicinal product)	4180186
36674548	Product containing selexipag in oral dose form (medicinal product form)	4180186
36674550	Genus Actinotalea (organism)	4180186
36674550	Actinotalea	4180186
36674551	Product containing only omadacycline (medicinal product)	4180186
36674552	Product containing omadacycline in oral dose form (medicinal product form)	4180186
36674556	Product containing precisely galsulfase 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	4180186
36674559	STEC (Shiga toxin-producing Escherichia coli) serogroup O128	4180186
36674559	Shiga toxin-producing Escherichia coli serogroup O128 (organism)	4180186
36674559	Shiga toxin-producing E. coli serogroup O128	4180186
36674566	Shiga toxin-producing E. coli serotype O104:H7	4180186
36674566	STEC (Shiga toxin-producing Escherichia coli) serotype O104:H7	4180186
36674566	Shiga toxin-producing Escherichia coli serotype O104:H7 (organism)	4180186
36674567	Nodule of subcutaneous tissue of leg	4180186
36674567	Nodule of subcutaneous tissue of lower extremity	4180186
36674567	Nodule of subcutaneous tissue of lower limb (finding)	4180186
36674573	Streptomyces jietaisiensis (organism)	4180186
36674574	Streptomyces amritsarensis (organism)	4180186
36674580	Product containing only amikacin liposome (medicinal product)	4180186
36674581	Product containing only galcanezumab (medicinal product)	4180186
36674586	Levofolinic acid-containing product	4180186
36674586	Product containing levofolinic acid (medicinal product)	4180186
36674587	Levofolinic acid only product	4180186
36674587	Product containing only levofolinic acid (medicinal product)	4180186
36674588	Levofolinic acid-containing product in parenteral dose form	4180186
36674588	Product containing levofolinic acid in parenteral dose form (medicinal product form)	4180186
36674590	Order Diphyllobothriidea (organism)	4180186
36674590	Diphyllobothriidea	4180186
36674593	Substance with pantothenate kinase inhibitor mechanism of action (substance)	4180186
36674595	Allergy to cow's milk protein (finding)	4180186
36674597	Arachidonate 5-lipoxygenase inhibitor (disposition)	4180186
36674598	Allergy to Hepatitis b surface antigen immunoglobulin (finding)	4180186
36674599	Asthma never causes night symptoms (finding)	4180186
36674600	Allergy to indanedione (finding)	4180186
36674601	Inotersen (substance)	4180186
36674602	Cyst of medial meniscus of right knee (disorder)	4180186
36674603	Motor control test (procedure)	4180186
36674604	Vertical jump test (procedure)	4180186
36674607	IGRA (gamma interferon assay) for TB (tuberculosis) screening	4180186
36674607	IGRA for TB screening	4180186
36674607	Screening for tuberculosis using gamma interferon assay (procedure)	4180186
36674610	Open fracture of left fibula (disorder)	4180186
36674611	Arthroplasty of finger of left hand (procedure)	4180186
36674612	Arthroplasty of finger of right hand (procedure)	4180186
36674614	Muscle spasticity absent (situation)	4180186
36674615	Muscle spasticity present (situation)	4180186
36674617	Assessment using REVEAL registry risk score calculator (procedure)	4180186
36674619	Assessment using Rehabilitation Complexity Scale (procedure)	4180186
36674622	Hulio (product)	4180186
36674623	Flucelvax Tetra (product)	4180186
36674624	N-methylspiperone	4180186
36674624	3-N-methylspiperone	4180186
36674624	Mespiperone (substance)	4180186
36674626	Childs Farm (qualifier value)	4180186
36674627	Rucaparib (product)	4180186
36674633	Ertugliflozin (product)	4180186
36674634	MIP Pharma GmbH (qualifier value)	4180186
36674637	Entire nail matrix (body structure)	4180186
36674638	Raoultibacter timonensis (organism)	4180186
36674639	Extension Namespace {1000218}	4180186
36674639	Extension Namespace {1000218} (namespace concept)	4180186
36674640	Transition out of youth care system	4180186
36674640	Transition out of youth care system (finding)	4180186
36674640	Care leaver	4180186
36674645	Cerium compound (substance)	4180186
36674647	Sphingobacterium hotanense (organism)	4180186
36674651	Vitreous haemorrhage of right eye with diabetes mellitus	4180186
36674651	Vitreous haemorrhage of right eye due to diabetes mellitus	4180186
36674651	Vitreous hemorrhage of right eye due to diabetes mellitus (disorder)	4180186
36674651	Vitreous hemorrhage of right eye with diabetes mellitus	4180186
36674651	Diabetic vitreous hemorrhage of right eye	4180186
36674651	Diabetic vitreous haemorrhage of right eye	4180186
36674652	Vitreous hemorrhage of left eye with diabetes mellitus	4180186
36674652	Diabetic vitreous hemorrhage of left eye	4180186
36674652	Diabetic vitreous haemorrhage of left eye	4180186
36674652	Vitreous hemorrhage of left eye due to diabetes mellitus (disorder)	4180186
36674652	Vitreous haemorrhage of left eye due to diabetes mellitus	4180186
36674652	Vitreous haemorrhage of left eye with diabetes mellitus	4180186
36674654	Product containing thymidine phosphorylase inhibitor (product)	4180186
36674655	Product containing tryptophan hydroxylase inhibitor (product)	4180186
36674656	Product containing RNA polymerase inhibitor (product)	4180186
36674658	Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product)	4180186
36674661	Product containing beta-lactamase inhibitor (product)	4180186
36674662	Product containing Cytomegalovirus terminase complex inhibitor (product)	4180186
36674664	Cryptococcus ater (organism)	4180186
36674666	Coriobacteriia	4180186
36674666	Class Coriobacteriia (organism)	4180186
36674670	Product containing antifilarial (product)	4180186
36674673	Beta-2 adrenergic receptor blocker-containing product	4180186
36674673	Product containing beta-2 adrenergic receptor antagonist (product)	4180186
36674675	ESBL Klebsiella	4180186
36674675	Extended spectrum beta-lactamase producing Klebsiella (organism)	4180186
36674679	Product containing aminopyridine (product)	4180186
36674680	Product containing dihydrocarbostyril derivative (product)	4180186
36674683	Product containing acridine (product)	4180186
36674684	Product containing acetic acid and/or acetic acid derivative (product)	4180186
36674684	Acetic acid and/or acetic acid derivative-containing product	4180186
36674684	Product containing acetic acid and acetic acid derivative (product)	4180186
36674685	Deep full thickness burn	4180186
36674685	Fourth degree burn injury (morphologic abnormality)	4180186
36674686	Monosomy 10q22.3q23.3	4180186
36674686	Deletion 10q22.3q23.3	4180186
36674686	10q22.3q23.3 microdeletion syndrome (disorder)	4180186
36674688	Autosomal recessive chorioretinopathy and microcephaly syndrome (disorder)	4180186
36674688	Autosomal recessive chorioretinopathy, microcephaly, intellectual disability syndrome	4180186
36674689	Benign familial mesial temporal lobe epilepsy (disorder)	4180186
36674689	Benign FMTLE (familial mesial temporal lobe epilepsy)	4180186
36674690	Brachydactyly type B2 (disorder)	4180186
36674691	Von Hippel Lindau dependent polycythaemia	4180186
36674691	Chuvash polycythemia	4180186
36674691	Chuvash polycythaemia	4180186
36674691	Von Hippel Lindau dependent polycythemia	4180186
36674691	Chuvash erythrocytosis (disorder)	4180186
36674692	Congenital narrowing of cervical spinal canal	4180186
36674692	Congenital cervical spinal stenosis	4180186
36674692	Congenital stenosis of cervical spinal canal (disorder)	4180186
36674694	Distal monosomy 14q	4180186
36674694	Distal monosomy 14q syndrome (disorder)	4180186
36674694	Distal deletion 14q	4180186
36674694	Telomeric deletion 14q	4180186
36674696	Pre-retirement general health medical examination (procedure)	4180186
36674697	Medical examination for retirement on medical grounds (procedure)	4180186
36674697	Medical examination for retirement for ill health	4180186
36674702	Product containing triazolam in oral dose form (medicinal product form)	4180186
36674705	Product containing oxazepam in oral dose form (medicinal product form)	4180186
36674707	Product containing treosulfan in oral dose form (medicinal product form)	4180186
36674710	Product containing trichlormethiazide in oral dose form (medicinal product form)	4180186
36674711	Distal spinal muscular atrophy type 3	4180186
36674711	Autosomal recessive distal spinal muscular atrophy type 3 (disorder)	4180186
36674713	Ectasia of left auricular appendage	4180186
36674713	Ectasia of left atrial appendage (disorder)	4180186
36674713	Dilatation of left atrial appendage	4180186
36674713	Dilatation of left auricular appendage	4180186
36674714	Ectasia of right auricular appendage	4180186
36674714	Dilatation of right atrial appendage	4180186
36674714	Dilatation of right auricular appendage	4180186
36674714	Ectasia of right atrial appendage (disorder)	4180186
36674717	Familial juvenile hypertrophy of the breast (disorder)	4180186
36674717	Familial juvenile gigantomastia	4180186
36674718	Fundus pulverulentus (disorder)	4180186
36674719	Infantile spasm and broad thumb syndrome (disorder)	4180186
36674719	Infantile spasms, broad thumbs syndrome	4180186
36674719	Tsao Ellingson syndrome	4180186
36674725	Congenital hypoplasia of entire upper limb (disorder)	4180186
36674728	Goal Attainment Scaling-Light (assessment scale)	4180186
36674728	Goal Attainment Scaling-Light	4180186
36674732	Fried Goldberg Mundel syndrome	4180186
36674732	Lower limb malformation hypospadias syndrome (disorder)	4180186
36674737	Monosomy 13q14	4180186
36674737	Monosomy 13q14 syndrome (disorder)	4180186
36674737	Deletion 13q14	4180186
36674738	Progeroid syndrome Petty type (disorder)	4180186
36674738	Petty syndrome	4180186
36674738	Petty Laxova Wiedemann syndrome	4180186
36674740	Biopsy of left breast using digital tomosynthesis guidance	4180186
36674740	Biopsy of left breast using digital tomosynthesis guidance (procedure)	4180186
36674741	Digital tomosynthesis guided biopsy of both breasts	4180186
36674741	Digital tomosynthesis guided biopsy of left and right breast	4180186
36674741	Biopsy of bilateral breasts using digital tomosynthesis guidance (procedure)	4180186
36674741	Biopsy of bilateral breasts using digital tomosynthesis guidance	4180186
36674741	Biopsy of both breasts using digital tomosynthesis guidance	4180186
36674742	Benzodiazepine therapy (procedure)	4180186
36674745	ERCP (endoscopic retrograde cholangiopancreatography) report	4180186
36674745	Endoscopic retrograde cholangiopancreatography report (record artifact)	4180186
36674747	Prevention of delirium care plan (record artifact)	4180186
36674748	Munich Alcoholism Test score	4180186
36674748	Munich Alcoholism Test score (observable entity)	4180186
36674750	Ultrasonography of soft tissue of thoracic region of back (procedure)	4180186
36674750	Ultrasound of soft tissue of thoracic region of back	4180186
36674750	Ultrasound scan of soft tissue of thoracic region of back	4180186
36674756	Liver transient elastography fibrosis score (observable entity)	4180186
36674756	Liver ultrasound elastography fibrosis score	4180186
36674757	Allergic contact dermatitis caused by iodophore (disorder)	4180186
36674758	Allergic contact dermatitis caused by povidone iodine (disorder)	4180186
36674762	MCDR2 - retinal macular dystrophy type 2	4180186
36674762	Retinal macular dystrophy type 2 (disorder)	4180186
36674765	Diabetic retinal venous beading of right eye	4180186
36674765	Venous beading of right retina due to diabetes mellitus (disorder)	4180186
36674765	Retinal venous beading of right eye with diabetes mellitus	4180186
36674766	Venous beading of left retina due to diabetes mellitus (disorder)	4180186
36674766	Diabetic retinal venous beading of left eye	4180186
36674766	Retinal venous beading of left eye with diabetes mellitus	4180186
36674767	Small cell carcinoma of ovary (disorder)	4180186
36674767	Small cell ovarian carcinoma	4180186
36674769	X-linked spondyloepimetaphyseal dysplasia (disorder)	4180186
36674770	X-linked cerebral, cerebellar, coloboma syndrome (disorder)	4180186
36674770	X-linked intellectual disability Kroes type	4180186
36674774	Second degree burn of finger	4180186
36674774	Partial thickness burn of skin of finger (disorder)	4180186
36674775	Full thickness burn of skin and/or subcutaneous tissue of finger	4180186
36674775	Third degree burn of finger	4180186
36674775	Full thickness burn of skin and/or subcutaneous tissue of finger (disorder)	4180186
36674776	Norris Amyotrophic Lateral Sclerosis Scale score (observable entity)	4180186
36674776	Norris ALS (Amyotrophic Lateral Sclerosis) Scale score	4180186
36674777	Deep partial thickness burn of skin of finger (disorder)	4180186
36674777	Deep partial thickness burn of skin of finger	4180186
36674777	Deep second degree burn of finger	4180186
36674778	First diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus vaccination	4180186
36674778	Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens	4180186
36674778	First diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunization	4180186
36674778	Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)	4180186
36674778	First diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunisation	4180186
36674780	Congenital upper esophageal web (disorder)	4180186
36674780	Congenital upper oesophageal web	4180186
36674781	Product containing interleukin receptor antagonist (product)	4180186
36674787	Combined immunodeficiency with faciooculoskeletal anomalies syndrome (disorder)	4180186
36674787	Roifman Chitayat syndrome	4180186
36674789	Desmin-related myofibrillar myopathy (disorder)	4180186
36674789	Desminopathy	4180186
36674790	Diffuse leptomeningeal melanocytosis (disorder)	4180186
36674792	Distal hereditary motor neuropathy type 1 (disorder)	4180186
36674792	Autosomal dominant distal juvenile spinal muscular atrophy type 1	4180186
36674793	Genetic transient congenital hypothyroidism (disorder)	4180186
36674794	Assessment using EuroQol Five Dimension (Youth) instrument	4180186
36674794	Assessment using EuroQol Five Dimension (Youth) instrument (procedure)	4180186
36674796	Abbey Pain Scale score (observable entity)	4180186
36674798	Assessment using Medical Outcomes Study 36-item Short Form Health Survey (procedure)	4180186
36674798	Assessment using Medical Outcomes Study 36-item Short Form Health Survey	4180186
36674799	Assessment using Abbey Pain Scale (procedure)	4180186
36674801	MR arthrography of carpometacarpal joint	4180186
36674801	Magnetic resonance arthrography of carpometacarpal joint (procedure)	4180186
36674801	Magnetic resonance arthrogram of carpometacarpal joint	4180186
36674803	Onychomycosis of nail of digit of hand (disorder)	4180186
36674803	Onychomycosis of nail of digit of hand	4180186
36674806	Stenosis of external auditory canal caused by ionising radiation	4180186
36674806	Stenosis of external auditory canal caused by ionizing radiation (disorder)	4180186
36674807	TEMPORARY parent for CDs that are not updated (product)	4180186
36674809	SAC - Standardized Assessment of Concussion	4180186
36674809	Standardized Assessment of Concussion (assessment scale)	4180186
36674814	Neonatal brainstem dysfunction (disorder)	4180186
36674815	Non-distal monosomy 10q (disorder)	4180186
36674815	Non-telomeric monosomy 10q	4180186
36674815	Non-distal deletion 10q	4180186
36674817	OMD - occult macular dystrophy	4180186
36674817	Occult macular dystrophy (disorder)	4180186
36674817	OCMD - occult macular dystrophy	4180186
36674819	Paternal uniparental disomy of chromosome 5 (disorder)	4180186
36674821	Tubercular lesion of lung (disorder)	4180186
36674821	Tubercular lesion of lung	4180186
36674821	Ghon tubercle	4180186
36674822	Neoplasm of thoracic vertebra (disorder)	4180186
36674823	Neoplasm of lumbar vertebra (disorder)	4180186
36674824	Referral to hyperbaric medicine service (procedure)	4180186
36674825	PEHOL (progressive encephalopathy with oedema, hypsarrhythmia, and optic atrophy-like) syndrome	4180186
36674825	PEHO-like syndrome	4180186
36674825	Progressive encephalopathy with oedema, hypsarrhythmia, and optic atrophy-like syndrome	4180186
36674825	PEHOL (progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like) syndrome	4180186
36674825	Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome (disorder)	4180186
36674826	Lundberg syndrome	4180186
36674826	Polyneuropathy, intellectual disability, acromicria, premature menopause syndrome (disorder)	4180186
36674828	Pierre Robin sequence, oligodactyly syndrome	4180186
36674828	Robin sequence and oligodactyly syndrome (disorder)	4180186
36674829	Rosette-forming glioneuronal neoplasm (disorder)	4180186
36674829	Rosette-forming glioneuronal tumor	4180186
36674829	Rosette-forming glioneuronal tumour	4180186
36674831	Squamous cell carcinoma of liver and intrahepatic biliary tract (disorder)	4180186
36674832	Undifferentiated carcinoma of liver and intrahepatic biliary tract (disorder)	4180186
36674833	Vaginal germ cell malignant tumor	4180186
36674833	Vaginal germ cell malignant tumour	4180186
36674833	Malignant germ cell neoplasm of vagina (disorder)	4180186
36674835	Biopsy of pelvis using fluoroscopic guidance	4180186
36674835	Biopsy of pelvis using fluoroscopic guidance (procedure)	4180186
36674836	Drainage of abdomen using fluoroscopic guidance	4180186
36674836	Drainage of abdomen using fluoroscopic guidance (procedure)	4180186
36674837	Peptostreptococcus russellii (organism)	4180186
36674840	Drainage of pelvis using fluoroscopic guidance	4180186
36674840	Drainage of pelvis using fluoroscopic guidance (procedure)	4180186
36674842	Drainage of thorax using fluoroscopic guidance	4180186
36674842	Fluoroscopy guided drainage of chest	4180186
36674842	Drainage of thorax using fluoroscopic guidance (procedure)	4180186
36674843	Insertion of stent into bile duct using fluoroscopic guidance	4180186
36674843	Insertion of stent into bile duct using fluoroscopic guidance (procedure)	4180186
36674844	Insertion of stent into duodenum using fluoroscopic guidance (procedure)	4180186
36674844	Insertion of stent into duodenum using fluoroscopic guidance	4180186
36674845	Insertion of stent into bronchus using fluoroscopic guidance	4180186
36674845	Insertion of stent into bronchus using fluoroscopic guidance (procedure)	4180186
36674848	Insertion of stent into ureter using fluoroscopic guidance	4180186
36674848	Insertion of stent into ureter using fluoroscopic guidance (procedure)	4180186
36674849	Factor IX adverse reaction (disorder)	4180186
36674850	Factor V adverse reaction (disorder)	4180186
36674851	Insertion of stent into urethra using fluoroscopic guidance	4180186
36674851	Insertion of stent into urethra using fluoroscopic guidance (procedure)	4180186
36674854	Factor XIII adverse reaction (disorder)	4180186
36674856	Factor VIII adverse reaction (disorder)	4180186
36674861	Avatrombopag (substance)	4180186
36674862	Sodium zirconium cyclosilicate (substance)	4180186
36674863	3q27.3 microdeletion syndrome (disorder)	4180186
36674865	Microcephaly, thin corpus callosum, intellectual disability syndrome (disorder)	4180186
36674866	Proximal myopathy with extrapyramidal signs (disorder)	4180186
36674869	Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (disorder)	4180186
36674870	Female infertility due to zona pellucida defect (disorder)	4180186
36674871	Spinal muscular atrophy with respiratory distress type 2 (disorder)	4180186
36674871	Severe infantile axonal neuropathy with respiratory failure type 2	4180186
36674871	Diaphragmatic spinal muscular atrophy type 2	4180186
36674871	X-linked spinal muscular atrophy with respiratory distress	4180186
36674871	SMARD2 - spinal muscular atrophy with respiratory distress type 2	4180186
36674875	Wound compression vacuum binder (physical object)	4180186
36674876	Cone beam computed tomography of left ankle	4180186
36674876	Cone beam computed tomography of left ankle (procedure)	4180186
36674877	Cone beam computed tomography of right ankle	4180186
36674877	Cone beam computed tomography of right ankle (procedure)	4180186
36674879	Long bone adjustable magnetic nail (physical object)	4180186
36674880	Bioabsorbable long bone nail (physical object)	4180186
36674884	Musculoskeletal infrared phototherapy unit skin-adhesive patch (physical object)	4180186
36674888	Calf implant (physical object)	4180186
36674897	Sinoatrial node dysfunction and deafness (disorder)	4180186
36674898	T-cell immunodeficiency due to RHOH deficiency	4180186
36674898	T-cell immunodeficiency due to ras homolog family member H deficiency (disorder)	4180186
36674898	T-cell immunodeficiency due to ras homolog family member H deficiency	4180186
36674898	T-cell immunodeficiency due to RHOH (ras homolog family member H) deficiency	4180186
36674899	Hereditary inclusion body myopathy type 4 (disorder)	4180186
36674900	Benign Samaritan congenital myopathy (disorder)	4180186
36674901	Tall stature, scoliosis, macrodactyly of hallux syndrome	4180186
36674901	Tall stature, scoliosis, macrodactyly of great toe syndrome (disorder)	4180186
36674903	Developmental delay with autism spectrum disorder and gait instability (disorder)	4180186
36674909	Referral to hospital diabetes antenatal clinic (procedure)	4180186
36674911	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of left ureter	4180186
36674911	Extracorporeal shockwave lithotripsy of calculus of left ureter using fluoroscopic guidance	4180186
36674911	Extracorporeal shockwave lithotripsy of calculus of left ureter using fluoroscopic guidance (procedure)	4180186
36674913	MITF (melanogenesis associated transcription factor) related melanoma and renal cell carcinoma predisposition syndrome	4180186
36674913	Melanogenesis associated transcription factor related melanoma and renal cell carcinoma predisposition syndrome (disorder)	4180186
36674913	Melanogenesis associated transcription factor related melanoma and renal cell carcinoma predisposition syndrome	4180186
36674914	Autosomal recessive cerebellar ataxia, epilepsy, intellectual disability syndrome due to WWOX (WW domain containing oxidoreductase) deficiency	4180186
36674914	Autosomal recessive cerebellar ataxia, epilepsy, intellectual disability syndrome due to WW domain containing oxidoreductase deficiency	4180186
36674914	Autosomal recessive spinocerebellar ataxia type 12	4180186
36674914	Autosomal recessive cerebellar ataxia, epilepsy, intellectual disability syndrome due to WW domain containing oxidoreductase deficiency (disorder)	4180186
36674915	Recessive intellectual disability, motor dysfunction, multiple joint contractures syndrome	4180186
36674915	Autosomal recessive intellectual disability, motor dysfunction, multiple joint contracture syndrome (disorder)	4180186
36674918	Varus stress test of knee	4180186
36674918	Adduction test of knee (procedure)	4180186
36674918	Varus test of knee	4180186
36674918	Adduction stress test of knee	4180186
36674919	Distal 7q11.23 microdeletion syndrome (disorder)	4180186
36674919	Distal monosomy 7q11.23	4180186
36674921	Multiple congenital anomalies due to 14q32.2 maternally expressed gene defect	4180186
36674921	Kagami Ogata syndrome (disorder)	4180186
36674923	Metaphyseal chondrodysplasia Kaitila type (disorder)	4180186
36674925	Magnetic resonance imaging of wall of blood vessel with contrast	4180186
36674925	Magnetic resonance imaging of wall of blood vessel with contrast (procedure)	4180186
36674927	Removal of verruca plantaris by occlusion using adhesive tape (procedure)	4180186
36674929	Laser destruction of verruca (procedure)	4180186
36674930	Gout flare	4180186
36674930	Acute gout (disorder)	4180186
36674930	Gout attack	4180186
36674933	Product containing clobetasone and nystatin and oxytetracycline (medicinal product)	4180186
36674935	Product containing dexamethasone and neomycin (medicinal product)	4180186
36674936	Product containing dexamethasone and neomycin and polymyxin B (medicinal product)	4180186
36674937	Product containing bacitracin and neomycin and polymyxin B (medicinal product)	4180186
36674938	Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	4180186
36674939	Product containing hydrazine (medicinal product)	4180186
36674942	Huntington disease-like 3 (disorder)	4180186
36674944	ANE (alopecia, progressive neurological defect, endocrinopathy) syndrome	4180186
36674944	Alopecia, progressive neurological defect, endocrinopathy syndrome (disorder)	4180186
36674944	ANE syndrome	4180186
36674945	Kostmann syndrome (disorder)	4180186
36674945	Severe congenital neutropaenia type 3	4180186
36674945	Severe congenital neutropenia type 3	4180186
36674945	Infantile genetic agranulocytosis	4180186
36674945	Infantile agranulocytosis	4180186
36674946	Dentin dysplasia, sclerotic bones syndrome	4180186
36674946	Dentin dysplasia with sclerotic bone syndrome (disorder)	4180186
36674947	Oculootodental syndrome (disorder)	4180186
36674948	Tetramelic monodactyly (disorder)	4180186
36674948	Sommer Hines syndrome	4180186
36674950	Autosomal dominant severe congenital neutropaenia	4180186
36674950	Autosomal dominant severe congenital neutropenia (disorder)	4180186
36674951	Rhizomelic syndrome Urbach type (disorder)	4180186
36674953	Hypoxylon operculatum	4180186
36674953	Sphaeria stigma	4180186
36674953	Hypoxylon stigma	4180186
36674953	Diatrype stigma (organism)	4180186
36674953	Diatrypella stigma	4180186
36674953	Nemania stigma	4180186
36674953	Stromatosphaeria stigma	4180186
36674955	Mucor lusitanicus	4180186
36674955	Mucor circinelloides forma lusitanicus	4180186
36674955	Mucor racemosus varient lusitanicus	4180186
36674955	Mucor circinelloides forma lusitanicus (organism)	4180186
36674956	Mucor janssenii	4180186
36674956	Mucor circinelloides forma janssenii	4180186
36674956	Mucor griseocyanus f. janssenii	4180186
36674956	Circinomucor janssenii	4180186
36674956	Mucor circinelloides forma janssenii (organism)	4180186
36674956	Mucor janseni	4180186
36674959	Metschnikowia koreensis (organism)	4180186
36674960	Metarhizium guizhouense (organism)	4180186
36674961	Metarhizium robertsii (organism)	4180186
36674963	Meripilaceae	4180186
36674963	Family Meripilaceae (organism)	4180186
36674964	Fusarium solani complex (organism)	4180186
36674972	Macrothrombocytopenia with mitral valve insufficiency (disorder)	4180186
36674976	Hereditary site-specific ovarian cancer syndrome (disorder)	4180186
36674984	Injection of carpometacarpal joint using fluoroscopic guidance	4180186
36674984	Injection of carpometacarpal joint using fluoroscopic guidance (procedure)	4180186
36674989	Cortical dysplasia with focal epilepsy syndrome (disorder)	4180186
36674989	CDFE (cortical dysplasia focal epilepsy) syndrome	4180186
36674993	Holoprosencephaly with caudal dysgenesis syndrome (disorder)	4180186
36674994	Isolated arhinencephaly (disorder)	4180186
36674995	X-linked colobomatous microphthalmia, microcephaly, short stature, psychomotor retardation syndrome	4180186
36674995	X-linked colobomatous microphthalmia, microcephaly, intellectual disability, short stature syndrome (disorder)	4180186
36674996	Thompson Baraitser syndrome	4180186
36674996	Hepatic fibrosis, renal cyst, intellectual disability syndrome (disorder)	4180186
36674997	Vascular conduit for coronary graft (observable entity)	4180186
36675000	Bite of venomous animal (event)	4180186
36675007	MacDermot Patton Williams syndrome	4180186
36675007	Hypertrichosis cubiti (disorder)	4180186
36675007	Hairy elbows syndrome	4180186
36675010	Hamano Tsukamoto syndrome	4180186
36675010	Spinal atrophy, ophthalmoplegia, pyramidal syndrome (disorder)	4180186
36675011	Hidrotic ectodermal dysplasia Christianson Fourie type (disorder)	4180186
36675011	Christianson Fourie syndrome	4180186
36675014	Inspection of external auditory canal using microscope (procedure)	4180186
36675014	Microscopy of external auditory canal	4180186
36675015	Deep full thickness burn involving muscle (disorder)	4180186
36675015	Fourth degree burn involving muscle	4180186
36675018	Fourth degree burn injury	4180186
36675018	Deep full thickness burn injury (disorder)	4180186
36675019	Dermatitis as late effect of radiation (disorder)	4180186
36675020	Bite of spider (event)	4180186
36675026	Ptosis and vocal cord paralysis syndrome (disorder)	4180186
36675026	Tucker syndrome	4180186
36675031	Fludroxycortide-containing product in cutaneous dose form	4180186
36675031	Product containing fludroxycortide in cutaneous dose form (medicinal product form)	4180186
36675034	Brettanomyces cidri	4180186
36675034	Mycotorula claussenii	4180186
36675034	Dekkera anomala (organism)	4180186
36675034	Candida beijingensis	4180186
36675034	Oospora vini	4180186
36675034	Brettanomyces dublinensis	4180186
36675034	Dekkera claussenii	4180186
36675034	Monilia vini	4180186
36675034	Brettanomyces claussenii	4180186
36675034	Brettanomyces anomalus	4180186
36675039	Severe congenital encephalopathy due to MECP2 (methyl-CpG binding protein 2) mutation	4180186
36675039	Severe congenital encephalopathy due to methyl-CpG binding protein 2 mutation	4180186
36675039	Severe congenital encephalopathy due to MECP2 mutation	4180186
36675039	Severe neonatal onset encephalopathy with microcephaly (disorder)	4180186
36675040	Benign nocturnal alternating hemiplegia of childhood (disorder)	4180186
36675043	Severe early-onset axonal neuropathy due to NEFL (neurofilament light) deficiency	4180186
36675043	Charcot-Marie-Tooth disease type 2B5 (disorder)	4180186
36675043	Severe early-onset axonal neuropathy due to NEFL deficiency	4180186
36675043	Autosomal recessive Charcot-Marie-Tooth disease type 2B5	4180186
36675043	Severe early-onset axonal neuropathy due to light neurofilament subunit deficiency	4180186
36675047	Bite of venomous spider (event)	4180186
36675048	Sting by bee (event)	4180186
36675049	Measurement of periodontal pocket depth (procedure)	4180186
36675051	Varibaculum anthropi (organism)	4180186
36675053	Neurological or neuromuscular procedure (procedure)	4180186
36675056	Procedure on perivesical tissue (procedure)	4180186
36675063	Hyperzincemia and hypercalprotectinemia (disorder)	4180186
36675063	Hyperzincaemia and hypercalprotectinaemia	4180186
36675063	Recurrent infection, inflammatory syndrome due to zinc metabolism disorder syndrome	4180186
36675064	15q11.2 microdeletion syndrome (disorder)	4180186
36675064	Monosomy 15q11.2	4180186
36675065	14q11.2 microduplication syndrome (disorder)	4180186
36675065	Trisomy 14q11.2	4180186
36675066	Microcornea, rod-cone dystrophy, cataract, posterior staphyloma syndrome (disorder)	4180186
36675066	MRCS (microcornea, rod-cone dystrophy, cataract, posterior staphyloma) syndrome	4180186
36675066	MRCS syndrome	4180186
36675069	Cartilage structure (body structure)	4180186
36675071	Substance with glucosyltransferase mechanism of action (substance)	4180186
36675072	Substance with Human immunodeficiency virus entry inhibitor mechanism of action (substance)	4180186
36675073	Substance with insulin antagonist mechanism of action (substance)	4180186
36675075	Substance with opioid receptor partial antagonist mechanism of action (substance)	4180186
36675077	Substance with potassium channel activator mechanism of action (substance)	4180186
36675083	Substance with receptor antagonist mechanism of action (substance)	4180186
36675085	Substance with acetylcholinesterase inhibitor mechanism of action (substance)	4180186
36675085	Anticholinesterase	4180186
36675086	Suspected victim of bullying (situation)	4180186
36675088	Substance with molecular messenger mechanism of action (substance)	4180186
36675089	Substance with etiopathic disposition mechanism of action (substance)	4180186
36675093	Stability of hand joint (observable entity)	4180186
36675094	Stability of metacarpophalangeal joint (observable entity)	4180186
36675095	Stability of spinal joint (observable entity)	4180186
36675095	Stability of joint of spine	4180186
36675096	Stability of lumbar spine joint (observable entity)	4180186
36675098	Stability of lumbosacral joint (observable entity)	4180186
36675099	Stability of cervicothoracic joint (observable entity)	4180186
36675100	Stability of thoracic joint (observable entity)	4180186
36675101	Stability of atlantooccipital joint (observable entity)	4180186
36675102	Stability of cervical spine joint (observable entity)	4180186
36675104	Stability of midtarsal joint (observable entity)	4180186
36675105	Right foot injury	4180186
36675105	Injury of right foot (disorder)	4180186
36675106	History of pelvic inflammatory disease (situation)	4180186
36675111	Hypoactive delirium following surgical procedure (disorder)	4180186
36675111	Hypoactive delirium following surgical procedure	4180186
36675114	Hemihyperplasia with multiple lipomatosis syndrome (disorder)	4180186
36675114	HHML (hemihyperplasia multiple lipomatosis) syndrome	4180186
36675116	Ogden syndrome (disorder)	4180186
36675116	Premature aging appearance, developmental delay, cardiac arrhythmia syndrome	4180186
36675116	Premature ageing appearance, developmental delay, cardiac arrhythmia syndrome	4180186
36675117	Complement component 3 deficiency (disorder)	4180186
36675117	C3 deficiency	4180186
36675118	Methylmalonic acidaemia TCb1R type	4180186
36675118	Methylmalonic aciduria due to transcobalamin receptor defect (disorder)	4180186
36675118	Methylmalonic acidemia TCb1R type	4180186
36675119	Autosomal recessive infantile hypercalcemia (disorder)	4180186
36675119	Autosomal recessive infantile hypercalcaemia	4180186
36675119	Familial infantile hypercalcaemia with suppressed intact parathyroid hormone	4180186
36675119	Familial infantile hypercalcemia with suppressed intact parathyroid hormone	4180186
36675120	Follicular pancreatocholangitis	4180186
36675120	Follicular cholangitis and pancreatitis (disorder)	4180186
36675121	Laminin subunit beta 2 related infantile-onset nephrotic syndrome	4180186
36675121	LAMB2 (laminin subunit beta 2) related infantile-onset nephrotic syndrome	4180186
36675121	Laminin subunit beta 2 related infantile-onset nephrotic syndrome (disorder)	4180186
36675124	Frostbite with tissue necrosis of upper arm (disorder)	4180186
36675126	Substance with platelet aggregation inhibitor mechanism of action (substance)	4180186
36675129	Burn of bilateral wrists and hands	4180186
36675129	Burn of bilateral wrists and hands (disorder)	4180186
36675129	Burn of both wrists and hands	4180186
36675131	Reversible anticholinesterase (disposition)	4180186
36675133	Genus Terrisporobacter	4180186
36675133	Genus Terrisporobacter (organism)	4180186
36675133	Terrisporobacter species	4180186
36675134	Product containing cresol structure (product)	4180186
36675136	Product containing benazepril and hydrochlorothiazide (medicinal product)	4180186
36675140	Enterobacter massiliensis	4180186
36675140	Metakosakonia massiliensis (organism)	4180186
36675141	Early-onset spastic ataxia, myoclonic epilepsy, neuropathy syndrome (disorder)	4180186
36675141	Autosomal recessive spastic ataxia type 5	4180186
36675141	AFG3L2-related spastic ataxia, myoclonic epilepsy, neuropathy syndrome	4180186
36675141	AFG3L2 (AFG3 like matrix AAA peptidase subunit 2) related spastic ataxia, myoclonic epilepsy, neuropathy syndrome	4180186
36675143	Optic nerve edema, splenomegaly syndrome (disorder)	4180186
36675143	Optic nerve oedema, splenomegaly syndrome	4180186
36675144	Developmental and speech delay due to SRY-box 5 deficiency (disorder)	4180186
36675144	Developmental and speech delay due to SOX5 (SRY-box 5) deficiency	4180186
36675144	Developmental and speech delay due to SRY-box 5 deficiency	4180186
36675145	Papular epidermal nevi with skyline basal cell layers syndrome (disorder)	4180186
36675145	PENS (papular epidermal naevi with skyline basal cell layers) syndrome	4180186
36675145	Papular epidermal naevi with skyline basal cell layers syndrome	4180186
36675145	PENS (papular epidermal nevi with skyline basal cell layers) syndrome	4180186
36675145	PENS syndrome	4180186
36675149	15q overgrowth syndrome (disorder)	4180186
36675150	COXPD10 - combined oxidative phosphorylation defect type 10	4180186
36675150	Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to mitochondrial transfer ribonucleic acid translation optimisation 1 deficiency	4180186
36675150	Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to mitochondrial transfer ribonucleic acid translation optimization 1 deficiency (disorder)	4180186
36675150	Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to mitochondrial transfer ribonucleic acid translation optimization 1 deficiency	4180186
36675150	Combined oxidative phosphorylation defect type 10	4180186
36675151	Combined immunodeficiency due to STK4 (serine/threonine kinase 4) deficiency	4180186
36675151	Combined immunodeficiency due to serine/threonine kinase 4 deficiency	4180186
36675151	Combined immunodeficiency due to serine/threonine kinase 4 deficiency (disorder)	4180186
36675153	Infection caused by Sporozoa (disorder)	4180186
36675155	Fracture of multiple bones (morphologic abnormality)	4180186
36675157	Compound fracture of multiple bones (morphologic abnormality)	4180186
36675157	Open fracture of multiple bones	4180186
36675159	Fractures involving multiple regions of left lower limb (disorder)	4180186
36675160	Fractures involving multiple regions of right lower limb (disorder)	4180186
36675161	Closed fractures involving multiple regions of left upper limb (disorder)	4180186
36675163	Fractures involving multiple regions of left upper limb (disorder)	4180186
36675165	Open fractures involving multiple regions of left upper limb (disorder)	4180186
36675170	Product containing naphazoline in pulmonary dose form (medicinal product form)	4180186
36675171	Product containing glucose and potassium chloride in parenteral dose form (medicinal product form)	4180186
36675174	Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial deoxyribonucleic acid mutation (disorder)	4180186
36675174	Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial deoxyribonucleic acid mutation	4180186
36675178	Infantile hypertrophic cardiomyopathy due to mitochondrial ribosomal protein L44 deficiency (disorder)	4180186
36675178	Infantile hypertrophic cardiomyopathy due to mitochondrial ribosomal protein L44 deficiency	4180186
36675178	Combined oxidative phosphorylation defect type 16	4180186
36675179	Early-onset progressive neurodegeneration, blindness, ataxia, spasticity syndrome (disorder)	4180186
36675181	CDG2M - congenital disorder of glycosylation type 2m	4180186
36675181	Solute carrier family 35 member A2 congenital disorder of glycosylation (disorder)	4180186
36675181	SLC35A2-CDG - solute carrier family 35 member A2 congenital disorder of glycosylation	4180186
36675181	Congenital disorder of glycosylation type 2m	4180186
36675181	Congenital disorder of glycosylation type IIm	4180186
36675184	Product containing silver nitrate in cutaneous dose form (medicinal product form)	4180186
36675185	Reconstruction of mandible using autogenous free vascularized bone flap (procedure)	4180186
36675185	Reconstruction of mandible using autogenous free vascularised bone flap	4180186
36675187	Superficial infection of soft tissue at puncture site due to and following neuraxial block	4180186
36675187	Superficial infection of soft tissue at puncture site due to and following neuraxial block (disorder)	4180186
36675188	Product containing technetium (99m-Tc) stannous pyrophosphate in parenteral dose form (medicinal product form)	4180186
36675189	Superficial soft tissue infection at puncture site due to and following peripheral nerve block (disorder)	4180186
36675189	Superficial soft tissue infection at puncture site due to and following peripheral nerve block	4180186
36675190	Product containing technetium (99m-Tc) tiatide in parenteral dose form (medicinal product form)	4180186
36675191	Infection of deep tissue at puncture site due to and following peripheral nerve block (disorder)	4180186
36675192	Product containing technetium (99m-Tc) tetrofosmin in parenteral dose form (medicinal product form)	4180186
36675196	Product containing technetium (99m-Tc) teboroxime in parenteral dose form (medicinal product form)	4180186
36675197	Leiotrametes	4180186
36675197	Genus Leiotrametes (organism)	4180186
36675199	Painful and cold arm	4180186
36675199	Painful and cold upper limb (finding)	4180186
36675200	Acinetobacter beijerinckii (organism)	4180186
36675202	Labrys wisconsinensis (organism)	4180186
36675203	Admission to paediatric cardiology department	4180186
36675203	Admission to pediatric cardiology department (procedure)	4180186
36675206	Provision of written information about female genital mutilation (procedure)	4180186
36675207	Monitoring of intravenous infusion (regime/therapy)	4180186
36675210	Replacement of cardiac biventricular implantable cardioverter defibrillator (procedure)	4180186
36675211	Measurement of periodontal pocket depth-four areas per tooth exam (procedure)	4180186
36675212	Measurement of periodontal pocket depth-two areas per tooth exam (procedure)	4180186
36675213	Closed reduction of fracture of short bone and fixation using screw (procedure)	4180186
36675215	Closed reduction of fracture of bone and internal fixation using bone plate (procedure)	4180186
36675216	Partial removal of transobturator tape (procedure)	4180186
36675219	Product containing methyl salicylate in cutaneous dose form (medicinal product form)	4180186
36675221	Product containing avatrombopag in oral dose form (medicinal product form)	4180186
36675224	Product containing ibalizumab (medicinal product)	4180186
36675225	Product containing ibalizumab in parenteral dose form (medicinal product form)	4180186
36675226	Lactam (substance)	4180186
36675228	Chokecherry (substance)	4180186
36675229	Sloe (substance)	4180186
36675229	Blackthorn berry	4180186
36675230	Incision and drainage of deep abscess of head (procedure)	4180186
36675231	Product containing heparinoid and lauromacrogol 400 in rectal dose form (medicinal product form)	4180186
36675233	Product containing aclidinium in pulmonary dose form (medicinal product form)	4180186
36675237	Erenumab (substance)	4180186
36675240	Interleukin 23 receptor antagonist (disposition)	4180186
36675243	Tezacaftor (substance)	4180186
36675245	Benzhydrocodone (substance)	4180186
36675247	Product containing technetium (99m-Tc) medronate in parenteral dose form (medicinal product form)	4180186
36675249	Product containing technetium (99m-Tc) nofetumomab in parenteral dose form (medicinal product form)	4180186
36675251	Product containing technetium (99m-Tc) pentetate in parenteral dose form (medicinal product form)	4180186
36675254	Product containing desflurane in pulmonary dose form (medicinal product form)	4180186
36675260	Fibreoptic endoscopic coagulation of haemorrhage of upper gastrointestinal tract	4180186
36675260	Fiberoptic endoscopic coagulation of hemorrhage of upper gastrointestinal tract (procedure)	4180186
36675261	Vacuum assisted biopsy of lesion of breast (procedure)	4180186
36675262	Open repair of femoral hernia using sutures (procedure)	4180186
36675263	Open repair of recurrent femoral hernia using sutures (procedure)	4180186
36675268	Open repair of recurrent lumbar hernia using synthetic mesh (procedure)	4180186
36675268	Open hernioplasty using synthetic mesh for recurrent lumbar hernia	4180186
36675271	Open repair of umbilical hernia using sutures (procedure)	4180186
36675272	Open repair of recurrent umbilical hernia using sutures (procedure)	4180186
36675273	Product containing tildrakizumab (medicinal product)	4180186
36675274	Product containing tildrakizumab in parenteral dose form (medicinal product form)	4180186
36675275	Benzhydrocodone- and paracetamol-containing product	4180186
36675275	Product containing benzhydrocodone and paracetamol (medicinal product)	4180186
36675277	Open umbilical hernioplasty using synthetic mesh	4180186
36675277	Open repair of umbilical hernia using synthetic mesh (procedure)	4180186
36675279	Product containing ivacaftor and tezacaftor (medicinal product)	4180186
36675286	Product containing interleukin 23 receptor antagonist (product)	4180186
36675288	Genus Actinomucor (organism)	4180186
36675288	Actinomucor species	4180186
36675288	Actinomucor	4180186
36675292	Open repair of spigelian hernia using sutures (procedure)	4180186
36675293	Mucor elegans	4180186
36675293	Mucor glomerula	4180186
36675293	Actinomucor elegans (organism)	4180186
36675293	Rhizopus elegans	4180186
36675295	Open repair of recurrent spigelian hernia using synthetic mesh (procedure)	4180186
36675295	Open hernioplasty using synthetic mesh for recurrent spigelian hernia	4180186
36675296	Open repair of recurrent spigelian hernia using biological mesh (procedure)	4180186
36675296	Open hernioplasty using biological mesh for recurrent spigelian hernia	4180186
36675300	Product containing sodium iothalamate (125-I) in parenteral dose form (medicinal product form)	4180186
36675301	Product containing technetium (99m-Tc) sodium pertechnetate in parenteral dose form (medicinal product form)	4180186
36675303	Product containing levonorgestrel in subcutaneous dose form (medicinal product form)	4180186
36675304	Ioflupane (substance)	4180186
36675305	Immunoglobulin E mediated allergic contact hypersensitivity process (qualifier value)	4180186
36675306	Hydride (substance)	4180186
36675307	Oxygen hydride (substance)	4180186
36675308	Technetium (99m-Tc) human immunoglobulin G (substance)	4180186
36675310	Muciporus corticola	4180186
36675310	Coriolus corticola	4180186
36675310	Poria corticola	4180186
36675310	Polyporus polystictus	4180186
36675310	Polyporus reticulatus var. corticola	4180186
36675310	Rigidoporus corticola	4180186
36675310	Polyporus corticola	4180186
36675310	Physisporus corticola	4180186
36675310	Chaetoporus corticola	4180186
36675310	Oxyporus corticola (organism)	4180186
36675313	Laparoscopic umbilical hernioplasty using synthetic mesh	4180186
36675313	Laparoscopic repair of umbilical hernia using synthetic mesh (procedure)	4180186
36675314	Laparoscopic repair of umbilical hernia (procedure)	4180186
36675317	Laparoscopic hernioplasty using synthetic mesh for recurrent umbilical hernia	4180186
36675317	Laparoscopic repair of recurrent umbilical hernia using synthetic mesh (procedure)	4180186
36675318	Laparoscopic hernioplasty using biological mesh for recurrent umbilical hernia	4180186
36675318	Laparoscopic repair of recurrent umbilical hernia using biological mesh (procedure)	4180186
36675320	Open inguinal hernioplasty using synthetic mesh	4180186
36675320	Open repair of inguinal hernia using synthetic mesh (procedure)	4180186
36675321	Open repair of inguinal hernia using biological mesh (procedure)	4180186
36675321	Open inguinal hernioplasty using biological mesh	4180186
36675323	Open repair of recurrent inguinal hernia using sutures (procedure)	4180186
36675325	Open repair of epigastric hernia using sutures (procedure)	4180186
36675328	Open repair of recurrent epigastric hernia using biological mesh (procedure)	4180186
36675328	Open hernioplasty using biological mesh for recurrent epigastric hernia	4180186
36675329	Laparoscopic epigastric hernioplasty using synthetic mesh	4180186
36675329	Laparoscopic repair of epigastric hernia using synthetic mesh (procedure)	4180186
36675332	Laparoscopic hernioplasty using synthetic mesh for recurrent epigastric hernia	4180186
36675332	Laparoscopic repair of recurrent epigastric hernia using synthetic mesh (procedure)	4180186
36675335	Product containing lidocaine in cutaneous dose form (medicinal product form)	4180186
36675337	Product containing moxisylyte in ocular dose form (medicinal product form)	4180186
36675340	Product containing neomycin in ocular dose form (medicinal product form)	4180186
36675341	Aluminium-containing product in cutaneous dose form	4180186
36675341	Product containing aluminium in cutaneous dose form (medicinal product form)	4180186
36675342	Product containing unoprostone isopropyl in ocular dose form (medicinal product form)	4180186
36675343	Product containing sodium chloride in ocular dose form (medicinal product form)	4180186
36675346	Product containing guanethidine in ocular dose form (medicinal product form)	4180186
36675348	Product containing benzoyl peroxide in cutaneous dose form (medicinal product form)	4180186
36675349	Product containing budesonide in pulmonary dose form (medicinal product form)	4180186
36675350	Product containing Podophyllum resin in cutaneous dose form (medicinal product form)	4180186
36675351	Product containing merbromin in cutaneous dose form (medicinal product form)	4180186
36675352	Product containing chloramphenicol in cutaneous dose form (medicinal product form)	4180186
36675353	Product containing fluocinolone in cutaneous dose form (medicinal product form)	4180186
36675354	Product containing chlorhexidine in cutaneous dose form (medicinal product form)	4180186
36675357	Product containing selenium in cutaneous dose form (medicinal product form)	4180186
36675358	Product containing silver sulfadiazine in cutaneous dose form (medicinal product form)	4180186
36675359	Glycerol-containing product in ocular dose form	4180186
36675359	Product containing glycerol in ocular dose form (medicinal product form)	4180186
36675360	Product containing calamine in cutaneous dose form (medicinal product form)	4180186
36675366	Product containing gatifloxacin in ocular dose form (medicinal product form)	4180186
36675367	Product containing edetate in ocular dose form (medicinal product form)	4180186
36675368	Product containing minoxidil in cutaneous dose form (medicinal product form)	4180186
36675369	Product containing estradiol in cutaneous dose form (medicinal product form)	4180186
36675372	Product containing tetracycline in cutaneous dose form (medicinal product form)	4180186
36675374	Product containing methacholine in pulmonary dose form (medicinal product form)	4180186
36675375	Open repair of incisional hernia using synthetic mesh (procedure)	4180186
36675375	Open incisional hernioplasty using synthetic mesh	4180186
36675376	Product containing triamcinolone in cutaneous dose form (medicinal product form)	4180186
36675378	Open incisional hernioplasty using biological mesh	4180186
36675378	Open repair of incisional hernia using biological mesh (procedure)	4180186
36675379	Product containing polymyxin B in cutaneous dose form (medicinal product form)	4180186
36675380	Product containing oxytetracycline in ocular dose form (medicinal product form)	4180186
36675384	Product containing pentamidine in pulmonary dose form (medicinal product form)	4180186
36675385	Product containing benzyl benzoate in cutaneous dose form (medicinal product form)	4180186
36675386	Product containing naftifine in cutaneous dose form (medicinal product form)	4180186
36675387	Product containing phenol in cutaneous dose form (medicinal product form)	4180186
36675388	Product containing betamethasone in ocular dose form (medicinal product form)	4180186
36675391	Product containing oxytetracycline in cutaneous dose form (medicinal product form)	4180186
36675395	Product containing amphotericin in cutaneous dose form (medicinal product form)	4180186
36675396	Product containing tropicamide in ocular dose form (medicinal product form)	4180186
36675398	Mepyramine-containing product in ocular dose form	4180186
36675398	Product containing mepyramine in ocular dose form (medicinal product form)	4180186
36675399	Product containing amorolfine in cutaneous dose form (medicinal product form)	4180186
36675403	Product containing witch hazel in cutaneous dose form (medicinal product form)	4180186
36675405	Product containing desonide in cutaneous dose form (medicinal product form)	4180186
36675406	Product containing ketotifen in ocular dose form (medicinal product form)	4180186
36675413	Product containing xenon-133 in pulmonary dose form (medicinal product form)	4180186
36675415	Product containing econazole in cutaneous dose form (medicinal product form)	4180186
36675417	Product containing sodium chloride in cutaneous dose form (medicinal product form)	4180186
36675418	Product containing tyloxapol in pulmonary dose form (medicinal product form)	4180186
36675419	Product containing potassium in ocular dose form (medicinal product form)	4180186
36675423	Product containing ciclopirox in cutaneous dose form (medicinal product form)	4180186
36675424	Product containing rivastigmine in cutaneous dose form (medicinal product form)	4180186
36675425	Product containing fluticasone in cutaneous dose form (medicinal product form)	4180186
36675426	Product containing physostigmine in ocular dose form (medicinal product form)	4180186
36675428	Product containing glucose in ocular dose form (medicinal product form)	4180186
36675430	Product containing sodium bicarbonate in ocular dose form (medicinal product form)	4180186
36675434	Product containing sulfacetamide in ocular dose form (medicinal product form)	4180186
36675435	Product containing lidocaine in ocular dose form (medicinal product form)	4180186
36675436	Product containing shark liver oil in cutaneous dose form (medicinal product form)	4180186
36675438	Product containing diclofenac in cutaneous dose form (medicinal product form)	4180186
36675439	Product containing naphazoline in ocular dose form (medicinal product form)	4180186
36675440	Product containing fluocinonide in cutaneous dose form (medicinal product form)	4180186
36675442	Product containing butenafine in cutaneous dose form (medicinal product form)	4180186
36675443	Product containing travoprost in ocular dose form (medicinal product form)	4180186
36675444	Product containing latanoprost in ocular dose form (medicinal product form)	4180186
36675445	Product containing amphotericin B in cutaneous dose form (medicinal product form)	4180186
36675449	Product containing acetic acid in cutaneous dose form (medicinal product form)	4180186
36675450	Product containing colistin in cutaneous dose form (medicinal product form)	4180186
36675453	Product containing ozenoxacin in cutaneous dose form (medicinal product form)	4180186
36675455	Product containing sulfafurazole in ocular dose form (medicinal product form)	4180186
36675455	Sulfafurazole-containing product in ocular dose form	4180186
36675460	Product containing azithromycin in ocular dose form (medicinal product form)	4180186
36675461	Product containing tetracaine in ocular dose form (medicinal product form)	4180186
36675463	Product containing azelastine in ocular dose form (medicinal product form)	4180186
36675464	Aciclovir-containing product in ocular dose form	4180186
36675464	Product containing aciclovir in ocular dose form (medicinal product form)	4180186
36675465	Product containing fluticasone and umeclidinium and vilanterol in pulmonary dose form (medicinal product form)	4180186
36675466	Product containing chloroxylenol in cutaneous dose form (medicinal product form)	4180186
36675468	Product containing idoxuridine in ocular dose form (medicinal product form)	4180186
36675469	Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form)	4180186
36675470	Product containing menthol in cutaneous dose form (medicinal product form)	4180186
36675471	Product containing gentamicin in cutaneous dose form (medicinal product form)	4180186
36675473	Product containing clotrimazole in ocular dose form (medicinal product form)	4180186
36675476	Product containing witch hazel in ocular dose form (medicinal product form)	4180186
36675479	Product containing beclometasone in cutaneous dose form (medicinal product form)	4180186
36675479	Beclometasone-containing product in cutaneous dose form	4180186
36675481	Product containing triclosan in cutaneous dose form (medicinal product form)	4180186
36675483	Product containing olodaterol and tiotropium in pulmonary dose form (medicinal product form)	4180186
36675484	Product containing chlortetracycline in ocular dose form (medicinal product form)	4180186
36675485	Product containing talc in cutaneous dose form (medicinal product form)	4180186
36675486	Product containing tioconazole in cutaneous dose form (medicinal product form)	4180186
36675490	Product containing bimatoprost in ocular dose form (medicinal product form)	4180186
36675491	Product containing dapsone in cutaneous dose form (medicinal product form)	4180186
36675492	Product containing nedocromil in ocular dose form (medicinal product form)	4180186
36675493	Product containing prednisolone in cutaneous dose form (medicinal product form)	4180186
36675499	Product containing ingenol mebutate in cutaneous dose form (medicinal product form)	4180186
36675501	Product containing sodium chloride in pulmonary dose form (medicinal product form)	4180186
36675505	Product containing clotrimazole in cutaneous dose form (medicinal product form)	4180186
36675509	Product containing flunisolide in pulmonary dose form (medicinal product form)	4180186
36675510	Product containing isotretinoin in cutaneous dose form (medicinal product form)	4180186
36675511	Product containing lucinactant in pulmonary dose form (medicinal product form)	4180186
36675512	Product containing oxybutynin in cutaneous dose form (medicinal product form)	4180186
36675518	Product containing pramocaine in cutaneous dose form (medicinal product form)	4180186
36675518	Pramocaine-containing product in cutaneous dose form	4180186
36675519	Product containing coal tar in cutaneous dose form (medicinal product form)	4180186
36675521	Product containing erythromycin in cutaneous dose form (medicinal product form)	4180186
36675522	Product containing selenium sulfide in cutaneous dose form (medicinal product form)	4180186
36675525	Product containing edetate in cutaneous dose form (medicinal product form)	4180186
36675526	Product containing tolnaftate in cutaneous dose form (medicinal product form)	4180186
36675530	Product containing tobramycin in pulmonary dose form (medicinal product form)	4180186
36675531	Product containing ibuprofen in cutaneous dose form (medicinal product form)	4180186
36675535	Mepyramine-containing product in cutaneous dose form	4180186
36675535	Product containing mepyramine in cutaneous dose form (medicinal product form)	4180186
36675536	Product containing sodium propionate in cutaneous dose form (medicinal product form)	4180186
36675539	Product containing progesterone in cutaneous dose form (medicinal product form)	4180186
36675540	Product containing benzalkonium in ocular dose form (medicinal product form)	4180186
36675545	Product containing tobramycin in ocular dose form (medicinal product form)	4180186
36675547	Product containing cefuroxime in ocular dose form (medicinal product form)	4180186
36675548	Ciclosporin-containing product in ocular dose form	4180186
36675548	Product containing ciclosporin in ocular dose form (medicinal product form)	4180186
36675549	Tetryzoline-containing product in ocular dose form	4180186
36675549	Product containing tetryzoline in ocular dose form (medicinal product form)	4180186
36675553	Product containing permethrin in cutaneous dose form (medicinal product form)	4180186
36675554	Product containing ribavirin in pulmonary dose form (medicinal product form)	4180186
36675555	Product containing iodophore in cutaneous dose form (medicinal product form)	4180186
36675556	Product containing cyclopentolate in ocular dose form (medicinal product form)	4180186
36675558	Product containing gentamicin in ocular dose form (medicinal product form)	4180186
36675566	Product containing doxepin in cutaneous dose form (medicinal product form)	4180186
36675569	Product containing zinc acetate in cutaneous dose form (medicinal product form)	4180186
36675572	Product containing nedocromil in pulmonary dose form (medicinal product form)	4180186
36675573	Product containing norfloxacin in ocular dose form (medicinal product form)	4180186
36675576	Product containing scopolamine in cutaneous dose form (medicinal product form)	4180186
36675576	Hyoscine-containing product in cutaneous dose form	4180186
36675577	Open repair of recurrent incisional hernia using synthetic mesh (procedure)	4180186
36675577	Open hernioplasty using synthetic mesh for recurrent incisional hernia	4180186
36675578	Reanastomosis of main bile duct	4180186
36675578	Reanastomosis of common bile duct (procedure)	4180186
36675579	Product containing cannabidiol (medicinal product)	4180186
36675580	Product containing cannabidiol in oral dose form (medicinal product form)	4180186
36675581	At risk for psychological abuse	4180186
36675581	At risk of psychological abuse (finding)	4180186
36675584	Product containing technetium (99m-Tc) human immunoglobulin G (medicinal product)	4180186
36675588	Product containing estradiol and levonorgestrel in transdermal dose form (medicinal product form)	4180186
36675589	Product containing levonorgestrel in intrauterine dose form (medicinal product form)	4180186
36675590	Product containing technetium (99m-Tc) aggregated albumin in parenteral dose form (medicinal product form)	4180186
36675591	Photodynamic therapy of lesion of skin (procedure)	4180186
36675597	Dental and/or maxillofacial surgical mesh (physical object)	4180186
36675598	Localized edema electrical impedance scanner (physical object)	4180186
36675598	Localised oedema electrical impedance scanner	4180186
36675599	Admission to acute internal medicine department (procedure)	4180186
36675601	Steam inhaler (physical object)	4180186
36675603	Short-term bare metal urethral stent (physical object)	4180186
36675605	Electromyographic electrode catheter (physical object)	4180186
36675606	Radionuclide imaging of whole body for detection of extra-articular leakage of rhenium-186 (procedure)	4180186
36675606	Radionuclide imaging of whole body for detection of extra-articular leakage of 186-Re (rhenium-186)	4180186
36675607	Adverse reaction caused by nebivolol (disorder)	4180186
36675607	Nebivolol adverse reaction	4180186
36675607	Adverse reaction caused by nebivolol	4180186
36675608	Nebivolol allergy	4180186
36675608	Allergy to nebivolol (finding)	4180186
36675609	Fostamatinib (substance)	4180186
36675611	Product containing serine protease (product)	4180186
36675612	Genus Clostridioides (organism)	4180186
36675612	Clostridioides	4180186
36675621	Product containing plazomicin (medicinal product)	4180186
36675622	Product containing plazomicin in parenteral dose form (medicinal product form)	4180186
36675625	Amputation of entire right lower limb and ipsilateral hemipelvis (procedure)	4180186
36675627	Melarsomine (substance)	4180186
36675628	Oxophenarsine (substance)	4180186
36675630	Referral to dentist (procedure)	4180186
36675631	Retained fragment of urethral catheter (disorder)	4180186
36675633	CYP2B6 ultra-rapid metaboliser	4180186
36675633	Cytochrome P450 family 2 subfamily B member 6 ultra-rapid metabolizer (finding)	4180186
36675633	Cytochrome P450 family 2 subfamily B member 6 ultra-rapid metaboliser	4180186
36675633	Cytochrome P450 family 2 subfamily B member 6 ultra-rapid metabolizer	4180186
36675643	Product containing encorafenib (medicinal product)	4180186
36675644	Product containing encorafenib in oral dose form (medicinal product form)	4180186
36675648	Product containing binimetinib in oral dose form (medicinal product form)	4180186
36675649	Repair of incisional hernia of abdominal wall (procedure)	4180186
36675650	Laparoscopic repair of incisional hernia of abdominal wall (procedure)	4180186
36675654	Nudix hydrolase 15 possible intermediate metaboliser	4180186
36675654	Nudix hydrolase 15 possible intermediate metabolizer (finding)	4180186
36675654	Nudix hydrolase 15 possible intermediate metabolizer	4180186
36675654	NUDT15 possible intermediate metaboliser	4180186
36675656	Laparoscopic repair of spigelian hernia using synthetic mesh (procedure)	4180186
36675656	Laparoscopic spigelian hernioplasty using synthetic mesh	4180186
36675659	Rigid video neuroscope (physical object)	4180186
36675663	Product containing glycopyrronium in cutaneous dose form (medicinal product form)	4180186
36675664	Laparoscopic repair of recurrent incisional hernia using synthetic mesh (procedure)	4180186
36675664	Laparoscopic hernioplasty using synthetic mesh for recurrent incisional hernia	4180186
36675665	Anomaly of fetal kidney (disorder)	4180186
36675665	Anomaly of foetal kidney	4180186
36675665	Foetal renal anomaly	4180186
36675665	Fetal renal anomaly	4180186
36675666	Poikiloderma with neutropenia Clericuzio type	4180186
36675666	Poikiloderma with neutropenia (disorder)	4180186
36675667	White Sutton syndrome (disorder)	4180186
36675668	Antecollis (disorder)	4180186
36675670	Rhabdoid tumour predisposition syndrome	4180186
36675670	Familial rhabdoid tumour	4180186
36675670	Rhabdoid tumor predisposition syndrome (disorder)	4180186
36675670	Familial rhabdoid tumor	4180186
36675671	Umbilical stump separated	4180186
36675671	Umbilical cord stump separated (finding)	4180186
36675671	Umbilical cord stump off	4180186
36675672	Moderate risk of harm to others (finding)	4180186
36675674	Obstruction co-occurrent and due to left femoral hernia (disorder)	4180186
36675677	Obstruction co-occurrent and due to recurrent left inguinal hernia (disorder)	4180186
36675679	Obstruction co-occurrent and due to right inguinal hernia (disorder)	4180186
36675686	Anthrax suspected (situation)	4180186
36675687	Measles suspected (situation)	4180186
36675689	Typhoid fever suspected (situation)	4180186
36675691	Invasive group A beta-hemolytic streptococcal disease suspected (situation)	4180186
36675691	Invasive group A beta-haemolytic streptococcal disease suspected	4180186
36675693	Viral haemorrhagic fever suspected	4180186
36675693	Viral hemorrhagic fever suspected (situation)	4180186
36675695	Cholera suspected (situation)	4180186
36675696	Plague suspected (situation)	4180186
36675697	Yellow fever suspected (situation)	4180186
36675698	Brucellosis suspected (situation)	4180186
36675700	Meningococcal septicemia suspected	4180186
36675700	Suspected meningococcemia (situation)	4180186
36675700	Meningococcal septicaemia suspected	4180186
36675700	Suspected meningococcaemia	4180186
36675703	Substance with mitogen-activated protein kinase kinase 1 inhibitor mechanism of action (substance)	4180186
36675704	Substance with mitogen-activated protein kinase kinase inhibitor mechanism of action (substance)	4180186
36675707	Typhus suspected (situation)	4180186
36675710	Mobile intraoperative three-dimensional computed tomography of thoracic spine (procedure)	4180186
36675710	Mobile intraoperative three-dimensional computed tomography of thoracic spine	4180186
36675711	Mobile intraoperative three-dimensional computed tomography of lumbar spine (procedure)	4180186
36675711	Mobile intraoperative three-dimensional computed tomography of lumbar spine	4180186
36675714	Warburg micro syndrome (disorder)	4180186
36675714	Micro syndrome	4180186
36675716	Polyketide (substance)	4180186
36675718	Ability to balance when standing with both feet together (observable entity)	4180186
36675720	Able to balance when standing with both feet apart (finding)	4180186
36675723	Able to balance when standing with both feet in semi tandem stance (finding)	4180186
36675728	Laparoscopic spigelian hernioplasty using synthetic mesh with fascial closure	4180186
36675728	Laparoscopic repair of spigelian hernia using synthetic mesh with fascial closure (procedure)	4180186
36675729	Laparoscopic repair of recurrent spigelian hernia using synthetic mesh with fascial closure (procedure)	4180186
36675729	Laparoscopic hernioplasty using synthetic mesh with fascial closure for recurrent spigelian hernia	4180186
36675730	Laparoscopic hernioplasty using biological mesh with fascial closure for recurrent spigelian hernia	4180186
36675730	Laparoscopic repair of recurrent spigelian hernia using biological mesh with fascial closure (procedure)	4180186
36675731	Wool alcohol (substance)	4180186
36675736	Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form)	4180186
36675737	Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form)	4180186
36675740	Product containing levomefolic acid in oral dose form (medicinal product form)	4180186
36675741	Product containing Podophyllum resin and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675744	Product containing adapalene and benzoyl peroxide in cutaneous dose form (medicinal product form)	4180186
36675745	Product containing adapalene in cutaneous dose form (medicinal product form)	4180186
36675746	Product containing adenosine in parenteral dose form (medicinal product form)	4180186
36675750	Product containing alteplase in parenteral dose form (medicinal product form)	4180186
36675751	Aluminium chloride-containing product in cutaneous dose form	4180186
36675751	Product containing aluminium chloride in cutaneous dose form (medicinal product form)	4180186
36675753	Product containing alverine and Sterculia gum in oral dose form (medicinal product form)	4180186
36675756	Product containing amphotericin B in oromucosal dose form (medicinal product form)	4180186
36675758	Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)	4180186
36675762	Aspirin- and caffeine- and dextropropoxyphene-containing product in oral dose form	4180186
36675762	Product containing aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form)	4180186
36675763	Product containing aspirin and metoclopramide in oral dose form (medicinal product form)	4180186
36675764	Product containing atenolol and nifedipine in oral dose form (medicinal product form)	4180186
36675765	Product containing atosiban in parenteral dose form (medicinal product form)	4180186
36675766	Product containing atovaquone in oral dose form (medicinal product form)	4180186
36675768	Product containing aztreonam in parenteral dose form (medicinal product form)	4180186
36675773	Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)	4180186
36675774	Product containing benzalkonium and dimeticone in cutaneous dose form (medicinal product form)	4180186
36675774	Benzalkonium- and dimeticone-containing product in cutaneous dose form	4180186
36675776	Product containing benzalkonium and cetrimide in cutaneous dose form (medicinal product form)	4180186
36675778	Product containing benzocaine and cetylpyridinium in oromucosal dose form (medicinal product form)	4180186
36675781	Product containing benzocaine and triclosan in cutaneous dose form (medicinal product form)	4180186
36675782	Product containing benzocaine and chloroxylenol in oromucosal dose form (medicinal product form)	4180186
36675783	Product containing benzocaine and mepyramine in cutaneous dose form (medicinal product form)	4180186
36675783	Benzocaine- and mepyramine-containing product in cutaneous dose form	4180186
36675785	Product containing benzocaine and tyrothricin in oromucosal dose form (medicinal product form)	4180186
36675786	Product containing benzoic acid and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675793	Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)	4180186
36675794	Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form)	4180186
36675796	Product containing betamethasone and clotrimazole in cutaneous dose form (medicinal product form)	4180186
36675800	Product containing bretylium in parenteral dose form (medicinal product form)	4180186
36675802	Product containing brinzolamide in ocular dose form (medicinal product form)	4180186
36675805	Product containing butalbital and caffeine and paracetamol in oral dose form (medicinal product form)	4180186
36675805	Butalbital- and caffeine- and paracetamol-containing product in oral dose form	4180186
36675808	Caffeine- and paracetamol-containing product in oral dose form	4180186
36675808	Product containing caffeine and paracetamol in oral dose form (medicinal product form)	4180186
36675809	Calamine- and dimeticone- and zinc-containing product in cutaneous dose form	4180186
36675809	Product containing calamine and dimeticone and zinc in cutaneous dose form (medicinal product form)	4180186
36675810	Product containing calcipotriol in cutaneous dose form (medicinal product form)	4180186
36675813	Product containing calcium gluconate in cutaneous dose form (medicinal product form)	4180186
36675814	Product containing capsaicin in cutaneous dose form (medicinal product form)	4180186
36675815	Product containing carbachol in ocular dose form (medicinal product form)	4180186
36675819	Product containing carboprost in parenteral dose form (medicinal product form)	4180186
36675821	Product containing cetrimide in cutaneous dose form (medicinal product form)	4180186
36675822	Product containing cetrimide and chlorhexidine in cutaneous dose form (medicinal product form)	4180186
36675823	Product containing cetrimide and dimeticone 1000 in cutaneous dose form (medicinal product form)	4180186
36675824	Product containing cetrorelix in parenteral dose form (medicinal product form)	4180186
36675827	Product containing chlorhexidine in oromucosal dose form (medicinal product form)	4180186
36675828	Product containing chlorhexidine and neomycin in cutaneous dose form (medicinal product form)	4180186
36675831	Product containing choriogonadotropin alfa in parenteral dose form (medicinal product form)	4180186
36675832	Product containing cidofovir in parenteral dose form (medicinal product form)	4180186
36675836	Product containing clioquinol and flumetasone in otic dose form (medicinal product form)	4180186
36675836	Clioquinol- and flumetasone-containing product in otic dose form	4180186
36675838	Product containing clobetasone in ocular dose form (medicinal product form)	4180186
36675840	Product containing clodronic acid in parenteral dose form (medicinal product form)	4180186
36675841	Product containing clorquinaldol and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675843	Product containing coagulation factor XIII in parenteral dose form (medicinal product form)	4180186
36675846	Product containing colloid sulfur and resorcinol in cutaneous dose form (medicinal product form)	4180186
36675854	Product containing dexamethasone and tobramycin in ocular dose form (medicinal product form)	4180186
36675857	Dextropropoxyphene-containing product in oral dose form	4180186
36675857	Product containing dextropropoxyphene in oral dose form (medicinal product form)	4180186
36675858	Product containing diamorphine in parenteral dose form (medicinal product form)	4180186
36675868	Product containing dobutamine in parenteral dose form (medicinal product form)	4180186
36675870	Product containing dopexamine in parenteral dose form (medicinal product form)	4180186
36675871	Product containing doripenem in parenteral dose form (medicinal product form)	4180186
36675874	Product containing doxapram in parenteral dose form (medicinal product form)	4180186
36675875	Dried aluminium hydroxide gel- and magnesium hydroxide-containing product in oral dose form	4180186
36675875	Product containing dried aluminium hydroxide gel and magnesium hydroxide in oral dose form (medicinal product form)	4180186
36675876	Product containing drotrecogin alfa in parenteral dose form (medicinal product form)	4180186
36675881	Product containing epinastine in ocular dose form (medicinal product form)	4180186
36675883	Product containing epirubicin in parenteral dose form (medicinal product form)	4180186
36675885	Product containing epoetin beta in parenteral dose form (medicinal product form)	4180186
36675887	Product containing eptifibatide in parenteral dose form (medicinal product form)	4180186
36675888	Product containing ergometrine and oxytocin in parenteral dose form (medicinal product form)	4180186
36675888	Ergometrine- and oxytocin-containing product in parenteral dose form	4180186
36675891	Product containing erythromycin and zinc in cutaneous dose form (medicinal product form)	4180186
36675892	Product containing esmolol in parenteral dose form (medicinal product form)	4180186
36675893	Product containing estradiol and norethisterone in transdermal dose form (medicinal product form)	4180186
36675893	Estradiol- and norethisterone-containing product in transdermal dose form	4180186
36675894	Product containing estradiol and medroxyprogesterone in oral dose form (medicinal product form)	4180186
36675896	Product containing estrone in oral dose form (medicinal product form)	4180186
36675897	Product containing etanercept in parenteral dose form (medicinal product form)	4180186
36675898	Product containing ethanolamine in parenteral dose form (medicinal product form)	4180186
36675900	Product containing felypressin and prilocaine in parenteral dose form (medicinal product form)	4180186
36675903	Product containing ferric hexacyanoferrate-II in oral dose form (medicinal product form)	4180186
36675905	Product containing pegfilgrastim in parenteral dose form (medicinal product form)	4180186
36675908	Product containing fluocinolone and neomycin in cutaneous dose form (medicinal product form)	4180186
36675912	Product containing fondaparinux in parenteral dose form (medicinal product form)	4180186
36675916	Product containing fosphenytoin in parenteral dose form (medicinal product form)	4180186
36675918	Product containing furosemide and spironolactone in oral dose form (medicinal product form)	4180186
36675920	Product containing gadodiamide in parenteral dose form (medicinal product form)	4180186
36675925	Product containing ganirelix in parenteral dose form (medicinal product form)	4180186
36675927	Product containing glacial acetic acid in otic dose form (medicinal product form)	4180186
36675929	Product containing glycopyrronium in oral dose form (medicinal product form)	4180186
36675937	Product containing hexetidine in oromucosal dose form (medicinal product form)	4180186
36675941	Product containing insulin glargine in parenteral dose form (medicinal product form)	4180186
36675942	Product containing hyaluronic acid in intraocular dose form (medicinal product form)	4180186
36675943	Product containing hyaluronidase in parenteral dose form (medicinal product form)	4180186
36675944	Product containing hydralazine and hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	4180186
36675945	Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)	4180186
36675947	Product containing hydrochlorothiazide and labetalol in oral dose form (medicinal product form)	4180186
36675949	Product containing hydrochlorothiazide and timolol in oral dose form (medicinal product form)	4180186
36675950	Product containing hydrochlorothiazide and triamterene in oral dose form (medicinal product form)	4180186
36675953	Product containing hydrocortisone and miconazole in cutaneous dose form (medicinal product form)	4180186
36675955	Product containing hydrocortisone and lidocaine in cutaneous dose form (medicinal product form)	4180186
36675959	Product containing hydroxyprogesterone in parenteral dose form (medicinal product form)	4180186
36675960	Product containing ibuprofen and levomenthol in cutaneous dose form (medicinal product form)	4180186
36675962	Product containing idursulfase in parenteral dose form (medicinal product form)	4180186
36675965	Product containing indoramin in oral dose form (medicinal product form)	4180186
36675966	Product containing infliximab in parenteral dose form (medicinal product form)	4180186
36675967	Product containing inosine pranobex in oral dose form (medicinal product form)	4180186
36675968	Product containing inositol in oral dose form (medicinal product form)	4180186
36675969	Product containing interferon alfa-2b in parenteral dose form (medicinal product form)	4180186
36675970	Product containing iotrolan in parenteral dose form (medicinal product form)	4180186
36675973	Product containing iron dextran in parenteral dose form (medicinal product form)	4180186
36675975	Product containing iron sucrose in parenteral dose form (medicinal product form)	4180186
36675977	Product containing isoxsuprine in oral dose form (medicinal product form)	4180186
36675978	Product containing ispaghula husk and mebeverine in oral dose form (medicinal product form)	4180186
36675979	Product containing ispaghula husk in oral dose form (medicinal product form)	4180186
36675980	Product containing ivacaftor in oral dose form (medicinal product form)	4180186
36675982	Product containing labetalol in parenteral dose form (medicinal product form)	4180186
36675983	Product containing lacidipine in oral dose form (medicinal product form)	4180186
36675984	Product containing lacosamide in oral dose form (medicinal product form)	4180186
36675987	Product containing lamivudine and stavudine in oral dose form (medicinal product form)	4180186
36675988	Product containing lamotrigine in oral dose form (medicinal product form)	4180186
36675989	Product containing lanreotide in parenteral dose form (medicinal product form)	4180186
36675990	Product containing lanthanum in oral dose form (medicinal product form)	4180186
36675991	Product containing lapatinib in oral dose form (medicinal product form)	4180186
36675992	Product containing latanoprost and timolol in ocular dose form (medicinal product form)	4180186
36675997	Product containing lercanidipine in oral dose form (medicinal product form)	4180186
36676004	Product containing levomepromazine in oral dose form (medicinal product form)	4180186
36676004	Levomepromazine-containing product in oral dose form	4180186
36676006	Product containing lidocaine and prilocaine in cutaneous dose form (medicinal product form)	4180186
36676010	Product containing lidocaine and phenylephrine in cutaneous dose form (medicinal product form)	4180186
36676016	Product containing lubiprostone in oral dose form (medicinal product form)	4180186
36676018	Product containing magnesium hydroxide in oral dose form (medicinal product form)	4180186
36676020	Product containing maprotiline in oral dose form (medicinal product form)	4180186
36676022	Product containing mecamylamine in oral dose form (medicinal product form)	4180186
36676023	Product containing mecasermin in parenteral dose form (medicinal product form)	4180186
36676025	Product containing melphalan in parenteral dose form (medicinal product form)	4180186
36676028	Product containing menadiol in oral dose form (medicinal product form)	4180186
36676029	Product containing mepacrine in oral dose form (medicinal product form)	4180186
36676029	Mepacrine-containing product in oral dose form	4180186
36676031	Product containing mephenytoin in oral dose form (medicinal product form)	4180186
36676032	Product containing meprobamate in oral dose form (medicinal product form)	4180186
36676034	Product containing mestranol and norethisterone in oral dose form (medicinal product form)	4180186
36676034	Mestranol- and norethisterone-containing product in oral dose form	4180186
36676035	Product containing metaraminol in parenteral dose form (medicinal product form)	4180186
36676039	Product containing methenamine in oral dose form (medicinal product form)	4180186
36676040	Product containing methenamine and monobasic sodium phosphate in oral dose form (medicinal product form)	4180186
36676041	Product containing methionine and paracetamol in oral dose form (medicinal product form)	4180186
36676041	Methionine- and paracetamol-containing product in oral dose form	4180186
36676043	Product containing methocarbamol in oral dose form (medicinal product form)	4180186
36676044	Product containing methoxamine in parenteral dose form (medicinal product form)	4180186
36676046	Product containing methyclothiazide and reserpine in oral dose form (medicinal product form)	4180186
36676049	Product containing methylcellulose-450 in oral dose form (medicinal product form)	4180186
36676050	Product containing methylcysteine in oral dose form (medicinal product form)	4180186
36676053	Product containing methylnaltrexone in parenteral dose form (medicinal product form)	4180186
36676054	Product containing methylphenobarbital in oral dose form (medicinal product form)	4180186
36676054	Methylphenobarbital-containing product in oral dose form	4180186
36676055	Product containing methyltestosterone in oral dose form (medicinal product form)	4180186
36676056	Product containing metoclopramide and paracetamol in oral dose form (medicinal product form)	4180186
36676056	Metoclopramide- and paracetamol-containing product in oral dose form	4180186
36676057	Product containing mexiletine in parenteral dose form (medicinal product form)	4180186
36676058	Product containing micafungin in parenteral dose form (medicinal product form)	4180186
36676059	Product containing milrinone in parenteral dose form (medicinal product form)	4180186
36676061	Product containing mirtazapine in oral dose form (medicinal product form)	4180186
36676063	Product containing mitomycin in parenteral dose form (medicinal product form)	4180186
36676069	Product containing molindone in oral dose form (medicinal product form)	4180186
36676073	Product containing nabilone in oral dose form (medicinal product form)	4180186
36676074	Product containing nandrolone in parenteral dose form (medicinal product form)	4180186
36676075	Product containing natalizumab in parenteral dose form (medicinal product form)	4180186
36676076	Product containing nefopam in parenteral dose form (medicinal product form)	4180186
36676077	Product containing neomycin and triamcinolone in otic dose form (medicinal product form)	4180186
36676081	Product containing nilutamide in oral dose form (medicinal product form)	4180186
36676082	Product containing nimodipine in parenteral dose form (medicinal product form)	4180186
36676083	Product containing nimodipine in oral dose form (medicinal product form)	4180186
36676084	Product containing nitisinone in oral dose form (medicinal product form)	4180186
36676085	Product containing nizatidine in parenteral dose form (medicinal product form)	4180186
36676086	Product containing nizatidine in oral dose form (medicinal product form)	4180186
36676088	Norethisterone-containing product in parenteral dose form	4180186
36676088	Product containing norethisterone in parenteral dose form (medicinal product form)	4180186
36676090	Product containing nystatin and tolnaftate in cutaneous dose form (medicinal product form)	4180186
36676092	Product containing olmesartan in oral dose form (medicinal product form)	4180186
36676093	Product containing omeprazole and sodium bicarbonate in oral dose form (medicinal product form)	4180186
36676095	Product containing oxerutins in oral dose form (medicinal product form)	4180186
36676096	Oxycodone- and paracetamol-containing product in oral dose form	4180186
36676096	Product containing oxycodone and paracetamol in oral dose form (medicinal product form)	4180186
36676097	Product containing oxymorphone in oral dose form (medicinal product form)	4180186
36676099	Product containing oxytetracycline and phenazopyridine and sulfamethizole in oral dose form (medicinal product form)	4180186
36676100	Product containing pafuramidine in oral dose form (medicinal product form)	4180186
36676104	Product containing panitumumab in parenteral dose form (medicinal product form)	4180186
36676108	Product containing paracetamol and tramadol in oral dose form (medicinal product form)	4180186
36676108	Paracetamol- and tramadol-containing product in oral dose form	4180186
36676110	Product containing penciclovir in cutaneous dose form (medicinal product form)	4180186
36676111	Product containing pentagastrin in parenteral dose form (medicinal product form)	4180186
36676114	Product containing pergolide in oral dose form (medicinal product form)	4180186
36676117	Product containing pethidine and promethazine in oral dose form (medicinal product form)	4180186
36676117	Pethidine- and promethazine-containing product in oral dose form	4180186
36676119	Product containing phenazopyridine in oral dose form (medicinal product form)	4180186
36676122	Product containing phenothrin in cutaneous dose form (medicinal product form)	4180186
36676123	Product containing phentolamine in parenteral dose form (medicinal product form)	4180186
36676124	Product containing pholcodine in oral dose form (medicinal product form)	4180186
36676132	Product containing porfimer in parenteral dose form (medicinal product form)	4180186
36676134	Product containing potassium bicarbonate and sodium alginate in oral dose form (medicinal product form)	4180186
36676138	Product containing primidone in oral dose form (medicinal product form)	4180186
36676140	Product containing propafenone in oral dose form (medicinal product form)	4180186
36676143	Product containing protirelin in parenteral dose form (medicinal product form)	4180186
36676145	Product containing raltitrexed in parenteral dose form (medicinal product form)	4180186
36676147	Product containing remifentanil in parenteral dose form (medicinal product form)	4180186
36676148	Product containing retapamulin in cutaneous dose form (medicinal product form)	4180186
36676150	Product containing rocuronium in parenteral dose form (medicinal product form)	4180186
36676153	Product containing ropivacaine in parenteral dose form (medicinal product form)	4180186
36676155	Product containing salmeterol in pulmonary dose form (medicinal product form)	4180186
36676156	Product containing salmon calcitonin in parenteral dose form (medicinal product form)	4180186
36676161	Product containing secretin in parenteral dose form (medicinal product form)	4180186
36676164	Product containing sibutramine in oral dose form (medicinal product form)	4180186
36676173	Product containing solifenacin in oral dose form (medicinal product form)	4180186
36676178	Product containing sucralfate in oral dose form (medicinal product form)	4180186
36676179	Product containing sulfaguanidine in oral dose form (medicinal product form)	4180186
36676180	Product containing sulfalene in oral dose form (medicinal product form)	4180186
36676190	Product containing teicoplanin in parenteral dose form (medicinal product form)	4180186
36676193	Product containing tetracosactide in parenteral dose form (medicinal product form)	4180186
36676193	Tetracosactide-containing product in parenteral dose form	4180186
36676194	Product containing thiopental in parenteral dose form (medicinal product form)	4180186
36676195	Product containing thiotepa in parenteral dose form (medicinal product form)	4180186
36676196	Product containing tramadol in parenteral dose form (medicinal product form)	4180186
36676198	Product containing triclofos in oral dose form (medicinal product form)	4180186
36676203	Product containing verteporfin in parenteral dose form (medicinal product form)	4180186
36676205	Reconstruction of mandible using osteocutaneous flap (procedure)	4180186
36676206	Sphincter pharyngoplasty and pharyngeal flap	4180186
36676206	Hynes pharyngoplasty	4180186
36676206	Plastic operation on palatopharyngeal sphincter with reconstruction using pharyngeal flap (procedure)	4180186
36676207	Laparoscopic repair of lumbar hernia using synthetic mesh with fascial closure (procedure)	4180186
36676207	Laparoscopic lumbar hernioplasty using synthetic mesh with fascial closure	4180186
36676208	Laparoscopic lumbar hernioplasty using biological mesh with fascial closure	4180186
36676208	Laparoscopic repair of lumbar hernia using biological mesh with fascial closure (procedure)	4180186
36676212	Acetamide and/or acetamide derivative	4180186
36676212	Acetamide and/or acetamide derivative (substance)	4180186
36676212	Acetamide and acetamide derivative (substance)	4180186
36676213	Obstruction co-occurrent and due to bilateral femoral hernia (disorder)	4180186
36676213	Bilateral femoral hernia with obstruction	4180186
36676213	Bilateral obstructed femoral hernia	4180186
36676214	Bilateral recurrent obstructed femoral hernia	4180186
36676214	Bilateral recurrent femoral hernia with obstruction	4180186
36676214	Obstruction co-occurrent and due to bilateral recurrent femoral hernia (disorder)	4180186
36676215	Obstruction co-occurrent and due to right recurrent femoral hernia (disorder)	4180186
36676217	Doctor's note	4180186
36676217	Medical certificate (record artifact)	4180186
36676218	Assessment for risk of delirium (procedure)	4180186
36676220	Influenza A virus subtype H1N2 (organism)	4180186
36676221	Influenza caused by Influenza A virus subtype H3N2 (disorder)	4180186
36676222	Assessment using Non-Alcoholic Fatty Liver Disease fibrosis score (procedure)	4180186
36676222	Assessment using Non-Alcoholic Fatty Liver Disease fibrosis score	4180186
36676223	Non-Alcoholic Fatty Liver Disease fibrosis score system	4180186
36676223	Non-Alcoholic Fatty Liver Disease fibrosis score	4180186
36676223	Non-Alcoholic Fatty Liver Disease fibrosis score system (assessment scale)	4180186
36676227	Product containing pamidronic acid (medicinal product)	4180186
36676228	Obstruction co-occurrent and due to internal hernia of abdomen (disorder)	4180186
36676230	Anti-CCP (anti-cyclic citrullinated peptide) antibody positive	4180186
36676230	Anti-cyclic citrullinated peptide antibody positive (finding)	4180186
36676234	Tetrofosmin (substance)	4180186
36676236	Ruscogenin (substance)	4180186
36676238	Pneumonia caused by Influenza A virus (disorder)	4180186
36676239	Product containing allantoin and coal tar extract (medicinal product)	4180186
36676244	Product containing calamine and dimeticone and zinc (medicinal product)	4180186
36676244	Calamine- and dimeticone- and zinc-containing product	4180186
36676245	Product containing calcium carbonate and light kaolin (medicinal product)	4180186
36676250	Product containing cod liver oil and zinc (medicinal product)	4180186
36676251	Product containing colloid sulfur and resorcinol (medicinal product)	4180186
36676253	Product containing diflorasone (medicinal product)	4180186
36676257	Product containing epinephrine and zinc (medicinal product)	4180186
36676257	Adrenaline- and zinc-containing product	4180186
36676258	Product containing erythromycin and zinc (medicinal product)	4180186
36676259	Product containing glacial acetic acid (medicinal product)	4180186
36676261	Product containing glycopyrronium (medicinal product)	4180186
36676262	Product containing guar gum (medicinal product)	4180186
36676263	Product containing heparin and lauromacrogol 400 (medicinal product)	4180186
36676264	Product containing heparinoid and salicylic acid (medicinal product)	4180186
36676265	Product containing surface antigen of Hepatitis B virus (medicinal product)	4180186
36676268	Product containing incobotulinumtoxinA (medicinal product)	4180186
36676270	Product containing methylcellulose-450 (medicinal product)	4180186
36676272	Product containing oxycodone and paracetamol (medicinal product)	4180186
36676272	Oxycodone- and paracetamol-containing product	4180186
36676277	Product containing ergotamine in oromucosal dose form (medicinal product form)	4180186
36676279	Product containing isosorbide in oromucosal dose form (medicinal product form)	4180186
36676280	Product containing pseudoephedrine and terfenadine (medicinal product)	4180186
36676282	Product containing salicylic acid and white petrolatum (medicinal product)	4180186
36676282	Salicylic acid- and white soft paraffin-containing product	4180186
36676283	Product containing dibunate (medicinal product)	4180186
36676284	Product containing thiosulfuric acid (medicinal product)	4180186
36676286	Product containing somatropin(rbe) (medicinal product)	4180186
36676289	Has surgical instruments quarantined (finding)	4180186
36676292	History of being in foster care (situation)	4180186
36676293	History of sleeping out (situation)	4180186
36676293	History of sleeping rough	4180186
36676294	Laparoscopic repair of recurrent epigastric hernia using synthetic mesh with fascial closure (procedure)	4180186
36676294	Laparoscopic hernioplasty using synthetic mesh with fascial closure for recurrent epigastric hernia	4180186
36676297	Harmful use of anxiolytic (disorder)	4180186
36676298	Sewing needle (physical object)	4180186
36676301	Gangrene co-occurrent and due to hernia of abdominal wall (disorder)	4180186
36676302	Gangrene co-occurrent and due to internal hernia of abdomen (disorder)	4180186
36676303	Infective meningitis suspected (situation)	4180186
36676307	Infective encephalitis suspected (situation)	4180186
36676310	Total removal of transobturator tape (procedure)	4180186
36676312	Reconstruction of anterior abdominal wall using prosthetic material (procedure)	4180186
36676313	Arthrotomy and drainage of joint of thumb (procedure)	4180186
36676314	Application of topical antifungal agent to skin (procedure)	4180186
36676318	Magnetic resonance imaging of bilateral orbits	4180186
36676318	Magnetic resonance imaging of left and right orbit	4180186
36676318	Magnetic resonance imaging of bilateral orbits (procedure)	4180186
36676318	Magnetic resonance imaging of both orbits	4180186
36676319	Magnetic resonance imaging of both orbits with contrast	4180186
36676319	Magnetic resonance imaging of left and right orbit with contrast	4180186
36676319	Magnetic resonance imaging of bilateral orbits with contrast (procedure)	4180186
36676319	Magnetic resonance imaging of bilateral orbits with contrast	4180186
36676322	Laparoscopic repair of umbilical hernia using biological mesh with fascial closure (procedure)	4180186
36676322	Laparoscopic umbilical hernioplasty using biological mesh with fascial closure	4180186
36676323	Laparoscopic repair of umbilical hernia using sutures with fascial closure (procedure)	4180186
36676326	Laparoscopic repair of umbilical hernia using synthetic mesh with fascial closure (procedure)	4180186
36676326	Laparoscopic umbilical hernioplasty using synthetic mesh with fascial closure	4180186
36676327	Laparoscopic repair of recurrent umbilical hernia using synthetic mesh with fascial closure (procedure)	4180186
36676327	Laparoscopic hernioplasty using synthetic mesh with fascial closure for recurrent umbilical hernia	4180186
36676328	Laparoscopic incisional hernioplasty using synthetic mesh with fascial closure	4180186
36676328	Laparoscopic repair of incisional hernia using synthetic mesh with fascial closure (procedure)	4180186
36676329	Laparoscopic repair of recurrent incisional hernia using synthetic mesh with fascial closure (procedure)	4180186
36676329	Laparoscopic hernioplasty using synthetic mesh with fascial closure for recurrent incisional hernia	4180186
36676330	Laparoscopic repair of incisional hernia using biological mesh with fascial closure (procedure)	4180186
36676330	Laparoscopic incisional hernioplasty using biological mesh with fascial closure	4180186
36676334	Laparoscopic epigastric hernioplasty using synthetic mesh with fascial closure	4180186
36676334	Laparoscopic repair of epigastric hernia using synthetic mesh with fascial closure (procedure)	4180186
36676336	Laparoscopic TEP (totally extraperitoneal) repair of inguinal hernia using synthetic mesh	4180186
36676336	Laparoscopic totally extraperitoneal repair of inguinal hernia using synthetic mesh (procedure)	4180186
36676336	Laparoscopic TEP (totally extraperitoneal) inguinal hernioplasty using synthetic mesh	4180186
36676341	Product containing amidotrizoic acid (medicinal product)	4180186
36676344	Local excision of lesion of bone of rib (procedure)	4180186
36676346	Angioplasty of thoracic artery using fluoroscopic guidance with contrast	4180186
36676346	Angioplasty of thoracic artery using fluoroscopic guidance with contrast (procedure)	4180186
36676347	Product containing tafenoquine (medicinal product)	4180186
36676348	Product containing tafenoquine in oral dose form (medicinal product form)	4180186
36676349	Product containing elagolix (medicinal product)	4180186
36676350	Product containing elagolix in oral dose form (medicinal product form)	4180186
36676351	Incomplete ossification of bone (morphologic abnormality)	4180186
36676352	Paenalcaligenes suwonensis (organism)	4180186
36676353	Fatty pancreas (disorder)	4180186
36676355	Infant acoustic earmuffs (physical object)	4180186
36676357	Custom-made hybrid corrective contact lens (physical object)	4180186
36676358	Pediatric urine collection diaper (physical object)	4180186
36676358	Paediatric urine collection nappy	4180186
36676361	Laparoscopic transabdominal preperitoneal repair of inguinal hernia using synthetic mesh (procedure)	4180186
36676361	Laparoscopic TAPP (transabdominal preperitoneal) inguinal hernioplasty using synthetic mesh	4180186
36676361	Laparoscopic TAPP (transabdominal preperitoneal) repair of inguinal hernia using synthetic mesh	4180186
36676363	Laparoscopic transabdominal preperitoneal repair of recurrent inguinal hernia using synthetic mesh (procedure)	4180186
36676363	Laparoscopic TAPP (transabdominal preperitoneal) repair of recurrent inguinal hernia using synthetic mesh	4180186
36676363	Laparoscopic TAPP (transabdominal preperitoneal) hernioplasty using synthetic mesh for recurrent inguinal hernia	4180186
36676365	Laparoscopic repair of femoral hernia using surgical mesh (procedure)	4180186
36676366	Laparoscopic TAPP (transabdominal preperitoneal) hernioplasty using synthetic mesh for recurrent femoral hernia	4180186
36676366	Laparoscopic transabdominal preperitoneal repair of recurrent femoral hernia using synthetic mesh (procedure)	4180186
36676366	Laparoscopic TAPP (transabdominal preperitoneal) repair of recurrent femoral hernia using synthetic mesh	4180186
36676368	IDH1 inhibitor	4180186
36676368	Isocitrate dehydrogenase-1 inhibitor (disposition)	4180186
36676369	Ivosidenib (substance)	4180186
36676371	Elagolix (substance)	4180186
36676374	Tafenoquine succinate (substance)	4180186
36676380	Product containing iobenguane (131-I) in parenteral dose form (medicinal product form)	4180186
36676381	Age at onset of menopause (observable entity)	4180186
36676381	Menopause age	4180186
36676381	Age of menopause	4180186
36676381	Age at onset of menopause	4180186
36676382	Diagnostic laparoscopy of liver (procedure)	4180186
36676386	Laparoscopic repair of recurrent incisional hernia of anterior abdominal wall using biological mesh with anterior component separation (procedure)	4180186
36676388	Laparoscopic repair of recurrent incisional hernia of anterior abdominal wall using synthetic mesh with anterior component separation (procedure)	4180186
36676391	Galvanism (procedure)	4180186
36676392	Product containing lusutrombopag (medicinal product)	4180186
36676394	Lusutrombopag (substance)	4180186
36676395	Obstruction co-occurrent and due to perineal hernia (disorder)	4180186
36676397	Simple perineal hernia (disorder)	4180186
36676400	X-linked intellectual disability, craniofacioskeletal syndrome (disorder)	4180186
36676401	Acute limbic encephalitis following transplant (disorder)	4180186
36676401	Acute limbic encephalitis following transplant	4180186
36676401	PALE - post-transplant acute limbic encephalitis	4180186
36676404	Postaxial polydactyly, dental, vertebral anomalies syndrome (disorder)	4180186
36676406	Thakker Donnai syndrome (disorder)	4180186
36676406	Facial dysmorphism, multiple structural anomalies syndrome	4180186
36676407	Teebi Al Saleh Hassoon syndrome	4180186
36676407	Macrosomia, microphthalmia, cleft palate syndrome (disorder)	4180186
36676412	Open repair of recurrent incisional hernia of anterior abdominal wall using synthetic mesh with anterior component separation (procedure)	4180186
36676413	Open repair of recurrent incisional hernia of anterior abdominal wall using biological mesh with anterior component separation (procedure)	4180186
36676421	Dental trauma consultation and report (procedure)	4180186
36676421	Trauma dental consultation and report	4180186
36676421	Dental trauma examination	4180186
36676422	Maternal uniparental disomy of chromosome 16 (disorder)	4180186
36676423	Whyte syndrome	4180186
36676423	Spondyloepimetaphyseal dysplasia, hypotrichosis syndrome (disorder)	4180186
36676424	Spondyloepimetaphyseal dysplasia Bieganski type (disorder)	4180186
36676425	Spondyloepimetaphyseal dysplasia, abnormal dentition syndrome (disorder)	4180186
36676426	SEMDG - spondyloepimetaphyseal dysplasia Genevieve type	4180186
36676426	Spondyloepimetaphyseal dysplasia Geneviève type	4180186
36676426	Spondyloepimetaphyseal dysplasia Genevieve type (disorder)	4180186
36676428	Microcephaly, polymicrogyria, corpus callosum agenesis syndrome (disorder)	4180186
36676430	Zechi Ceide syndrome (disorder)	4180186
36676430	Occipital atretic cephalocele, unusual facies, large feet syndrome	4180186
36676433	Open repair of recurrent incisional hernia of anterior abdominal wall using synthetic mesh with posterior component separation (procedure)	4180186
36676440	X-linked intellectual disability, microcephaly, cortical malformation, thin habitus syndrome	4180186
36676440	CK syndrome (disorder)	4180186
36676444	Familial systemic lupus erythematosus	4180186
36676444	Autosomal systemic lupus erythematosus (disorder)	4180186
36676444	Autosomal SLE (systemic lupus erythematosus)	4180186
36676445	Epimacular brachytherapy with vitrectomy	4180186
36676445	Epiretinal brachytherapy with vitrectomy (procedure)	4180186
36676446	Oligodontia and cancer predisposition syndrome (disorder)	4180186
36676449	Product containing only vincristine (medicinal product)	4180186
36676451	Product containing only vincristine in parenteral dose form (medicinal product form)	4180186
36676452	Product containing only vincristine liposome in parenteral dose form (medicinal product form)	4180186
36676455	Product containing only irinotecan in parenteral dose form (medicinal product form)	4180186
36676458	Product containing only daunorubicin liposome (medicinal product)	4180186
36676459	Product containing only daunorubicin in parenteral dose form (medicinal product form)	4180186
36676463	Product containing only cisplatin in parenteral dose form (medicinal product form)	4180186
36676464	Product containing only cisplatin liposome in parenteral dose form (medicinal product form)	4180186
36676467	Product containing only doxorubicin in parenteral dose form (medicinal product form)	4180186
36676469	Product containing only cytarabine (medicinal product)	4180186
36676470	Product containing only cytarabine liposome (medicinal product)	4180186
36676471	Product containing only cytarabine in parenteral dose form (medicinal product form)	4180186
36676472	Product containing only cytarabine liposome in parenteral dose form (medicinal product form)	4180186
36676477	Product containing only morphine liposome in parenteral dose form (medicinal product form)	4180186
36676478	Product containing only amphotericin B (medicinal product)	4180186
36676479	Product containing only amphotericin B liposome (medicinal product)	4180186
36676480	Product containing only amphotericin B lipid complex (medicinal product)	4180186
36676482	Product containing only amphotericin B cholesteryl sulfate complex (medicinal product)	4180186
36676485	Product containing only amphotericin B lipid complex in parenteral dose form (medicinal product form)	4180186
36676487	Product containing only amphotericin B cholesteryl sulfate complex in parenteral dose form (medicinal product form)	4180186
36676488	Product containing platelet aggregation inhibitor (product)	4180186
36676489	Product containing renal hormone (product)	4180186
36676491	Product containing axitinib in oral dose form (medicinal product form)	4180186
36676493	Autosomal dominant Charcot-Marie-Tooth disease type 2Q (disorder)	4180186
36676494	Autosomal recessive frontotemporal pachygyria (disorder)	4180186
36676495	Limbic encephalitis with dipeptidyl-peptidase 6 antibodies (disorder)	4180186
36676495	Limbic encephalitis with DPP6 antibodies	4180186
36676495	Limbic encephalitis with DPPX antibodies	4180186
36676495	Limbic encephalitis with DPP6 (dipeptidyl-peptidase 6) antibodies	4180186
36676496	DA5D - distal arthrogryposis type 5D	4180186
36676496	Distal arthrogryposis type 5 without ophthalmoparesis	4180186
36676496	Distal arthrogryposis type 5 without ophthalmoplegia	4180186
36676496	Distal arthrogryposis type 5D (disorder)	4180186
36676498	Congenital cataract, progressive muscular hypotonia, hearing loss, developmental delay syndrome (disorder)	4180186
36676498	Congenital cataract, progressive muscular hypotonia, deafness, developmental delay syndrome	4180186
36676500	Bainbridge Roppers syndrome	4180186
36676500	Severe feeding difficulties, failure to thrive, microcephaly due to ASXL transcriptional regulator 3 deficiency syndrome	4180186
36676500	Severe feeding difficulties, failure to thrive, microcephaly due to ASXL transcriptional regulator 3 deficiency syndrome (disorder)	4180186
36676501	Spondyloepiphyseal dysplasia, retinal dystrophy, immunodeficiency syndrome	4180186
36676501	Roifman syndrome (disorder)	4180186
36676502	Intellectual disability with strabismus syndrome (disorder)	4180186
36676503	Mandibular hypoplasia, deafness, progeroid syndrome (disorder)	4180186
36676503	MDP (mandibular hypoplasia, deafness, progeroid) syndrome	4180186
36676503	Mandibular hypoplasia, hearing loss, progeroid syndrome	4180186
36676504	Open repair of recurrent incisional hernia of anterior abdominal wall using biological mesh with component separation (procedure)	4180186
36676505	Radiographic imaging of cisterna magna (procedure)	4180186
36676506	Radiographic imaging of cisterna magna with contrast (procedure)	4180186
36676509	Traditional medicine (regime/therapy)	4180186
36676509	Indigenous medicine	4180186
36676510	Provision of eyeglass-mounted near telescope	4180186
36676510	Provision of near eyeglass telescope	4180186
36676510	Provision of spectacle-mounted near telescope	4180186
36676510	Provision of telescopic spectacles for near vision	4180186
36676510	Provision of telescopic eyeglasses near	4180186
36676510	Provision of spectacle near telescope (procedure)	4180186
36676512	Contiguous ABCD1 DXS1357E deletion syndrome (disorder)	4180186
36676512	Zellweger-like contiguous gene deletion syndrome	4180186
36676512	CADDS - contiguous ABCD1 DXS1357E deletion syndrome	4180186
36676515	Xylosyltransferase 1 congenital disorder of glycosylation (disorder)	4180186
36676515	Xylosyltransferase 1 congenital disorder of glycosylation	4180186
36676515	XYLT1-CDG	4180186
36676518	Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression (disorder)	4180186
36676520	Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency (disorder)	4180186
36676521	Citric acid allergy	4180186
36676521	Allergy to citric acid (finding)	4180186
36676522	Autosomal recessive spastic paraplegia type 59 (disorder)	4180186
36676523	Lamin A/C related cardiocutaneous progeria syndrome (disorder)	4180186
36676523	Lamin A/C related cardiocutaneous progeria syndrome	4180186
36676527	Obstetric perinatal care plan	4180186
36676527	Obstetric perinatal care plan (record artifact)	4180186
36676528	Obstetric postnatal care plan (record artifact)	4180186
36676529	Obstetric antenatal care plan (record artifact)	4180186
36676530	Excision of varicocele with repair of inguinal hernia (procedure)	4180186
36676531	Surgical care plan (record artifact)	4180186
36676534	Oral surgery care plan (record artifact)	4180186
36676537	Hand surgery care plan (record artifact)	4180186
36676540	Pancreatic surgery care plan (record artifact)	4180186
36676542	Rehabilitation psychiatry care plan (record artifact)	4180186
36676545	Old age psychiatry care plan (record artifact)	4180186
36676546	Liaison psychiatry care plan (record artifact)	4180186
36676547	Psychotherapy care plan (record artifact)	4180186
36676551	Product containing only atorvastatin (medicinal product)	4180186
36676552	Product containing only atorvastatin in oral dose form (medicinal product form)	4180186
36676553	Product containing only amlodipine and atorvastatin (medicinal product)	4180186
36676557	Product containing only guaifenesin (medicinal product)	4180186
36676560	Product containing only guaifenesin and pseudoephedrine in oral dose form (medicinal product form)	4180186
36676562	Morniflumate (substance)	4180186
36676564	Product containing nadroparin (medicinal product)	4180186
36676567	Product containing only nadroparin in parenteral dose form (medicinal product form)	4180186
36676570	Product containing zofenopril in oral dose form (medicinal product form)	4180186
36676571	Product containing only zofenopril in oral dose form (medicinal product form)	4180186
36676574	Allergy to nitroprusside (finding)	4180186
36676574	Nitroprusside allergy	4180186
36676575	Valproic acid allergy	4180186
36676575	Allergy to valproic acid (finding)	4180186
36676579	Hereditary cryohydrocytosis with normal stomatin (disorder)	4180186
36676580	Allergy to dihydroergotamine (finding)	4180186
36676580	Dihydroergotamine allergy	4180186
36676582	Childhood-onset spasticity with variant non-ketotic hyperglycinaemia	4180186
36676582	Childhood-onset spasticity with hyperglycinaemia	4180186
36676582	Childhood-onset spasticity with hyperglycinemia (disorder)	4180186
36676582	Childhood-onset spasticity with variant non-ketotic hyperglycinemia	4180186
36676582	Spasticity, ataxia, gait anomalies syndrome	4180186
36676583	Monosomy 9q31.1q31.3	4180186
36676583	9q31.1q31.3 microdeletion syndrome (disorder)	4180186
36676586	Drostanolone allergy	4180186
36676586	Allergy to drostanolone (finding)	4180186
36676587	Partial corpus callosum agenesis, cerebellar vermis hypoplasia with posterior fossa cysts syndrome (disorder)	4180186
36676588	Spinocerebellar ataxia autosomal recessive type 23	4180186
36676588	SCAR23 - spinocerebellar ataxia autosomal recessive type 23	4180186
36676588	Autosomal recessive cerebellar ataxia, epilepsy, intellectual disability syndrome due to TUD deficiency (disorder)	4180186
36676591	DST (dystonin) related epidermolysis bullosa simplex	4180186
36676591	Epidermolysis bullosa simplex due to BP230 deficiency (disorder)	4180186
36676593	Epidermolysis bullosa simplex due to exophilin 5 deficiency (disorder)	4180186
36676595	Allergy to propamidine (finding)	4180186
36676595	Propamidine allergy	4180186
36676597	Gynecology oncology care plan (record artifact)	4180186
36676597	Gynaecology oncology care plan	4180186
36676600	Allergy to dipotassium clorazepate	4180186
36676600	Allergy to dipotassium clorazepate (finding)	4180186
36676600	Dipotassium clorazepate allergy	4180186
36676601	Occupational therapy care plan (record artifact)	4180186
36676602	Genitourinary medicine care plan (record artifact)	4180186
36676603	Physiotherapy care plan (record artifact)	4180186
36676607	Osteopathic manipulative medicine care plan (record artifact)	4180186
36676609	Product containing mogamulizumab (medicinal product)	4180186
36676610	Mogamulizumab (substance)	4180186
36676612	Frederiksenia canicola (organism)	4180186
36676615	Leukokeratosis (disorder)	4180186
36676615	Leucokeratosis	4180186
36676616	Ethinylestradiol- and segesterone-containing product	4180186
36676616	Product containing ethinylestradiol and segesterone (medicinal product)	4180186
36676618	Product containing migalastat (medicinal product)	4180186
36676621	Early-onset epileptic encephalopathy, cortical blindness, intellectual disability, facial dysmorphism syndrome (disorder)	4180186
36676621	Epilepsy, cortical blindness, intellectual disability, facial dysmorphism syndrome	4180186
36676622	Maternal riboflavin deficiency (disorder)	4180186
36676625	Intellectual disability, feeding difficulties, developmental delay, microcephaly syndrome (disorder)	4180186
36676628	Severe neurodegenerative syndrome due to BSCL2, seipin lipid droplet biogenesis associated deficiency	4180186
36676628	Severe neurodegenerative syndrome with lipodystrophy (disorder)	4180186
36676628	Severe neurodegenerative syndrome due to BSCL2 deficiency	4180186
36676629	Short ulna, dysmorphism, hypotonia, intellectual disability syndrome (disorder)	4180186
36676630	Macroblepharon, ectropion, hypertelorism, macrostomia syndrome	4180186
36676630	Mandibulofacial dysostosis, macroblepharon, macrostomia syndrome (disorder)	4180186
36676633	Corneal intraepithelial dyskeratosis, palmoplantar hyperkeratosis, laryngeal dyskeratosis syndrome (disorder)	4180186
36676634	Spondylocostal dysostosis, hypospadias, intellectual disability syndrome (disorder)	4180186
36676635	Congenital chronic diarrhea with exudative enteropathy	4180186
36676635	Congenital chronic diarrhoea with exudative enteropathy	4180186
36676635	Congenital chronic diarrhea with protein-losing enteropathy (disorder)	4180186
36676635	Congenital chronic diarrhoea with protein-losing enteropathy	4180186
36676636	Sting by insect (event)	4180186
36676639	Aphonia, deafness, retinal dystrophy, bifid halluces, intellectual disability syndrome (disorder)	4180186
36676639	Aphonia, hearing loss, retinal dystrophy, duplicated halluces, intellectual disability syndrome	4180186
36676639	Aphonia, deafness, retinal dystrophy, duplicated halluces, intellectual disability syndrome	4180186
36676640	Muscular hypertrophy, hepatomegaly, polyhydramnios syndrome (disorder)	4180186
36676641	Incomplete ossification of cranium	4180186
36676641	Incomplete ossification of skull (disorder)	4180186
36676642	X-linked intellectual disability, cardiomegaly, congestive heart failure syndrome (disorder)	4180186
36676643	Incomplete ossification of vertebra (disorder)	4180186
36676644	Periconia byssoides (organism)	4180186
36676645	Dietetic care plan (record artifact)	4180186
36676647	Occupational health care plan (record artifact)	4180186
36676648	Urology care plan (record artifact)	4180186
36676650	Respiratory medicine care plan (record artifact)	4180186
36676650	Thoracic medicine care plan	4180186
36676650	Chest medicine care plan	4180186
36676650	Pulmonary medicine care plan (record artifact)	4180186
36676650	Pulmonary medicine care plan	4180186
36676652	Orthopaedic care plan	4180186
36676652	Orthopedic care plan (record artifact)	4180186
36676653	Gastroenterology care plan (record artifact)	4180186
36676654	Haemophilia care plan	4180186
36676654	Hemophilia care plan (record artifact)	4180186
36676656	Segesterone (substance)	4180186
36676657	Progesterone receptor agonist (disposition)	4180186
36676658	Progestogen	4180186
36676658	Substance with progesterone receptor agonist mechanism of action (substance)	4180186
36676659	Segesterone acetate (substance)	4180186
36676660	Patisiran (substance)	4180186
36676662	Sting by nettle (event)	4180186
36676663	Product containing patisiran (medicinal product)	4180186
36676664	Product containing patisiran in parenteral dose form (medicinal product form)	4180186
36676666	Larva of Ancylostoma caninum (organism)	4180186
36676668	Strangulated hernia of abdominal wall (disorder)	4180186
36676672	Primary ameloblastic carcinoma (disorder)	4180186
36676674	Joint contracture, webbed neck, micrognathia, hypoplastic nipple syndrome (disorder)	4180186
36676674	Contractures, webbed neck, micrognathia, hypoplastic nipples syndrome	4180186
36676674	Dinno syndrome	4180186
36676677	Onychomatricoma (disorder)	4180186
36676678	Haemodialysis catheter submitted as specimen	4180186
36676678	Hemodialysis catheter submitted as specimen (specimen)	4180186
36676684	Periconiaceae	4180186
36676684	Family Periconiaceae (organism)	4180186
36676686	Recurrent umbilical hernia (disorder)	4180186
36676687	Recurrent femoral hernia (disorder)	4180186
36676688	Neonatal inflammatory skin and bowel disease (disorder)	4180186
36676689	ROHHAD (rapid-onset childhood obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation) syndrome	4180186
36676689	Rapid-onset childhood obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation syndrome (disorder)	4180186
36676689	ROHHADNET (rapid-onset childhood obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation, neural tumours) syndrome	4180186
36676689	ROHHADNET (rapid-onset childhood obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation, neural tumors) syndrome	4180186
36676691	Hypogonadotropic hypogonadism, severe microcephaly, sensorineural deafness, dysmorphism syndrome	4180186
36676691	Hypogonadotropic hypogonadism, severe microcephaly, sensorineural hearing loss, dysmorphism syndrome (disorder)	4180186
36676693	Hypertelorism, preauricular sinus, punctual pits, hearing loss syndrome	4180186
36676693	HPPD (hypertelorism, preauricular sinus, punctual pits, deafness) syndrome	4180186
36676693	Hypertelorism, preauricular sinus, punctual pits, deafness syndrome (disorder)	4180186
36676694	Childhood encephalopathy due to thiamine pyrophosphokinase deficiency (disorder)	4180186
36676694	Childhood encephalopathy due to thiamin pyrophosphokinase deficiency	4180186
36676697	Assessment using Padua Inventory (procedure)	4180186
36676699	Hypoplastic pancreas, intestinal atresia, hypoplastic gallbladder syndrome	4180186
36676699	Hypoplasia of pancreas, intestinal atresia, hypoplasia of gallbladder syndrome (disorder)	4180186
36676700	Hepatitis A virus genotype I (organism)	4180186
36676702	Hepatitis A virus genotype III (organism)	4180186
36676703	Hepatitis A virus genotype IV (organism)	4180186
36676706	Hepatitis A virus genotype IA (organism)	4180186
36676707	Hepatitis A virus genotype IIA (organism)	4180186
36676710	Hepatitis A virus genotype IIIB (organism)	4180186
36676712	Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (disorder)	4180186
36676712	CLIPPERS - chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids	4180186
36676714	Congenital erosive and vesicular dermatosis with reticulated supple scarring	4180186
36676714	CEVD - congenital erosive and vesicular dermatosis	4180186
36676714	Congenital erosive and vesicular dermatosis (disorder)	4180186
36676715	Late-onset localized junctional epidermolysis bullosa, intellectual disability syndrome (disorder)	4180186
36676715	Late-onset localised junctional epidermolysis bullosa, intellectual disability syndrome	4180186
36676716	Spondylo-megaepiphyseal-metaphyseal dysplasia (disorder)	4180186
36676717	Linear focal dermal elastosis	4180186
36676717	Elastotic striae	4180186
36676717	Linear focal elastosis (disorder)	4180186
36676718	Pseudoxanthoma-like late-onset focal dermal elastosis	4180186
36676718	Late-onset focal dermal elastosis (disorder)	4180186
36676718	PXE (pseudoxanthoma elasticum) like late-onset focal dermal elastosis	4180186
36676719	Pitt Hopkins-like syndrome (disorder)	4180186
36676720	Leukonychia totalis, acanthosis-nigricans-like lesions, abnormal hair syndrome (disorder)	4180186
36676725	Rare isolated myopia (disorder)	4180186
36676727	Acrodysplasia scoliosis (disorder)	4180186
36676727	Prata Liberal Goncalves syndrome	4180186
36676727	Brachydactyly, scoliosis, carpal fusion syndrome	4180186
36676729	High-grade neuroendocrine carcinoma of uterine cervix	4180186
36676729	High-grade neuroendocrine carcinoma of cervix uteri (disorder)	4180186
36676729	Poorly differentiated neuroendocrine carcinoma of cervix uteri	4180186
36676729	Poorly differentiated neuroendocrine cervical carcinoma	4180186
36676730	Antidementia therapeutic role (role)	4180186
36676732	Antidiabetic therapeutic role (role)	4180186
36676733	Adsorbent therapeutic role (role)	4180186
36676739	Antiemetic therapeutic role (role)	4180186
36676741	Antiinflammatory therapeutic role (role)	4180186
36676742	Antilipaemic therapeutic role	4180186
36676742	Antilipemic therapeutic role (role)	4180186
36676748	Antirheumatic therapeutic role (role)	4180186
36676749	Antiseborrhoeic therapeutic role	4180186
36676749	Antiseborrheic therapeutic role (role)	4180186
36676750	Antiseptic therapeutic role (role)	4180186
36676751	Antispasmodic therapeutic role (role)	4180186
36676752	Antitussive therapeutic role (role)	4180186
36676754	Laxative therapeutic role (role)	4180186
36676756	Magnesium supplement therapeutic role (role)	4180186
36676757	Migraine prophylaxis therapeutic role (role)	4180186
36676758	Miotic therapeutic role (role)	4180186
36676762	Muscle stimulant therapeutic role (role)	4180186
36676763	Mydriatic therapeutic role (role)	4180186
36676765	Pediculicide therapeutic role (role)	4180186
36676766	Saluretic therapeutic role (role)	4180186
36676767	Sclerosant therapeutic role (role)	4180186
36676769	Thrombolytic therapeutic role (role)	4180186
36676771	Uricosuric therapeutic role (role)	4180186
36676772	Urinary acidifier therapeutic role (role)	4180186
36676773	Counterirritant therapeutic role (role)	4180186
36676774	Immunosuppressant therapeutic role (role)	4180186
36676777	Genus Tripospermum (organism)	4180186
36676777	Tripospermum	4180186
36676781	Genus Diheterospora (organism)	4180186
36676781	Diheterospora	4180186
36676783	Pestalotia	4180186
36676783	Genus Pestalotia (organism)	4180186
36676783	Pestalozzia	4180186
36676784	Genus Chalara (organism)	4180186
36676784	Chalara	4180186
36676785	Necrotising otitis externa of right external auditory canal	4180186
36676785	Necrotizing otitis externa of right external auditory canal (disorder)	4180186
36676786	Nerve growth factor agonist (disposition)	4180186
36676787	Substance with nerve growth factor agonist mechanism of action (substance)	4180186
36676788	Cenegermin (substance)	4180186
36676794	Product containing lanadelumab in parenteral dose form (medicinal product form)	4180186
36676795	NEVADA (nevus epidermicus verrucosus with angiodysplasia and aneurysm) syndrome	4180186
36676795	Nevus epidermicus verrucosus with angiodysplasia and aneurysm syndrome (disorder)	4180186
36676795	NEVADA (naevus epidermicus verrucosus with angiodysplasia and aneurysm) syndrome	4180186
36676795	Naevus epidermicus verrucosus with angiodysplasia and aneurysm syndrome	4180186
36676795	Nevus epidermicus verrucosus with angiodysplasia and aneurysm syndrome	4180186
36676798	Late-onset isolated ACTH (adrenocorticotropic hormone) deficiency	4180186
36676798	Late-onset isolated adrenocorticotropic hormone deficiency (disorder)	4180186
36676798	Late-onset isolated ACTH deficiency	4180186
36676799	Isolated asymptomatic elevation of creatine phosphokinase (disorder)	4180186
36676800	Idiopathic posterior uveitis (disorder)	4180186
36676801	Idiopathic macular telangiectasia type 3 (disorder)	4180186
36676801	Occlusive idiopathic juxtafoveolar retinal telangiectasis	4180186
36676808	Benzazocine (substance)	4180186
36676811	Poly-L-lactic acid suture (physical object)	4180186
36676812	Glaucoma supraciliary implant (physical object)	4180186
36676813	Thoracic cage orthosis (physical object)	4180186
36676815	Wearable neonatal heart rate meter (physical object)	4180186
36676818	Left macular scar	4180186
36676818	Scarred macula of left eye (disorder)	4180186
36676819	High intensity focused ultrasound ablation of lesion of spleen using magnetic resonance imaging guidance	4180186
36676819	High intensity focused ultrasound ablation of lesion of spleen using magnetic resonance imaging guidance (procedure)	4180186
36676824	Artificial saliva therapeutic role (role)	4180186
36676826	Global Deterioration Scale level (observable entity)	4180186
36676826	GDS (Global Deterioration Scale) level	4180186
36676828	Assessment using Apnea Hypopnea Index (procedure)	4180186
36676828	Assessment using AHI (Apnea Hypopnea Index)	4180186
36676829	Apnea Hypopnea Index (observable entity)	4180186
36676829	AHI - Apnea Hypopnea Index	4180186
36676832	Acquired deformity of right hand (disorder)	4180186
36676833	Acquired deformity of left hand (disorder)	4180186
36676834	Acquired deformity of right foot (disorder)	4180186
36676835	Acquired deformity of left foot (disorder)	4180186
36676837	Arthropathy of right knee joint (disorder)	4180186
36676837	Disorder of joint of right knee	4180186
36676841	Pain of right shoulder blade (finding)	4180186
36676841	Right scapulalgia	4180186
36676844	Pain of left acromioclavicular joint (finding)	4180186
36676845	Instability of right hip joint (finding)	4180186
36676851	Spasm of left piriformis muscle (finding)	4180186
36676852	Charcot-Marie-Tooth disease type 2R (disorder)	4180186
36676853	Polyglucosan body myopathy type 1 (disorder)	4180186
36676853	PGBM1 - polyglucosan body myopathy type 1	4180186
36676855	Sacral agenesis, abnormal ossification of vertebral bodies, persistent notochordal canal syndrome (disorder)	4180186
36676856	Cerebro-cutaneous syndrome with iron overload	4180186
36676856	Ferro-cerebro-cutaneous syndrome (disorder)	4180186
36676857	Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies (disorder)	4180186
36676857	Retinal dystrophy with inner nuclear layer and ganglion cell anomalies	4180186
36676858	Periodic paralysis with transient compartment-like syndrome (disorder)	4180186
36676861	Has product name (attribute)	4180186
36676862	Has supplier (attribute)	4180186
36676863	Contains clinical drug (attribute)	4180186
36676865	Has pack size unit (attribute)	4180186
36676866	Supplier (supplier)	4180186
36676868	Helium radioisotope (substance)	4180186
36676872	Dysfunction of inferior oblique muscle of left eye (disorder)	4180186
36676873	Cramp of muscle of right upper limb (finding)	4180186
36676874	Cramp of muscle of left upper limb (finding)	4180186
36676875	Product containing aloin in oral dose form (medicinal product form)	4180186
36676876	Product containing Arachis oil in rectal dose form (medicinal product form)	4180186
36676879	Product containing casanthranol in oral dose form (medicinal product form)	4180186
36676880	Product containing cascara in oral dose form (medicinal product form)	4180186
36676883	Product containing castor oil in oral dose form (medicinal product form)	4180186
36676884	Product containing cellulose in oral dose form (medicinal product form)	4180186
36676885	Product containing lactitol in oral dose form (medicinal product form)	4180186
36676886	Product containing prucalopride (medicinal product)	4180186
36676887	Product containing prucalopride in oral dose form (medicinal product form)	4180186
36676888	Product containing phenolphthalein in oral dose form (medicinal product form)	4180186
36676890	Product containing sennoside in rectal dose form (medicinal product form)	4180186
36676891	Assessment using ABS (Affect Balance Scale)	4180186
36676891	Assessment using Affect Balance Scale (procedure)	4180186
36676892	ABS (Affect Balance Scale) score	4180186
36676892	Affect Balance Scale score (observable entity)	4180186
36676893	Assessment using Androgen Deficiency in the Aging Male questionnaire	4180186
36676893	Assessment using Androgen Deficiency in the Aging Male questionnaire (procedure)	4180186
36676896	Special care baby care plan (record artifact)	4180186
36676898	Growth retardation, mild developmental delay, chronic hepatitis syndrome (disorder)	4180186
36676904	Angora hair naevus	4180186
36676904	Schauder syndrome	4180186
36676904	Angora hair nevus (disorder)	4180186
36676907	Product containing Sterculia gum in oral dose form (medicinal product form)	4180186
36676908	Product containing psyllium in oral dose form (medicinal product form)	4180186
36676909	Invitation to participate in research study declined (situation)	4180186
36676910	Na+/K+-exchanging ATPase inhibitor	4180186
36676910	Sodium/potassium adenosine triphosphatase enzyme inhibitor	4180186
36676910	Sodium/potassium adenosine triphosphatase enzyme inhibitor (disposition)	4180186
36676910	Sodium/potassium transporting ATPase inhibitor	4180186
36676911	Substance with sodium/potassium adenosine triphosphatase enzyme inhibitor mechanism of action (substance)	4180186
36676911	Substance with Na+/K+-transporting ATPase inhibitor mechanism of action	4180186
36676913	MTP inhibitor	4180186
36676913	Microsomal triglyceride transfer protein inhibitor (disposition)	4180186
36676914	Macrogol-containing product in oral dose form	4180186
36676914	Product containing macrogol in oral dose form (medicinal product form)	4180186
36676918	Product containing levobetaxolol in ocular dose form (medicinal product form)	4180186
36676919	Product containing metipranolol in ocular dose form (medicinal product form)	4180186
36676920	Product containing microsomal triglyceride transfer protein inhibitor (product)	4180186
36676922	Product containing only 1,2-benzisothiazolin-3-one (medicinal product)	4180186
36676925	Product containing only 1,6-hexamethylene di-isocyanate (medicinal product)	4180186
36676929	Product containing only drometrizole (medicinal product)	4180186
36676931	Product containing only 2-chloro-N-hydroxy methylacetamide (medicinal product)	4180186
36676936	Product containing only 2-hydroxypropyl methacrylate (medicinal product)	4180186
36676937	Product containing only 2-monomethylol phenol (medicinal product)	4180186
36676938	Product containing only 2-phenylindole (medicinal product)	4180186
36676939	Product containing only 2-phenylphenol (medicinal product)	4180186
36676940	Product containing only 2-n-octyl-4-isothiazolin-3-one (medicinal product)	4180186
36676941	Product containing only 2-octyl cyanoacrylate (medicinal product)	4180186
36676943	Product containing only 3'-deoxyadenosine (medicinal product)	4180186
36676944	Product containing only 3,4-diaminopyridine (medicinal product)	4180186
36676946	Product containing only 4,4'-dihydroxybiphenyl (medicinal product)	4180186
36676947	Product containing only 4-amino-N,N-diethylaniline sulfate (medicinal product)	4180186
36676948	Product containing only 4-aminoazobenzene (medicinal product)	4180186
36676949	Fampridine only product	4180186
36676949	Product containing only fampridine (medicinal product)	4180186
36676952	Product containing only 4-tertiary butylcatechol (medicinal product)	4180186
36676957	Product containing only 9 cis-octadecenoic acid (medicinal product)	4180186
36676958	Product containing only 9 cis-octadecenoic acid and turpentine oil (medicinal product)	4180186
36676959	Product containing only Acacia and starch and tragacanth (medicinal product)	4180186
36676961	Product containing only Ceratonia siliqua extract (medicinal product)	4180186
36676962	Product containing only Clostridium botulinum toxin (medicinal product)	4180186
36676963	Product containing only D-usnic acid (medicinal product)	4180186
36676964	Product containing only denileukin diftitox (medicinal product)	4180186
36676967	Product containing only Erysipelothrix rhusiopathiae antiserum (medicinal product)	4180186
36676968	Product containing only Escherichia coli antibody (medicinal product)	4180186
36676974	Product containing only levomefolic acid (medicinal product)	4180186
36676975	Product containing only L-tartaric acid (medicinal product)	4180186
36676976	Product containing only L-usnic acid (medicinal product)	4180186
36676978	Product containing only Lactobacillus acidophilus (medicinal product)	4180186
36676980	Product containing only Latrodectus mactans antivenom (medicinal product)	4180186
36676984	Product containing only N,N-dimethyl-p-toluidine (medicinal product)	4180186
36676985	Product containing only N,N-methylenebisacrylamide (medicinal product)	4180186
36676986	Product containing only N-cyclohexyl-N'-phenyl paraphenylenediamine (medicinal product)	4180186
36676987	Product containing only N-cyclohexylbenzothiazyl sulfenamide (medicinal product)	4180186
36676989	Product containing only N-phenyl-2-naphthylamine (medicinal product)	4180186
36676990	Product containing only Notechis scutatus antivenom (medicinal product)	4180186
36676991	Product containing only Oak Moss Absolute (medicinal product)	4180186
36676992	Product containing only Podophyllum resin (medicinal product)	4180186
36676993	Product containing only Podophyllum resin and salicylic acid (medicinal product)	4180186
36676995	Product containing only Salmonella typhimurium antiserum (medicinal product)	4180186
36676997	Product containing only Sterculia gum (medicinal product)	4180186
36677001	Product containing only Synanceia trachynis antivenom (medicinal product)	4180186
36677006	Product containing only abciximab (medicinal product)	4180186
36677007	Product containing only abemaciclib (medicinal product)	4180186
36677010	Product containing only acalabrutinib (medicinal product)	4180186
36677012	Product containing only acarbose (medicinal product)	4180186
36677013	Product containing only acebutolol (medicinal product)	4180186
36677014	Product containing only acebutolol and hydrochlorothiazide (medicinal product)	4180186
36677016	Product containing only acemetacin (medicinal product)	4180186
36677018	Product containing only acephate (medicinal product)	4180186
36677019	Product containing only acesulfame potassium (medicinal product)	4180186
36677020	Acetarsol only product	4180186
36677020	Product containing only acetarsol (medicinal product)	4180186
36677021	Product containing only acetazolamide (medicinal product)	4180186
36677025	Product containing only acetic acid and turpentine oil (medicinal product)	4180186
36677031	Product containing only acetylcholine (medicinal product)	4180186
36677035	Product containing only acitretin (medicinal product)	4180186
36677037	Product containing only aclidinium (medicinal product)	4180186
36677038	Product containing only acriflavine (medicinal product)	4180186
36677039	Product containing only acrivastine (medicinal product)	4180186
36677040	Product containing only acrivastine and pseudoephedrine (medicinal product)	4180186
36677045	Product containing only adapalene (medicinal product)	4180186
36677048	Product containing only ademetionine (medicinal product)	4180186
36677049	Product containing only adenosine (medicinal product)	4180186
36677050	Product containing only afatinib (medicinal product)	4180186
36677052	Product containing only agalsidase alfa (medicinal product)	4180186
36677053	Product containing only agalsidase beta (medicinal product)	4180186
36677055	Product containing only albendazole (medicinal product)	4180186
36677057	Product containing only alcaftadine (medicinal product)	4180186
36677062	Product containing only aldioxa (medicinal product)	4180186
36677063	Product containing only aldioxa and chloroxylenol (medicinal product)	4180186
36677064	Product containing only aldosterone (medicinal product)	4180186
36677065	Product containing only alefacept (medicinal product)	4180186
36677066	Product containing only alemtuzumab (medicinal product)	4180186
36677067	Product containing only alendronic acid (medicinal product)	4180186
36677068	Product containing only alendronic acid and colecalciferol (medicinal product)	4180186
36677068	Alendronic acid and colecalciferol only product	4180186
36677069	Product containing only alexitol sodium (medicinal product)	4180186
36677070	Product containing only alfacalcidol (medicinal product)	4180186
36677073	Product containing only alginic acid (medicinal product)	4180186
36677075	Product containing only alglucerase (medicinal product)	4180186
36677077	Alimemazine only product	4180186
36677077	Product containing only alimemazine (medicinal product)	4180186
36677079	Product containing only aliskiren and amlodipine and hydrochlorothiazide (medicinal product)	4180186
36677080	Product containing only aliskiren and hydrochlorothiazide (medicinal product)	4180186
36677082	Product containing only alitretinoin (medicinal product)	4180186
36677083	Product containing only alkalase (medicinal product)	4180186
36677085	Product containing only allantoin (medicinal product)	4180186
36677088	Product containing only allantoin and lidocaine (medicinal product)	4180186
36677093	Product containing only almond oil and mineral oil (medicinal product)	4180186
36677094	Product containing only almotriptan (medicinal product)	4180186
36677095	Product containing only Aloe and benzoin (medicinal product)	4180186
36677097	Product containing only alogliptin (medicinal product)	4180186
36677101	Product containing only alpha-glucosidase (medicinal product)	4180186
36677104	Product containing only alphaxolone (medicinal product)	4180186
36677110	Product containing only alum (medicinal product)	4180186
36677111	Product containing only aluminium (medicinal product)	4180186
36677111	Aluminium only product	4180186
36677114	Product containing only aluminium hydroxide and belladonna alkaloid (medicinal product)	4180186
36677114	Aluminium hydroxide and belladonna alkaloid only product	4180186
36677115	Aluminium hydroxide and magnesium carbonate only product	4180186
36677115	Product containing only aluminium hydroxide and magnesium carbonate (medicinal product)	4180186
36677116	Aluminium hydroxide and magnesium hydroxide only product	4180186
36677116	Product containing only aluminium hydroxide and magnesium hydroxide (medicinal product)	4180186
36677119	Aluminium hydroxide and simeticone only product	4180186
36677119	Product containing only aluminium hydroxide and simeticone (medicinal product)	4180186
36677120	Aluminium oxide only product	4180186
36677120	Product containing only aluminium oxide (medicinal product)	4180186
36677121	Aluminium oxide and magnesium hydroxide and oxetacaine only product	4180186
36677121	Product containing only aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product)	4180186
36677123	Product containing only alverine (medicinal product)	4180186
36677124	Product containing only alverine and Sterculia gum (medicinal product)	4180186
36677125	Product containing only alvimopan (medicinal product)	4180186
36677126	Product containing only amantadine (medicinal product)	4180186
36677130	Product containing only amcinonide (medicinal product)	4180186
36677131	Product containing only amfepramone (medicinal product)	4180186
36677131	Amfepramone only product	4180186
36677132	Amfetamine and dexamfetamine only product	4180186
36677132	Product containing only amfetamine and dexamfetamine (medicinal product)	4180186
36677133	Product containing only amifloxacin (medicinal product)	4180186
36677134	Product containing only amifostine (medicinal product)	4180186
36677137	Product containing only amiloride and atenolol and hydrochlorothiazide (medicinal product)	4180186
36677140	Product containing only amiloride and furosemide (medicinal product)	4180186
36677141	Product containing only amiloride and hydrochlorothiazide (medicinal product)	4180186
36677143	Aminoacridine only product	4180186
36677143	Product containing only aminoacridine (medicinal product)	4180186
36677145	Product containing only aminocaproic acid (medicinal product)	4180186
36677146	Product containing only aminoglutethimide (medicinal product)	4180186
36677147	Product containing only aminophylline (medicinal product)	4180186
36677150	Product containing only amiodarone (medicinal product)	4180186
36677152	Product containing only amitriptyline (medicinal product)	4180186
36677153	Product containing only amitriptyline and chlordiazepoxide (medicinal product)	4180186
36677154	Product containing only amitriptyline and perphenazine (medicinal product)	4180186
36677155	Product containing only amlexanox (medicinal product)	4180186
36677156	Product containing only amlodipine (medicinal product)	4180186
36677159	Product containing only amlodipine and hydrochlorothiazide and valsartan (medicinal product)	4180186
36677163	Product containing only ammonia (medicinal product)	4180186
36677166	Product containing only ammonium acetate (medicinal product)	4180186
36677169	Product containing only ammonium bicarbonate and ipecacuanha and sodium bicarbonate (medicinal product)	4180186
36677171	Product containing only ammonium chloride (medicinal product)	4180186
36677173	Product containing only ammonium chloride and diphenhydramine (medicinal product)	4180186
36677174	Product containing only ammonium lactate (medicinal product)	4180186
36677176	Product containing only ammonium tetrachloroplatinate (medicinal product)	4180186
36677178	Product containing only amobarbital (medicinal product)	4180186
36677180	Product containing only amodiaquine (medicinal product)	4180186
36677186	Product containing only amphotericin (medicinal product)	4180186
36677187	Product containing only amphotericin and tetracycline (medicinal product)	4180186
36677189	Product containing only ampicillin and cloxacillin (medicinal product)	4180186
36677191	Product containing only ampicillin and sulbactam (medicinal product)	4180186
36677192	Product containing only amprenavir (medicinal product)	4180186
36677193	Product containing only amrinone (medicinal product)	4180186
36677193	Amrinone only product	4180186
36677194	Product containing only amsacrine (medicinal product)	4180186
36677195	Product containing only amyl cinnamaldehyde (medicinal product)	4180186
36677198	Product containing only amylase and pancrelipase and triacylglycerol lipase (medicinal product)	4180186
36677199	Product containing only amylase and substance with protease mechanism of action and triacylglycerol lipase (medicinal product)	4180186
36677202	Product containing only anagrelide (medicinal product)	4180186
36677205	Product containing only ancrod (medicinal product)	4180186
36677206	Product containing only anethole (medicinal product)	4180186
36677206	Anethol only product	4180186
36677208	Product containing only anidulafungin (medicinal product)	4180186
36677209	Product containing only anise oil (medicinal product)	4180186
36677212	Product containing only anistreplase (medicinal product)	4180186
36677213	Product containing only antazoline (medicinal product)	4180186
36677214	Product containing only antazoline and xylometazoline (medicinal product)	4180186
36677215	Product containing only anti-inhibitor coagulant complex (medicinal product)	4180186
36677216	Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product)	4180186
36677216	Diphtheria toxoid and whole cell pertussis and tetanus toxoid adsorbed vaccine	4180186
36677217	Antihaemophilic factor agent only product	4180186
36677217	Product containing only antihemophilic factor agent (medicinal product)	4180186
36677218	Product containing only antilymphocyte immunoglobulin (medicinal product)	4180186
36677219	Product containing only antimony (medicinal product)	4180186
36677221	Product containing only apalutamide (medicinal product)	4180186
36677222	Product containing only apixaban (medicinal product)	4180186
36677225	Product containing only apramycin (medicinal product)	4180186
36677226	Product containing only apremilast (medicinal product)	4180186
36677227	Product containing only aprepitant (medicinal product)	4180186
36677228	Product containing only aprobarbital (medicinal product)	4180186
36677229	Product containing only aprotinin (medicinal product)	4180186
36677230	Product containing only Arachis oil (medicinal product)	4180186
36677231	Product containing only ardeparin (medicinal product)	4180186
36677232	Product containing only arformoterol (medicinal product)	4180186
36677233	Product containing only argatroban (medicinal product)	4180186
36677235	Product containing only armodafinil (medicinal product)	4180186
36677236	Product containing only arsenic (medicinal product)	4180186
36677237	Product containing only arsenic trioxide (medicinal product)	4180186
36677243	Product containing only ascorbic acid and cetylpyridinium (medicinal product)	4180186
36677244	Product containing only ascorbic acid and clioquinol (medicinal product)	4180186
36677249	Product containing only ascorbic acid and paracetamol (medicinal product)	4180186
36677249	Ascorbic acid and paracetamol only product	4180186
36677251	Product containing only asfotase alfa (medicinal product)	4180186
36677252	Product containing only asparaginase (medicinal product)	4180186
36677253	Product containing only aspartame (medicinal product)	4180186
36677255	Product containing only aspirin and butalbital and caffeine (medicinal product)	4180186
36677257	Product containing only aspirin and caffeine (medicinal product)	4180186
36677258	Product containing only aspirin and caffeine and cinnamedrine (medicinal product)	4180186
36677263	Product containing only aspirin and carisoprodol (medicinal product)	4180186
36677264	Product containing only aspirin and carisoprodol and codeine (medicinal product)	4180186
36677269	Product containing only aspirin and hydrocodone (medicinal product)	4180186
36677271	Product containing only aspirin and meprobamate (medicinal product)	4180186
36677272	Product containing only aspirin and methocarbamol (medicinal product)	4180186
36677277	Aspirin and paracetamol only product	4180186
36677277	Product containing only aspirin and paracetamol (medicinal product)	4180186
36677280	Product containing only astemizole (medicinal product)	4180186
36677281	Product containing only atazanavir (medicinal product)	4180186
36677282	Product containing only atazanavir and cobicistat (medicinal product)	4180186
36677284	Product containing only atenolol and bendroflumethiazide (medicinal product)	4180186
36677286	Product containing only atenolol and nifedipine (medicinal product)	4180186
36677287	Product containing only atezolizumab (medicinal product)	4180186
36677288	Product containing only atomoxetine (medicinal product)	4180186
36677289	Product containing only atosiban (medicinal product)	4180186
36677292	Product containing only atracurium (medicinal product)	4180186
36677296	Product containing only atropine and diphenoxylate (medicinal product)	4180186
36677297	Product containing only atropine and edrophonium (medicinal product)	4180186
36677298	Product containing only atropine and hyoscyamine and scopolamine (medicinal product)	4180186
36677298	Atropine and hyoscine and hyoscyamine only product	4180186
36677300	Product containing only antigen of live attenuated Mycobacterium bovis (medicinal product)	4180186
36677300	Live attenuated Mycobacterium bovis antigen only product	4180186
36677305	Product containing only avelumab (medicinal product)	4180186
36677308	Product containing only avobenzone (medicinal product)	4180186
36677310	Avobenzone and ecamsule and octocrilene and titanium dioxide only product	4180186
36677310	Product containing only avobenzone and ecamsule and octocrilene and titanium dioxide (medicinal product)	4180186
36677311	Product containing only axicabtagene ciloleucel (medicinal product)	4180186
36677312	Product containing only azacitidine (medicinal product)	4180186
36677313	Product containing only azapropazone (medicinal product)	4180186
36677313	Azapropazone only product	4180186
36677314	Product containing only azatadine (medicinal product)	4180186
36677315	Product containing only azatadine and pseudoephedrine (medicinal product)	4180186
36677316	Product containing only azathioprine (medicinal product)	4180186
36677317	Product containing only azelaic acid (medicinal product)	4180186
36677320	Product containing only azithromycin (medicinal product)	4180186
36677323	Product containing only aztreonam (medicinal product)	4180186
36677327	Product containing only bacitracin and neomycin and polymyxin B (medicinal product)	4180186
36677328	Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	4180186
36677328	Bacitracin and neomycin and polymyxin B and pramocaine only product	4180186
36677332	Product containing only balsam of Peru (medicinal product)	4180186
36677333	Product containing only bambermycin (medicinal product)	4180186
36677336	Product containing only baricitinib (medicinal product)	4180186
36677337	Product containing only barium (medicinal product)	4180186
36677338	Product containing only basic red 46 (medicinal product)	4180186
36677339	Product containing only basiliximab (medicinal product)	4180186
36677340	Product containing only bazedoxifene and conjugated estrogen (medicinal product)	4180186
36677341	Product containing only becaplermin (medicinal product)	4180186
36677343	Beclometasone only product	4180186
36677343	Product containing only beclometasone (medicinal product)	4180186
36677344	Product containing only beclometasone and salbutamol (medicinal product)	4180186
36677344	Beclometasone and salbutamol only product	4180186
36677345	Product containing only bedaquiline (medicinal product)	4180186
36677346	Product containing only bee venom (medicinal product)	4180186
36677348	Product containing only beeswax (medicinal product)	4180186
36677349	Product containing only belatacept (medicinal product)	4180186
36677352	Product containing only belladonna alkaloid (medicinal product)	4180186
36677354	Product containing only belladonna alkaloid and magnesium trisilicate (medicinal product)	4180186
36677355	Product containing only belladonna alkaloid and opium alkaloid (medicinal product)	4180186
36677357	Belladonna alkaloid and secbutabarbital only product	4180186
36677357	Product containing only belladonna alkaloid and secbutabarbital (medicinal product)	4180186
36677358	Product containing only bemiparin (medicinal product)	4180186
36677360	Product containing only benazepril and hydrochlorothiazide (medicinal product)	4180186
36677362	Product containing only bendroflumethiazide (medicinal product)	4180186
36677365	Product containing only bendroflumethiazide and potassium chloride (medicinal product)	4180186
36677366	Product containing only bendroflumethiazide and propranolol (medicinal product)	4180186
36677367	Product containing only bendroflumethiazide and timolol (medicinal product)	4180186
36677370	Product containing only benomyl (medicinal product)	4180186
36677372	Product containing only benperidol (medicinal product)	4180186
36677374	Product containing only benralizumab (medicinal product)	4180186
36677376	Product containing only benserazide and levodopa (medicinal product)	4180186
36677378	Product containing only benzaldehyde (medicinal product)	4180186
36677380	Product containing only benzalkonium and cetrimide (medicinal product)	4180186
36677381	Benzalkonium and dimeticone only product	4180186
36677381	Product containing only benzalkonium and dimeticone (medicinal product)	4180186
36677382	Product containing only benzalkonium and hexylresorcinol (medicinal product)	4180186
36677384	Benzatropine only product	4180186
36677384	Product containing only benzatropine (medicinal product)	4180186
36677391	Product containing only benzocaine (medicinal product)	4180186
36677393	Product containing only benzocaine and chloroxylenol (medicinal product)	4180186
36677395	Product containing only benzocaine and menthol (medicinal product)	4180186
36677399	Product containing only benzocaine and phenol (medicinal product)	4180186
36677400	Product containing only benzocaine and resorcinol (medicinal product)	4180186
36677401	Product containing only benzocaine and salicylamide (medicinal product)	4180186
36677402	Product containing only benzocaine and triclosan (medicinal product)	4180186
36677404	Product containing only benzoic acid (medicinal product)	4180186
36677407	Product containing only benzonatate (medicinal product)	4180186
36677412	Product containing only benzoyl peroxide and hydrocortisone (medicinal product)	4180186
36677417	Product containing only benzthiazide and triamterene (medicinal product)	4180186
36677418	Product containing only benzydamine (medicinal product)	4180186
36677421	Product containing only benzyl cinnamate (medicinal product)	4180186
36677425	Product containing only benzylpenicilloyl polylysine (medicinal product)	4180186
36677426	Product containing only bephenium (medicinal product)	4180186
36677430	Product containing only berberine (medicinal product)	4180186
36677431	Product containing only besifloxacin (medicinal product)	4180186
36677435	Product containing only betahistine (medicinal product)	4180186
36677436	Product containing only betaine (medicinal product)	4180186
36677437	Product containing only betamethasone (medicinal product)	4180186
36677442	Product containing only betamethasone and neomycin (medicinal product)	4180186
36677444	Betanidine only product	4180186
36677444	Product containing only betanidine (medicinal product)	4180186
36677445	Product containing only betaxolol (medicinal product)	4180186
36677448	Product containing only bevacizumab (medicinal product)	4180186
36677450	Product containing only bezafibrate (medicinal product)	4180186
36677457	Product containing only bilastine (medicinal product)	4180186
36677464	Product containing only biphasic isophane insulin porcine (medicinal product)	4180186
36677465	Product containing only bis (dibutyldithiocarbamato) zinc (medicinal product)	4180186
36677468	Product containing only bisacodyl and macrogol (medicinal product)	4180186
36677468	Bisacodyl and macrogol only product	4180186
36677471	Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product)	4180186
36677472	Product containing only bismuth subcarbonate (medicinal product)	4180186
36677474	Product containing only bismuth subnitrate (medicinal product)	4180186
36677475	Product containing only bismuth subnitrate and iodoform (medicinal product)	4180186
36677476	Product containing only bismuth subsalicylate (medicinal product)	4180186
36677477	Product containing only bismuth subsalicylate and metronidazole and tetracycline (medicinal product)	4180186
36677479	Product containing only bisoprolol and hydrochlorothiazide (medicinal product)	4180186
36677483	Product containing only bivalirudin (medicinal product)	4180186
36677484	Product containing only bleomycin (medicinal product)	4180186
36677489	Product containing only bosentan (medicinal product)	4180186
36677490	Product containing only bosutinib (medicinal product)	4180186
36677491	Product containing only botulinum antitoxin (medicinal product)	4180186
36677492	Product containing only botulinum toxin type A (medicinal product)	4180186
36677494	Product containing only botulism immunoglobulin (medicinal product)	4180186
36677500	Product containing only bovine serum albumin and glutaraldehyde (medicinal product)	4180186
36677502	Product containing only bran (medicinal product)	4180186
36677506	Product containing only brilliant green (medicinal product)	4180186
36677507	Product containing only brilliant green and methylrosanilinium chloride (medicinal product)	4180186
36677507	Brilliant green and methylrosanilinium chloride only product	4180186
36677510	Product containing only brinzolamide (medicinal product)	4180186
36677511	Product containing only brodalumab (medicinal product)	4180186
36677514	Bromazine and codeine only product	4180186
36677514	Product containing only bromazine and codeine (medicinal product)	4180186
36677515	Product containing only bromelains (medicinal product)	4180186
36677519	Product containing only brompheniramine and guaifenesin and hydrocodone (medicinal product)	4180186
36677520	Product containing only brompheniramine and pseudoephedrine (medicinal product)	4180186
36677521	Product containing only buclizine (medicinal product)	4180186
36677522	Product containing only budesonide (medicinal product)	4180186
36677527	Product containing only bumetanide (medicinal product)	4180186
36677528	Product containing only bumetanide and potassium (medicinal product)	4180186
36677529	Product containing only bumetanide and potassium chloride (medicinal product)	4180186
36677531	Adrenaline and bupivacaine only product	4180186
36677531	Product containing only bupivacaine and epinephrine (medicinal product)	4180186
36677532	Product containing only bupivacaine and glucose (medicinal product)	4180186
36677535	Product containing only buprenorphine and naloxone (medicinal product)	4180186
36677542	Product containing only busulfan (medicinal product)	4180186
36677543	Product containing only butacaine (medicinal product)	4180186
36677549	Product containing only butobarbital (medicinal product)	4180186
36677552	Product containing only butriptyline (medicinal product)	4180186
36677554	Product containing only butamben (medicinal product)	4180186
36677557	Product containing only butylated hydroxytoluene (medicinal product)	4180186
36677561	Product containing only cade oil (medicinal product)	4180186
36677564	Product containing only caffeine (medicinal product)	4180186
36677571	Caffeine and paracetamol and salicylamide only product	4180186
36677571	Product containing only caffeine and paracetamol and salicylamide (medicinal product)	4180186
36677577	Product containing only calamine and zinc oxide (medicinal product)	4180186
36677583	Product containing only calcium acetate (medicinal product)	4180186
36677584	Product containing only calcium and ergocalciferol (medicinal product)	4180186
36677586	Product containing only calcium and risedronic acid (medicinal product)	4180186
36677589	Product containing only calcium carbonate and etidronic acid (medicinal product)	4180186
36677591	Product containing only calcium carbonate and kaolin (medicinal product)	4180186
36677595	Product containing only calcium carbonate and opium (medicinal product)	4180186
36677597	Product containing only calcium carbonate and sodium bicarbonate (medicinal product)	4180186
36677598	Product containing only calcium chloride (medicinal product)	4180186
36677601	Product containing only calcium glycinate (medicinal product)	4180186
36677609	Calcium phosphate and colecalciferol only product	4180186
36677609	Product containing only calcium phosphate and colecalciferol (medicinal product)	4180186
36677612	Product containing only calcium undecylenate (medicinal product)	4180186
36677615	Product containing only calfactant (medicinal product)	4180186
36677618	Product containing only camphor and chloroxylenol (medicinal product)	4180186
36677619	Product containing only camphor and menthol (medicinal product)	4180186
36677623	Product containing only canagliflozin (medicinal product)	4180186
36677626	Product containing only candesartan (medicinal product)	4180186
36677627	Product containing only candesartan and hydrochlorothiazide (medicinal product)	4180186
36677631	Product containing only capecitabine (medicinal product)	4180186
36677635	Product containing only captan (medicinal product)	4180186
36677638	Product containing only caramiphen (medicinal product)	4180186
36677640	Product containing only carbamazepine (medicinal product)	4180186
36677641	Product containing only carbamide peroxide (medicinal product)	4180186
36677641	Urea hydrogen peroxide only product	4180186
36677642	Product containing only carbaryl (medicinal product)	4180186
36677644	Product containing only carbenicillin (medicinal product)	4180186
36677647	Product containing only carbidopa (medicinal product)	4180186
36677650	Product containing only carbimazole (medicinal product)	4180186
36677652	Product containing only carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product)	4180186
36677655	Product containing only carbol-fuchsin (medicinal product)	4180186
36677658	Product containing only carbomycin (medicinal product)	4180186
36677659	Product containing only carbon (medicinal product)	4180186
36677661	Product containing only carboplatin (medicinal product)	4180186
36677662	Product containing only carboprost (medicinal product)	4180186
36677664	Product containing only carfilzomib (medicinal product)	4180186
36677665	Product containing only carglumic acid (medicinal product)	4180186
36677668	Carmellose only product	4180186
36677668	Product containing only carmellose (medicinal product)	4180186
36677670	Product containing only carob (medicinal product)	4180186
36677671	Product containing only carprofen (medicinal product)	4180186
36677673	Product containing only carvedilol (medicinal product)	4180186
36677674	Product containing only casanthranol (medicinal product)	4180186
36677677	Product containing only casein (medicinal product)	4180186
36677678	Product containing only caspofungin (medicinal product)	4180186
36677682	Product containing only cefaclor (medicinal product)	4180186
36677683	Product containing only cefadroxil (medicinal product)	4180186
36677686	Product containing only cefamandole (medicinal product)	4180186
36677688	Product containing only cefazolin (medicinal product)	4180186
36677690	Product containing only cefditoren (medicinal product)	4180186
36677692	Product containing only cefetamet (medicinal product)	4180186
36677693	Product containing only cefixime (medicinal product)	4180186
36677695	Product containing only cefodizime (medicinal product)	4180186
36677696	Product containing only cefonicid (medicinal product)	4180186
36677698	Product containing only cefoperazone and sulbactam (medicinal product)	4180186
36677699	Product containing only cefotaxime (medicinal product)	4180186
36677700	Product containing only cefotetan (medicinal product)	4180186
36677701	Product containing only cefotiam (medicinal product)	4180186
36677703	Product containing only cefoxitin (medicinal product)	4180186
36677704	Product containing only cefpirome (medicinal product)	4180186
36677709	Product containing only cefsulodin (medicinal product)	4180186
36677710	Product containing only ceftaroline (medicinal product)	4180186
36677711	Product containing only ceftazidime (medicinal product)	4180186
36677713	Product containing only ceftiofur (medicinal product)	4180186
36677716	Product containing only ceftriaxone (medicinal product)	4180186
36677717	Product containing only cefuroxime (medicinal product)	4180186
36677718	Product containing only cefuroxime and metronidazole (medicinal product)	4180186
36677720	Product containing only celiprolol (medicinal product)	4180186
36677721	Product containing only cellulose (medicinal product)	4180186
36677722	Product containing only cenegermin (medicinal product)	4180186
36677727	Product containing only cerium nitrate and sulfadiazine (medicinal product)	4180186
36677731	Product containing only certoparin (medicinal product)	4180186
36677732	Product containing only cetalkonium (medicinal product)	4180186
36677733	Product containing only cetalkonium and lidocaine (medicinal product)	4180186
36677735	Product containing only cetirizine (medicinal product)	4180186
36677737	Product containing only cetrimide and chlorhexidine (medicinal product)	4180186
36677738	Cetrimide and dimeticone only product	4180186
36677738	Product containing only cetrimide and dimeticone (medicinal product)	4180186
36677739	Product containing only cetrimide and dimeticone 1000 (medicinal product)	4180186
36677742	Product containing only cetuximab (medicinal product)	4180186
36677744	Product containing only cetylpyridinium (medicinal product)	4180186
36677749	Product containing only chalk (medicinal product)	4180186
36677751	Product containing only chenodeoxycholic acid (medicinal product)	4180186
36677758	Product containing only chlordiazepoxide and clidinium (medicinal product)	4180186
36677760	Product containing only chlorhexidine and chlorobutanol (medicinal product)	4180186
36677761	Product containing only chlorhexidine and ethanol (medicinal product)	4180186
36677762	Product containing only chlorhexidine and industrial methylated spirit (medicinal product)	4180186
36677763	Product containing only chlorhexidine and isopropyl alcohol (medicinal product)	4180186
36677764	Product containing only chlorhexidine and lidocaine (medicinal product)	4180186
36677766	Product containing only chlorhexidine and nystatin (medicinal product)	4180186
36677768	Product containing only chlorhexidine and tetracaine (medicinal product)	4180186
36677770	Product containing only chlormethine (medicinal product)	4180186
36677770	Chlormethine only product	4180186
36677773	Product containing only chloroacetamide (medicinal product)	4180186
36677774	Product containing only chlorobutanol (medicinal product)	4180186
36677780	Product containing only chloroprocaine (medicinal product)	4180186
36677781	Chloropyrilene only product	4180186
36677781	Product containing only chloropyrilene (medicinal product)	4180186
36677782	Product containing only chloroquine (medicinal product)	4180186
36677785	Product containing only chlorothiazide and reserpine (medicinal product)	4180186
36677786	Product containing only chlorothiazide and spironolactone (medicinal product)	4180186
36677787	Product containing only chlorotrianisene (medicinal product)	4180186
36677788	Product containing only chloroxine (medicinal product)	4180186
36677789	Product containing only chloroxylenol (medicinal product)	4180186
36677790	Chlorphenamine only product	4180186
36677790	Product containing only chlorphenamine (medicinal product)	4180186
36677792	Chlorphenamine and codeine and pseudoephedrine only product	4180186
36677792	Product containing only chlorphenamine and codeine and pseudoephedrine (medicinal product)	4180186
36677794	Chlorphenamine and dextromethorphan and pseudoephedrine only product	4180186
36677794	Product containing only chlorphenamine and dextromethorphan and pseudoephedrine (medicinal product)	4180186
36677797	Product containing only chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product)	4180186
36677797	Chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine only product	4180186
36677800	Chlorphenamine and ibuprofen and pseudoephedrine only product	4180186
36677800	Product containing only chlorphenamine and ibuprofen and pseudoephedrine (medicinal product)	4180186
36677801	Product containing only chlorphenamine and mepyramine and phenylephrine (medicinal product)	4180186
36677801	Chlorphenamine and mepyramine and phenylephrine only product	4180186
36677802	Chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine only product	4180186
36677802	Product containing only chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	4180186
36677803	Product containing only chlorphenamine and paracetamol (medicinal product)	4180186
36677803	Chlorphenamine and paracetamol only product	4180186
36677804	Chlorphenamine and paracetamol and phenylpropanolamine only product	4180186
36677804	Product containing only chlorphenamine and paracetamol and phenylpropanolamine (medicinal product)	4180186
36677805	Product containing only chlorphenamine and paracetamol and pseudoephedrine (medicinal product)	4180186
36677805	Chlorphenamine and paracetamol and pseudoephedrine only product	4180186
36677806	Product containing only chlorphenamine and pentoxyverine (medicinal product)	4180186
36677806	Chlorphenamine and pentoxyverine only product	4180186
36677807	Product containing only chlorphenamine and phenylephrine (medicinal product)	4180186
36677807	Chlorphenamine and phenylephrine only product	4180186
36677809	Chlorphenamine and pseudoephedrine only product	4180186
36677809	Product containing only chlorphenamine and pseudoephedrine (medicinal product)	4180186
36677810	Product containing only chlorphenesin (medicinal product)	4180186
36677813	Product containing only chlorprothixene (medicinal product)	4180186
36677814	Chlortalidone only product	4180186
36677814	Product containing only chlortalidone (medicinal product)	4180186
36677816	Product containing only chlortalidone and triamterene (medicinal product)	4180186
36677816	Chlortalidone and triamterene only product	4180186
36677817	Product containing only chlortetracycline (medicinal product)	4180186
36677818	Product containing only chlortetracycline and triamcinolone (medicinal product)	4180186
36677824	Product containing only choline salicylate (medicinal product)	4180186
36677826	Product containing only choriogonadotropin (medicinal product)	4180186
36677830	Product containing only chromium-51 (medicinal product)	4180186
36677831	Product containing only chymopapain (medicinal product)	4180186
36677832	Product containing only chymotrypsin (medicinal product)	4180186
36677838	Product containing only cidofovir (medicinal product)	4180186
36677840	Product containing only cilastatin and imipenem (medicinal product)	4180186
36677841	Product containing only cilazapril (medicinal product)	4180186
36677842	Product containing only cilostazol (medicinal product)	4180186
36677844	Product containing only cimetidine and sodium alginate (medicinal product)	4180186
36677849	Product containing only cinnamaldehyde (medicinal product)	4180186
36677852	Product containing only cinnarizine (medicinal product)	4180186
36677853	Product containing only cinnarizine and dimenhydrinate (medicinal product)	4180186
36677854	Product containing only cinoxacin (medicinal product)	4180186
36677855	Product containing only ciprofibrate (medicinal product)	4180186
36677856	Product containing only ciprofloxacin (medicinal product)	4180186
36677857	Product containing only ciprofloxacin and dexamethasone (medicinal product)	4180186
36677858	Product containing only ciprofloxacin and hydrocortisone (medicinal product)	4180186
36677861	Product containing only citalopram (medicinal product)	4180186
36677862	Product containing only citric acid (medicinal product)	4180186
36677866	Product containing only citric acid and magnesium oxide and sodium picosulfate (medicinal product)	4180186
36677867	Product containing only citric acid and nalidixic acid (medicinal product)	4180186
36677868	Product containing only citric acid and potassium citrate (medicinal product)	4180186
36677870	Product containing only citrulline (medicinal product)	4180186
36677871	Product containing only cladribine (medicinal product)	4180186
36677872	Product containing only clarithromycin (medicinal product)	4180186
36677873	Product containing only clavulanic acid (medicinal product)	4180186
36677876	Clemastine and paracetamol and phenylpropanolamine only product	4180186
36677876	Product containing only clemastine and paracetamol and phenylpropanolamine (medicinal product)	4180186
36677879	Product containing only clevidipine (medicinal product)	4180186
36677881	Product containing only climbazole (medicinal product)	4180186
36677882	Product containing only clinafloxacin (medicinal product)	4180186
36677883	Product containing only clindamycin (medicinal product)	4180186
36677886	Product containing only clioquinol and flumetasone (medicinal product)	4180186
36677886	Clioquinol and flumetasone only product	4180186
36677887	Product containing only clioquinol and fluocinolone (medicinal product)	4180186
36677888	Product containing only clioquinol and hydrocortisone (medicinal product)	4180186
36677889	Product containing only clobazam (medicinal product)	4180186
36677890	Product containing only clobetasol (medicinal product)	4180186
36677895	Product containing only clocortolone (medicinal product)	4180186
36677897	Product containing only clofarabine (medicinal product)	4180186
36677898	Product containing only clofazimine (medicinal product)	4180186
36677899	Product containing only clofibrate (medicinal product)	4180186
36677902	Product containing only clomipramine (medicinal product)	4180186
36677909	Product containing only clopidogrel (medicinal product)	4180186
36677910	Cloral betaine only product	4180186
36677910	Product containing only cloral betaine (medicinal product)	4180186
36677911	Product containing only clorazepate (medicinal product)	4180186
36677913	Product containing only clorquinaldol and hydrocortisone (medicinal product)	4180186
36677915	Product containing only clotrimazole and fluconazole (medicinal product)	4180186
36677917	Product containing only clove oil (medicinal product)	4180186
36677918	Product containing only clove oil and lidocaine (medicinal product)	4180186
36677919	Product containing only cloxacillin (medicinal product)	4180186
36677920	Product containing only clozapine (medicinal product)	4180186
36677921	Product containing only coagulation factor II and coagulation factor IX and coagulation factor VIIa and coagulation factor VIII and coagulation factor X (medicinal product)	4180186
36677922	Product containing only coagulation factor IX (medicinal product)	4180186
36677923	Product containing only coagulation factor VIIa (medicinal product)	4180186
36677924	Product containing only eptacog alfa (medicinal product)	4180186
36677925	Product containing only coagulation factor XI (medicinal product)	4180186
36677926	Product containing only coagulation factor XIII (medicinal product)	4180186
36677927	Product containing only coagulation factor Xa (medicinal product)	4180186
36677930	Product containing only coal tar and lecithin (medicinal product)	4180186
36677931	Product containing only coal tar and salicylic acid and sulfur (medicinal product)	4180186
36677934	Product containing only cobalt-57 and cobalt-58 (medicinal product)	4180186
36677937	Product containing only cobicistat and darunavir (medicinal product)	4180186
36677938	Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	4180186
36677940	Product containing only cocaine (medicinal product)	4180186
36677941	Product containing only cocaine and epinephrine (medicinal product)	4180186
36677941	Adrenaline and cocaine only product	4180186
36677942	Product containing only cocaine and homatropine (medicinal product)	4180186
36677943	Product containing only cocaine and morphine (medicinal product)	4180186
36677944	Product containing only coccidioidin (medicinal product)	4180186
36677950	Product containing only codeine and guaiacol (medicinal product)	4180186
36677952	Product containing only codeine and guaifenesin and pseudoephedrine (medicinal product)	4180186
36677954	Product containing only codeine and kaolin (medicinal product)	4180186
36677955	Product containing only codeine and paracetamol (medicinal product)	4180186
36677955	Codeine and paracetamol only product	4180186
36677957	Product containing only codeine and pseudoephedrine (medicinal product)	4180186
36677959	Product containing only colchicine (medicinal product)	4180186
36677962	Colecalciferol and retinol only product	4180186
36677962	Product containing only colecalciferol and retinol (medicinal product)	4180186
36677964	Product containing only colestipol (medicinal product)	4180186
36677965	Colestyramine only product	4180186
36677965	Product containing only colestyramine (medicinal product)	4180186
36677966	Product containing only colfosceril (medicinal product)	4180186
36677967	Product containing only colistimethate (medicinal product)	4180186
36677971	Product containing only collagenase (medicinal product)	4180186
36677973	Product containing only colloid sulfur and resorcinol (medicinal product)	4180186
36677975	Product containing only compound tincture benzoin (medicinal product)	4180186
36677976	Product containing only conivaptan (medicinal product)	4180186
36677980	Product containing only copanlisib (medicinal product)	4180186
36677990	Product containing only crisaborole (medicinal product)	4180186
36677993	Product containing only crofelemer (medicinal product)	4180186
36677996	Cromoglicic acid and salbutamol only product	4180186
36677996	Product containing only cromoglicic acid and salbutamol (medicinal product)	4180186
36677997	Cromoglicic acid and xylometazoline only product	4180186
36677997	Product containing only cromoglicic acid and xylometazoline (medicinal product)	4180186
36678000	Product containing only crotamiton and hydrocortisone (medicinal product)	4180186
36678001	Product containing only cuprous oxide (medicinal product)	4180186
36678004	Product containing only cyclandelate (medicinal product)	4180186
36678005	Product containing only cyclizine (medicinal product)	4180186
36678008	Product containing only cyclobarbital (medicinal product)	4180186
36678013	Product containing only cyclopenthiazide (medicinal product)	4180186
36678014	Product containing only cyclopenthiazide and oxprenolol (medicinal product)	4180186
36678015	Product containing only cyclopentolate (medicinal product)	4180186
36678017	Product containing only cyclophosphamide (medicinal product)	4180186
36678018	Product containing only cyclopropane (medicinal product)	4180186
36678023	Product containing only cysteine (medicinal product)	4180186
36678024	Cytomegalovirus immunoglobulin only product	4180186
36678024	Product containing only Cytomegalovirus antibody (medicinal product)	4180186
36678026	Product containing only dabrafenib (medicinal product)	4180186
36678027	Product containing only dacarbazine (medicinal product)	4180186
36678028	Product containing only daclatasvir (medicinal product)	4180186
36678029	Product containing only daclizumab (medicinal product)	4180186
36678030	Product containing only dactinomycin (medicinal product)	4180186
36678033	Product containing only dalfopristin and quinupristin (medicinal product)	4180186
36678035	Product containing only danaparoid (medicinal product)	4180186
36678036	Product containing only danazol (medicinal product)	4180186
36678040	Product containing only dantron and poloxamer 188 (medicinal product)	4180186
36678040	Dantron and poloxamer 188 only product	4180186
36678051	Product containing only dasatinib (medicinal product)	4180186
36678054	Product containing only deferasirox (medicinal product)	4180186
36678055	Product containing only deferiprone (medicinal product)	4180186
36678056	Product containing only deferoxamine (medicinal product)	4180186
36678057	Product containing only defibrotide (medicinal product)	4180186
36678058	Product containing only deflazacort (medicinal product)	4180186
36678060	Product containing only dehydrocholic acid (medicinal product)	4180186
36678061	Product containing only dehydrocholic acid and pancreatin and simeticone (medicinal product)	4180186
36678061	Dehydrocholic acid and pancreatin and simeticone only product	4180186
36678062	Product containing only dehydroepiandrosterone (medicinal product)	4180186
36678065	Product containing only delavirdine (medicinal product)	4180186
36678072	Product containing only denufosol (medicinal product)	4180186
36678076	Product containing only deracoxib (medicinal product)	4180186
36678078	Product containing only deserpidine and methyclothiazide (medicinal product)	4180186
36678079	Product containing only desflurane (medicinal product)	4180186
36678080	Product containing only desipramine (medicinal product)	4180186
36678081	Product containing only desirudin (medicinal product)	4180186
36678083	Product containing only desloratadine (medicinal product)	4180186
36678088	Product containing only desonide (medicinal product)	4180186
36678090	Product containing only desoximetasone and salicylic acid (medicinal product)	4180186
36678091	Product containing only desvenlafaxine (medicinal product)	4180186
36678093	Product containing only dexamethasone (medicinal product)	4180186
36678096	Product containing only dexamethasone and tobramycin (medicinal product)	4180186
36678098	Product containing only dexamfetamine (medicinal product)	4180186
36678098	Dexamfetamine only product	4180186
36678099	Product containing only dexbrompheniramine (medicinal product)	4180186
36678100	Product containing only dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product)	4180186
36678100	Dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine only product	4180186
36678104	Product containing only dexchlorpheniramine (medicinal product)	4180186
36678108	Product containing only dexlansoprazole (medicinal product)	4180186
36678110	Product containing only dexmethylphenidate (medicinal product)	4180186
36678112	Product containing only dexrazoxane (medicinal product)	4180186
36678113	Product containing only dextran (medicinal product)	4180186
36678114	Product containing only dextran 70 (medicinal product)	4180186
36678116	Product containing only dextranomer (medicinal product)	4180186
36678117	Product containing only dextromethorphan and diphenhydramine (medicinal product)	4180186
36678119	Product containing only dextromethorphan and doxylamine and paracetamol and pseudoephedrine (medicinal product)	4180186
36678119	Dextromethorphan and doxylamine and paracetamol and pseudoephedrine only product	4180186
36678120	Product containing only dextromethorphan and guaifenesin (medicinal product)	4180186
36678121	Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	4180186
36678122	Product containing only dextromethorphan and guaifenesin and pseudoephedrine (medicinal product)	4180186
36678124	Product containing only dextromethorphan and paracetamol and pseudoephedrine (medicinal product)	4180186
36678124	Dextromethorphan and paracetamol and pseudoephedrine only product	4180186
36678125	Product containing only dextromethorphan and phenylephrine (medicinal product)	4180186
36678126	Product containing only dextromethorphan and promethazine (medicinal product)	4180186
36678127	Product containing only dextromethorphan and pseudoephedrine (medicinal product)	4180186
36678128	Product containing only dextromethorphan and triprolidine (medicinal product)	4180186
36678129	Product containing only dextromoramide (medicinal product)	4180186
36678132	Product containing only dextrothyroxine (medicinal product)	4180186
36678134	Product containing only di-2-ethylhexyl phthalate (medicinal product)	4180186
36678137	Product containing only diamorphine (medicinal product)	4180186
36678138	Product containing only diazepam (medicinal product)	4180186
36678139	Product containing only diazoxide (medicinal product)	4180186
36678140	Product containing only dibenzothiazyl disulfide (medicinal product)	4180186
36678141	Product containing only dibotermin alfa (medicinal product)	4180186
36678144	Product containing only dibrompropamidine and undecylenic acid (medicinal product)	4180186
36678144	Dibrompropamidine and undecylenic acid only product	4180186
36678147	Product containing only dibutylthiourea (medicinal product)	4180186
36678149	Product containing only dichloralphenazone and isometheptene and paracetamol (medicinal product)	4180186
36678149	Dichloralphenazone and isometheptene and paracetamol only product	4180186
36678153	Product containing only dichlorophen (medicinal product)	4180186
36678155	Product containing only dichloroxylenol (medicinal product)	4180186
36678157	Product containing only diclofenac and misoprostol (medicinal product)	4180186
36678160	Product containing only dicoumarol (medicinal product)	4180186
36678160	Dicoumarol only product	4180186
36678161	Dicycloverine only product	4180186
36678161	Product containing only dicycloverine (medicinal product)	4180186
36678163	Product containing only dienestrol (medicinal product)	4180186
36678164	Product containing only dienogest (medicinal product)	4180186
36678165	Product containing only diethyl methacrylate (medicinal product)	4180186
36678166	Product containing only diethyl phthalate (medicinal product)	4180186
36678168	Product containing only diethylcarbamazine (medicinal product)	4180186
36678173	Product containing only diethylthiourea (medicinal product)	4180186
36678174	Product containing only diflorasone (medicinal product)	4180186
36678176	Product containing only diflunisal (medicinal product)	4180186
36678178	Product containing only Digitalis (medicinal product)	4180186
36678179	Product containing only digitoxin (medicinal product)	4180186
36678180	Product containing only digoxin (medicinal product)	4180186
36678183	Product containing only dihydrocodeine and paracetamol (medicinal product)	4180186
36678183	Dihydrocodeine and paracetamol only product	4180186
36678187	Product containing only dihydrotachysterol (medicinal product)	4180186
36678188	Product containing only androstanolone (medicinal product)	4180186
36678189	Product containing only diiodohydroxyquinoline (medicinal product)	4180186
36678189	Diiodohydroxyquinoline only product	4180186
36678190	Product containing only diiodohydroxyquinoline and hydrocortisone (medicinal product)	4180186
36678190	Diiodohydroxyquinoline and hydrocortisone only product	4180186
36678191	Product containing only diloxanide (medicinal product)	4180186
36678193	Product containing only diltiazem (medicinal product)	4180186
36678194	Product containing only diltiazem and enalapril (medicinal product)	4180186
36678195	Product containing only dimenhydrinate (medicinal product)	4180186
36678198	Product containing only dimethyl fumarate (medicinal product)	4180186
36678204	Product containing only dimethylphthalate (medicinal product)	4180186
36678205	Dimeticone only product	4180186
36678205	Product containing only dimeticone (medicinal product)	4180186
36678206	Product containing only dimeticone and white paraffin (medicinal product)	4180186
36678206	Dimeticone and white paraffin only product	4180186
36678207	Product containing only dimeticone and zinc oxide (medicinal product)	4180186
36678207	Dimeticone and zinc oxide only product	4180186
36678208	Dimetindene only product	4180186
36678208	Product containing only dimetindene (medicinal product)	4180186
36678212	Product containing only dioctahedral smectite (medicinal product)	4180186
36678214	Product containing only diperodon (medicinal product)	4180186
36678216	Product containing only diphenhydramine (medicinal product)	4180186
36678219	Diphenhydramine and paracetamol only product	4180186
36678219	Product containing only diphenhydramine and paracetamol (medicinal product)	4180186
36678221	Product containing only diphenhydramine and pseudoephedrine (medicinal product)	4180186
36678224	Product containing only diphenoxylate (medicinal product)	4180186
36678225	Product containing only diphenylbutylpiperidine (medicinal product)	4180186
36678227	Product containing only diphenylmethane di-isocyanate (medicinal product)	4180186
36678228	Product containing only diphenylpyraline (medicinal product)	4180186
36678229	Product containing only diphenylthiourea (medicinal product)	4180186
36678230	Product containing only diphtheria antitoxin (medicinal product)	4180186
36678232	Product containing only dipipanone (medicinal product)	4180186
36678239	Product containing only disperse blue 106 (medicinal product)	4180186
36678240	Product containing only disperse blue 124 (medicinal product)	4180186
36678241	Product containing only disperse blue 153 (medicinal product)	4180186
36678242	Product containing only disperse blue 3 (medicinal product)	4180186
36678243	Product containing only disperse blue 35 (medicinal product)	4180186
36678247	Product containing only disperse orange 13 (medicinal product)	4180186
36678248	Product containing only disperse orange 3 (medicinal product)	4180186
36678252	Product containing only disperse yellow 9 (medicinal product)	4180186
36678253	Product containing only distigmine (medicinal product)	4180186
36678255	Product containing only dithiodimorpholine (medicinal product)	4180186
36678258	Product containing only dobutamine (medicinal product)	4180186
36678259	Product containing only docetaxel (medicinal product)	4180186
36678260	Product containing only docosahexaenoic acid and eicosapentaenoic acid (medicinal product)	4180186
36678262	Product containing only docusate and ferrous fumarate (medicinal product)	4180186
36678266	Product containing only dofetilide (medicinal product)	4180186
36678268	Product containing only dolutegravir (medicinal product)	4180186
36678270	Product containing only domiphen (medicinal product)	4180186
36678271	Product containing only domiphen and lidocaine (medicinal product)	4180186
36678272	Product containing only domperidone (medicinal product)	4180186
36678275	Product containing only donepezil and memantine (medicinal product)	4180186
36678277	Product containing only dopexamine (medicinal product)	4180186
36678278	Product containing only doripenem (medicinal product)	4180186
36678280	Product containing only dorzolamide (medicinal product)	4180186
36678282	Dosulepin only product	4180186
36678282	Product containing only dosulepin (medicinal product)	4180186
36678283	Product containing only doxacurium (medicinal product)	4180186
36678285	Product containing only doxepin (medicinal product)	4180186
36678288	Product containing only doxylamine (medicinal product)	4180186
36678292	Product containing only dronedarone (medicinal product)	4180186
36678294	Product containing only droperidol and fentanyl (medicinal product)	4180186
36678296	Product containing only drospirenone and estradiol (medicinal product)	4180186
36678300	Product containing only droxidopa (medicinal product)	4180186
36678301	Product containing only dulaglutide (medicinal product)	4180186
36678304	Product containing only durvalumab (medicinal product)	4180186
36678305	Product containing only dutasteride (medicinal product)	4180186
36678307	Product containing only duvoglustat (medicinal product)	4180186
36678310	Product containing only dydrogesterone and estradiol (medicinal product)	4180186
36678311	Product containing only ecallantide (medicinal product)	4180186
36678315	Product containing only econazole and hydrocortisone (medicinal product)	4180186
36678318	Product containing only eculizumab (medicinal product)	4180186
36678319	Product containing only edaravone (medicinal product)	4180186
36678321	Product containing only edoxaban (medicinal product)	4180186
36678323	Product containing only efalizumab (medicinal product)	4180186
36678324	Product containing only efavirenz (medicinal product)	4180186
36678328	Product containing only eicosapentaenoic acid (medicinal product)	4180186
36678330	Product containing only elagolix (medicinal product)	4180186
36678332	Product containing only eliglustat (medicinal product)	4180186
36678333	Product containing only elosulfase alfa (medicinal product)	4180186
36678334	Product containing only eltrombopag (medicinal product)	4180186
36678335	Product containing only eluxadoline (medicinal product)	4180186
36678336	Product containing only elvitegravir (medicinal product)	4180186
36678338	Product containing only emepronium (medicinal product)	4180186
36678339	Product containing only emetine (medicinal product)	4180186
36678340	Product containing only emicizumab (medicinal product)	4180186
36678341	Product containing only empagliflozin (medicinal product)	4180186
36678344	Product containing only emtricitabine (medicinal product)	4180186
36678346	Product containing only emtricitabine and tenofovir (medicinal product)	4180186
36678350	Product containing only enasidenib (medicinal product)	4180186
36678355	Product containing only enfuvirtide (medicinal product)	4180186
36678356	Product containing only enoxacin (medicinal product)	4180186
36678357	Product containing only enoxaparin (medicinal product)	4180186
36678358	Product containing only enoximone (medicinal product)	4180186
36678359	Product containing only enoxolone (medicinal product)	4180186
36678359	Enoxolone only product	4180186
36678360	Enoxolone and hyaluronic acid and povidone only product	4180186
36678360	Product containing only enoxolone and hyaluronic acid and povidone (medicinal product)	4180186
36678362	Product containing only entacapone (medicinal product)	4180186
36678363	Product containing only entecavir (medicinal product)	4180186
36678365	Product containing only enzalutamide (medicinal product)	4180186
36678372	Product containing only epinastine (medicinal product)	4180186
36678373	Product containing only epinephrine (medicinal product)	4180186
36678373	Adrenaline only product	4180186
36678375	Product containing only epinephrine and fluorouracil (medicinal product)	4180186
36678375	Adrenaline and fluorouracil only product	4180186
36678376	Product containing only epinephrine and guanethidine (medicinal product)	4180186
36678376	Adrenaline and guanethidine only product	4180186
36678379	Product containing only epinephrine and pilocarpine (medicinal product)	4180186
36678379	Adrenaline and pilocarpine only product	4180186
36678381	Product containing epinephrine and zinc sulfate (medicinal product)	4180186
36678381	Adrenaline- and zinc sulfate-containing product	4180186
36678385	Product containing only epoetin alfa (medicinal product)	4180186
36678389	Product containing only epoetin zeta (medicinal product)	4180186
36678393	Product containing only eprosartan (medicinal product)	4180186
36678394	Product containing only eprosartan and hydrochlorothiazide (medicinal product)	4180186
36678396	Product containing only eravacycline (medicinal product)	4180186
36678397	Product containing only erbium-169 (medicinal product)	4180186
36678399	Product containing only erenumab (medicinal product)	4180186
36678400	Product containing only ergocalciferol (medicinal product)	4180186
36678403	Product containing only ergosterol (medicinal product)	4180186
36678407	Product containing only erlotinib (medicinal product)	4180186
36678409	Product containing only ertugliflozin (medicinal product)	4180186
36678410	Product containing only erythromycin (medicinal product)	4180186
36678416	Product containing only erythropoietin (medicinal product)	4180186
36678417	Product containing only erythrosin B stain (medicinal product)	4180186
36678419	Product containing only escitalopram (medicinal product)	4180186
36678420	Product containing only eslicarbazepine (medicinal product)	4180186
36678421	Product containing only esmolol (medicinal product)	4180186
36678422	Product containing only esomeprazole (medicinal product)	4180186
36678423	Product containing only esomeprazole and naproxen (medicinal product)	4180186
36678424	Product containing only estazolam (medicinal product)	4180186
36678425	Product containing only esterified estrogen (medicinal product)	4180186
36678426	Product containing only esterified estrogen and methyltestosterone (medicinal product)	4180186
36678428	Product containing only estradiol and levonorgestrel (medicinal product)	4180186
36678429	Product containing only estradiol and medroxyprogesterone (medicinal product)	4180186
36678430	Product containing only estradiol and norethisterone (medicinal product)	4180186
36678430	Estradiol and norethisterone only product	4180186
36678431	Product containing only estradiol and norgestrel (medicinal product)	4180186
36678432	Product containing only estramustine (medicinal product)	4180186
36678435	Product containing only eszopiclone (medicinal product)	4180186
36678437	Product containing only etamivan (medicinal product)	4180186
36678437	Etamivan only product	4180186
36678438	Product containing only etamsylate (medicinal product)	4180186
36678439	Product containing only etanercept (medicinal product)	4180186
36678441	Product containing only eteplirsen (medicinal product)	4180186
36678445	Ethambutol and isoniazid and pyrazinamide and rifampicin only product	4180186
36678445	Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product)	4180186
36678446	Ethambutol and isoniazid and rifampicin only product	4180186
36678446	Product containing only ethambutol and isoniazid and rifampicin (medicinal product)	4180186
36678447	Product containing only ethanolamine (medicinal product)	4180186
36678448	Product containing only ethchlorvynol (medicinal product)	4180186
36678449	Product containing only ethinylestradiol (medicinal product)	4180186
36678449	Ethinylestradiol only product	4180186
36678453	Ethinylestradiol and gestodene only product	4180186
36678453	Product containing only ethinylestradiol and gestodene (medicinal product)	4180186
36678458	Ethinylestradiol and norgestrel only product	4180186
36678458	Product containing only ethinylestradiol and norgestrel (medicinal product)	4180186
36678461	Product containing only ethionamide (medicinal product)	4180186
36678462	Product containing only ethisterone (medicinal product)	4180186
36678464	Product containing only ethosuximide (medicinal product)	4180186
36678466	Product containing only ethyl 4-hydroxybenzoate (medicinal product)	4180186
36678468	Product containing only ethanol (medicinal product)	4180186
36678469	Product containing only ethanol and glycine (medicinal product)	4180186
36678472	Product containing only ethyl chloride (medicinal product)	4180186
36678473	Product containing only ethyl methacrylate (medicinal product)	4180186
36678478	Product containing only ethylenediamine dihydrochloride (medicinal product)	4180186
36678480	Product containing only ethylestrenol (medicinal product)	4180186
36678481	Product containing only etidocaine (medicinal product)	4180186
36678483	Product containing only etodolac (medicinal product)	4180186
36678484	Product containing only etofenamate (medicinal product)	4180186
36678485	Product containing only etofibrate (medicinal product)	4180186
36678486	Product containing only etomidate (medicinal product)	4180186
36678487	Product containing only etonogestrel (medicinal product)	4180186
36678488	Product containing only etoposide (medicinal product)	4180186
36678489	Product containing only etoricoxib (medicinal product)	4180186
36678490	Product containing only etravirine (medicinal product)	4180186
36678491	Product containing only etretinate (medicinal product)	4180186
36678492	Product containing only etynodiol (medicinal product)	4180186
36678492	Etynodiol only product	4180186
36678497	VPS45 deficiency	4180186
36678497	Congenital neutropenia, bone marrow fibrosis, nephromegaly syndrome	4180186
36678497	Congenital neutropenia, myelofibrosis, nephromegaly syndrome (disorder)	4180186
36678498	Product containing only evolocumab (medicinal product)	4180186
36678499	Product containing only exalamide (medicinal product)	4180186
36678502	Product containing only ezetimibe (medicinal product)	4180186
36678503	Product containing only ezetimibe and simvastatin (medicinal product)	4180186
36678505	Product containing only coagulation factor VIII and von Willebrand factor (medicinal product)	4180186
36678506	Product containing only famciclovir (medicinal product)	4180186
36678508	Product containing only febuxostat (medicinal product)	4180186
36678509	Product containing only felbamate (medicinal product)	4180186
36678511	Product containing only felodipine (medicinal product)	4180186
36678514	Product containing only fenbufen (medicinal product)	4180186
36678515	Product containing only fenfluramine (medicinal product)	4180186
36678516	Product containing only fenofibrate (medicinal product)	4180186
36678519	Product containing only fenoprofen (medicinal product)	4180186
36678525	Product containing only ferric ammonium citrate (medicinal product)	4180186
36678527	Product containing only ferric carboxymaltose (medicinal product)	4180186
36678529	Product containing only ferric citrate (medicinal product)	4180186
36678530	Product containing only ferric hexacyanoferrate-II (medicinal product)	4180186
36678534	Product containing only ferrous gluconate (medicinal product)	4180186
36678535	Product containing only ferrous gluconate and folic acid (medicinal product)	4180186
36678536	Product containing only ferrous glycine sulfate (medicinal product)	4180186
36678540	Product containing only ferrous sulfate and folic acid (medicinal product)	4180186
36678541	Product containing only ferucarbotran (medicinal product)	4180186
36678542	Product containing only ferumoxide (medicinal product)	4180186
36678546	Product containing only fexofenadine (medicinal product)	4180186
36678547	Product containing only fexofenadine and pseudoephedrine (medicinal product)	4180186
36678548	Product containing only plant fiber (medicinal product)	4180186
36678548	Plant fibre only product	4180186
36678549	Product containing only fidaxomicin (medicinal product)	4180186
36678550	Product containing only filgrastim (medicinal product)	4180186
36678551	Product containing only finafloxacin (medicinal product)	4180186
36678553	Product containing only fingolimod (medicinal product)	4180186
36678554	Product containing only firocoxib (medicinal product)	4180186
36678556	Product containing only fish insulin (medicinal product)	4180186
36678559	Product containing only fleroxacin (medicinal product)	4180186
36678560	Product containing only flibanserin (medicinal product)	4180186
36678561	Product containing only florfenicol (medicinal product)	4180186
36678562	Product containing only flosequinan (medicinal product)	4180186
36678563	Product containing only floxuridine (medicinal product)	4180186
36678565	Product containing only fluclorolone (medicinal product)	4180186
36678567	Product containing only fluconazole (medicinal product)	4180186
36678569	Product containing only fludarabine (medicinal product)	4180186
36678570	Product containing only fludrocortisone (medicinal product)	4180186
36678573	Flumetasone only product	4180186
36678573	Product containing only flumetasone (medicinal product)	4180186
36678574	Product containing only flunisolide (medicinal product)	4180186
36678575	Product containing only flunitrazepam (medicinal product)	4180186
36678577	Product containing only fluocinolone and hydroquinone and tretinoin (medicinal product)	4180186
36678580	Product containing only fluocortolone (medicinal product)	4180186
36678581	Product containing only fluorescein stain (medicinal product)	4180186
36678585	Product containing only fluorine-18 (medicinal product)	4180186
36678587	Product containing only fluorometholone and tobramycin (medicinal product)	4180186
36678588	Product containing only fluorouracil (medicinal product)	4180186
36678589	Product containing only fluoxetine (medicinal product)	4180186
36678596	Product containing only fluprednidene and miconazole (medicinal product)	4180186
36678597	Product containing only fluprednisolone (medicinal product)	4180186
36678599	Product containing only flurbiprofen (medicinal product)	4180186
36678604	Product containing only fluticasone and umeclidinium and vilanterol (medicinal product)	4180186
36678606	Product containing only fluvastatin (medicinal product)	4180186
36678607	Product containing only fluvoxamine (medicinal product)	4180186
36678611	Product containing only follitropin alfa and lutropin alfa (medicinal product)	4180186
36678612	Product containing only follitropin delta (medicinal product)	4180186
36678616	Product containing only fomepizole (medicinal product)	4180186
36678622	Product containing only formoterol and mometasone (medicinal product)	4180186
36678626	Product containing only foscarnet (medicinal product)	4180186
36678631	Product containing only fospropofol (medicinal product)	4180186
36678634	Product containing only frovatriptan (medicinal product)	4180186
36678637	Product containing only furazolidone (medicinal product)	4180186
36678638	Product containing only furosemide (medicinal product)	4180186
36678643	Product containing only fusafungine (medicinal product)	4180186
36678644	Product containing only fusidic acid (medicinal product)	4180186
36678645	Product containing only fusidic acid and hydrocortisone (medicinal product)	4180186
36678646	Product containing only gabapentin (medicinal product)	4180186
36678650	Product containing only gadofosveset (medicinal product)	4180186
36678651	Product containing only gadopentetic acid (medicinal product)	4180186
36678652	Product containing only gadoterate meglumine (medicinal product)	4180186
36678653	Product containing only gadoteridol (medicinal product)	4180186
36678654	Product containing only gadoversetamide (medicinal product)	4180186
36678657	Product containing only galactose and palmitic acid (medicinal product)	4180186
36678658	Product containing only galantamine (medicinal product)	4180186
36678661	Product containing only gallium-67 (medicinal product)	4180186
36678662	Product containing only galsulfase (medicinal product)	4180186
36678663	Product containing only lindane (medicinal product)	4180186
36678671	Product containing only gatifloxacin (medicinal product)	4180186
36678673	Autosomal recessive cerebral atrophy (disorder)	4180186
36678674	Product containing only gelatin (medicinal product)	4180186
36678675	Product containing only gemcitabine (medicinal product)	4180186
36678676	Product containing only gemeprost (medicinal product)	4180186
36678677	Product containing only gemfibrozil (medicinal product)	4180186
36678678	Product containing only gemifloxacin (medicinal product)	4180186
36678680	Product containing only gentamicin (medicinal product)	4180186
36678681	Product containing only gentamicin and hydrocortisone (medicinal product)	4180186
36678682	Product containing only gentamicin and prednisolone (medicinal product)	4180186
36678684	Product containing only Geranium oil bourbon (medicinal product)	4180186
36678686	Product containing only gestonorone (medicinal product)	4180186
36678688	Product containing only glacial acetic acid (medicinal product)	4180186
36678691	Product containing only glibenclamide (medicinal product)	4180186
36678691	Glibenclamide only product	4180186
36678693	Product containing only glibornuride (medicinal product)	4180186
36678697	Product containing only glimepiride and rosiglitazone (medicinal product)	4180186
36678698	Product containing only glipizide (medicinal product)	4180186
36678699	Product containing only glipizide and metformin (medicinal product)	4180186
36678701	Product containing only glucagon (medicinal product)	4180186
36678702	Product containing only glucarpidase (medicinal product)	4180186
36678704	Product containing only glucosamine (medicinal product)	4180186
36678705	Product containing only glucose (medicinal product)	4180186
36678706	Product containing only glucose and glutathione and hypromellose (medicinal product)	4180186
36678709	Product containing only glucose and potassium chloride and sodium chloride (medicinal product)	4180186
36678710	Product containing only glucose and sodium chloride (medicinal product)	4180186
36678711	Product containing only glutamic acid (medicinal product)	4180186
36678713	Product containing only glutaraldehyde (medicinal product)	4180186
36678716	Product containing only glycerol and honey (medicinal product)	4180186
36678716	Glycerol and honey only product	4180186
36678717	Product containing only glycerol and sucrose (medicinal product)	4180186
36678717	Glycerol and sucrose only product	4180186
36678719	Product containing only glyceryl monothioglycolate (medicinal product)	4180186
36678723	Product containing only glycopyrronium (medicinal product)	4180186
36678724	Product containing only glycopyrronium and neostigmine (medicinal product)	4180186
36678725	Product containing only glymidine (medicinal product)	4180186
36678726	Product containing only gold (medicinal product)	4180186
36678732	Product containing only gramicidin d (medicinal product)	4180186
36678734	Product containing only green soap (medicinal product)	4180186
36678734	Soft soap only product	4180186
36678735	Product containing only green soap and industrial methylated spirit (medicinal product)	4180186
36678735	Industrial methylated spirit and soft soap only product	4180186
36678736	Product containing only grepafloxacin (medicinal product)	4180186
36678737	Product containing only griseofulvin (medicinal product)	4180186
36678738	Product containing only guaiacol (medicinal product)	4180186
36678740	Product containing only guaifenesin and phenylephrine (medicinal product)	4180186
36678742	Product containing only guaifenesin and phenylpropanolamine (medicinal product)	4180186
36678743	Product containing only guaifenesin and theophylline (medicinal product)	4180186
36678748	Product containing only guanfacine (medicinal product)	4180186
36678749	Product containing only guanidine (medicinal product)	4180186
36678751	Product containing only guselkumab (medicinal product)	4180186
36678753	Product containing only halcinonide (medicinal product)	4180186
36678754	Product containing only halibut liver oil (medicinal product)	4180186
36678755	Product containing only halobetasol (medicinal product)	4180186
36678758	Product containing only haloperidol (medicinal product)	4180186
36678759	Product containing only haloprogin (medicinal product)	4180186
36678764	Product containing only heparin (medicinal product)	4180186
36678768	Product containing only heparinoid and salicylic acid (medicinal product)	4180186
36678769	Product containing only surface antigen of Hepatitis B virus (medicinal product)	4180186
36678772	Product containing only hetastarch and sodium chloride (medicinal product)	4180186
36678773	Product containing only hexachlorophene (medicinal product)	4180186
36678775	Product containing only hexestrol (medicinal product)	4180186
36678776	Product containing only hexetidine (medicinal product)	4180186
36678778	Product containing only hexocyclium (medicinal product)	4180186
36678780	Product containing only hexylresorcinol (medicinal product)	4180186
36678784	Product containing only homatropine and hydrocodone (medicinal product)	4180186
36678786	Product containing only human chorionic gonadotropin (medicinal product)	4180186
36678789	Product containing only human immunoglobulin (medicinal product)	4180186
36678790	Colobomatous microphthalmia, obesity, hypogenitalism, intellectual disability syndrome (disorder)	4180186
36678791	Product containing only human immunoglobulin G (medicinal product)	4180186
36678793	Human insulin soluble only product	4180186
36678793	Product containing only human regular insulin (medicinal product)	4180186
36678794	Product containing only human insulin zinc suspension crystalline (medicinal product)	4180186
36678798	Product containing only human protease inhibitor protein (medicinal product)	4180186
36678802	Product containing only hyaluronic acid (medicinal product)	4180186
36678803	Product containing only hyaluronic acid and lidocaine (medicinal product)	4180186
36678804	Product containing only hyaluronidase (medicinal product)	4180186
36678808	Product containing only hydralazine and isosorbide (medicinal product)	4180186
36678812	Product containing only hydrochlorothiazide (medicinal product)	4180186
36678813	Product containing only hydrochlorothiazide and irbesartan (medicinal product)	4180186
36678818	Product containing only hydrochlorothiazide and metoprolol (medicinal product)	4180186
36678820	Product containing only hydrochlorothiazide and olmesartan (medicinal product)	4180186
36678821	Product containing only hydrochlorothiazide and propranolol (medicinal product)	4180186
36678824	Product containing only hydrochlorothiazide and spironolactone (medicinal product)	4180186
36678828	Product containing only hydrochlorothiazide and valsartan (medicinal product)	4180186
36678829	Product containing only hydrocodone (medicinal product)	4180186
36678830	Product containing only hydrocodone and ibuprofen (medicinal product)	4180186
36678832	Product containing only hydrocodone and phenylephrine (medicinal product)	4180186
36678837	Product containing only hydrocortisone (medicinal product)	4180186
36678840	Product containing only hydrocortisone and neomycin (medicinal product)	4180186
36678843	Product containing only hydrocortisone and oxytetracycline (medicinal product)	4180186
36678845	Product containing only hydrocortisone and pramocaine (medicinal product)	4180186
36678845	Hydrocortisone and pramocaine only product	4180186
36678846	Product containing only hydrocortisone and urea (medicinal product)	4180186
36678849	Product containing only hydrogen peroxide (medicinal product)	4180186
36678850	Product containing only hydromorphone (medicinal product)	4180186
36678852	Product containing only hydrotalcite (medicinal product)	4180186
36678853	Product containing only hydrotalcite and simeticone (medicinal product)	4180186
36678853	Hydrotalcite and simeticone only product	4180186
36678855	Product containing only hydroxyalprazolam (medicinal product)	4180186
36678860	Product containing only hydroxycitronellal (medicinal product)	4180186
36678862	Product containing only hydroxyprogesterone (medicinal product)	4180186
36678863	Product containing only hydroxypropyl cellulose (medicinal product)	4180186
36678864	Product containing only hydroxyzine (medicinal product)	4180186
36678865	Product containing only hyoscyamine (medicinal product)	4180186
36678866	Hyoscyamine and phenazopyridine and secbutabarbital only product	4180186
36678866	Product containing only hyoscyamine and phenazopyridine and secbutabarbital (medicinal product)	4180186
36678867	Product containing only hypromellose (medicinal product)	4180186
36678868	Product containing only hypromellose and phenylephrine (medicinal product)	4180186
36678871	Product containing only ibritumomab tiuxetan (medicinal product)	4180186
36678873	Product containing only ibuprofen (medicinal product)	4180186
36678880	Product containing only ichthammol (medicinal product)	4180186
36678881	Product containing only ichthammol and zinc (medicinal product)	4180186
36678882	Product containing only ichthammol and zinc oxide (medicinal product)	4180186
36678886	Product containing only idebenone (medicinal product)	4180186
36678887	Product containing only idelalisib (medicinal product)	4180186
36678888	Product containing only idoxuridine (medicinal product)	4180186
36678889	Product containing only idursulfase (medicinal product)	4180186
36678891	Product containing only iloperidone (medicinal product)	4180186
36678896	Product containing only imidazolidinyl urea (medicinal product)	4180186
36678897	Product containing only imidocarb (medicinal product)	4180186
36678898	Product containing only imiglucerase (medicinal product)	4180186
36678900	Product containing only imipramine (medicinal product)	4180186
36678904	Product containing only indacaterol (medicinal product)	4180186
36678907	Product containing only indinavir (medicinal product)	4180186
36678909	Product containing only indium colloid (medicinal product)	4180186
36678912	Product containing only indium-111 (medicinal product)	4180186
36678913	Product containing only indium-113m (medicinal product)	4180186
36678914	Product containing only indocyanine green (medicinal product)	4180186
36678916	Product containing only indoramin (medicinal product)	4180186
36678917	Product containing only industrial methylated spirit (medicinal product)	4180186
36678919	Product containing only ingenol mebutate (medicinal product)	4180186
36678921	Product containing only inositol (medicinal product)	4180186
36678923	Product containing only insulin (medicinal product)	4180186
36678925	Product containing only insulin aspart and insulin degludec (medicinal product)	4180186
36678926	Product containing only insulin degludec (medicinal product)	4180186
36678927	Product containing only insulin degludec and liraglutide (medicinal product)	4180186
36678928	Product containing only insulin detemir (medicinal product)	4180186
36678931	Product containing only insulin lispro protamine (medicinal product)	4180186
36678933	Product containing only interferon alfa-2a (medicinal product)	4180186
36678934	Product containing only interferon alfa-2b (medicinal product)	4180186
36678935	Product containing only interferon alfa-n1 (medicinal product)	4180186
36678937	Product containing only interferon alfacon-1 (medicinal product)	4180186
36678940	Product containing only interferon beta-1b (medicinal product)	4180186
36678941	Product containing only interferon gamma (medicinal product)	4180186
36678948	Product containing only iodine and isopropyl alcohol (medicinal product)	4180186
36678953	Product containing only iodine-125 (medicinal product)	4180186
36678956	Product containing only iodixanol (medicinal product)	4180186
36678957	Product containing only iodoform (medicinal product)	4180186
36678958	Product containing only iodophore (medicinal product)	4180186
36678960	Product containing only iomeprol (medicinal product)	4180186
36678961	Product containing only iopamidol (medicinal product)	4180186
36678965	Product containing only iothiouracil (medicinal product)	4180186
36678966	Product containing only iotrolan (medicinal product)	4180186
36678967	Product containing only ioversol (medicinal product)	4180186
36678968	Product containing only ioxaglate (medicinal product)	4180186
36678969	Product containing only ioxilan (medicinal product)	4180186
36678971	Product containing only ipecacuanha and sodium bicarbonate (medicinal product)	4180186
36678973	Product containing only ipratropium (medicinal product)	4180186
36678974	Product containing only ipratropium and salbutamol (medicinal product)	4180186
36678974	Ipratropium and salbutamol only product	4180186
36678979	Product containing only iron (medicinal product)	4180186
36678980	Product containing only iron carbonyl (medicinal product)	4180186
36678982	Product containing only iron ferrite (medicinal product)	4180186
36678988	Product containing only isocarboxazid (medicinal product)	4180186
36678989	Product containing only isoconazole (medicinal product)	4180186
36678990	Isoetarine only product	4180186
36678990	Product containing only isoetarine (medicinal product)	4180186
36678993	Product containing only isoflurane (medicinal product)	4180186
36678996	Product containing only isometheptene (medicinal product)	4180186
36678997	Product containing only isometheptene and paracetamol (medicinal product)	4180186
36678997	Isometheptene and paracetamol only product	4180186
36679003	Premature aging syndrome, Penttinen type	4180186
36679003	Acroosteolysis, keloid-like lesions, premature aging syndrome (disorder)	4180186
36679003	Premature ageing syndrome Penttinen type	4180186
36679003	Acroosteolysis, keloid-like lesions, premature ageing syndrome	4180186
36679006	Product containing only isopropamide (medicinal product)	4180186
36679011	Product containing only isosorbide (medicinal product)	4180186
36679014	Product containing only isoxsuprine (medicinal product)	4180186
36679019	Product containing only ivabradine (medicinal product)	4180186
36679021	Product containing only ivacaftor and lumacaftor (medicinal product)	4180186
36679023	Product containing only ivermectin (medicinal product)	4180186
36679025	Product containing only ixabepilone (medicinal product)	4180186
36679028	Product containing only jasmine synthetic (medicinal product)	4180186
36679029	Product containing only kanamycin (medicinal product)	4180186
36679032	Product containing only ketamine (medicinal product)	4180186
36679034	Product containing only ketazolam (medicinal product)	4180186
36679036	Product containing only ketoprofen (medicinal product)	4180186
36679037	Product containing only ketorolac (medicinal product)	4180186
36679039	Product containing only ketotifen (medicinal product)	4180186
36679040	Product containing only labetalol (medicinal product)	4180186
36679041	Product containing only lachesine chloride (medicinal product)	4180186
36679044	Product containing only lactic acid (medicinal product)	4180186
36679048	Product containing only lactitol (medicinal product)	4180186
36679051	Product containing only lamivudine (medicinal product)	4180186
36679054	Product containing only lamivudine and stavudine (medicinal product)	4180186
36679056	Product containing only lamotrigine (medicinal product)	4180186
36679057	Product containing only lanadelumab (medicinal product)	4180186
36679060	Product containing only lanreotide (medicinal product)	4180186
36679061	Product containing only lansoprazole (medicinal product)	4180186
36679062	Product containing only lansoprazole and naproxen (medicinal product)	4180186
36679064	Product containing only lapatinib (medicinal product)	4180186
36679065	Product containing only laronidase (medicinal product)	4180186
36679066	Product containing only latamoxef (medicinal product)	4180186
36679066	Latamoxef only product	4180186
36679067	Product containing only latanoprost (medicinal product)	4180186
36679068	Product containing only latanoprost and timolol (medicinal product)	4180186
36679070	Product containing only laurel oil (medicinal product)	4180186
36679071	Product containing only lauromacrogol 400 (medicinal product)	4180186
36679075	Product containing only lavender oil (medicinal product)	4180186
36679077	Product containing only ledipasvir (medicinal product)	4180186
36679080	Product containing only lemon oil (medicinal product)	4180186
36679084	Product containing only lepirudin (medicinal product)	4180186
36679087	Product containing only letermovir (medicinal product)	4180186
36679089	Product containing only leucine (medicinal product)	4180186
36679090	Product containing only leucocyanidin (medicinal product)	4180186
36679092	Levosalbutamol only product	4180186
36679092	Product containing only levosalbutamol (medicinal product)	4180186
36679092	Product containing only levalbuterol (medicinal product)	4180186
36679095	Product containing only levobetaxolol (medicinal product)	4180186
36679096	Product containing only levobunolol (medicinal product)	4180186
36679097	Product containing only levobupivacaine (medicinal product)	4180186
36679098	Product containing only levocabastine (medicinal product)	4180186
36679099	Product containing only levocarnitine (medicinal product)	4180186
36679100	Product containing only levocetirizine (medicinal product)	4180186
36679103	Product containing only levofloxacin (medicinal product)	4180186
36679105	Product containing only levomenthol and pentane (medicinal product)	4180186
36679106	Product containing only levomepromazine (medicinal product)	4180186
36679106	Levomepromazine only product	4180186
36679107	Product containing only levomethadyl (medicinal product)	4180186
36679108	Product containing only corbadrine (medicinal product)	4180186
36679108	Corbadrine only product	4180186
36679109	Product containing only levonorgestrel (medicinal product)	4180186
36679110	Product containing only levorphanol (medicinal product)	4180186
36679112	Product containing only levothyroxine (medicinal product)	4180186
36679114	Product containing only lidocaine (medicinal product)	4180186
36679115	Product containing only lidocaine and methylprednisolone (medicinal product)	4180186
36679116	Product containing only lidocaine and neomycin and polymyxin B (medicinal product)	4180186
36679117	Product containing only lidocaine and oxytetracycline (medicinal product)	4180186
36679119	Product containing only lidocaine and prilocaine (medicinal product)	4180186
36679120	Product containing only lidocaine and tetracaine (medicinal product)	4180186
36679121	Product containing only lidocaine and zinc oxide (medicinal product)	4180186
36679123	Product containing only lifitegrast (medicinal product)	4180186
36679126	Product containing only linaclotide (medicinal product)	4180186
36679128	Product containing only linagliptin and metformin (medicinal product)	4180186
36679133	Product containing only lipoic acid (medicinal product)	4180186
36679133	Thioctic acid only product	4180186
36679134	Product containing only liraglutide (medicinal product)	4180186
36679136	Product containing only lisinopril (medicinal product)	4180186
36679138	Product containing only lissamine green B stain (medicinal product)	4180186
36679139	Product containing only lisuride (medicinal product)	4180186
36679141	Product containing only lithium carbonate (medicinal product)	4180186
36679142	Product containing only lithium citrate (medicinal product)	4180186
36679148	Product containing only lofepramine (medicinal product)	4180186
36679151	Product containing only lomustine (medicinal product)	4180186
36679152	Product containing only loperamide (medicinal product)	4180186
36679153	Loperamide and simeticone only product	4180186
36679153	Product containing only loperamide and simeticone (medicinal product)	4180186
36679154	Product containing only lopinavir (medicinal product)	4180186
36679155	Product containing only lopinavir and ritonavir (medicinal product)	4180186
36679159	Product containing only loratadine and pseudoephedrine (medicinal product)	4180186
36679161	Product containing only lormetazepam (medicinal product)	4180186
36679162	Product containing only lornoxicam (medicinal product)	4180186
36679163	Product containing only losartan (medicinal product)	4180186
36679164	Product containing only loteprednol (medicinal product)	4180186
36679167	Lovastatin and nicotinic acid only product	4180186
36679167	Product containing only lovastatin and nicotinic acid (medicinal product)	4180186
36679169	Product containing only lubiprostone (medicinal product)	4180186
36679171	Product containing only luliconazole (medicinal product)	4180186
36679175	Product containing only lusupultide (medicinal product)	4180186
36679176	Product containing only lusutrombopag (medicinal product)	4180186
36679177	Product containing only lutropin alfa (medicinal product)	4180186
36679179	Product containing only lymecycline (medicinal product)	4180186
36679180	Product containing only lymphocyte immunoglobulin (medicinal product)	4180186
36679182	Product containing only lysine (medicinal product)	4180186
36679184	Product containing only macrogol 3350 (medicinal product)	4180186
36679184	Macrogol 3350 only product	4180186
36679185	Product containing only macrogol 4000 (medicinal product)	4180186
36679185	Macrogol 4000 only product	4180186
36679186	Product containing only macrogol and propylene glycol (medicinal product)	4180186
36679186	Macrogol and propylene glycol only product	4180186
36679187	Product containing only macrogol (medicinal product)	4180186
36679187	Macrogol only product	4180186
36679188	Product containing only mafenide (medicinal product)	4180186
36679189	Product containing only magaldrate (medicinal product)	4180186
36679190	Magaldrate and simeticone only product	4180186
36679190	Product containing only magaldrate and simeticone (medicinal product)	4180186
36679191	Product containing only magnesium (medicinal product)	4180186
36679195	Product containing only magnesium carbonate (medicinal product)	4180186
36679198	Product containing only magnesium chloride (medicinal product)	4180186
36679199	Product containing only magnesium citrate (medicinal product)	4180186
36679201	Product containing only magnesium glycinate (medicinal product)	4180186
36679202	Product containing only magnesium hydroxide (medicinal product)	4180186
36679203	Product containing only magnesium hydroxide and mineral oil (medicinal product)	4180186
36679204	Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product)	4180186
36679206	Product containing only magnesium orotate (medicinal product)	4180186
36679210	Product containing only magnesium sulfate (medicinal product)	4180186
36679211	Product containing only magnesium trisilicate (medicinal product)	4180186
36679212	Product containing only malathion (medicinal product)	4180186
36679213	Product containing only mandelic acid (medicinal product)	4180186
36679216	Product containing only manganese chloride (medicinal product)	4180186
36679217	Product containing only mannitol (medicinal product)	4180186
36679218	Product containing only mannitol and sorbitol (medicinal product)	4180186
36679219	Product containing only maprotiline (medicinal product)	4180186
36679221	Product containing only maribavir (medicinal product)	4180186
36679223	Product containing only masoprocol (medicinal product)	4180186
36679224	Product containing only maxatase (medicinal product)	4180186
36679226	Product containing only mebendazole (medicinal product)	4180186
36679227	Product containing only mebeverine (medicinal product)	4180186
36679229	Product containing only mecamylamine (medicinal product)	4180186
36679231	Product containing only mecillinam (medicinal product)	4180186
36679231	Mecillinam only product	4180186
36679232	Product containing only meclocycline (medicinal product)	4180186
36679237	Medium chain triglyceride and soya oil only product	4180186
36679237	Product containing only medium chain triglyceride and soya oil (medicinal product)	4180186
36679237	Medium chain triglyceride and soya bean oil only product	4180186
36679237	Product containing only Glycine max oil and medium chain triglyceride (medicinal product)	4180186
36679238	Product containing only medroxyprogesterone (medicinal product)	4180186
36679239	Product containing only medrysone (medicinal product)	4180186
36679242	Product containing only mefruside (medicinal product)	4180186
36679245	Product containing only meglumine antimoniate (medicinal product)	4180186
36679247	Product containing only melamine formaldehyde resin (medicinal product)	4180186
36679248	Product containing only melarsoprol (medicinal product)	4180186
36679251	Product containing only meloxicam (medicinal product)	4180186
36679255	Product containing only menadiol (medicinal product)	4180186
36679258	Product containing only menthol and methyl salicylate (medicinal product)	4180186
36679264	Product containing only meprednisone (medicinal product)	4180186
36679265	Product containing only meprobamate (medicinal product)	4180186
36679266	Product containing only meptazinol (medicinal product)	4180186
36679267	Mepyramine only product	4180186
36679267	Product containing only mepyramine (medicinal product)	4180186
36679271	Product containing only merbromin (medicinal product)	4180186
36679273	Product containing only mercaptobenzothiazole (medicinal product)	4180186
36679274	Product containing only mercaptopurine (medicinal product)	4180186
36679280	Product containing only meropenem and vaborbactam (medicinal product)	4180186
36679285	Product containing only mesoridazine (medicinal product)	4180186
36679289	Mesuximide only product	4180186
36679289	Product containing only mesuximide (medicinal product)	4180186
36679291	Product containing only metalloporphyrin (medicinal product)	4180186
36679292	Metamfetamine only product	4180186
36679292	Product containing only metamfetamine (medicinal product)	4180186
36679293	Product containing only metamizole (medicinal product)	4180186
36679295	Product containing only metaraminol (medicinal product)	4180186
36679296	Product containing only metaxalone (medicinal product)	4180186
36679297	Metenolone only product	4180186
36679297	Product containing only metenolone (medicinal product)	4180186
36679299	Product containing only metformin and pioglitazone (medicinal product)	4180186
36679301	Product containing only metformin and rosiglitazone (medicinal product)	4180186
36679302	Product containing only metformin and sitagliptin (medicinal product)	4180186
36679303	Product containing only methacholine (medicinal product)	4180186
36679304	Product containing only methadone (medicinal product)	4180186
36679305	Product containing only methallenestril (medicinal product)	4180186
36679306	Product containing only methandriol (medicinal product)	4180186
36679307	Metandienone only product	4180186
36679307	Product containing only methandrostenolone (medicinal product)	4180186
36679308	Product containing only methazolamide (medicinal product)	4180186
36679310	Product containing only methenamine (medicinal product)	4180186
36679311	Product containing only methenamine and monobasic sodium phosphate (medicinal product)	4180186
36679312	Product containing only methionine (medicinal product)	4180186
36679312	Methionine only product	4180186
36679313	Methionine and paracetamol only product	4180186
36679313	Product containing only methionine and paracetamol (medicinal product)	4180186
36679315	Product containing only methocarbamol (medicinal product)	4180186
36679320	Product containing only methscopolamine (medicinal product)	4180186
36679322	Product containing only methyclothiazide (medicinal product)	4180186
36679324	Product containing only methyl 4-hydroxybenzoate (medicinal product)	4180186
36679326	Product containing only methyl nicotinate (medicinal product)	4180186
36679327	Product containing only methyl salicylate (medicinal product)	4180186
36679329	Product containing only methylcellulose-450 (medicinal product)	4180186
36679330	Mecobalamin only product	4180186
36679330	Product containing only mecobalamin (medicinal product)	4180186
36679330	Product containing only methylcobalamin (medicinal product)	4180186
36679331	Product containing only methylcysteine (medicinal product)	4180186
36679334	Product containing only methylephedrine (medicinal product)	4180186
36679335	Product containing only methylergometrine (medicinal product)	4180186
36679335	Methylergometrine only product	4180186
36679336	Product containing only methylnaltrexone (medicinal product)	4180186
36679337	Product containing only methylphenidate (medicinal product)	4180186
36679339	Product containing only methylprednisolone (medicinal product)	4180186
36679340	Product containing only methylprednisolone and neomycin (medicinal product)	4180186
36679341	Product containing only methylrosanilinium chloride (medicinal product)	4180186
36679341	Methylrosanilinium chloride only product	4180186
36679344	Product containing only methylthiouracil (medicinal product)	4180186
36679346	Product containing only methysergide (medicinal product)	4180186
36679349	Product containing only metipranolol (medicinal product)	4180186
36679350	Product containing only metirosine (medicinal product)	4180186
36679350	Metirosine only product	4180186
36679354	Product containing only metolazone (medicinal product)	4180186
36679357	Product containing only metrizamide (medicinal product)	4180186
36679358	Product containing only metrizoate (medicinal product)	4180186
36679359	Product containing only metronidazole (medicinal product)	4180186
36679360	Product containing only metronidazole and nystatin (medicinal product)	4180186
36679361	Product containing only metyrapone (medicinal product)	4180186
36679363	Product containing only mezlocillin (medicinal product)	4180186
36679365	Product containing only mibefradil (medicinal product)	4180186
36679367	Product containing only miconazole (medicinal product)	4180186
36679368	Product containing only miconazole and tioconazole (medicinal product)	4180186
36679370	Product containing only midazolam (medicinal product)	4180186
36679372	Product containing only midodrine (medicinal product)	4180186
36679373	Product containing only midostaurin (medicinal product)	4180186
36679374	Product containing only mifepristone (medicinal product)	4180186
36679377	Product containing only miglustat (medicinal product)	4180186
36679380	Product containing only miltefosine (medicinal product)	4180186
36679381	Product containing only mineral oil (medicinal product)	4180186
36679382	Product containing only mineral oil and paraffin wax and wool alcohol (medicinal product)	4180186
36679383	Product containing only mineral oil and white paraffin (medicinal product)	4180186
36679384	Product containing only mineral oil and white petrolatum (medicinal product)	4180186
36679384	Mineral oil and white soft paraffin only product	4180186
36679385	Product containing only minocycline (medicinal product)	4180186
36679390	Product containing only misoprostol and naproxen (medicinal product)	4180186
36679391	Product containing only mitobronitol (medicinal product)	4180186
36679392	Product containing only mitomycin (medicinal product)	4180186
36679395	Product containing only mivacurium (medicinal product)	4180186
36679397	Product containing only moclobemide (medicinal product)	4180186
36679398	Product containing only modafinil (medicinal product)	4180186
36679399	Product containing only moexipril (medicinal product)	4180186
36679401	Product containing only molgramostim (medicinal product)	4180186
36679407	Monobenzone only product	4180186
36679407	Product containing only monobenzone (medicinal product)	4180186
36679408	Product containing only monoctanoin (medicinal product)	4180186
36679411	Product containing only moroctocog alfa (medicinal product)	4180186
36679412	Product containing only moroxydine (medicinal product)	4180186
36679414	Product containing only morpholinylmercaptobenzothiazole (medicinal product)	4180186
36679415	Product containing only motilin (medicinal product)	4180186
36679416	Product containing only moxifloxacin (medicinal product)	4180186
36679417	Product containing only moxisylyte (medicinal product)	4180186
36679418	Product containing only moxonidine (medicinal product)	4180186
36679421	Product containing only mumps human immune globulin (medicinal product)	4180186
36679422	Product containing only mupirocin (medicinal product)	4180186
36679423	Product containing only muromonab-CD3 (medicinal product)	4180186
36679424	Product containing only musk ambrette (medicinal product)	4180186
36679425	Product containing only musk ketone (medicinal product)	4180186
36679426	Product containing only musk moskene (medicinal product)	4180186
36679430	Product containing only mycophenolic acid (medicinal product)	4180186
36679433	Product containing only N-butyl glycidyl ether (medicinal product)	4180186
36679436	Product containing only nafarelin (medicinal product)	4180186
36679442	Product containing only naldemedine (medicinal product)	4180186
36679444	Product containing only nalmefene (medicinal product)	4180186
36679445	Product containing only nalorphine (medicinal product)	4180186
36679447	Product containing only naloxone (medicinal product)	4180186
36679448	Product containing only naloxone and oxycodone (medicinal product)	4180186
36679449	Product containing only naloxone and pentazocine (medicinal product)	4180186
36679451	Product containing only nandrolone (medicinal product)	4180186
36679452	Product containing only naphazoline (medicinal product)	4180186
36679453	Product containing only naphazoline and pheniramine (medicinal product)	4180186
36679454	Product containing only naphazoline and witch hazel (medicinal product)	4180186
36679455	Product containing only naproxen (medicinal product)	4180186
36679456	Product containing only naproxen and pseudoephedrine (medicinal product)	4180186
36679457	Product containing only naproxen and sumatriptan (medicinal product)	4180186
36679458	Product containing only naptumomab (medicinal product)	4180186
36679462	Product containing only nateglinide (medicinal product)	4180186
36679463	Product containing only nebivolol (medicinal product)	4180186
36679464	Product containing only nedocromil (medicinal product)	4180186
36679466	Product containing only nefopam (medicinal product)	4180186
36679471	Product containing only neomycin and polymyxin B and pramocaine (medicinal product)	4180186
36679471	Neomycin and polymyxin B and pramocaine only product	4180186
36679472	Product containing only neomycin and polymyxin B and prednisolone (medicinal product)	4180186
36679478	Product containing only nesiritide (medicinal product)	4180186
36679479	Product containing only netilmicin (medicinal product)	4180186
36679481	Product containing only nevirapine (medicinal product)	4180186
36679482	Product containing only nicardipine (medicinal product)	4180186
36679484	Product containing only nickel sulfate (medicinal product)	4180186
36679485	Product containing only niclosamide (medicinal product)	4180186
36679486	Product containing only nicofuranose (medicinal product)	4180186
36679491	Product containing only nicotinyl alcohol (medicinal product)	4180186
36679492	Product containing only nifedipine (medicinal product)	4180186
36679494	Product containing only nifuroxazide (medicinal product)	4180186
36679495	Product containing only nifurtimox (medicinal product)	4180186
36679496	Product containing only nigrosine (medicinal product)	4180186
36679498	Product containing only nilotinib (medicinal product)	4180186
36679500	Product containing only nimesulide (medicinal product)	4180186
36679503	Product containing only nintedanib (medicinal product)	4180186
36679504	Product containing only niraparib (medicinal product)	4180186
36679505	Product containing only nisoldipine (medicinal product)	4180186
36679506	Product containing only nitazoxanide (medicinal product)	4180186
36679511	Product containing only nitrofurantoin (medicinal product)	4180186
36679517	Product containing only nivolumab (medicinal product)	4180186
36679518	Product containing only nizatidine (medicinal product)	4180186
36679520	Product containing only nonoxinol (medicinal product)	4180186
36679520	Nonoxinol only product	4180186
36679521	Product containing only norelgestromin (medicinal product)	4180186
36679522	Product containing only norepinephrine (medicinal product)	4180186
36679522	Noradrenaline only product	4180186
36679531	Product containing only nortriptyline (medicinal product)	4180186
36679532	Product containing only noscapine (medicinal product)	4180186
36679535	Product containing only nusinersen (medicinal product)	4180186
36679536	Product containing only nutmeg oil (medicinal product)	4180186
36679537	Product containing only nystatin (medicinal product)	4180186
36679539	Product containing only nystatin and tolnaftate (medicinal product)	4180186
36679540	Product containing only nystatin and triamcinolone (medicinal product)	4180186
36679541	Product containing only o-nitro-p-phenylenediamine (medicinal product)	4180186
36679542	Product containing only obeticholic acid (medicinal product)	4180186
36679543	Product containing only obiltoxaximab (medicinal product)	4180186
36679544	Product containing only obinutuzumab (medicinal product)	4180186
36679545	Product containing only oblimersen (medicinal product)	4180186
36679546	Product containing only ocrelizumab (medicinal product)	4180186
36679548	Product containing only octadecanoic acid (medicinal product)	4180186
36679549	Product containing only octafluorocyclobutane (medicinal product)	4180186
36679550	Product containing only octocog alfa (medicinal product)	4180186
36679551	Octocrilene only product	4180186
36679551	Product containing only octocrilene (medicinal product)	4180186
36679556	Product containing only ofloxacin (medicinal product)	4180186
36679559	Product containing only oil of mustard (medicinal product)	4180186
36679562	Product containing only olaratumab (medicinal product)	4180186
36679565	Product containing only olmesartan (medicinal product)	4180186
36679566	Product containing only olodaterol (medicinal product)	4180186
36679571	Product containing only omalizumab (medicinal product)	4180186
36679581	Product containing only orciprenaline (medicinal product)	4180186
36679581	Orciprenaline only product	4180186
36679582	Product containing only oregovomab (medicinal product)	4180186
36679584	Product containing only orlistat (medicinal product)	4180186
36679586	Product containing only orphenadrine (medicinal product)	4180186
36679587	Product containing only orphenadrine and paracetamol (medicinal product)	4180186
36679587	Orphenadrine and paracetamol only product	4180186
36679594	Product containing only oxamniquine (medicinal product)	4180186
36679595	Product containing only oxandrolone (medicinal product)	4180186
36679596	Product containing only oxaprozin (medicinal product)	4180186
36679598	Product containing only oxazepam (medicinal product)	4180186
36679599	Product containing only oxcarbazepine (medicinal product)	4180186
36679600	Product containing only oxerutins (medicinal product)	4180186
36679601	Oxetacaine only product	4180186
36679601	Product containing only oxetacaine (medicinal product)	4180186
36679603	Oxidised cellulose only product	4180186
36679603	Product containing only oxidized cellulose (medicinal product)	4180186
36679605	Product containing only oxprenolol (medicinal product)	4180186
36679608	Product containing only oxychlorosene (medicinal product)	4180186
36679609	Product containing only oxycodone (medicinal product)	4180186
36679610	Oxycodone and paracetamol only product	4180186
36679610	Product containing only oxycodone and paracetamol (medicinal product)	4180186
36679611	Product containing only oxygen (medicinal product)	4180186
36679612	Product containing only oxymetazoline (medicinal product)	4180186
36679613	Product containing only oxymetholone (medicinal product)	4180186
36679614	Product containing only oxymorphone (medicinal product)	4180186
36679617	Product containing only oxytetracycline (medicinal product)	4180186
36679619	Product containing only oxytocin (medicinal product)	4180186
36679626	Product containing only p-tert-butylphenol (medicinal product)	4180186
36679627	Product containing only paclitaxel (medicinal product)	4180186
36679631	Product containing only paliperidone (medicinal product)	4180186
36679636	Product containing only pancreatin (medicinal product)	4180186
36679644	Product containing only papain and urea (medicinal product)	4180186
36679645	Product containing only papaveretum (medicinal product)	4180186
36679646	Product containing only papaveretum and scopolamine (medicinal product)	4180186
36679646	Hyoscine and papaveretum only product	4180186
36679648	Product containing only para-aminobenzoic acid (medicinal product)	4180186
36679649	Paracetamol only product	4180186
36679649	Product containing only paracetamol (medicinal product)	4180186
36679654	Paracetamol and salicylamide only product	4180186
36679654	Product containing only paracetamol and salicylamide (medicinal product)	4180186
36679655	Product containing only paracetamol and sodium salicylate (medicinal product)	4180186
36679655	Paracetamol and sodium salicylate only product	4180186
36679656	Product containing only paracetamol and tramadol (medicinal product)	4180186
36679656	Paracetamol and tramadol only product	4180186
36679658	Product containing only paraffin wax (medicinal product)	4180186
36679661	Product containing only paramethasone (medicinal product)	4180186
36679662	Product containing only parecoxib (medicinal product)	4180186
36679664	Product containing only paricalcitol (medicinal product)	4180186
36679665	Product containing only paritaprevir (medicinal product)	4180186
36679667	Product containing only paroxetine (medicinal product)	4180186
36679670	Product containing only pasireotide (medicinal product)	4180186
36679671	Product containing only patiromer (medicinal product)	4180186
36679674	Product containing only pectin (medicinal product)	4180186
36679675	Product containing only pefloxacin (medicinal product)	4180186
36679678	Product containing only pegaspargase (medicinal product)	4180186
36679680	Product containing only peginterferon alfa-2a (medicinal product)	4180186
36679682	Product containing only peginterferon beta-1a (medicinal product)	4180186
36679683	Product containing only pegloticase (medicinal product)	4180186
36679685	Product containing only pembrolizumab (medicinal product)	4180186
36679686	Product containing only pemetrexed (medicinal product)	4180186
36679687	Product containing only pemirolast (medicinal product)	4180186
36679688	Product containing only pemoline (medicinal product)	4180186
36679692	Pentaerithrityl tetranitrate only product	4180186
36679692	Product containing only pentaerithrityl tetranitrate (medicinal product)	4180186
36679696	Product containing only pentastarch (medicinal product)	4180186
36679699	Product containing only pentobarbital (medicinal product)	4180186
36679703	Pentoxyverine only product	4180186
36679703	Product containing only pentoxyverine (medicinal product)	4180186
36679706	Product containing only peramivir (medicinal product)	4180186
36679708	Product containing only percoid liver oil (medicinal product)	4180186
36679709	Product containing only percomorph liver oil (medicinal product)	4180186
36679710	Product containing only perflexane (medicinal product)	4180186
36679711	Product containing only perflunafene (medicinal product)	4180186
36679712	Product containing only perfluoroalkylpolyether and polytetrafluoroethylene (medicinal product)	4180186
36679713	Product containing only perfluorobutane (medicinal product)	4180186
36679714	Product containing only perfluoroethane (medicinal product)	4180186
36679715	Product containing only perfluoromethane (medicinal product)	4180186
36679720	Product containing only pergolide (medicinal product)	4180186
36679722	Product containing only periciazine (medicinal product)	4180186
36679723	Product containing only perindopril (medicinal product)	4180186
36679726	Product containing only peroxyacetic acid (medicinal product)	4180186
36679727	Product containing only perphenazine (medicinal product)	4180186
36679730	Pethidine only product	4180186
36679730	Product containing only pethidine (medicinal product)	4180186
36679731	Pethidine and promethazine only product	4180186
36679731	Product containing only pethidine and promethazine (medicinal product)	4180186
36679732	Product containing only phenacemide (medicinal product)	4180186
36679733	Product containing only phenazocine (medicinal product)	4180186
36679734	Phenazone only product	4180186
36679734	Product containing only phenazone (medicinal product)	4180186
36679735	Product containing only phenazopyridine (medicinal product)	4180186
36679739	Product containing only phendimetrazine (medicinal product)	4180186
36679740	Product containing only phenelzine (medicinal product)	4180186
36679741	Pheneticillin only product	4180186
36679741	Product containing only pheneticillin (medicinal product)	4180186
36679742	Product containing only phenidone (medicinal product)	4180186
36679746	Product containing only pheniramine and phenylephrine (medicinal product)	4180186
36679747	Product containing only phenmetrazine (medicinal product)	4180186
36679749	Product containing only phenol (medicinal product)	4180186
36679750	Product containing only phenolphthalein (medicinal product)	4180186
36679752	Product containing only phenoperidine (medicinal product)	4180186
36679753	Product containing only phenothrin (medicinal product)	4180186
36679754	Product containing only phenoxybenzamine (medicinal product)	4180186
36679755	Product containing only phenoxyethanol (medicinal product)	4180186
36679756	Phenoxymethylpenicillin only product	4180186
36679756	Product containing only phenoxymethylpenicillin (medicinal product)	4180186
36679757	Product containing only phensuximide (medicinal product)	4180186
36679759	Product containing only phentolamine (medicinal product)	4180186
36679760	Product containing only phenyl glycidyl ether (medicinal product)	4180186
36679761	Product containing only phenyl salicylate (medicinal product)	4180186
36679762	Product containing only phenylalanine (medicinal product)	4180186
36679765	Product containing only phenylephrine and promethazine (medicinal product)	4180186
36679768	Product containing only phenytoin (medicinal product)	4180186
36679769	Product containing only pholcodine (medicinal product)	4180186
36679770	Product containing only phospholipase (medicinal product)	4180186
36679771	Product containing only phosphorus (medicinal product)	4180186
36679772	Product containing only phosphorus-32 (medicinal product)	4180186
36679773	Product containing only physostigmine (medicinal product)	4180186
36679775	Phytomenadione only product	4180186
36679775	Product containing only phytomenadione (medicinal product)	4180186
36679781	Product containing only pinazepam (medicinal product)	4180186
36679782	Product containing only pindolol (medicinal product)	4180186
36679783	Product containing only pine needle oil (medicinal product)	4180186
36679784	Product containing only pine oil (medicinal product)	4180186
36679785	Product containing only pinene (medicinal product)	4180186
36679786	Product containing only pioglitazone (medicinal product)	4180186
36679789	Product containing only pipemidic acid (medicinal product)	4180186
36679792	Product containing only piperacillin (medicinal product)	4180186
36679795	Product containing only piperazine and sennoside (medicinal product)	4180186
36679796	Product containing only piperonyl butoxide (medicinal product)	4180186
36679797	Product containing only piperonyl butoxide and pyrethrin (medicinal product)	4180186
36679800	Product containing only pirbuterol (medicinal product)	4180186
36679802	Product containing only piretanide (medicinal product)	4180186
36679805	Product containing only pitavastatin (medicinal product)	4180186
36679806	Product containing only pivampicillin (medicinal product)	4180186
36679808	Product containing only pivmecillinam (medicinal product)	4180186
36679808	Pivmecillinam only product	4180186
36679810	Product containing only plasmin (medicinal product)	4180186
36679811	Product containing only plazomicin (medicinal product)	4180186
36679812	Product containing only plecanatide (medicinal product)	4180186
36679813	Product containing only plerixafor (medicinal product)	4180186
36679815	Product containing only plicamycin (medicinal product)	4180186
36679817	Product containing only poldine (medicinal product)	4180186
36679818	Product containing only policosanol (medicinal product)	4180186
36679819	Product containing only polihexanide (medicinal product)	4180186
36679821	Product containing only polycarbophil (medicinal product)	4180186
36679822	Product containing only polyestradiol phosphate (medicinal product)	4180186
36679825	Product containing only polymethyl methacrylate (medicinal product)	4180186
36679829	Product containing only polysaccharide-iron complex (medicinal product)	4180186
36679830	Product containing only polysorbate (medicinal product)	4180186
36679831	Product containing only polythiazide (medicinal product)	4180186
36679834	Product containing only pomalidomide (medicinal product)	4180186
36679839	Product containing only porcine heparin (medicinal product)	4180186
36679840	Product containing only porcine regular insulin (medicinal product)	4180186
36679840	Porcine insulin soluble only product	4180186
36679842	Product containing only pork insulin (medicinal product)	4180186
36679843	Product containing only posaconazole (medicinal product)	4180186
36679844	Product containing only potassium (medicinal product)	4180186
36679846	Product containing only potassium bicarbonate (medicinal product)	4180186
36679849	Product containing only potassium bicarbonate and sodium alginate (medicinal product)	4180186
36679850	Product containing only potassium bitartrate (medicinal product)	4180186
36679851	Product containing only potassium bromide (medicinal product)	4180186
36679853	Product containing only potassium chlorate (medicinal product)	4180186
36679854	Product containing only potassium chloride (medicinal product)	4180186
36679855	Product containing only potassium chloride and sodium chloride (medicinal product)	4180186
36679857	Product containing only potassium citrate (medicinal product)	4180186
36679859	Product containing only potassium gluconate (medicinal product)	4180186
36679860	Product containing only potassium hydroxyquinoline sulfate (medicinal product)	4180186
36679861	Product containing only potassium iodate (medicinal product)	4180186
36679865	Product containing only potassium perchlorate (medicinal product)	4180186
36679868	Product containing only potassium phosphate (medicinal product)	4180186
36679870	Product containing only povidone iodine (medicinal product)	4180186
36679872	Product containing only pralatrexate (medicinal product)	4180186
36679873	Product containing only pralidoxime (medicinal product)	4180186
36679874	Product containing only pramipexole (medicinal product)	4180186
36679875	Product containing only pramlintide (medicinal product)	4180186
36679876	Pramocaine only product	4180186
36679876	Product containing only pramocaine (medicinal product)	4180186
36679878	Product containing only prasugrel (medicinal product)	4180186
36679880	Product containing only prazepam (medicinal product)	4180186
36679884	Product containing cod liver oil and zinc oxide in cutaneous dose form (medicinal product form)	4180186
36679885	Product containing erythromycin and zinc acetate in cutaneous dose form (medicinal product form)	4180186
36679886	Product containing permanganic acid in cutaneous dose form (medicinal product form)	4180186
36679892	Product containing only prenylamine (medicinal product)	4180186
36679893	Product containing only prilocaine (medicinal product)	4180186
36679894	Product containing only primaquine (medicinal product)	4180186
36679898	Product containing only procainamide (medicinal product)	4180186
36679899	Product containing only procaine (medicinal product)	4180186
36679900	Product containing only procaine and tetracycline (medicinal product)	4180186
36679902	Product containing only prochlorperazine (medicinal product)	4180186
36679903	Product containing only procyclidine (medicinal product)	4180186
36679905	Product containing only progesterone (medicinal product)	4180186
36679907	Product containing only prolactin (medicinal product)	4180186
36679908	Product containing only prolactin inhibiting factor (medicinal product)	4180186
36679917	Product containing only propantheline (medicinal product)	4180186
36679919	Product containing only propionate (medicinal product)	4180186
36679922	Product containing only propolis (medicinal product)	4180186
36679926	Product containing only propyl gallate (medicinal product)	4180186
36679930	Product containing only protamine (medicinal product)	4180186
36679932	Product containing only protionamide (medicinal product)	4180186
36679936	Product containing only pseudoephedrine (medicinal product)	4180186
36679939	Product containing only psyllium (medicinal product)	4180186
36679940	Product containing only psyllium and senna (medicinal product)	4180186
36679942	Product containing only pumactant (medicinal product)	4180186
36679943	Product containing only pyrantel (medicinal product)	4180186
36679945	Product containing only pyrethrin (medicinal product)	4180186
36679946	Product containing only pyrethrum (medicinal product)	4180186
36679947	Product containing only pyridostigmine (medicinal product)	4180186
36679948	Product containing only pyridoxal (medicinal product)	4180186
36679951	Product containing only pyrimethamine and sulfadoxine (medicinal product)	4180186
36679953	Product containing only pyrogallol (medicinal product)	4180186
36679954	Product containing only quaternium 15 (medicinal product)	4180186
36679956	Product containing only quercetin (medicinal product)	4180186
36679957	Product containing only quetiapine (medicinal product)	4180186
36679958	Product containing only quinagolide (medicinal product)	4180186
36679960	Product containing only quinestradol (medicinal product)	4180186
36679963	Product containing only quinidine (medicinal product)	4180186
36679971	Product containing only raloxifene (medicinal product)	4180186
36679973	Product containing only raltitrexed (medicinal product)	4180186
36679974	Product containing only ramelteon (medicinal product)	4180186
36679976	Product containing only ramucirumab (medicinal product)	4180186
36679977	Product containing only ranibizumab (medicinal product)	4180186
36679980	Product containing only rapacuronium (medicinal product)	4180186
36679981	Product containing only rasagiline (medicinal product)	4180186
36679984	Product containing only razoxane (medicinal product)	4180186
36679985	Product containing only reboxetine (medicinal product)	4180186
36679987	Product containing only recombinant coagulation factor IX (medicinal product)	4180186
36679988	Product containing only recombinant human antithrombin III (medicinal product)	4180186
36679989	Product containing only recombinant human chorionic gonadotrophin (medicinal product)	4180186
36679991	Product containing only recombinant levo iduronidase (medicinal product)	4180186
36679994	Product containing only rectified pine tar oil (medicinal product)	4180186
36679996	Product containing only regorafenib (medicinal product)	4180186
36679997	Product containing only remifentanil (medicinal product)	4180186
36680000	Product containing only reproterol (medicinal product)	4180186
36680002	Product containing only resorcinol (medicinal product)	4180186
36680005	Product containing only retapamulin (medicinal product)	4180186
36680008	Product containing only retinol (medicinal product)	4180186
36680010	Product containing only reviparin (medicinal product)	4180186
36680014	Product containing only ribavirin (medicinal product)	4180186
36680015	Product containing only ribociclib (medicinal product)	4180186
36680019	Product containing only rifapentine (medicinal product)	4180186
36680020	Product containing only rifaximin (medicinal product)	4180186
36680021	Product containing only rilonacept (medicinal product)	4180186
36680024	Product containing only rimantadine (medicinal product)	4180186
36680025	Product containing only rimexolone (medicinal product)	4180186
36680027	Product containing only rimonabant (medicinal product)	4180186
36680031	Product containing only ristocetin (medicinal product)	4180186
36680034	Product containing only rituximab (medicinal product)	4180186
36680040	Product containing only roflumilast (medicinal product)	4180186
36680043	Product containing only romiplostim (medicinal product)	4180186
36680045	Product containing only ropivacaine (medicinal product)	4180186
36680048	Product containing only rose oil of Bulgaria (medicinal product)	4180186
36680054	Product containing only rucaparib (medicinal product)	4180186
36680055	Product containing only rufinamide (medicinal product)	4180186
36680057	Product containing only ruxolitinib (medicinal product)	4180186
36680059	Product containing only sacrosidase (medicinal product)	4180186
36680060	Product containing only sacubitril and valsartan (medicinal product)	4180186
36680061	Product containing only safflower oil (medicinal product)	4180186
36680063	Product containing only salbutamol (medicinal product)	4180186
36680063	Salbutamol only product	4180186
36680064	Product containing only salicylaldehyde (medicinal product)	4180186
36680065	Product containing only salicylamide (medicinal product)	4180186
36680067	Product containing only salicylic acid and sulfur (medicinal product)	4180186
36680069	Product containing only salicylic acid and zinc oxide (medicinal product)	4180186
36680070	Product containing only salinomycin (medicinal product)	4180186
36680074	Product containing only samarium (153-Sm) lexidronam (medicinal product)	4180186
36680079	Product containing only sarilumab (medicinal product)	4180186
36680080	Product containing only savinase (medicinal product)	4180186
36680083	Product containing only sebelipase alfa (medicinal product)	4180186
36680087	Product containing only secretin (medicinal product)	4180186
36680090	Product containing only selenium (medicinal product)	4180186
36680093	Product containing only selenium-75 (medicinal product)	4180186
36680096	Product containing only sennoside (medicinal product)	4180186
36680097	Product containing only sennoside B (medicinal product)	4180186
36680101	Product containing only sertraline (medicinal product)	4180186
36680102	Product containing only sesame oil (medicinal product)	4180186
36680103	Product containing only sevelamer (medicinal product)	4180186
36680105	Product containing only shark liver oil (medicinal product)	4180186
36680106	Product containing only sibutramine (medicinal product)	4180186
36680107	Product containing only sildenafil (medicinal product)	4180186
36680110	Product containing only siltuximab (medicinal product)	4180186
36680111	Product containing only silver nitrate (medicinal product)	4180186
36680112	Product containing only sulfadiazine (medicinal product)	4180186
36680113	Product containing only simeprevir (medicinal product)	4180186
36680114	Product containing only simeprevir and sofosbuvir (medicinal product)	4180186
36680117	Product containing only simvastatin (medicinal product)	4180186
36680118	Product containing only sincalide (medicinal product)	4180186
36680119	Product containing only sirolimus (medicinal product)	4180186
36680121	Product containing only sitagliptin (medicinal product)	4180186
36680122	Product containing only sitaxentan (medicinal product)	4180186
36680127	Sodium aurotiosulfate only product	4180186
36680127	Product containing only sodium aurotiosulfate (medicinal product)	4180186
36680128	Product containing only sodium benzoate (medicinal product)	4180186
36680133	Product containing only sodium chloride (medicinal product)	4180186
36680135	Product containing only sodium citrate (medicinal product)	4180186
36680137	Product containing only sodium dichloroisocyanurate (medicinal product)	4180186
36680141	Product containing only sodium glycerophosphate (medicinal product)	4180186
36680142	Product containing only sodium hypochlorite (medicinal product)	4180186
36680144	Product containing only ipodate (medicinal product)	4180186
36680145	Product containing only sodium lactate (medicinal product)	4180186
36680146	Product containing only sodium metabisulfite (medicinal product)	4180186
36680147	Sodium morrhuate only product	4180186
36680147	Product containing only sodium morrhuate (medicinal product)	4180186
36680148	Product containing only sodium nitrite (medicinal product)	4180186
36680149	Product containing only sodium oxybate (medicinal product)	4180186
36680151	Product containing only sodium perborate (medicinal product)	4180186
36680152	Product containing only sodium phenylacetate (medicinal product)	4180186
36680155	Product containing only sodium pidolate (medicinal product)	4180186
36680156	Product containing only polystyrene sulfonate (medicinal product)	4180186
36680157	Product containing only sodium propionate (medicinal product)	4180186
36680158	Product containing only sodium salicylate (medicinal product)	4180186
36680161	Product containing only sodium tetradecyl sulfate (medicinal product)	4180186
36680162	Product containing only sofosbuvir (medicinal product)	4180186
36680163	Product containing only sofosbuvir and velpatasvir (medicinal product)	4180186
36680164	Product containing only sofosbuvir and velpatasvir and voxilaprevir (medicinal product)	4180186
36680165	Product containing only solifenacin (medicinal product)	4180186
36680167	Product containing only somatostatin (medicinal product)	4180186
36680169	Product containing only somatrem (medicinal product)	4180186
36680171	Product containing only somatropin(epr) (medicinal product)	4180186
36680172	Product containing only somatropin(rbe) (medicinal product)	4180186
36680174	Product containing only sorafenib (medicinal product)	4180186
36680176	Product containing only sorbitol (medicinal product)	4180186
36680177	Product containing only sotalol (medicinal product)	4180186
36680183	Product containing only spironolactone (medicinal product)	4180186
36680184	Product containing only stannous fluoride (medicinal product)	4180186
36680185	Product containing only stanozolol (medicinal product)	4180186
36680189	Product containing only stavudine (medicinal product)	4180186
36680195	Product containing only streptozocin (medicinal product)	4180186
36680196	Product containing only strontium (medicinal product)	4180186
36680198	Product containing only strontium-89 (medicinal product)	4180186
36680202	Product containing only succinylcholine (medicinal product)	4180186
36680203	Product containing only sucralfate (medicinal product)	4180186
36680204	Product containing only sucrose (medicinal product)	4180186
36680207	Product containing only sulbactam (medicinal product)	4180186
36680208	Product containing only sulbutiamine (medicinal product)	4180186
36680209	Product containing only sulconazole (medicinal product)	4180186
36680213	Product containing only sulfacetamide (medicinal product)	4180186
36680214	Product containing only sulfadimethoxine (medicinal product)	4180186
36680215	Sulfadimidine only product	4180186
36680215	Product containing only sulfadimidine (medicinal product)	4180186
36680218	Product containing only sulfaguanidine (medicinal product)	4180186
36680219	Product containing only sulfalene (medicinal product)	4180186
36680222	Product containing only sulfamethoxazole and trimethoprim (medicinal product)	4180186
36680224	Product containing only sulfanilamide (medicinal product)	4180186
36680226	Product containing only sulfathiazole (medicinal product)	4180186
36680229	Product containing only sulfur (medicinal product)	4180186
36680230	Product containing only sulfur hexafluoride (medicinal product)	4180186
36680232	Product containing only sulindac (medicinal product)	4180186
36680234	Product containing only sulthiamine (medicinal product)	4180186
36680235	Product containing only sumatriptan (medicinal product)	4180186
36680238	Product containing only suprofen (medicinal product)	4180186
36680239	Product containing only suramin (medicinal product)	4180186
36680240	Product containing only suvorexant (medicinal product)	4180186
36680244	Product containing only tadalafil (medicinal product)	4180186
36680246	Product containing only tafenoquine (medicinal product)	4180186
36680248	Product containing only talampicillin (medicinal product)	4180186
36680251	Product containing only talimogene laherparepvec (medicinal product)	4180186
36680254	Product containing only tansy extract (medicinal product)	4180186
36680256	Product containing only tar (medicinal product)	4180186
36680259	Product containing only tasonermin (medicinal product)	4180186
36680260	Product containing only taurine (medicinal product)	4180186
36680267	Product containing only teduglutide (medicinal product)	4180186
36680268	Product containing only tegafur (medicinal product)	4180186
36680275	Product containing only telithromycin (medicinal product)	4180186
36680277	Product containing only telotristat (medicinal product)	4180186
36680278	Product containing only temafloxacin (medicinal product)	4180186
36680279	Product containing only temazepam (medicinal product)	4180186
36680280	Product containing only temocillin (medicinal product)	4180186
36680283	Product containing only temsirolimus (medicinal product)	4180186
36680286	Product containing only tenofovir (medicinal product)	4180186
36680289	Product containing only terazosin (medicinal product)	4180186
36680293	Product containing only terebene (medicinal product)	4180186
36680294	Product containing only terfenadine (medicinal product)	4180186
36680297	Product containing only terlipressin (medicinal product)	4180186
36680299	Product containing only tert-butylhydroquinone (medicinal product)	4180186
36680300	Product containing only tesamorelin (medicinal product)	4180186
36680302	Product containing only testosterone (medicinal product)	4180186
36680304	Product containing only human tetanus immunoglobulin (medicinal product)	4180186
36680307	Product containing only tetracaine (medicinal product)	4180186
36680308	Product containing only tetrachlorosalicylanilide (medicinal product)	4180186
36680311	Product containing only tetrahydrofurfuryl methacrylate (medicinal product)	4180186
36680312	Product containing only tetramethylthiuram monosulfide (medicinal product)	4180186
36680313	Product containing only tetrastarch (medicinal product)	4180186
36680315	Product containing only thalidomide (medicinal product)	4180186
36680317	Product containing only theophylline (medicinal product)	4180186
36680318	Thiamazole only product	4180186
36680318	Product containing only thiamazole (medicinal product)	4180186
36680319	Product containing only thiamine (medicinal product)	4180186
36680320	Product containing only thiamphenicol (medicinal product)	4180186
36680321	Product containing only thiamylal (medicinal product)	4180186
36680322	Product containing only thiethylperazine (medicinal product)	4180186
36680323	Product containing only thimerosal (medicinal product)	4180186
36680329	Product containing only thiourea (medicinal product)	4180186
36680331	Product containing only thrombin (medicinal product)	4180186
36680332	Product containing only thymol (medicinal product)	4180186
36680334	Product containing only thyroglobulin (medicinal product)	4180186
36680337	Product containing only thyrotropin alfa (medicinal product)	4180186
36680338	Product containing only thyrotropin releasing factor (medicinal product)	4180186
36680341	Product containing only tiagabine (medicinal product)	4180186
36680344	Product containing only tibolone (medicinal product)	4180186
36680352	Product containing only timolol (medicinal product)	4180186
36680353	Product containing only timolol and travoprost (medicinal product)	4180186
36680356	Product containing only tioconazole (medicinal product)	4180186
36680357	Product containing only tioguanine (medicinal product)	4180186
36680357	Tioguanine only product	4180186
36680362	Product containing only tipranavir (medicinal product)	4180186
36680366	Product containing only titanium dioxide (medicinal product)	4180186
36680367	Product containing only titanium dioxide and titanium peroxide and titanium salicylate (medicinal product)	4180186
36680370	Product containing only tobramycin (medicinal product)	4180186
36680372	Product containing only toceranib (medicinal product)	4180186
36680373	Product containing only tocilizumab (medicinal product)	4180186
36680374	Product containing only tofacitinib (medicinal product)	4180186
36680377	Product containing only tolbutamide (medicinal product)	4180186
36680378	Product containing only tolcapone (medicinal product)	4180186
36680379	Product containing only tolfenamic acid (medicinal product)	4180186
36680382	Product containing only tolonium chloride (medicinal product)	4180186
36680384	Product containing only toluene di-isocyanate (medicinal product)	4180186
36680387	Product containing only topiramate (medicinal product)	4180186
36680388	Product containing only topotecan (medicinal product)	4180186
36680389	Torasemide only product	4180186
36680389	Product containing only torasemide (medicinal product)	4180186
36680390	Product containing only toremifene (medicinal product)	4180186
36680392	Tosylchloramide sodium only product	4180186
36680392	Product containing only tosylchloramide sodium (medicinal product)	4180186
36680395	Product containing only tramadol (medicinal product)	4180186
36680396	Product containing only tramazoline (medicinal product)	4180186
36680400	Product containing only tranexamic acid (medicinal product)	4180186
36680404	Product containing only travoprost (medicinal product)	4180186
36680406	Product containing only treosulfan (medicinal product)	4180186
36680407	Product containing only treprostinil (medicinal product)	4180186
36680408	Product containing only tretinoin (medicinal product)	4180186
36680414	Product containing only trichlormethiazide (medicinal product)	4180186
36680415	Product containing only trichloroacetic acid (medicinal product)	4180186
36680417	Product containing only trichloroethylene (medicinal product)	4180186
36680418	Product containing only trichlorofluoromethane (medicinal product)	4180186
36680420	Product containing only triclofos (medicinal product)	4180186
36680422	Product containing only tricresyl phosphate (medicinal product)	4180186
36680424	Product containing only triethanolamine (medicinal product)	4180186
36680426	Product containing only triethyleneglycol dimethacrylate (medicinal product)	4180186
36680431	Product containing only triglycidyl isocyanurate (medicinal product)	4180186
36680435	Product containing only trimethadione (medicinal product)	4180186
36680436	Product containing only trimethobenzamide (medicinal product)	4180186
36680437	Product containing only trimethoprim (medicinal product)	4180186
36680438	Product containing only trimethylolpropane triacrylate (medicinal product)	4180186
36680440	Product containing only trimipramine (medicinal product)	4180186
36680441	Product containing only tripelennamine (medicinal product)	4180186
36680443	Product containing only triphenylmethane triisocyanate (medicinal product)	4180186
36680446	Product containing only tripropyleneglycol diacrylate (medicinal product)	4180186
36680450	Product containing only trolamine salicylate (medicinal product)	4180186
36680452	Trometamol only product	4180186
36680452	Product containing only trometamol (medicinal product)	4180186
36680458	Product containing only trypan blue stain (medicinal product)	4180186
36680459	Product containing only tryptophan (medicinal product)	4180186
36680461	Product containing only tubocurarine (medicinal product)	4180186
36680463	Product containing only turpentine oil (medicinal product)	4180186
36680464	Product containing only tylosin (medicinal product)	4180186
36680466	Product containing only tyrosine (medicinal product)	4180186
36680468	Product containing only ubidecarenone (medicinal product)	4180186
36680471	Product containing only undecylenic acid (medicinal product)	4180186
36680473	Product containing only unoprostone isopropyl (medicinal product)	4180186
36680474	Product containing only uracil (medicinal product)	4180186
36680475	Product containing only urea (medicinal product)	4180186
36680476	Product containing only urea formaldehyde resin (medicinal product)	4180186
36680477	Product containing only urethane diacrylate aliphatic (medicinal product)	4180186
36680480	Product containing only urofollitropin (medicinal product)	4180186
36680481	Product containing only urokinase (medicinal product)	4180186
36680483	Product containing only usnic acid (medicinal product)	4180186
36680484	Product containing only ustekinumab (medicinal product)	4180186
36680485	Product containing only valaciclovir (medicinal product)	4180186
36680485	Valaciclovir only product	4180186
36680486	Product containing only valbenazine (medicinal product)	4180186
36680488	Product containing only valganciclovir (medicinal product)	4180186
36680491	Product containing only valrubicin (medicinal product)	4180186
36680493	Product containing only vancomycin (medicinal product)	4180186
36680496	Product containing only vardenafil (medicinal product)	4180186
36680498	Product containing only Varicella-zoster virus antibody (medicinal product)	4180186
36680499	Product containing only antidiuretic hormone (medicinal product)	4180186
36680503	Product containing only vemurafenib (medicinal product)	4180186
36680504	Product containing only venetoclax (medicinal product)	4180186
36680507	Product containing only verteporfin (medicinal product)	4180186
36680508	Product containing only vestronidase alfa (medicinal product)	4180186
36680512	Product containing only vilazodone (medicinal product)	4180186
36680515	Product containing only vinblastine (medicinal product)	4180186
36680516	Product containing only vindesine (medicinal product)	4180186
36680517	Product containing only vinorelbine (medicinal product)	4180186
36680518	Product containing only virginiamycin (medicinal product)	4180186
36680520	Product containing only vitamin K5 (medicinal product)	4180186
36680523	Product containing only voriconazole (medicinal product)	4180186
36680524	Product containing only vorinostat (medicinal product)	4180186
36680527	Product containing only wasp venom (medicinal product)	4180186
36680528	Product containing only water (medicinal product)	4180186
36680531	Product containing only witch hazel (medicinal product)	4180186
36680532	Product containing only wool alcohol (medicinal product)	4180186
36680537	Product containing only xylitol (medicinal product)	4180186
36680539	Product containing only xylose (medicinal product)	4180186
36680540	Product containing only yellow paraffin (medicinal product)	4180186
36680543	Product containing only yohimbine (medicinal product)	4180186
36680546	Product containing only zalcitabine (medicinal product)	4180186
36680548	Product containing only zanamivir (medicinal product)	4180186
36680551	Product containing only ziconotide (medicinal product)	4180186
36680552	Product containing only zidovudine (medicinal product)	4180186
36680554	Product containing only zinc (medicinal product)	4180186
36680556	Product containing only zinc citrate (medicinal product)	4180186
36680557	Product containing only zinc diethyldithiocarbamate (medicinal product)	4180186
36680562	Product containing only zinc sulfate (medicinal product)	4180186
36680563	Product containing only zineb (medicinal product)	4180186
36680568	Product containing only zolmitriptan (medicinal product)	4180186
36680569	Product containing only zolpidem (medicinal product)	4180186
36680575	Alleged being subjected to abuse (situation)	4180186
36680576	Temtamy preaxial brachydactyly syndrome (disorder)	4180186
36680584	Autosomal dominant aplastic anaemia and myelodysplasia	4180186
36680584	Autosomal dominant aplastic anemia and myelodysplasia	4180186
36680584	Autosomal dominant aplasia and myelodysplasia (disorder)	4180186
36680586	Perinatal lethal bent bone dysplasia	4180186
36680586	Fibroblast growth factor receptor 2-related bent bone dysplasia	4180186
36680586	Fibroblast growth factor receptor 2-related bent bone dysplasia (disorder)	4180186
36680587	Blepharophimosis, intellectual disability syndrome type V	4180186
36680587	Blepharophimosis, intellectual disability syndrome, Verloes type (disorder)	4180186
36680589	Immunodeficiency due to CD25 deficiency (disorder)	4180186
36680589	Interleukin-2 receptor alpha chain deficiency	4180186
36680591	Autosomal recessive spastic paraplegia type 27 (disorder)	4180186
36680592	Excision of synovium of joint	4180186
36680592	Synovectomy of joint (procedure)	4180186
36680593	Excision of synovial membrane (procedure)	4180186
36680593	Excision of synovium	4180186
36680594	O'Donnell Pappas syndrome	4180186
36680594	Foveal hypoplasia with presenile cataract syndrome (disorder)	4180186
36680596	Primary non-essential cutis verticis gyrata (disorder)	4180186
36680597	Signal transducer and activator of transcription 1 deficiency	4180186
36680597	STAT1 deficiency	4180186
36680597	Susceptibility to viral and mycobacterial infection (disorder)	4180186
36680598	Somatoprolactinoma	4180186
36680598	Growth hormone and prolactin co-secreting pituitary adenoma	4180186
36680598	Somatolactotropinoma	4180186
36680598	Somatomammotropinoma (disorder)	4180186
36680599	Myoclonic epilepsy in non-progressive encephalopathy (disorder)	4180186
36680602	Idiopathic eosinophilic myositis (disorder)	4180186
36680602	Idiopathic eosinophilia-associated myopathy	4180186
36680606	Diffuse palmoplantar keratoderma with painful fissures (disorder)	4180186
36680607	Cryptogenic late-onset epileptic spasms (disorder)	4180186
36680607	Late-onset infantile spasms	4180186
36680610	Carcinofibroma of corpus uteri (disorder)	4180186
36680614	Autosomal dominant primary microcephaly (disorder)	4180186
36680617	3q26 microduplication syndrome (disorder)	4180186
36680617	Trisomy 3q26	4180186
36680620	Larva of Echinococcus (organism)	4180186
36680621	Product containing only 5-aminolevulinic acid in cutaneous dose form (medicinal product form)	4180186
36680626	Product containing only Notechis scutatus antivenom in parenteral dose form (medicinal product form)	4180186
36680629	Product containing only Saccharomyces boulardii in oral dose form (medicinal product form)	4180186
36680630	Product containing only abaloparatide in parenteral dose form (medicinal product form)	4180186
36680632	Product containing only abemaciclib in oral dose form (medicinal product form)	4180186
36680633	Product containing only abiraterone in oral dose form (medicinal product form)	4180186
36680634	Product containing only acalabrutinib in oral dose form (medicinal product form)	4180186
36680635	Product containing only acamprosate in oral dose form (medicinal product form)	4180186
36680637	Product containing only acebutolol and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
36680639	Product containing only aceclofenac in oral dose form (medicinal product form)	4180186
36680643	Product containing only acetazolamide in parenteral dose form (medicinal product form)	4180186
36680647	Product containing only acetohexamide in oral dose form (medicinal product form)	4180186
36680650	Product containing only acetylcysteine in ocular dose form (medicinal product form)	4180186
36680651	Product containing only acetylcysteine in oral dose form (medicinal product form)	4180186
36680652	Product containing only acetylcysteine in parenteral dose form (medicinal product form)	4180186
36680653	Product containing only acetylcysteine in pulmonary dose form (medicinal product form)	4180186
36680655	Aciclovir only product in ocular dose form	4180186
36680655	Product containing only aciclovir in ocular dose form (medicinal product form)	4180186
36680656	Aciclovir only product in oral dose form	4180186
36680656	Product containing only aciclovir in oral dose form (medicinal product form)	4180186
36680663	Product containing only activated charcoal in oral dose form (medicinal product form)	4180186
36680664	Product containing only adalimumab in parenteral dose form (medicinal product form)	4180186
36680665	Product containing only adapalene and benzoyl peroxide in cutaneous dose form (medicinal product form)	4180186
36680666	Product containing only adapalene in cutaneous dose form (medicinal product form)	4180186
36680667	Product containing only adefovir in oral dose form (medicinal product form)	4180186
36680669	Product containing only afatinib in oral dose form (medicinal product form)	4180186
36680673	Product containing only alclometasone in cutaneous dose form (medicinal product form)	4180186
36680675	Product containing only alendronic acid in oral dose form (medicinal product form)	4180186
36680676	Product containing only alfacalcidol in oral dose form (medicinal product form)	4180186
36680677	Product containing only alfacalcidol in parenteral dose form (medicinal product form)	4180186
36680678	Product containing only alfentanil in parenteral dose form (medicinal product form)	4180186
36680679	Product containing only alfuzosin in oral dose form (medicinal product form)	4180186
36680680	Product containing only alimemazine in oral dose form (medicinal product form)	4180186
36680680	Alimemazine only product in oral dose form	4180186
36680681	Product containing only aliskiren and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
36680682	Product containing only aliskiren and valsartan in oral dose form (medicinal product form)	4180186
36680687	Product containing only allopurinol in parenteral dose form (medicinal product form)	4180186
36680688	Product containing only almotriptan in oral dose form (medicinal product form)	4180186
36680690	Product containing only aloin in oral dose form (medicinal product form)	4180186
36680691	Product containing only alosetron in oral dose form (medicinal product form)	4180186
36680695	Product containing only alprostadil in urethral dose form (medicinal product form)	4180186
36680696	Product containing only alteplase in parenteral dose form (medicinal product form)	4180186
36680697	Product containing only altretamine in oral dose form (medicinal product form)	4180186
36680699	Product containing only aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form)	4180186
36680699	Aluminium hydroxide and magnesium hydroxide only product in oral dose form	4180186
36680700	Product containing only aluminium hydroxide in oral dose form (medicinal product form)	4180186
36680700	Aluminium hydroxide only product in oral dose form	4180186
36680705	Product containing only alverine and Sterculia gum in oral dose form (medicinal product form)	4180186
36680706	Product containing only alverine in oral dose form (medicinal product form)	4180186
36680707	Product containing only alvimopan in oral dose form (medicinal product form)	4180186
36680709	Product containing only ambenonium in oral dose form (medicinal product form)	4180186
36680710	Product containing only ambrisentan in oral dose form (medicinal product form)	4180186
36680711	Product containing only amcinonide in cutaneous dose form (medicinal product form)	4180186
36680712	Product containing only amfepramone in oral dose form (medicinal product form)	4180186
36680712	Amfepramone only product in oral dose form	4180186
36680713	Product containing only amifostine in parenteral dose form (medicinal product form)	4180186
36680714	Product containing only amikacin in parenteral dose form (medicinal product form)	4180186
36680715	Product containing only amiloride and atenolol and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
36680718	Product containing only amiloride and furosemide in oral dose form (medicinal product form)	4180186
36680719	Product containing only amiloride and hydrochlorothiazide and timolol in oral dose form (medicinal product form)	4180186
36680721	Product containing only amiloride in oral dose form (medicinal product form)	4180186
36680722	Product containing only aminocaproic acid in oral dose form (medicinal product form)	4180186
36680723	Product containing only aminocaproic acid in parenteral dose form (medicinal product form)	4180186
36680724	Product containing only aminoglutethimide in oral dose form (medicinal product form)	4180186
36680727	Product containing only aminophylline in rectal dose form (medicinal product form)	4180186
36680730	Product containing only amiodarone in parenteral dose form (medicinal product form)	4180186
36680731	Product containing only amisulpride in oral dose form (medicinal product form)	4180186
36680732	Product containing only amitriptyline and chlordiazepoxide in oral dose form (medicinal product form)	4180186
36680734	Product containing only amitriptyline in oral dose form (medicinal product form)	4180186
36680739	Product containing only amlodipine and valsartan in oral dose form (medicinal product form)	4180186
36680741	Product containing only amobarbital and secobarbital in oral dose form (medicinal product form)	4180186
36680743	Product containing only amobarbital in parenteral dose form (medicinal product form)	4180186
36680746	Product containing only amorolfine in cutaneous dose form (medicinal product form)	4180186
36680747	Product containing only amoxapine in oral dose form (medicinal product form)	4180186
36680750	Product containing only amoxicillin in oral dose form (medicinal product form)	4180186
36680753	Product containing only amphotericin B in oral dose form (medicinal product form)	4180186
36680754	Product containing only amphotericin B in oromucosal dose form (medicinal product form)	4180186
36680758	Product containing only ampicillin and flucloxacillin in oral dose form (medicinal product form)	4180186
36680758	Ampicillin and flucloxacillin only product in oral dose form	4180186
36680759	Product containing only ampicillin and flucloxacillin in parenteral dose form (medicinal product form)	4180186
36680759	Ampicillin and flucloxacillin only product in parenteral dose form	4180186
36680767	Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	4180186
36680768	Product containing only apalutamide in oral dose form (medicinal product form)	4180186
36680772	Product containing only apraclonidine in ocular dose form (medicinal product form)	4180186
36680773	Product containing only aprepitant in oral dose form (medicinal product form)	4180186
36680775	Product containing only argatroban in parenteral dose form (medicinal product form)	4180186
36680777	Product containing only aripiprazole in parenteral dose form (medicinal product form)	4180186
36680778	Product containing only armodafinil in oral dose form (medicinal product form)	4180186
36680779	Product containing only artemether and lumefantrine in oral dose form (medicinal product form)	4180186
36680780	Product containing only artemether in parenteral dose form (medicinal product form)	4180186
36680783	Product containing only artesunate in parenteral dose form (medicinal product form)	4180186
36680785	Product containing only ascorbic acid and cyanocobalamin and ferrous fumarate in oral dose form (medicinal product form)	4180186
36680786	Product containing only ascorbic acid and ferrous gluconate and folic acid in oral dose form (medicinal product form)	4180186
36680787	Product containing only ascorbic acid in cutaneous dose form (medicinal product form)	4180186
36680790	Product containing only ascorbic acid in parenteral dose form (medicinal product form)	4180186
36680792	Product containing only asparaginase in parenteral dose form (medicinal product form)	4180186
36680794	Product containing only aspirin and butalbital and caffeine in oral dose form (medicinal product form)	4180186
36680795	Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form)	4180186
36680795	Aspirin and caffeine and dextropropoxyphene only product in oral dose form	4180186
36680796	Product containing only aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form)	4180186
36680797	Product containing only aspirin and caffeine and orphenadrine in oral dose form (medicinal product form)	4180186
36680799	Product containing only aspirin and carisoprodol and codeine in oral dose form (medicinal product form)	4180186
36680800	Product containing only aspirin and carisoprodol in oral dose form (medicinal product form)	4180186
36680801	Product containing only aspirin and codeine in oral dose form (medicinal product form)	4180186
36680803	Product containing only aspirin and hydrocodone in oral dose form (medicinal product form)	4180186
36680807	Product containing only aspirin and omeprazole in oral dose form (medicinal product form)	4180186
36680808	Product containing only aspirin and oxycodone in oral dose form (medicinal product form)	4180186
36680809	Product containing only aspirin and pravastatin in oral dose form (medicinal product form)	4180186
36680810	Product containing only aspirin in oral dose form (medicinal product form)	4180186
36680819	Product containing only atenolol in parenteral dose form (medicinal product form)	4180186
36680822	Product containing only atosiban in parenteral dose form (medicinal product form)	4180186
36680825	Product containing only atracurium in parenteral dose form (medicinal product form)	4180186
36680826	Product containing only atropine and difenoxin in oral dose form (medicinal product form)	4180186
36680828	Atropine and hyoscine and hyoscyamine only product in oral dose form	4180186
36680828	Product containing only atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form)	4180186
36680829	Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form)	4180186
36680832	Product containing only atropine in parenteral dose form (medicinal product form)	4180186
36680833	Product containing only auranofin in oral dose form (medicinal product form)	4180186
36680834	Product containing only aurothioglucose in parenteral dose form (medicinal product form)	4180186
36680835	Product containing only avanafil in oral dose form (medicinal product form)	4180186
36680836	Product containing only avatrombopag in oral dose form (medicinal product form)	4180186
36680837	Product containing only avelumab in parenteral dose form (medicinal product form)	4180186
36680838	Product containing only axicabtagene ciloleucel in parenteral dose form (medicinal product form)	4180186
36680843	Product containing only azathioprine in parenteral dose form (medicinal product form)	4180186
36680844	Product containing only azelaic acid in cutaneous dose form (medicinal product form)	4180186
36680845	Product containing only azelastine in nasal dose form (medicinal product form)	4180186
36680846	Product containing only azelastine in ocular dose form (medicinal product form)	4180186
36680847	Product containing only azilsartan in oral dose form (medicinal product form)	4180186
36680850	Product containing only azithromycin in parenteral dose form (medicinal product form)	4180186
36680856	Product containing only bacitracin in parenteral dose form (medicinal product form)	4180186
36680858	Product containing only baclofen in oral dose form (medicinal product form)	4180186
36680860	Product containing only balsalazide in oral dose form (medicinal product form)	4180186
36680862	Product containing only baricitinib in oral dose form (medicinal product form)	4180186
36680867	Beclometasone only product in nasal dose form	4180186
36680867	Product containing only beclometasone in nasal dose form (medicinal product form)	4180186
36680869	Beclometasone only product in pulmonary dose form	4180186
36680869	Product containing only beclometasone in pulmonary dose form (medicinal product form)	4180186
36680870	Product containing only bedaquiline in oral dose form (medicinal product form)	4180186
36680871	Product containing only belatacept in parenteral dose form (medicinal product form)	4180186
36680873	Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form)	4180186
36680874	Belladonna alkaloid and secbutabarbital only product in oral dose form	4180186
36680874	Product containing only belladonna alkaloid and secbutabarbital in oral dose form (medicinal product form)	4180186
36680881	Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)	4180186
36680887	Product containing only benperidol in oral dose form (medicinal product form)	4180186
36680889	Product containing only benzalkonium and cetrimide in cutaneous dose form (medicinal product form)	4180186
36680891	Product containing only benzalkonium and tolnaftate in cutaneous dose form (medicinal product form)	4180186
36680894	Product containing only benzalkonium in oromucosal dose form (medicinal product form)	4180186
36680895	Benzatropine only product in oral dose form	4180186
36680895	Product containing only benzatropine in oral dose form (medicinal product form)	4180186
36680899	Product containing only benznidazole in oral dose form (medicinal product form)	4180186
36680904	Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form)	4180186
36680906	Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form)	4180186
36680913	Product containing only benzoic acid and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36680914	Product containing only benzoin and menthol in pulmonary dose form (medicinal product form)	4180186
36680920	Product containing only benzydamine in cutaneous dose form (medicinal product form)	4180186
36680923	Benzylpenicillin only product in parenteral dose form	4180186
36680923	Product containing only benzylpenicillin in parenteral dose form (medicinal product form)	4180186
36680924	Product containing only benzylpenicilloyl polylysine in parenteral dose form (medicinal product form)	4180186
36680927	Product containing only besifloxacin in ocular dose form (medicinal product form)	4180186
36680933	Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	4180186
36680936	Product containing only betamethasone in ocular dose form (medicinal product form)	4180186
36680937	Product containing only betamethasone in oral dose form (medicinal product form)	4180186
36680942	Product containing only bethanechol in oral dose form (medicinal product form)	4180186
36680945	Product containing only bexarotene in cutaneous dose form (medicinal product form)	4180186
36680946	Product containing only bexarotene in oral dose form (medicinal product form)	4180186
36680950	Product containing only bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	4180186
36680952	Product containing only bimatoprost in ocular dose form (medicinal product form)	4180186
36680954	Product containing only biperiden in oral dose form (medicinal product form)	4180186
36680956	Product containing only biphasic isophane insulin human in parenteral dose form (medicinal product form)	4180186
36680958	Product containing only bisacodyl in oral dose form (medicinal product form)	4180186
36680959	Product containing only bisacodyl in rectal dose form (medicinal product form)	4180186
36680960	Product containing only bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form)	4180186
36680962	Product containing only bisoprolol in oral dose form (medicinal product form)	4180186
36680963	Product containing only bleomycin in parenteral dose form (medicinal product form)	4180186
36680964	Product containing only blinatumomab (medicinal product)	4180186
36680965	Product containing only blinatumomab in parenteral dose form (medicinal product form)	4180186
36680967	Product containing only boceprevir in oral dose form (medicinal product form)	4180186
36680968	Product containing only boric acid in cutaneous dose form (medicinal product form)	4180186
36680969	Product containing only boric acid in ocular dose form (medicinal product form)	4180186
36680970	Product containing only boric acid in otic dose form (medicinal product form)	4180186
36680971	Product containing only bosentan in oral dose form (medicinal product form)	4180186
36680974	Product containing only bovine insulin protamine zinc in parenteral dose form (medicinal product form)	4180186
36680975	Product containing only bovine regular insulin in parenteral dose form (medicinal product form)	4180186
36680975	Bovine insulin soluble only product in parenteral dose form	4180186
36680976	Product containing only bovine thrombin in cutaneous dose form (medicinal product form)	4180186
36680979	Product containing only brigatinib in oral dose form (medicinal product form)	4180186
36680980	Product containing only brimonidine in ocular dose form (medicinal product form)	4180186
36680986	Product containing only brompheniramine and pseudoephedrine in oral dose form (medicinal product form)	4180186
36680988	Product containing only buclizine in oral dose form (medicinal product form)	4180186
36680989	Product containing only budesonide and formoterol in pulmonary dose form (medicinal product form)	4180186
36680990	Product containing only budesonide in cutaneous dose form (medicinal product form)	4180186
36680992	Product containing only budesonide in oral dose form (medicinal product form)	4180186
36680995	Product containing only bumetanide and potassium chloride in oral dose form (medicinal product form)	4180186
36680996	Product containing only bumetanide in oral dose form (medicinal product form)	4180186
36681002	Product containing only buprenorphine in parenteral dose form (medicinal product form)	4180186
36681003	Product containing only buprenorphine in transdermal dose form (medicinal product form)	4180186
36681004	Product containing only bupropion and naltrexone in oral dose form (medicinal product form)	4180186
36681005	Product containing only bupropion in oral dose form (medicinal product form)	4180186
36681008	Product containing only buserelin in parenteral dose form (medicinal product form)	4180186
36681009	Product containing only buspirone in oral dose form (medicinal product form)	4180186
36681011	Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form)	4180186
36681011	Butalbital and caffeine and codeine and paracetamol only product in oral dose form	4180186
36681013	Butalbital and paracetamol only product in oral dose form	4180186
36681013	Product containing only butalbital and paracetamol in oral dose form (medicinal product form)	4180186
36681014	Product containing only butenafine in cutaneous dose form (medicinal product form)	4180186
36681015	Product containing only butobarbital in oral dose form (medicinal product form)	4180186
36681017	Product containing only butorphanol in parenteral dose form (medicinal product form)	4180186
36681021	Product containing only caffeine and dihydrocodeine and paracetamol in oral dose form (medicinal product form)	4180186
36681021	Caffeine and dihydrocodeine and paracetamol only product in oral dose form	4180186
36681022	Product containing only caffeine and ergotamine in oral dose form (medicinal product form)	4180186
36681024	Product containing only caffeine and paracetamol in oral dose form (medicinal product form)	4180186
36681024	Caffeine and paracetamol only product in oral dose form	4180186
36681026	Product containing only caffeine in oral dose form (medicinal product form)	4180186
36681027	Product containing only caffeine in parenteral dose form (medicinal product form)	4180186
36681028	Product containing only caffeine in rectal dose form (medicinal product form)	4180186
36681031	Product containing only calamine in cutaneous dose form (medicinal product form)	4180186
36681033	Product containing only calcipotriol in cutaneous dose form (medicinal product form)	4180186
36681041	Product containing only calcium carbonate and colecalciferol in oral dose form (medicinal product form)	4180186
36681041	Calcium carbonate and colecalciferol only product in oral dose form	4180186
36681043	Product containing only calcium carbonate in oral dose form (medicinal product form)	4180186
36681044	Product containing only calcium chloride in parenteral dose form (medicinal product form)	4180186
36681047	Product containing only calcium gluconate in oral dose form (medicinal product form)	4180186
36681050	Product containing only calcium in parenteral dose form (medicinal product form)	4180186
36681051	Product containing only calcium lactate in oral dose form (medicinal product form)	4180186
36681052	Product containing only calcium leucovorin in oral dose form (medicinal product form)	4180186
36681056	Product containing only canagliflozin in oral dose form (medicinal product form)	4180186
36681057	Product containing only candesartan and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
36681058	Product containing only candesartan in oral dose form (medicinal product form)	4180186
36681060	Product containing only cannabidiol in oral dose form (medicinal product form)	4180186
36681061	Product containing only capecitabine in oral dose form (medicinal product form)	4180186
36681062	Product containing only capreomycin in parenteral dose form (medicinal product form)	4180186
36681063	Product containing only capsaicin in cutaneous dose form (medicinal product form)	4180186
36681066	Product containing only captopril in oral dose form (medicinal product form)	4180186
36681067	Product containing only carbachol in ocular dose form (medicinal product form)	4180186
36681068	Product containing only carbamazepine in oral dose form (medicinal product form)	4180186
36681069	Product containing only carbamazepine in rectal dose form (medicinal product form)	4180186
36681070	Product containing only carbamide peroxide in oromucosal dose form (medicinal product form)	4180186
36681070	Urea hydrogen peroxide only product in oromucosal dose form	4180186
36681071	Product containing only carbamide peroxide in otic dose form (medicinal product form)	4180186
36681071	Urea hydrogen peroxide only product in otic dose form	4180186
36681072	Product containing only carbaryl in cutaneous dose form (medicinal product form)	4180186
36681073	Product containing only carbenicillin in oral dose form (medicinal product form)	4180186
36681074	Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	4180186
36681075	Product containing only carbidopa and levodopa in enteral dose form (medicinal product form)	4180186
36681076	Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	4180186
36681077	Product containing only carbidopa in oral dose form (medicinal product form)	4180186
36681078	Product containing only carbimazole in oral dose form (medicinal product form)	4180186
36681080	Product containing only carbinoxamine in oral dose form (medicinal product form)	4180186
36681082	Product containing only carbomer-980 in ocular dose form (medicinal product form)	4180186
36681083	Product containing only carboplatin in parenteral dose form (medicinal product form)	4180186
36681084	Product containing only carboprost in parenteral dose form (medicinal product form)	4180186
36681085	Product containing only carfilzomib in parenteral dose form (medicinal product form)	4180186
36681086	Product containing only cariprazine in oral dose form (medicinal product form)	4180186
36681089	Product containing only carteolol in ocular dose form (medicinal product form)	4180186
36681092	Product containing only casanthranol in oral dose form (medicinal product form)	4180186
36681093	Product containing only cascara in oral dose form (medicinal product form)	4180186
36681094	Product containing only castor oil (medicinal product)	4180186
36681097	Product containing only cefadroxil in oral dose form (medicinal product form)	4180186
36681098	Product containing only cefalexin in oral dose form (medicinal product form)	4180186
36681098	Cefalexin only product in oral dose form	4180186
36681099	Product containing only cefamandole in parenteral dose form (medicinal product form)	4180186
36681101	Product containing only cefazolin in parenteral dose form (medicinal product form)	4180186
36681102	Product containing only cefdinir in oral dose form (medicinal product form)	4180186
36681104	Product containing only cefepime in parenteral dose form (medicinal product form)	4180186
36681106	Product containing only cefmetazole in parenteral dose form (medicinal product form)	4180186
36681107	Product containing only cefoperazone in parenteral dose form (medicinal product form)	4180186
36681111	Product containing only cefpirome in parenteral dose form (medicinal product form)	4180186
36681118	Product containing only ceftibuten in oral dose form (medicinal product form)	4180186
36681119	Product containing only ceftiofur in parenteral dose form (medicinal product form)	4180186
36681124	Product containing only cefuroxime in oral dose form (medicinal product form)	4180186
36681125	Product containing only cefuroxime in parenteral dose form (medicinal product form)	4180186
36681127	Product containing only celiprolol in oral dose form (medicinal product form)	4180186
36681128	Product containing only cellulose in oral dose form (medicinal product form)	4180186
36681129	Product containing only cenegermin in ocular dose form (medicinal product form)	4180186
36681133	Product containing only certoparin in parenteral dose form (medicinal product form)	4180186
36681134	Product containing only cetirizine in oral dose form (medicinal product form)	4180186
36681136	Product containing only cetrimide and dimeticone 1000 in cutaneous dose form (medicinal product form)	4180186
36681137	Product containing only cetrimide in cutaneous dose form (medicinal product form)	4180186
36681139	Product containing only cetylpyridinium and lidocaine in dental dose form (medicinal product form)	4180186
36681141	Product containing only cetylpyridinium in oromucosal dose form (medicinal product form)	4180186
36681142	Product containing only cevimeline in oral dose form (medicinal product form)	4180186
36681143	Product containing only chenodeoxycholic acid in oral dose form (medicinal product form)	4180186
36681145	Product containing only chloral hydrate in rectal dose form (medicinal product form)	4180186
36681147	Product containing only chloramphenicol in cutaneous dose form (medicinal product form)	4180186
36681148	Product containing only chloramphenicol in ocular dose form (medicinal product form)	4180186
36681150	Product containing only chloramphenicol in otic dose form (medicinal product form)	4180186
36681153	Product containing only chlordiazepoxide in oral dose form (medicinal product form)	4180186
36681154	Product containing only chlordiazepoxide in parenteral dose form (medicinal product form)	4180186
36681155	Product containing only chlorhexidine and chlorobutanol in oromucosal dose form (medicinal product form)	4180186
36681156	Product containing only chlorhexidine and neomycin in cutaneous dose form (medicinal product form)	4180186
36681157	Product containing only chlorhexidine and nystatin in cutaneous dose form (medicinal product form)	4180186
36681159	Product containing only chlorhexidine in cutaneous dose form (medicinal product form)	4180186
36681162	Product containing only chloroquine in oral dose form (medicinal product form)	4180186
36681164	Product containing only cod liver oil in oral dose form (medicinal product form)	4180186
36681166	Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form)	4180186
36681169	Product containing only chloroxylenol in cutaneous dose form (medicinal product form)	4180186
36681173	Chlorphenamine and pseudoephedrine only product in oral dose form	4180186
36681173	Product containing only chlorphenamine and pseudoephedrine in oral dose form (medicinal product form)	4180186
36681174	Product containing only chlorphenamine in oral dose form (medicinal product form)	4180186
36681174	Chlorphenamine only product in oral dose form	4180186
36681175	Product containing only chlorphenamine in parenteral dose form (medicinal product form)	4180186
36681175	Chlorphenamine only product in parenteral dose form	4180186
36681176	Product containing only chlorpromazine in oral dose form (medicinal product form)	4180186
36681177	Product containing only chlorpromazine in parenteral dose form (medicinal product form)	4180186
36681178	Product containing only chlorpromazine in rectal dose form (medicinal product form)	4180186
36681180	Chlortalidone and clonidine only product in oral dose form	4180186
36681180	Product containing only chlortalidone and clonidine in oral dose form (medicinal product form)	4180186
36681183	Product containing only chlortetracycline in cutaneous dose form (medicinal product form)	4180186
36681184	Product containing only chlortetracycline in ocular dose form (medicinal product form)	4180186
36681187	Product containing only choline magnesium trisalicylate in oral dose form (medicinal product form)	4180186
36681191	Product containing only ciclesonide in nasal dose form (medicinal product form)	4180186
36681192	Product containing only ciclesonide in pulmonary dose form (medicinal product form)	4180186
36681195	Ciclosporin only product in oral dose form	4180186
36681195	Product containing only ciclosporin in oral dose form (medicinal product form)	4180186
36681196	Product containing only ciclosporin in parenteral dose form (medicinal product form)	4180186
36681196	Ciclosporin only product in parenteral dose form	4180186
36681197	Product containing only cidofovir in parenteral dose form (medicinal product form)	4180186
36681198	Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form)	4180186
36681205	Product containing only cinchocaine in rectal dose form (medicinal product form)	4180186
36681205	Cinchocaine only product in rectal dose form	4180186
36681206	Product containing only cinnarizine in oral dose form (medicinal product form)	4180186
36681208	Product containing only ciprofibrate in oral dose form (medicinal product form)	4180186
36681212	Product containing only ciprofloxacin in otic dose form (medicinal product form)	4180186
36681213	Product containing only ciprofloxacin in parenteral dose form (medicinal product form)	4180186
36681214	Product containing only cisapride in oral dose form (medicinal product form)	4180186
36681220	Product containing only clarithromycin in parenteral dose form (medicinal product form)	4180186
36681226	Product containing only clindamycin in cutaneous dose form (medicinal product form)	4180186
36681227	Product containing only clindamycin in oral dose form (medicinal product form)	4180186
36681228	Product containing only clindamycin in parenteral dose form (medicinal product form)	4180186
36681229	Product containing only clindamycin in vaginal dose form (medicinal product form)	4180186
36681230	Product containing only clioquinol and flumetasone in otic dose form (medicinal product form)	4180186
36681230	Clioquinol and flumetasone only product in otic dose form	4180186
36681235	Product containing only clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form)	4180186
36681236	Product containing only clobetasol in cutaneous dose form (medicinal product form)	4180186
36681237	Product containing only clobetasone in cutaneous dose form (medicinal product form)	4180186
36681242	Product containing only clomethiazole in oral dose form (medicinal product form)	4180186
36681242	Clomethiazole only product in oral dose form	4180186
36681250	Product containing only clonidine in transdermal dose form (medicinal product form)	4180186
36681251	Product containing only clopamide and pindolol in oral dose form (medicinal product form)	4180186
36681253	Product containing only clorazepate in oral dose form (medicinal product form)	4180186
36681256	Product containing only clotrimazole in cutaneous dose form (medicinal product form)	4180186
36681257	Product containing only clotrimazole in ocular dose form (medicinal product form)	4180186
36681259	Product containing only clotrimazole in vaginal dose form (medicinal product form)	4180186
36681262	Product containing only clozapine in oral dose form (medicinal product form)	4180186
36681263	Product containing only coagulation factor XIII in parenteral dose form (medicinal product form)	4180186
36681274	Product containing only cocaine in nasal dose form (medicinal product form)	4180186
36681275	Product containing only cocaine in ocular dose form (medicinal product form)	4180186
36681276	Product containing only cocaine in oral dose form (medicinal product form)	4180186
36681277	Product containing only cocaine in oromucosal dose form (medicinal product form)	4180186
36681278	Product containing only cod liver oil and zinc in cutaneous dose form (medicinal product form)	4180186
36681281	Product containing only codeine and ibuprofen in oral dose form (medicinal product form)	4180186
36681282	Codeine and paracetamol only product in oral dose form	4180186
36681282	Product containing only codeine and paracetamol in oral dose form (medicinal product form)	4180186
36681283	Product containing only codeine in oral dose form (medicinal product form)	4180186
36681287	Colecalciferol only product in oral dose form	4180186
36681287	Product containing only colecalciferol in oral dose form (medicinal product form)	4180186
36681292	Product containing only colistimethate in pulmonary dose form (medicinal product form)	4180186
36681294	Product containing only colistin in oral dose form (medicinal product form)	4180186
36681296	Product containing only colistin in parenteral dose form (medicinal product form)	4180186
36681299	Product containing only conjugated estrogen and norgestrel in oral dose form (medicinal product form)	4180186
36681300	Product containing only conjugated estrogen in oral dose form (medicinal product form)	4180186
36681304	Product containing only corifollitropin alfa in parenteral dose form (medicinal product form)	4180186
36681305	Product containing only cortisone in oral dose form (medicinal product form)	4180186
36681306	Product containing only cortisone in parenteral dose form (medicinal product form)	4180186
36681307	Product containing only crisaborole in cutaneous dose form (medicinal product form)	4180186
36681308	Product containing only crizotinib in oral dose form (medicinal product form)	4180186
36681312	Product containing only cromoglicic acid in ocular dose form (medicinal product form)	4180186
36681312	Cromoglicic acid only product in ocular dose form	4180186
36681315	Product containing only crotamiton and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36681316	Product containing only crotamiton in cutaneous dose form (medicinal product form)	4180186
36681317	Product containing only cyanocobalamin in nasal dose form (medicinal product form)	4180186
36681318	Product containing only cyanocobalamin in oral dose form (medicinal product form)	4180186
36681320	Product containing only cyclizine and dipipanone in oral dose form (medicinal product form)	4180186
36681324	Product containing only cyclopenthiazide and oxprenolol in oral dose form (medicinal product form)	4180186
36681329	Product containing only cycloserine in oral dose form (medicinal product form)	4180186
36681332	Product containing only cyproterone in oral dose form (medicinal product form)	4180186
36681336	Product containing only dactinomycin in parenteral dose form (medicinal product form)	4180186
36681339	Product containing only danaparoid in parenteral dose form (medicinal product form)	4180186
36681342	Product containing only dantrolene in parenteral dose form (medicinal product form)	4180186
36681344	Dantron and poloxamer 188 only product in oral dose form	4180186
36681344	Product containing only dantron and poloxamer 188 in oral dose form (medicinal product form)	4180186
36681345	Product containing only dantron in oral dose form (medicinal product form)	4180186
36681345	Dantron only product in oral dose form	4180186
36681347	Product containing only dapiprazole in ocular dose form (medicinal product form)	4180186
36681348	Product containing only dapsone and pyrimethamine in oral dose form (medicinal product form)	4180186
36681352	Product containing only darifenacin in oral dose form (medicinal product form)	4180186
36681353	Product containing only darunavir in oral dose form (medicinal product form)	4180186
36681354	Product containing only dasabuvir and ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)	4180186
36681357	Product containing only debrisoquine in oral dose form (medicinal product form)	4180186
36681360	Product containing only deferiprone in oral dose form (medicinal product form)	4180186
36681361	Product containing only deferoxamine in parenteral dose form (medicinal product form)	4180186
36681363	Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form)	4180186
36681363	Dehydrocholic acid and pancreatin and simeticone only product in oral dose form	4180186
36681365	Product containing only delafloxacin in parenteral dose form (medicinal product form)	4180186
36681366	Product containing only delamanid in oral dose form (medicinal product form)	4180186
36681368	Product containing only demeclocycline in oral dose form (medicinal product form)	4180186
36681369	Product containing only dequalinium in oromucosal dose form (medicinal product form)	4180186
36681372	Product containing only desipramine in oral dose form (medicinal product form)	4180186
36681376	Product containing only desmopressin in nasal dose form (medicinal product form)	4180186
36681377	Product containing only desmopressin in oral dose form (medicinal product form)	4180186
36681379	Desogestrel and ethinylestradiol only product in oral dose form	4180186
36681379	Product containing only desogestrel and ethinylestradiol in oral dose form (medicinal product form)	4180186
36681381	Product containing only desonide in cutaneous dose form (medicinal product form)	4180186
36681382	Product containing only desonide in otic dose form (medicinal product form)	4180186
36681383	Product containing only desoximetasone in cutaneous dose form (medicinal product form)	4180186
36681388	Product containing only dexamethasone in cutaneous dose form (medicinal product form)	4180186
36681389	Product containing only dexamethasone in nasal dose form (medicinal product form)	4180186
36681392	Product containing only dexamethasone in otic dose form (medicinal product form)	4180186
36681393	Product containing only dexamethasone in parenteral dose form (medicinal product form)	4180186
36681395	Dexamfetamine only product in oral dose form	4180186
36681395	Product containing only dexamfetamine in oral dose form (medicinal product form)	4180186
36681396	Product containing only dexbrompheniramine and pseudoephedrine in oral dose form (medicinal product form)	4180186
36681397	Product containing only dexchlorpheniramine in oral dose form (medicinal product form)	4180186
36681401	Product containing only dextran 70 in parenteral dose form (medicinal product form)	4180186
36681402	Product containing only dextran in ocular dose form (medicinal product form)	4180186
36681407	Product containing only diamorphine in oral dose form (medicinal product form)	4180186
36681408	Product containing only diamorphine in parenteral dose form (medicinal product form)	4180186
36681409	Product containing only diazepam in oral dose form (medicinal product form)	4180186
36681410	Product containing only diazepam in parenteral dose form (medicinal product form)	4180186
36681412	Product containing only diazoxide in oral dose form (medicinal product form)	4180186
36681413	Product containing only diazoxide in parenteral dose form (medicinal product form)	4180186
36681418	Product containing only diclofenac and misoprostol in oral dose form (medicinal product form)	4180186
36681420	Product containing only diclofenac in ocular dose form (medicinal product form)	4180186
36681421	Product containing only diclofenac in oral dose form (medicinal product form)	4180186
36681423	Product containing only diclofenac in rectal dose form (medicinal product form)	4180186
36681424	Diclofenamide only product in oral dose form	4180186
36681424	Product containing only diclofenamide in oral dose form (medicinal product form)	4180186
36681425	Product containing only dicloxacillin in oral dose form (medicinal product form)	4180186
36681427	Product containing only dicycloverine in oral dose form (medicinal product form)	4180186
36681427	Dicycloverine only product in oral dose form	4180186
36681430	Product containing only dienogest in oral dose form (medicinal product form)	4180186
36681431	Product containing only diethylcarbamazine in oral dose form (medicinal product form)	4180186
36681434	Product containing only diflucortolone in cutaneous dose form (medicinal product form)	4180186
36681435	Product containing only diflunisal in oral dose form (medicinal product form)	4180186
36681437	Product containing only digoxin in oral dose form (medicinal product form)	4180186
36681438	Product containing only digoxin in parenteral dose form (medicinal product form)	4180186
36681439	Dihydrocodeine and paracetamol only product in oral dose form	4180186
36681439	Product containing only dihydrocodeine and paracetamol in oral dose form (medicinal product form)	4180186
36681440	Product containing only dihydrocodeine in oral dose form (medicinal product form)	4180186
36681441	Product containing only dihydrocodeine in parenteral dose form (medicinal product form)	4180186
36681442	Product containing only dihydroergotamine in nasal dose form (medicinal product form)	4180186
36681443	Product containing only dihydroergotamine in oral dose form (medicinal product form)	4180186
36681445	Diiodohydroxyquinoline only product in oral dose form	4180186
36681445	Product containing only diiodohydroxyquinoline in oral dose form (medicinal product form)	4180186
36681447	Product containing only diloxanide in oral dose form (medicinal product form)	4180186
36681448	Product containing only diltiazem and enalapril in oral dose form (medicinal product form)	4180186
36681451	Product containing only dimenhydrinate in oral dose form (medicinal product form)	4180186
36681452	Product containing only dimercaprol in parenteral dose form (medicinal product form)	4180186
36681453	Product containing only dimethyl fumarate in oral dose form (medicinal product form)	4180186
36681454	Dimeticone only product in oral dose form	4180186
36681454	Product containing only dimeticone in oral dose form (medicinal product form)	4180186
36681456	Product containing only dinoprostone in parenteral dose form (medicinal product form)	4180186
36681457	Product containing only dinoprostone in vaginal dose form (medicinal product form)	4180186
36681458	Product containing only dinutuximab in parenteral dose form (medicinal product form)	4180186
36681459	Product containing only dioctahedral smectite in oral dose form (medicinal product form)	4180186
36681460	Product containing only diphenhydramine and ibuprofen in oral dose form (medicinal product form)	4180186
36681462	Product containing only diphenhydramine in cutaneous dose form (medicinal product form)	4180186
36681465	Product containing only difenidol in oral dose form (medicinal product form)	4180186
36681465	Difenidol only product in oral dose form	4180186
36681466	Diprophylline and guaifenesin only product in oral dose form	4180186
36681466	Product containing only diprophylline and guaifenesin in oral dose form (medicinal product form)	4180186
36681468	Product containing only diprophylline in parenteral dose form (medicinal product form)	4180186
36681468	Diprophylline only product in parenteral dose form	4180186
36681469	Product containing only dipyridamole in oral dose form (medicinal product form)	4180186
36681471	Product containing only dirithromycin in oral dose form (medicinal product form)	4180186
36681472	Product containing only distigmine in oral dose form (medicinal product form)	4180186
36681478	Product containing only docusate in oral dose form (medicinal product form)	4180186
36681481	Product containing only dofetilide in oral dose form (medicinal product form)	4180186
36681483	Product containing only dolasetron in parenteral dose form (medicinal product form)	4180186
36681484	Product containing only dolutegravir and rilpivirine in oral dose form (medicinal product form)	4180186
36681486	Product containing only domiphen and lidocaine in oromucosal dose form (medicinal product form)	4180186
36681487	Domperidone and paracetamol only product in oral dose form	4180186
36681487	Product containing only domperidone and paracetamol in oral dose form (medicinal product form)	4180186
36681491	Product containing only donepezil in oral dose form (medicinal product form)	4180186
36681493	Product containing only dopexamine in parenteral dose form (medicinal product form)	4180186
36681494	Product containing only doripenem in parenteral dose form (medicinal product form)	4180186
36681502	Product containing only doxercalciferol in parenteral dose form (medicinal product form)	4180186
36681503	Product containing only doxycycline in oral dose form (medicinal product form)	4180186
36681504	Product containing only doxycycline in oromucosal dose form (medicinal product form)	4180186
36681505	Product containing only doxycycline in parenteral dose form (medicinal product form)	4180186
36681508	Dried aluminium hydroxide gel and magnesium hydroxide only product in oral dose form	4180186
36681508	Product containing only dried aluminium hydroxide gel and magnesium hydroxide in oral dose form (medicinal product form)	4180186
36681509	Product containing only dronabinol in oral dose form (medicinal product form)	4180186
36681510	Product containing only dronedarone in oral dose form (medicinal product form)	4180186
36681511	Product containing only droperidol in oral dose form (medicinal product form)	4180186
36681512	Product containing only droperidol in parenteral dose form (medicinal product form)	4180186
36681513	Product containing only drospirenone and estradiol in oral dose form (medicinal product form)	4180186
36681514	Drospirenone and ethinylestradiol only product in oral dose form	4180186
36681514	Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form)	4180186
36681515	Product containing only drotrecogin alfa in parenteral dose form (medicinal product form)	4180186
36681519	Product containing only dutasteride and tamsulosin in oral dose form (medicinal product form)	4180186
36681521	Product containing only dydrogesterone in oral dose form (medicinal product form)	4180186
36681523	Product containing only econazole in cutaneous dose form (medicinal product form)	4180186
36681524	Product containing only econazole in ocular dose form (medicinal product form)	4180186
36681528	Product containing only edetate in cutaneous dose form (medicinal product form)	4180186
36681529	Product containing only edetate in ocular dose form (medicinal product form)	4180186
36681530	Product containing only edetate in parenteral dose form (medicinal product form)	4180186
36681531	Product containing only edrophonium in parenteral dose form (medicinal product form)	4180186
36681532	Product containing only efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form)	4180186
36681534	Product containing only eflornithine in cutaneous dose form (medicinal product form)	4180186
36681535	Product containing only eflornithine in parenteral dose form (medicinal product form)	4180186
36681537	Product containing only eletriptan in oral dose form (medicinal product form)	4180186
36681538	Product containing only elosulfase alfa in parenteral dose form (medicinal product form)	4180186
36681539	Product containing only eltrombopag in oral dose form (medicinal product form)	4180186
36681541	Product containing only elvitegravir in oral dose form (medicinal product form)	4180186
36681542	Product containing only emedastine in ocular dose form (medicinal product form)	4180186
36681543	Product containing only emicizumab in parenteral dose form (medicinal product form)	4180186
36681545	Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form)	4180186
36681548	Product containing only enalapril in oral dose form (medicinal product form)	4180186
36681549	Product containing only enalaprilat in parenteral dose form (medicinal product form)	4180186
36681550	Product containing only enasidenib in oral dose form (medicinal product form)	4180186
36681552	Product containing only enflurane in pulmonary dose form (medicinal product form)	4180186
36681553	Product containing only enoxacin in oral dose form (medicinal product form)	4180186
36681554	Product containing only enoxaparin in parenteral dose form (medicinal product form)	4180186
36681555	Product containing only entacapone in oral dose form (medicinal product form)	4180186
36681556	Product containing only entecavir in oral dose form (medicinal product form)	4180186
36681558	Product containing only ephedrine and guaifenesin in oral dose form (medicinal product form)	4180186
36681559	Product containing only ephedrine and theophylline in oral dose form (medicinal product form)	4180186
36681560	Product containing only ephedrine in nasal dose form (medicinal product form)	4180186
36681562	Product containing only ephedrine in parenteral dose form (medicinal product form)	4180186
36681563	Product containing only ephedrine in rectal dose form (medicinal product form)	4180186
36681564	Product containing only epinastine in ocular dose form (medicinal product form)	4180186
36681567	Adrenaline and zinc sulfate only product	4180186
36681567	Product containing only epinephrine and zinc sulfate (medicinal product)	4180186
36681568	Product containing only epinephrine and zinc sulfate in ocular dose form (medicinal product form)	4180186
36681568	Adrenaline and zinc sulfate only product in ocular dose form	4180186
36681569	Adrenaline only product in cutaneous dose form	4180186
36681569	Product containing only epinephrine in cutaneous dose form (medicinal product form)	4180186
36681571	Product containing only epinephrine in nasal dose form (medicinal product form)	4180186
36681571	Adrenaline only product in nasal dose form	4180186
36681573	Product containing only epinephrine in oromucosal dose form (medicinal product form)	4180186
36681573	Adrenaline only product in oromucosal dose form	4180186
36681577	Product containing only eplerenone in oral dose form (medicinal product form)	4180186
36681578	Product containing only epoetin alfa in parenteral dose form (medicinal product form)	4180186
36681579	Product containing only epoetin beta in parenteral dose form (medicinal product form)	4180186
36681582	Product containing only eprosartan in oral dose form (medicinal product form)	4180186
36681586	Product containing only ergocalciferol in oral dose form (medicinal product form)	4180186
36681588	Product containing only ergometrine in oral dose form (medicinal product form)	4180186
36681588	Ergometrine only product in oral dose form	4180186
36681589	Ergometrine only product in parenteral dose form	4180186
36681589	Product containing only ergometrine in parenteral dose form (medicinal product form)	4180186
36681590	Product containing only ergotamine in oromucosal dose form (medicinal product form)	4180186
36681593	Product containing only ertugliflozin in oral dose form (medicinal product form)	4180186
36681594	Product containing only erythromycin and isotretinoin in cutaneous dose form (medicinal product form)	4180186
36681596	Product containing only erythromycin and zinc acetate in cutaneous dose form (medicinal product form)	4180186
36681597	Product containing only erythromycin and zinc in cutaneous dose form (medicinal product form)	4180186
36681600	Product containing only erythromycin in oral dose form (medicinal product form)	4180186
36681602	Product containing only escitalopram in oral dose form (medicinal product form)	4180186
36681606	Product containing only esomeprazole in oral dose form (medicinal product form)	4180186
36681608	Product containing only estazolam in oral dose form (medicinal product form)	4180186
36681609	Product containing only estradiol and levonorgestrel in transdermal dose form (medicinal product form)	4180186
36681610	Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form)	4180186
36681612	Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form)	4180186
36681612	Estradiol and norethisterone only product in transdermal dose form	4180186
36681613	Product containing only estradiol in cutaneous dose form (medicinal product form)	4180186
36681615	Product containing only estradiol in oral dose form (medicinal product form)	4180186
36681617	Product containing only estradiol in transdermal dose form (medicinal product form)	4180186
36681618	Product containing only estradiol in vaginal dose form (medicinal product form)	4180186
36681621	Product containing only estriol in vaginal dose form (medicinal product form)	4180186
36681622	Product containing only estrone in oral dose form (medicinal product form)	4180186
36681623	Product containing only eszopiclone in oral dose form (medicinal product form)	4180186
36681624	Product containing only etacrynic acid in oral dose form (medicinal product form)	4180186
36681624	Etacrynic acid only product in oral dose form	4180186
36681625	Product containing only etamsylate in oral dose form (medicinal product form)	4180186
36681627	Product containing only etelcalcetide in parenteral dose form (medicinal product form)	4180186
36681628	Product containing only eteplirsen in parenteral dose form (medicinal product form)	4180186
36681629	Product containing only ethacridine in cutaneous dose form (medicinal product form)	4180186
36681630	Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form)	4180186
36681630	Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form	4180186
36681631	Ethambutol and isoniazid and rifampicin only product in oral dose form	4180186
36681631	Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form)	4180186
36681632	Product containing only ethambutol and isoniazid in oral dose form (medicinal product form)	4180186
36681636	Ethinylestradiol and ferrous fumarate and norgestrel only product in oral dose form	4180186
36681636	Product containing only ethinylestradiol and ferrous fumarate and norgestrel in oral dose form (medicinal product form)	4180186
36681637	Ethinylestradiol and gestodene only product in oral dose form	4180186
36681637	Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)	4180186
36681639	Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form)	4180186
36681639	Ethinylestradiol and norelgestromin only product in transdermal dose form	4180186
36681640	Ethinylestradiol and norethisterone only product in oral dose form	4180186
36681640	Product containing only ethinylestradiol and norethisterone in oral dose form (medicinal product form)	4180186
36681646	Product containing only ethosuximide in oral dose form (medicinal product form)	4180186
36681647	Product containing only ethotoin in oral dose form (medicinal product form)	4180186
36681648	Product containing only ethanol in cutaneous dose form (medicinal product form)	4180186
36681649	Product containing only etidronic acid in oral dose form (medicinal product form)	4180186
36681651	Product containing only etonogestrel in parenteral dose form (medicinal product form)	4180186
36681652	Product containing only etoposide in oral dose form (medicinal product form)	4180186
36681654	Product containing only etoricoxib in oral dose form (medicinal product form)	4180186
36681655	Product containing only etravirine in oral dose form (medicinal product form)	4180186
36681656	Product containing only etynodiol in oral dose form (medicinal product form)	4180186
36681656	Etynodiol only product in oral dose form	4180186
36681658	Product containing only evolocumab in parenteral dose form (medicinal product form)	4180186
36681661	Product containing only ezetimibe and simvastatin in oral dose form (medicinal product form)	4180186
36681667	Product containing only felbamate in oral dose form (medicinal product form)	4180186
36681670	Product containing only felodipine in oral dose form (medicinal product form)	4180186
36681671	Product containing only felypressin and prilocaine in parenteral dose form (medicinal product form)	4180186
36681672	Product containing only fenbufen in oral dose form (medicinal product form)	4180186
36681673	Product containing only fenofibrate in oral dose form (medicinal product form)	4180186
36681674	Product containing only fenofibric acid in oral dose form (medicinal product form)	4180186
36681675	Product containing only fenoprofen in oral dose form (medicinal product form)	4180186
36681680	Product containing only ferric hexacyanoferrate-II in oral dose form (medicinal product form)	4180186
36681682	Product containing only ferrous fumarate and folic acid in oral dose form (medicinal product form)	4180186
36681683	Product containing only ferrous fumarate in oral dose form (medicinal product form)	4180186
36681684	Product containing only ferrous gluconate in oral dose form (medicinal product form)	4180186
36681685	Product containing only ferrous sulfate and folic acid in oral dose form (medicinal product form)	4180186
36681686	Product containing only ferrous sulfate in oral dose form (medicinal product form)	4180186
36681688	Product containing only fexofenadine in oral dose form (medicinal product form)	4180186
36681689	Plant fibre only product in oral dose form	4180186
36681689	Product containing only plant fiber in oral dose form (medicinal product form)	4180186
36681691	Product containing only filgrastim in parenteral dose form (medicinal product form)	4180186
36681692	Product containing only finasteride in oral dose form (medicinal product form)	4180186
36681693	Product containing only fingolimod in oral dose form (medicinal product form)	4180186
36681697	Product containing only flecainide in parenteral dose form (medicinal product form)	4180186
36681699	Product containing only floxuridine in parenteral dose form (medicinal product form)	4180186
36681700	Product containing only flucloxacillin in oral dose form (medicinal product form)	4180186
36681700	Flucloxacillin only product in oral dose form	4180186
36681701	Flucloxacillin only product in parenteral dose form	4180186
36681701	Product containing only flucloxacillin in parenteral dose form (medicinal product form)	4180186
36681703	Product containing only fluconazole in parenteral dose form (medicinal product form)	4180186
36681708	Product containing only fludrocortisone in oral dose form (medicinal product form)	4180186
36681710	Product containing only flumazenil in parenteral dose form (medicinal product form)	4180186
36681711	Product containing only flunisolide in nasal dose form (medicinal product form)	4180186
36681714	Product containing only fluocinolone and neomycin in cutaneous dose form (medicinal product form)	4180186
36681715	Product containing only fluocinolone in cutaneous dose form (medicinal product form)	4180186
36681716	Product containing only fluocinolone in ocular dose form (medicinal product form)	4180186
36681717	Product containing only fluocinonide in cutaneous dose form (medicinal product form)	4180186
36681720	Product containing only fluoride in oral dose form (medicinal product form)	4180186
36681721	Product containing only fluoride in oromucosal dose form (medicinal product form)	4180186
36681722	Product containing only fluorometholone in ocular dose form (medicinal product form)	4180186
36681723	Product containing only fluorouracil in cutaneous dose form (medicinal product form)	4180186
36681724	Product containing only fluorouracil in oral dose form (medicinal product form)	4180186
36681726	Product containing only fluoxetine and olanzapine in oral dose form (medicinal product form)	4180186
36681729	Product containing only flupentixol in oral dose form (medicinal product form)	4180186
36681730	Product containing only flupentixol in parenteral dose form (medicinal product form)	4180186
36681731	Product containing only fluphenazine and nortriptyline in oral dose form (medicinal product form)	4180186
36681734	Product containing only fluprednidene and miconazole in cutaneous dose form (medicinal product form)	4180186
36681736	Product containing only flurbiprofen in ocular dose form (medicinal product form)	4180186
36681737	Product containing only flurbiprofen in oral dose form (medicinal product form)	4180186
36681739	Product containing only flurbiprofen in rectal dose form (medicinal product form)	4180186
36681741	Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)	4180186
36681748	Product containing only fluvoxamine in oral dose form (medicinal product form)	4180186
36681749	Product containing only folic acid in oral dose form (medicinal product form)	4180186
36681750	Folinic acid only product in oral dose form	4180186
36681750	Product containing only folinic acid in oral dose form (medicinal product form)	4180186
36681752	Product containing only fomepizole in parenteral dose form (medicinal product form)	4180186
36681753	Product containing only fondaparinux in parenteral dose form (medicinal product form)	4180186
36681754	Product containing only formoterol in pulmonary dose form (medicinal product form)	4180186
36681755	Product containing only fosamprenavir in oral dose form (medicinal product form)	4180186
36681757	Product containing only foscarnet in parenteral dose form (medicinal product form)	4180186
36681763	Product containing only frovatriptan in oral dose form (medicinal product form)	4180186
36681764	Product containing only fructose in parenteral dose form (medicinal product form)	4180186
36681766	Product containing only furosemide and spironolactone in oral dose form (medicinal product form)	4180186
36681770	Product containing only fusidic acid and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36681774	Product containing only fusidic acid in parenteral dose form (medicinal product form)	4180186
36681777	Product containing only gadoterate meglumine in parenteral dose form (medicinal product form)	4180186
36681780	Product containing only gallamine in parenteral dose form (medicinal product form)	4180186
36681783	Product containing only ganciclovir in ocular dose form (medicinal product form)	4180186
36681785	Product containing only ganciclovir in parenteral dose form (medicinal product form)	4180186
36681787	Product containing only gatifloxacin in ocular dose form (medicinal product form)	4180186
36681788	Product containing only gatifloxacin in oral dose form (medicinal product form)	4180186
36681791	Product containing only gemcitabine in parenteral dose form (medicinal product form)	4180186
36681793	Product containing only gemfibrozil in oral dose form (medicinal product form)	4180186
36681794	Product containing only gemifloxacin in oral dose form (medicinal product form)	4180186
36681796	Product containing only gentamicin and hydrocortisone in otic dose form (medicinal product form)	4180186
36681797	Product containing only gentamicin in cutaneous dose form (medicinal product form)	4180186
36681798	Product containing only gentamicin in ocular dose form (medicinal product form)	4180186
36681800	Product containing only gentamicin in parenteral dose form (medicinal product form)	4180186
36681802	Product containing only glacial acetic acid in otic dose form (medicinal product form)	4180186
36681803	Product containing only glatiramer in parenteral dose form (medicinal product form)	4180186
36681806	Product containing only glibenclamide in oral dose form (medicinal product form)	4180186
36681806	Glibenclamide only product in oral dose form	4180186
36681808	Product containing only glimepiride and pioglitazone in oral dose form (medicinal product form)	4180186
36681809	Product containing only glimepiride and rosiglitazone in oral dose form (medicinal product form)	4180186
36681812	Product containing only glipizide in oral dose form (medicinal product form)	4180186
36681816	Product containing only glucosamine in oral dose form (medicinal product form)	4180186
36681818	Product containing only glucose and potassium chloride in parenteral dose form (medicinal product form)	4180186
36681823	Product containing only glutaraldehyde in cutaneous dose form (medicinal product form)	4180186
36681825	Glycerol only product in ocular dose form	4180186
36681825	Product containing only glycerol in ocular dose form (medicinal product form)	4180186
36681829	Product containing only glycerol in rectal dose form (medicinal product form)	4180186
36681829	Glycerol only product in rectal dose form	4180186
36681830	Glyceryl trinitrate only product in cutaneous dose form	4180186
36681830	Product containing only glyceryl trinitrate in cutaneous dose form (medicinal product form)	4180186
36681831	Glyceryl trinitrate only product in oral dose form	4180186
36681831	Product containing only glyceryl trinitrate in oral dose form (medicinal product form)	4180186
36681832	Glyceryl trinitrate only product in oromucosal dose form	4180186
36681832	Product containing only glyceryl trinitrate in oromucosal dose form (medicinal product form)	4180186
36681837	Product containing only glycopyrronium in cutaneous dose form (medicinal product form)	4180186
36681838	Product containing only glycopyrronium in oral dose form (medicinal product form)	4180186
36681840	Product containing only gonadorelin in parenteral dose form (medicinal product form)	4180186
36681841	Product containing only gramicidin in cutaneous dose form (medicinal product form)	4180186
36681842	Product containing only gramicidin in ocular dose form (medicinal product form)	4180186
36681844	Product containing only granisetron in parenteral dose form (medicinal product form)	4180186
36681845	Product containing only granisetron in transdermal dose form (medicinal product form)	4180186
36681849	Product containing only guaifenesin and theophylline in oral dose form (medicinal product form)	4180186
36681850	Product containing only guanabenz in oral dose form (medicinal product form)	4180186
36681861	Product containing only halcinonide in cutaneous dose form (medicinal product form)	4180186
36681862	Product containing only halibut liver oil in oral dose form (medicinal product form)	4180186
36681865	Product containing only haloperidol in parenteral dose form (medicinal product form)	4180186
36681867	Product containing only halothane in pulmonary dose form (medicinal product form)	4180186
36681874	Product containing only heparinoid in cutaneous dose form (medicinal product form)	4180186
36681875	Product containing only surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form)	4180186
36681878	Product containing only hexobarbital in oral dose form (medicinal product form)	4180186
36681880	Product containing only homatropine and hydrocodone in oral dose form (medicinal product form)	4180186
36681881	Product containing only homatropine in ocular dose form (medicinal product form)	4180186
36681882	Product containing only homatropine in oral dose form (medicinal product form)	4180186
36681883	Product containing only human insulin in pulmonary dose form (medicinal product form)	4180186
36681884	Human insulin soluble only product in parenteral dose form	4180186
36681884	Product containing only human regular insulin in parenteral dose form (medicinal product form)	4180186
36681887	Product containing only human insulin zinc suspension mixed in parenteral dose form (medicinal product form)	4180186
36681891	Product containing only hyaluronidase in parenteral dose form (medicinal product form)	4180186
36681892	Product containing only hydralazine and hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	4180186
36681893	Product containing only hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
36681897	Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)	4180186
36681899	Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)	4180186
36681900	Product containing only hydrochlorothiazide and losartan in oral dose form (medicinal product form)	4180186
36681901	Product containing only hydrochlorothiazide and methyldopa in oral dose form (medicinal product form)	4180186
36681903	Product containing only hydrochlorothiazide and moexipril in oral dose form (medicinal product form)	4180186
36681904	Product containing only hydrochlorothiazide and olmesartan in oral dose form (medicinal product form)	4180186
36681905	Product containing only hydrochlorothiazide and propranolol in oral dose form (medicinal product form)	4180186
36681907	Product containing only hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	4180186
36681908	Product containing only hydrochlorothiazide and spironolactone in oral dose form (medicinal product form)	4180186
36681910	Product containing only hydrochlorothiazide and timolol in oral dose form (medicinal product form)	4180186
36681912	Product containing only hydrochlorothiazide and valsartan in oral dose form (medicinal product form)	4180186
36681914	Product containing only hydrocodone and ibuprofen in oral dose form (medicinal product form)	4180186
36681915	Product containing only hydrocodone and paracetamol in oral dose form (medicinal product form)	4180186
36681915	Hydrocodone and paracetamol only product in oral dose form	4180186
36681916	Product containing only hydrocodone in oral dose form (medicinal product form)	4180186
36681917	Product containing only hydrocortisone and lidocaine in cutaneous dose form (medicinal product form)	4180186
36681919	Product containing only hydrocortisone and neomycin in cutaneous dose form (medicinal product form)	4180186
36681920	Product containing only hydrocortisone and oxytetracycline in cutaneous dose form (medicinal product form)	4180186
36681922	Product containing only hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36681924	Product containing only hydrocortisone in ocular dose form (medicinal product form)	4180186
36681925	Product containing only hydrocortisone in oral dose form (medicinal product form)	4180186
36681931	Product containing only hydroflumethiazide in oral dose form (medicinal product form)	4180186
36681934	Product containing only hydromorphone in oral dose form (medicinal product form)	4180186
36681936	Product containing only hydromorphone in rectal dose form (medicinal product form)	4180186
36681937	Product containing only hydroquinone in cutaneous dose form (medicinal product form)	4180186
36681938	Product containing only hydrotalcite in oral dose form (medicinal product form)	4180186
36681939	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)	4180186
36681941	Hydroxycarbamide only product in oral dose form	4180186
36681941	Product containing only hydroxycarbamide in oral dose form (medicinal product form)	4180186
36681943	Product containing only hydroxyprogesterone in parenteral dose form (medicinal product form)	4180186
36681949	Product containing only hypromellose in parenteral dose form (medicinal product form)	4180186
36681950	Product containing only ibalizumab in parenteral dose form (medicinal product form)	4180186
36681951	Product containing only ibandronic acid in oral dose form (medicinal product form)	4180186
36681953	Product containing only ibrutinib in oral dose form (medicinal product form)	4180186
36681954	Product containing only ibuprofen and levomenthol in cutaneous dose form (medicinal product form)	4180186
36681956	Product containing only ibuprofen and pseudoephedrine in oral dose form (medicinal product form)	4180186
36681958	Product containing only ibuprofen in oral dose form (medicinal product form)	4180186
36681959	Product containing only ibuprofen in parenteral dose form (medicinal product form)	4180186
36681961	Product containing only idarubicin in oral dose form (medicinal product form)	4180186
36681964	Product containing only idoxuridine in ocular dose form (medicinal product form)	4180186
36681965	Product containing only idursulfase in parenteral dose form (medicinal product form)	4180186
36681968	Product containing only iloprost in parenteral dose form (medicinal product form)	4180186
36681969	Product containing only iloprost in pulmonary dose form (medicinal product form)	4180186
36681970	Product containing only imatinib in oral dose form (medicinal product form)	4180186
36681971	Product containing only imidapril in oral dose form (medicinal product form)	4180186
36681972	Product containing only imiglucerase in parenteral dose form (medicinal product form)	4180186
36681973	Product containing only imipramine in oral dose form (medicinal product form)	4180186
36681974	Product containing only imipramine in parenteral dose form (medicinal product form)	4180186
36681976	Product containing only indapamide and perindopril in oral dose form (medicinal product form)	4180186
36681978	Product containing only indinavir in oral dose form (medicinal product form)	4180186
36681985	Product containing only inosine pranobex in oral dose form (medicinal product form)	4180186
36681991	Product containing only insulin degludec in parenteral dose form (medicinal product form)	4180186
36681993	Product containing only insulin glulisine in parenteral dose form (medicinal product form)	4180186
36681994	Product containing only interferon alfa-2a in parenteral dose form (medicinal product form)	4180186
36681995	Product containing only interferon alfa-2b in oral dose form (medicinal product form)	4180186
36681997	Product containing only interferon alfa-n3 in parenteral dose form (medicinal product form)	4180186
36681998	Product containing only interferon alfacon-1 in parenteral dose form (medicinal product form)	4180186
36682000	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)	4180186
36682002	Product containing only iobitridol in parenteral dose form (medicinal product form)	4180186
36682003	Product containing only iodine and potassium iodide in oral dose form (medicinal product form)	4180186
36682004	Product containing only iodine in oral dose form (medicinal product form)	4180186
36682005	Product containing only iodine in parenteral dose form (medicinal product form)	4180186
36682006	Product containing only iodine norcholestenol in parenteral dose form (medicinal product form)	4180186
36682008	Product containing only iodine-123 in parenteral dose form (medicinal product form)	4180186
36682011	Product containing only iopanoic acid in oral dose form (medicinal product form)	4180186
36682012	Product containing only iotrolan in parenteral dose form (medicinal product form)	4180186
36682013	Product containing only ipilimumab in parenteral dose form (medicinal product form)	4180186
36682014	Product containing only ipratropium in nasal dose form (medicinal product form)	4180186
36682015	Product containing only ipratropium in pulmonary dose form (medicinal product form)	4180186
36682017	Product containing only iron carbonyl in oral dose form (medicinal product form)	4180186
36682018	Product containing only iron dextran in parenteral dose form (medicinal product form)	4180186
36682019	Product containing only iron in oral dose form (medicinal product form)	4180186
36682024	Product containing only isocarboxazid in oral dose form (medicinal product form)	4180186
36682025	Product containing only isoflurane in pulmonary dose form (medicinal product form)	4180186
36682031	Product containing only isoniazid in parenteral dose form (medicinal product form)	4180186
36682032	Product containing only isophane insulin in parenteral dose form (medicinal product form)	4180186
36682034	Product containing only isoprenaline in oral dose form (medicinal product form)	4180186
36682034	Isoprenaline only product in oral dose form	4180186
36682037	Product containing only isosorbide in oral dose form (medicinal product form)	4180186
36682038	Product containing only isosorbide in oromucosal dose form (medicinal product form)	4180186
36682039	Product containing only isosorbide in parenteral dose form (medicinal product form)	4180186
36682040	Product containing only isosorbide in transdermal dose form (medicinal product form)	4180186
36682042	Product containing only isotretinoin in oral dose form (medicinal product form)	4180186
36682044	Product containing only ispaghula husk and mebeverine in oral dose form (medicinal product form)	4180186
36682045	Product containing only ispaghula husk in oral dose form (medicinal product form)	4180186
36682046	Product containing only isradipine in oral dose form (medicinal product form)	4180186
36682048	Product containing only itraconazole in parenteral dose form (medicinal product form)	4180186
36682049	Product containing only ivacaftor and lumacaftor in oral dose form (medicinal product form)	4180186
36682052	Product containing only ivermectin in oral dose form (medicinal product form)	4180186
36682053	Product containing only ivosidenib in oral dose form (medicinal product form)	4180186
36682054	Product containing only ixekizumab in parenteral dose form (medicinal product form)	4180186
36682055	Product containing only kanamycin in oral dose form (medicinal product form)	4180186
36682057	Product containing only ketamine in parenteral dose form (medicinal product form)	4180186
36682059	Product containing only ketoconazole in oral dose form (medicinal product form)	4180186
36682066	Product containing only ketorolac in ocular dose form (medicinal product form)	4180186
36682067	Product containing only ketorolac in oral dose form (medicinal product form)	4180186
36682070	Product containing only ketotifen in oral dose form (medicinal product form)	4180186
36682072	Product containing only labetalol in parenteral dose form (medicinal product form)	4180186
36682076	Product containing only lactic acid and urea in cutaneous dose form (medicinal product form)	4180186
36682077	Product containing only lactitol in oral dose form (medicinal product form)	4180186
36682081	Product containing only lamivudine and stavudine in oral dose form (medicinal product form)	4180186
36682082	Product containing only lamivudine and zidovudine in oral dose form (medicinal product form)	4180186
36682086	Product containing only lanreotide in parenteral dose form (medicinal product form)	4180186
36682087	Product containing only lansoprazole in oral dose form (medicinal product form)	4180186
36682089	Product containing only lanthanum in oral dose form (medicinal product form)	4180186
36682094	Product containing only lauromacrogol and urea in cutaneous dose form (medicinal product form)	4180186
36682095	Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)	4180186
36682096	Product containing only ledipasvir in oral dose form (medicinal product form)	4180186
36682098	Product containing only lenalidomide in oral dose form (medicinal product form)	4180186
36682099	Product containing only lenograstim in parenteral dose form (medicinal product form)	4180186
36682102	Product containing only lesinurad in oral dose form (medicinal product form)	4180186
36682103	Product containing only letermovir in oral dose form (medicinal product form)	4180186
36682105	Product containing only leuprorelin in parenteral dose form (medicinal product form)	4180186
36682105	Leuprolide only product in parenteral dose form	4180186
36682106	Product containing only levamisole in oral dose form (medicinal product form)	4180186
36682110	Product containing only levobunolol in ocular dose form (medicinal product form)	4180186
36682111	Product containing only levobupivacaine in parenteral dose form (medicinal product form)	4180186
36682112	Product containing only levocabastine in ocular dose form (medicinal product form)	4180186
36682114	Product containing only levocarnitine in parenteral dose form (medicinal product form)	4180186
36682117	Product containing only levofloxacin in ocular dose form (medicinal product form)	4180186
36682119	Product containing only levofloxacin in parenteral dose form (medicinal product form)	4180186
36682120	Product containing only levomepromazine in oral dose form (medicinal product form)	4180186
36682120	Levomepromazine only product in oral dose form	4180186
36682121	Levomepromazine only product in parenteral dose form	4180186
36682121	Product containing only levomepromazine in parenteral dose form (medicinal product form)	4180186
36682122	Product containing only levonorgestrel in cutaneous dose form (medicinal product form)	4180186
36682124	Product containing only levonorgestrel in oral dose form (medicinal product form)	4180186
36682125	Product containing only levonorgestrel in parenteral dose form (medicinal product form)	4180186
36682126	Product containing only levorphanol in oral dose form (medicinal product form)	4180186
36682130	Product containing only lidocaine and methylprednisolone in parenteral dose form (medicinal product form)	4180186
36682131	Product containing only lidocaine and phenylephrine in cutaneous dose form (medicinal product form)	4180186
36682133	Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form)	4180186
36682136	Product containing only lidocaine in nasal dose form (medicinal product form)	4180186
36682140	Product containing only lifitegrast in ocular dose form (medicinal product form)	4180186
36682141	Product containing only linagliptin and metformin in oral dose form (medicinal product form)	4180186
36682142	Product containing only linagliptin in oral dose form (medicinal product form)	4180186
36682144	Product containing only lincomycin in parenteral dose form (medicinal product form)	4180186
36682145	Product containing only linezolid in oral dose form (medicinal product form)	4180186
36682146	Product containing only linezolid in parenteral dose form (medicinal product form)	4180186
36682147	Product containing only liothyronine in oral dose form (medicinal product form)	4180186
36682148	Product containing only liothyronine in parenteral dose form (medicinal product form)	4180186
36682149	Product containing only lipoic acid in oral dose form (medicinal product form)	4180186
36682149	Thioctic acid only product in oral dose form	4180186
36682155	Product containing only lithium carbonate in oral dose form (medicinal product form)	4180186
36682156	Product containing only lithium citrate in oral dose form (medicinal product form)	4180186
36682157	Product containing only lithium in cutaneous dose form (medicinal product form)	4180186
36682160	Product containing only lodoxamide in ocular dose form (medicinal product form)	4180186
36682163	Product containing only lomefloxacin in ocular dose form (medicinal product form)	4180186
36682165	Product containing only lomustine in oral dose form (medicinal product form)	4180186
36682168	Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)	4180186
36682169	Product containing only lopinavir in oral dose form (medicinal product form)	4180186
36682170	Product containing only loprazolam in oral dose form (medicinal product form)	4180186
36682171	Product containing only loracarbef in oral dose form (medicinal product form)	4180186
36682172	Product containing only loratadine and pseudoephedrine in oral dose form (medicinal product form)	4180186
36682175	Product containing only lorazepam in parenteral dose form (medicinal product form)	4180186
36682176	Product containing only lormetazepam in oral dose form (medicinal product form)	4180186
36682177	Product containing only lornoxicam in oral dose form (medicinal product form)	4180186
36682179	Product containing only losartan in oral dose form (medicinal product form)	4180186
36682181	Lovastatin and nicotinic acid only product in oral dose form	4180186
36682181	Product containing only lovastatin and nicotinic acid in oral dose form (medicinal product form)	4180186
36682183	Product containing only loxapine in oral dose form (medicinal product form)	4180186
36682185	Product containing only lucinactant in pulmonary dose form (medicinal product form)	4180186
36682187	Product containing only lurasidone in oral dose form (medicinal product form)	4180186
36682189	Product containing only lymecycline in oral dose form (medicinal product form)	4180186
36682190	Product containing only macitentan in oral dose form (medicinal product form)	4180186
36682191	Product containing only magaldrate in oral dose form (medicinal product form)	4180186
36682194	Product containing only magnesium chloride in parenteral dose form (medicinal product form)	4180186
36682198	Product containing only magnesium sulfate in oral dose form (medicinal product form)	4180186
36682200	Product containing only malathion in cutaneous dose form (medicinal product form)	4180186
36682202	Product containing only maprotiline in oral dose form (medicinal product form)	4180186
36682203	Product containing only maraviroc in oral dose form (medicinal product form)	4180186
36682204	Product containing only mazindol in oral dose form (medicinal product form)	4180186
36682209	Product containing only meclocycline in cutaneous dose form (medicinal product form)	4180186
36682211	Product containing only meclozine in oral dose form (medicinal product form)	4180186
36682211	Meclozine only product in oral dose form	4180186
36682214	Product containing only medrysone in ocular dose form (medicinal product form)	4180186
36682216	Product containing only mefloquine in oral dose form (medicinal product form)	4180186
